73
Ελληνικό περιοδικό της Νοσηλευτικής Επιστήμης [Πιστοποίηση και αναγνώριση της συνεχιζόμενης νοσηλευτικής εκπαίδευσης] [Η αποτελεσματικότητα της διαχείρισης του πόνου στο Τμήμα Επειγόντων Περιστατικών και ο βαθμός ανταπόκρισής της στις ανάγκες των ασθενών] [Death Attitude Profile-Revised (DAP-R)-Ερωτηματολόγιο διερεύνησης στάσης απέναντι στο θάνατο. Στάθμιση της ελληνικής εκδοχής του ερωτηματολογίου] [Εμβολιαστική κάλυψη μαθητών ηλικίας 6-16 ετών σε περιοχή της ελληνικής επαρχίας] [Εκτίμηση των Αναγκών Εκπαίδευσης και Κατάρτισης των Ανθρώπινων Πόρων Υγείας στη Χώρα μας στο Πλαίσιο του Εθνικού Στρατηγικού Σχεδίου Ανάπτυξης 2007-2013] [Θεραπεία της χρόνιας νεφρικής ανεπάρκειας: μελέτη κόστους των μεθόδων αιμοκάθαρσης με φύσιγγα και διττανθρακικό διάλυμα και της αιμοδιαδιήθησης] [Συναισθηματική νοημοσύνη-θεωρία και εφαρμογές στη νοσηλευτική διοίκηση] [Ο ρόλος των επαγγελματιών υγείας και η βελτίωση της ποιότητας υπηρεσιών στα νοσοκομεία] [Η συζήτηση ως αποτελεσματικός τρόπος επικοινωνίας στην καθημερινή νοσηλευτική πράξη] [Ευφυή φορετά συστήματα υγείας για την εκτίμηση καρδιαγγειακών και αναπνευστικών προβλημάτων] Το Επιστημονικό Περιοδικό Ένωσης Νοσηλευτών Ελλάδος Τόμος 4, Τεύχος 1, Ιανουάριος-Φεβρουάριος-Μάρτιος 2011 της

Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

! " " # $ % & '( ) * % + , % & ' - # ./+0#")1-%&2.! ( % 0 - 2 µ # .

[!"#$%&%'(#( )*" *+*,+-."#( $(/ #0+12"34µ1+(/ +%#(510$")6/ 1)&*'710#(/]

[8 *&%$151#µ*$")4$($* $(/ 7"*21'."#(/ $%0 &4+%0 #$% 9µ6µ*:&1",4+$;+ !1."#$*$")-+ )*" % <*=µ4/ *+$*&4)."#6/ $(/ #$"/ *+>,)1/ $;+ *#=1+-+]

[Death Attitude Profile-Revised (DAP-R)-:.;$(µ*$%54,"% 7"1.1?+(#(/ #$>#(/ *&@+*+$" #$% =>+*$%. A$>=µ"#( $(/ 155(+")6/ 1)7%26/ $%0 1.;$(µ*$%5%,'%0]

[:µ<%5"*#$")6 )>50B( µ*=($-+ (5")'*/ 6-16 1$-+ #1 &1."%26 $(/ 155(+")6/ 1&*.2'*/]

[:)$'µ(#( $;+ C+*,)-+ :)&*'710#(/ )*" D*$>.$"#(/ $;+ C+=.-&"+;+ !4.;+ E,1'*/ #$( F-.* µ*/ #$% !5*'#"% $%0 :=+")%? A$.*$(,")%? A217'%0 C+>&$0G(/ 2007-2013]

[H1.*&1'* $(/ 2.4+"*/ +1I.")6/ *+1&>.)1"*/: µ15@$( )4#$%0/ $;+ µ1=47;+ *"µ%)>=*.#(/ µ1 I?#",,* )*" 7"$$*+=.*)")4 7">50µ* )*" $(/ *"µ%7"*7"6=(#(/]

[A0+*"#=(µ*$")6 +%(µ%#?+(-=1;.'* )*" 1I*.µ%,@/ #$( +%#(510$")6 7"%')(#(]

[J .45%/ $;+ 1&*,,15µ*$"-+ 0,1'*/ )*" ( <15$';#( $(/ &%"4$($*/ 0&(.1#"-+ #$* +%#%)%µ1'*]

[8 #036$(#( ;/ *&%$151#µ*$")4/ $.4&%/ 1&")%"+;+'*/ #$(+ )*=(µ1."+6 +%#(510$")6 &.>G(]

[:0I06 I%.1$> #0#$6µ*$* 0,1'*/ ,"* $(+ 1)$'µ(#( )*.7"*,,1"*)-+ )*" *+*&+10#$")-+ &.%<5(µ>$;+]

!! ""#$%&µ!'#() #*+#!,#()

$'-$&. %!$&/*0%1' "//2,!.!!""""##

$$%%&&''

((!!))

%%''**

%%&&''

++##

,,$$''

,,##""!!

--++%%&&

##,,

!!((%%,,

++##..

##,,

! TTOO

MMOO

,, 44,,

++!!--

//'',,

11,, %%00

$$''--00

))%%''

,,--11

!!22))''

--00))%%

'',,--

..00))

++%%''

,, 2200

1111

!!""µµ##$$ 44,, !!%%&&''##$$ 11,, (())**##++,,--..##$$--//%%00--##++,,--..##$$--11,,--22..##$$ 22001111

www.enne.gr

%&.

EXOFILO 5/11/11 2:56 PM Page 1

Page 2: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"#$%&': ##&&((&&%%))&&'' ''""$$**%%!!++&&''**#,!*-*.%&' !"#$'&': //)),,''%%!!,,##&&'' ##//00++//''**'*(1$*+$' !"#$'&': ((,,22//++&&'' 33,,%%'',,++,,##&&''/)2,'*.%/"%&': ##44.. //--&&..// ""//++$$""//,,)),,..$$** /567894:;4<6 "6=9>?;4<6 %µ?µ6;@A .@B98CD;<E?A !"3/ #,$,"&%,"& *3$'%&),F&: ++//((33))$$'' ((33,,GG//''**,, ##&&((&&%%))&&'' 33,,''%%$$++//''***3!*-*.OI '*.#)$(H.: ""HH..''%%//..%%,,// ((33!!++//++&&**,, ##&&(($$''--!!..&&'' ''//++&&"",,##&&''***3!*-*.$, #,/.$(&' !.%*3$*: 00!!HH))00,,$$'' ##))//22%%,,##&&''**

%@ #' ;9A !.!*:##99µµ??;;44<<@@AA ''EE@@DD;;II8899AA:: 34JCK4@A, //44<<BB;;CCLLKK99AA ##MM>>8866AA:: 0C5<EJA 046µµ6;I6A, ..<<EEJJ8866@@AA $$44NN6655JJAA:: /O /5;<74JCK4@A, ""PP55//55@@AA ((77@@DDµµ77MM4499AA:: 1O /5;<74JCK4@A, ##99µµ??;;44<<@@AA 33<<BB;;JJ8866AA:: %6µL6A, ++MMµµ7744@@AA ((77LLQQ66AA,,:: /5. 046µµ6;I6A, !!88II5599 //88µµ77MM5599:: $4>65. 046µµ6;I6A, ##99µµ@@BB==II5599AA ''668899EELLKK99AA:: /5. %6µL6A

(I89 #.':"P5B;65;L6 (7C868?, !D;I479 16B<8C<MK@D, 0C:4><@A #46R;LK9A, /7JB;@8@A "P;B?A, 0CP4>L6 (78M5;6, 0C:4><@A #J5;B<@A,.<EJ86@A '6SSLK9A

!"#$%&$'&( )*'$+,*(##44.. !!++!!..&& //33$$''%%$$++$$33$$**++$$** /567894:;4<6 "6=9>?;4<6 %µ?µ6;@A .@B98CD;<E?A !"3/ ##44.. ((//)),,// 00"",,""// .@B98CT;4<6 !E76LKCDB9A !!' ##44.. ''$$UU,,// GG**00// !7LE@D49 "6=9>?;4<6 %µ?µ6;@A .@B98CD;<E?A 365C7<B;9µL@D 3C8@7@55?B@D ##44.. 33//..//00,,HH%%// ,,$$))##//..$$** /567894:;4<6 "6=9>?;4<6 %µ?µ6;@A .@B98CD;<E?A / /%!, /-&.H. ##44.. !!**(($$))UU,,// ""$$**"",,// +IE;@46A %µ?µ6;@A .@B98CD;<E?A !"3/ --!!$$22//))&&'' ""HH..''%%//..%%,,..,,##&&'' MMSScc "6=9>9;?A !N64µ@>:5 %µ?µ6;@A .@B98CD;<E?A /%!, "4?;9A ##44.. UUHH%%$$**++// ((33//((33//%%'',,""$$** !7LE@D49 "6=9>?;4<6 %µ?µ6;@A .@B98CD;<E?A / /%!, /-&.H. ##44.. 33//..//00,,HH%%&&'' 33))!!GG!!))//""$$'' !7LE@D4@A "6=9>9;?A %µ?µ6;@A .@B98CD;<E?A 365C7<B;9µL@D 3C8@7@55?B@D

-).( /')0#,"! )*'!$(-,#'&(! )*'$+,*(!DDrr.. EEhhrreennffeelldd MMaallllyy,, RN, PhD, Head of Nursing dep. Associate Professor Tel-Aviv University,Dep of Nursing, Israel.DDrr.. MMeerrkkoouurriiss AAnnaassttaassiiooss.. RN, PhD, Associate Professor, Cyprus University of Technology.DDrr.. PPaavvllaakkiiss AAnnddrreeaass,, Professor of Open University of Cyprus.DDrr.. PPaappaaddooppoouullooss IIrreennaa PhD, MA(Ed), BA, DipNEd, DipN, NDNCert, RGN, RM Professor of Transcultural Health andNursing and Head of Research Centre for Transcultural Studies in Health Middlesex University, London UK.DDrr.. PPaappaassttaavvrroouu EEvvrriiddiikkii Lecturer Department of Nursing, Cyprus University of Technology.President of the Council ofNursing and Midwifery.SSiirroonnii CCeecciilliiaa RN, BSc, MSc Universita degli Studi dell’ Insubria-Varese Italy.

)'/'&,' !"-1,".,': 11.. ,,HH//....&&'' **UU//..%%$$33$$**++$$'',, "6=9;9;?A "@<5P5<E?A 3@8<;<E?A, .@µ<E? 'R@8? !"3/22.. ,,HH//....&&'' ""**)),,$$33$$**++$$'',, "6=9>9;?A $<E@5@µ<E:5 ;9A *>CL6A, "@Bµ?;P4 !'#*33.. ..,,""$$++//$$'' ((//..,,//##//""&&'',, !7LE@D4@A "6=9>9;?A $<E@5@µ<E:5 E6< #<@LE9B9A ;9A *>CL6A, 365C7<B;?µ<@ 3C<46<M44.. 00!!))//'',,(($$'' ((33$$..//%%''$$'' "6=9>9;?A ,6;4<E?A, 34JCK4@A %µ?µ6;@A .@B98CD;<E?A !"3/ 55.. 00!!HH))00,,$$'' ((33//++%%$$33$$**++$$'' "6=9>9;?A %µ?µ6;@A .@B98CD;<E?A !"3/ 66.. 00!!HH))00,,$$'' ''//))$$00++$$** "6=9>9;?A %µ?µ6;@A .@B98CD;<E?A !"3/, 34JCK4@A "!!+3.$77.. //++!!FF,,$$'' 33//))//))//'',, #<E9>J4@A #9µ@B<@8J>@A, .@µ<EJA 'TµS@D8@A !.!88.. ''33**))$$'' 11))!!%%%%$$'',, 'D>>46NI6A, #<KME;P4 U<8@8@>L6A99.. UUHH%%,,$$'' ++!!33,,##//'',, .@µ<EJA 'TµS@D8@A ;9A 69A *3!, DEA, #<@<E9;<EJ #LE6<@, Montpellier France

! " " # $ % & '( ) * % + , % & ' - # ./+0#")1-%&2.! ( % 0 - 2 µ # .

II##,,$$""%%&&'',,//:: !.H'& .$'&+!*%H. !++/#$'16B<8LBB9A '@NL6A 47, 10676 /=?56, %98.: 210 3648 044Fax: 210 3617 859, e-mail: [email protected], www.enne.gr

!!33,,((!!++!!,,// !!""##$$''&&''--##,,//UU&&((,,''!!,,'':: (. 3,%',+,#&' /.!./>. .<E@8M@D 102, 16674 08DNMK6,

%98.: 210-8947 002, Fax: 210 8941 551 e-mail: [email protected], www.pitsilidis.gr

ISSN 1791-9002

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 1

Page 3: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

++AA((33))$$'' ((33IIGG//''3<B;@7@L9B9 E6< 656>5:4<B9 ;9A BD5CR<QJµC59A 5@B98CD;<E?A CE76LKCDB9A ..............................................................3

00,,HH))00$$'' UU,,++,,3333//%%$$'' & 67@;C8CBµ6;<EJ;9;6 ;9A K<6RCL4<B9A ;@D 7J5@D B;@ %µ?µ6 !7C<>J5;P5 3C4<B;6;<E:5 E6< @ S6=µJA 65;67JE4<B?A ;9A B;<A 65M>ECA ;P5 6B=C5:5 ..........................................................................................5THE EFFECTIVENESS OF PAIN MANAGEMENT IN THE EMERGENCY DEPARTMENT AND THE DEGREE OF RESPONSIVENESS TO THE PATIENT’S NEEDS

((//++++,,//))$$** ((//)),,//,, ''//))//UU&&'' 33//**++$$'',, ""//))//--//..//''&& ""HH''%%//..%%,,..,,//,, ''!!))//UU!!,,(( %%//%%,,//..//,, ''HH%%&&)),,//##$$** ""**)),,//""&&,,--!!$$##$$''$$33$$**++$$** !!++!!..&&Death Attitude Profile-Revised (DAP-R)-!4P;9µ6;@8J><@ K<C4CT59B9A B;MB9A 67I565;< B;@ =M56;@. ';M=µ<B9 ;9A C8895<E?A CEK@R?A ;@D C4P;9µ6;@8@>L@D............................................................14[DEATH ATTITUDE PROFILE-REVISED (DAP-R)-VALIDATION OF GREEK VERSION]

!!**//0000!!++II// ((//''%%))//33AA,, AA))&&'' **UU//..%%HH'',, ##EE''33$$,,..// 22//..,,HH%%&&,, !!++!!..&& '',,//((//00""//,, ,,HH//....&&'' 33))!!''''//'',, 00!!HH))00,,// ))//33%%&&,, ''$$UU,,// %%'',,)),,00""//!µS@8<6B;<E? EM8DV9 µ6=9;:5 98<EL6A 6-16 C;:5 BC 7C4<@R? ;9A C8895<E?A C764RL6A ............................................27[THE VACCINE COVERAGE OF SCHOOLCHILDREN ( 6-16 YEARS OLD) IN A GREEK PROVINCE]

##!!''33$$,,..// //..##)),,HH%%&&,,##&&((&&%%))&&'' ""$$((((//%%//'',, //++!!FF//..##))// ''"",,%%''$$**,, 00,,HH))00$$'' 22//))//++//((33$$**'',, 22))**''// ((33//))$$!E;Lµ9B9 ;P5 /56>E:5 !E76LKCDB9A E6< "6;M4;<B9A ;P5 /5=4:7<5P5 3J4P5 *>CL6A B;9 2:46 µ6A B;@ 386LB<@ ;@D !=5<E@T ';46;9><E@T 'RCKL@D /5M7;DW9A 2007-2013 ........................................................................32[HUMAN RESOURCES FOR HEALTH NEEDS ASSESSMENT OF LIFE-LONG LEARNING IN THE FRAMEWORK OF THE STRATEGIC NATIONAL DEVELOPMENT PLAN 2007-2013]

33//))//''""!!**&& --!!$$UU,,++$$** -C467CL6 ;9A R4J5<6A 5CN4<E?A 65C7M4EC<6A: µC8I;9 EJB;@DA ;P5 µC=JKP5 6<µ@EM=64B9A µC NTB<>>6 E6< K<;;65=46E<EJ K<M8Dµ6 E6< ;9A 6<µ@K<6K<?=9B9A ......................................................39[TREATMENT OF CHRONIC KIDNEY DISEASE: COST ANALYSIS OF BICARBONATE DIALYSIS ANDHAEMODIAFILTRATION]

GGHH&& 11$$))))&&'D56<B=9µ6;<E? 5@9µ@BT59-=CP4L6 E6< CN64µ@>IA B;9 5@B98CD;<E? K<@LE9B9 ........................................................46[EMOTIONAL INTELLIGENCE: THEORY AND THE IMPLICATIONS IN THE NURSING LEADERSHIP]

##)).. 00,,//....&&'' ((//))""$$11,,%%'',, ''$$UU,,// (($$..//''%%&&)),,##$$**$ 4J8@A ;P5 C76>>C8µ6;<:5 D>CL6A E6< 9 SC8;LPB9 ;9A 7@<J;9;6A D794CB<:5 B;6 5@B@E@µCL6 ................................51[THE ROLE OF HEALTHCARE PROFESSIONALS AND THE IMPROVEMENT OF SERVICE QUALITY IN HOSPITALS]

22))&&''%%$$'' ((//))..!!))//'',, 00!!HH))00,,$$'' //))11//..,,%%&&'' & BDQ?;9B9 PA 67@;C8CBµ6;<EJA ;4J7@A C7<E@<5P5L6A B;95 E6=9µC4<5? 5@B98CD;<E? 74MW9 ..................................57[THE DISCUSSION AS AN EFFECTIVE WAY OF COMMUNICATION IN DAILY NURSING PRACTICE]

22.. ""//++$$""//,,)),,..$$'',, ##.. GG&&""$$'',, ,,.. ((//..%%//''!DND? N@4C;M BDB;?µ6;6 D>CL6A ><6 ;95 CE;Lµ9B9 E64K<6>>C<6E:5 E6< 65675CDB;<E:5 74@S89µM;P5 ....................62[“SMART WEARABLE BIOMEDICAL SYSTEMS” FOR THE MONITORING OF CARDIOVASCULAR AND RESPIRATORY DISORDERS]

1. /#/(/",#$* -!$#$*+&2. /+!F/.#)$3$*+$* (/),/.-&3. /3$'%$+/)/ 3/)/'"!*&4. 1!+$./"& 1!.!%,/-'$U,/5. 0/+/.&' 3!%)$' 6. 0!)/+& (/),/7. 0"$+U,.$3$*+$* "/'',/.& 8. 0"$*1/ (/,)&9. 0"$*G$* (/),/10. #/++/' #&(&%),$'11. #)!+,HG& /00!+,"&

12. G&"$' #&(&%),$'13. ,H/..,#& 1/',+,"&14. "/,%!+,#$* #/U.&15. "/3!++/ (/),/16. "/)/,'"$* /00!+,"&17. "/'%/.,H%& /,"/%!),.&18. "/%'/)/0/"&' '%*+,/.$'19. "/*",/ -!$#H)/20. "$+$1$' 3!%)$'21. +/(3)$* 3/./0,H%/22. +/'"/)& /./'%/',/

23. (/00$*+,/ 3$+*F!.&24. (/++,/)$* (/),/25. (!++$* "/'',/.&26. ($*0,/ 1/',+,"& 27. .%/U$0,/..& 2)*'$*+/28. 3/./0,H%$* /'3/',/29. 3!%)$0+$* .,"&30. )$"/ 1/',+,"&31. '/)/U&' 3/*+$'32. '/),#& (/),/33. '%/-/)$* /00!+,"&

34. '%/-$3$*+$' -!$#H)$'35. '%/(/%/"& 3!%)$*+/36. '%!U/.$3$*+$' .,"$+/$'37. %G,/U!)& '%*+,/.& 38. %$*)$*"& 0!H)0,/39. %',/)/' "H.'%/.%,.$' 40. U!'%!),#$* 2),'%,./41. UH%&' -!$U/.&'42. 2/)/+/(3,#$* /+/F/.#)/43. 2),'%$#$*+$* !+!.&

&+'$)! E..(#'&," *)+',/'&," $(! #,!(.)"$'&(! )*'!$(-(!

!"#$"%&µ"'(

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 2

Page 4: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [3]

!"#"$ %&'(!)*%

3<B;@7@L9B9 E6< 656>5:4<B9 ;9A BD5CR<QJµC59A 5@B98CD;<E?A

CE76LKCDB9A

%%@@DD ++MMµµ7744@@DD ((77LLQQ66,, //55.. 004466µµµµ66;;II66 !!..!!

( #<6 1L@D (M=9B9 (Life Long Learning - LLL),C5JA .@B98CD;? 64RLQC< 67J ;95 74:;9 µI46;P5 74@7;DR<6E:5 B7@DK:5 E6< BD5CRLQC;6<

6E6;M76DB;6 E6=’ J89 ;9 K<M4EC<6 ;9A C7<B;9µ@5<-E?A ;@D B;6K<@K4@µL6A. -6 74I7C< 56 B9µC<P=CL J;<9 K<6 SL@D 67@E;:µC59 >5:B9 ;P5 5@B98CD;:5 74@-I4RC;6< 67J ;95 74@7;DR<6E? CE76LKCDB9, 67J ;9µC;67;DR<6E? E6< 67J ;9 'D5CR<QJµC59 .@B98CD;<-E? !E76LKCDB9.

& .@B98CD;<E? !E76LKCDB9 (N!) 7C4<86µSM5C<;95 67JE;9B9 >5:BCP5 (knowledge), <E65@;?;P5(skills), BDµ7C4<N@4:5 (attitudes) E6< 9=<E:5 6W<:5(values) CE µI4@DA ;P5 N@<;9;:5, :B;C 56 µ7@4@T556 CW6BE?B@D5 ;@ .@B98CD;<EJ C7M>>C8µ6. $< 5@B9-8CD;IA µ6=6L5@D5 56 µC8C;@T5 B;6 S?µ6;6 µL6A K<6SL@D CE76LKCDB9A E6< 74I7C< 56 CL56< <E65@L 56 764I-R@D5 B;@DA 7@8L;CA ;9A R:46A D794CBLCA D>CL6A DV9-8?A 7@<J;9;6A BDµSM88@5;6A BC J86 ;6 C7L7CK6 J7PA6D;M ;9A 74J89V9A, K<M>5PB9A, =C467CL6A E6< 67@-E6;MB;6B9A. 0<6 ;@ BE@7J 6D;J, 9 'D5CR<QJµC59 .@B9-8CD;<E? !E76LKCDB9 ('.!) - Continuing NursingEducation (CNE), ;P5 5@B98CD;:5 E6=LB;6;6< 676-46L;9;9 IR@5;6A PA BE@7J ;95 CW6BNM8<B9 ;9A K<6SL@D CE76LKCDB9A ;P5 5@B98CD;:5.

/56N@4<EM µC ;9 'D5CR<QJµC59 !76>>C8µ6;<E?/5M7;DW9 ('!/) - Continuing Professional Development(CPD), 9 5I6 >5:B9 CL56< SIS6<6 67646L;9;9, 688M67J µJ59 ;9A KC5 C764ECL ><6 56 688MWC< ;<A <E65J-;9;CA, ;<A KCW<J;9;CA, ;9 BDµ7C4<N@4M E6< ;<A 9=<-EIA 6WLCA ;@D 5@B98CD;?, :B;C 56 7646;949=@T5@DB<6B;<EIA SC8;<:BC<A B;<A 764CRJµC5CA D794C-BLCA D>CL6A. #L5C;6< I;B< SM4@A B;9 K<64E? =CP49-;<E? C59µI4PB9 E6< 746E;<E? E6;M4;<B9 ;@D 5@B9-8CD;? B;<A ;4IR@DBCA C7<B;9µ@5<EIA CWC8LWC<A.

,K<6L;C4@ C5K<6NI4@5 C7L ;@D Q9;?µ6;@A ;9A '!/,KLKC;6< E6< 67J ;95 !D4P76XE? !7<;4@7?. 'D>EC-E4<µI56, 9 0C5<E? #<CT=D5B9 !BP;C4<E?A />@4MAE6< *794CB<:5 B;@ 786LB<@ ;9A C7<ECLµC59A 656=C-:49B9A ;9A !D4P76XE?A $K9>L6A (!$) 36/2005 ><6;95 656>5:4<B9 ;P5 C76>>C8µ6;<E:5 74@BJ5;P5,I=CBC ;@ 7C46BµI5@ ,65@DM4<@ ECLµC5@ 74@A K<6-S@T8CDB9 ><6 ;95 6W<@8J>9B9 ;9A !$ J7@D >L5C;6<µ5CL6 ><6 ;9 '!/. /56NI4C;6< 9 B7@DK6<J;9;6 ;9A'!/ B;95 676<;@TµC59 67JE;9B9 5IP5 <E65@;?;P5

E6< KCW<@;?;P5 ><6 ;95 C7<K<PEJµC59 74@BP7<E?C76>>C8µ6;<E? 65M7;DW9 688M E6< 9 656>E6<J;9;M;9A 67J ;95 78CD4M ;P5 BD5CR:A 6DW65JµC5P5 676<-;?BCP5 ;P5 E6;6568P;:5 D>CL6A ><6 DV98@T C7<7I-K@D 764@RIA D794CB<:5. !7LB9A, 656KC<E5TC;6< 9BD5CRJµC56 6DW65JµC59 ;MB9 ><6 ;95 67@;T7PB9;@D D7@R4CP;<E@T R646E;?46 ;9A '!/ ><6 ;6 ;@µC-6EM C76>>I8µ6;6 B;95 656=CP49µI59 µ@4N? ;9A!D4P76XE?A $K9>L6A 36/2005.

'Dµ7C46Bµ6;<EM, 9 'D5CR<QJµC59 .@B98CD;<E?!E76LKCDB9 E6< 9 'D5CR<QJµC59 !76>>C8µ6;<E? /5M-7;DW9 67@;C8@T5 78I@5, C7L ;9A @DBL6A, µL6 C5<6L6I55@<6 '.!-'!/. ';@5 74@N@4<EJ E6< B;@ >467;J8J>@ R49B<µ@7@<@T5;6< E6< @< KT@ J4@< C5688MW, 688M,CW @4<Bµ@T, 9 EM=C µL6 67J ;<A KT@ I55@<CA Cµ7C4<I-RC< E6< ;95 M889, BC S6=µJ 7@D µ7@4CL 56 C<7P=CLJ;< 9 '.! 67@;C8CL ;95 CN64µ@>?-67JK@B9 ;@D J4@D'!/ ><6 ;@5 !76>>C8µ6;L6 .@B98CD;?.

36>E@BµLPA, B’ @8JE894@ ;@ NMBµ6 ;P5 74@>46µ-µM;P5 '.!-'!/, R49B<µ@7@<CL;6< µ<6 7@<E<8L6 67Jµ@4<@K@;@TµC5CA µ6=9B<6EIA K46B;94<J;9;CA, @<@7@LCA 764IR@5;6< 65CWM4;9;6, ? µIB6 B;@ 786LB<@C5JA 'D5CK4L@D ? M889A C7<B;9µ@5<E?A CEK?8PB9A,7@D @4>65:5C;6< 67J: 365C7<B;?µ<6, 'R@8IA, %µ?-µ6;6, %@µCLA, .@B@E@µCL6, "8<5<EIA, !4>6B;?4<6,(@5MKCA, !7<B;9µ@5<EIA !;6<4CLCA !<K<E@;?;P5,!76>>C8µ6;<EIA !5:BC<A (!.!), #<C=5CLA !5:BC<A -$4>65<Bµ@L (WHO, ICN, FEPI). %I;@<CA K46B;94<J;9-;CA KT56;6< 56 CL56< @< 7646EM;P.

((@@44<<@@KK@@;;@@TTµµCC55CCAA µµ66==99BB<<66EEIIAA KK4466BB;;9944<<JJ;;99;;CCAA µµIIBB66 BB;;66 ..@@BB@@EE@@µµCCLL66::

! !7<B;9µ@5<EIA BD565;?BC<A ;P5 E8<5<E:5 (grand rounds)

! 1<S8<@>46N<E? C59µI4PB9 (journal club)! Y88CA CE76<KCD;<EIA K46B;94<J;9;CA B;@ .@B@E@µCL@

! #<68IWC<A BC µC>M8CA @µMKCA! 'DQ9;?BC<A BC µ<E4IA @µMKCA! !7L8DB9 74@S89µM;P5 S6B<BµI5P5 BC 746>µ6;<EM7C4<B;6;<EM

! %D7@7@<9µI5CA CWC;MBC<A 6B=C5:5! !E76<KCD;<EIA K46B;94<J;9;CA µC ;9 R4?B9 &/*! /5M7;DW9-SC8;LPB9 KCW<@;?;P5 7M5P BC K<MN@4CA ;CR5<EIA E6< 5@B98CD;<EIA 74MWC<A

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 3

Page 5: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[4] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"#"$ %&'(!)*%

! /5M7;DW9-SC8;LPB9 K<K6E;<E:5 <E65@;?;P5(CE76LKCDB9 CE76<KCD;:5)

((@@44<<@@KK@@;;@@TTµµCC55CCAA µµ66==99BB<<66EEIIAA KK4466BB;;9944<<JJ;;99;;CCAA BB;;9955 !!8888MMKK66 ?? ;;@@ CCWWPP;;CC44<<EEJJ::

! !7<B;9µ@5<EM BD5IK4<6! !E76<KCD;<EM 'Cµ<5M4<6! U4@5;<B;?4<6! On-line K46B;94<J;9;CA '.!-'!/, 74@BNC4JµC5CA B;@ K<6KLE;D@

/5 E6< B;95 67I565;< 78CD4M ;@D /;865;<E@T 9 '!/67@;C8CL 764MK@B9 (<K<6L;C46 JB@5 6N@4M B;@DA ><6-;4@TA), B;95 !D4:79 (C5;JA E6< CE;JA ;9A !!) KC5D7M4RC< E@<5? >46µµ? C5: @< µ@4NIA CN64µ@>?A ;9A7@<EL8@D5. /56N@4<EM µC ;6 ;@µC6EM C76>>I8µ6;6(J7PA E6< 6D;J ;@D 5@B98CD;?), 9 '!/ KC5 CL56< D7@-R4CP;<E? BC J8CA ;<A R:4CA E6< KC5 BD5KIC;6< MµC-B6 µC ;95 C76>>C8µ6;<E? CWI8<W9 ? ;95 6565IPB9;9A MKC<6A MBE9B9A ;@D C76>>I8µ6;@A. & D7@R4IP-B9 67I565;< B;9 '!/ S64T5C< M88@;C ;@5 C76>>C8µ6-;L6 E6< M88@;C ;@5 C4>@KJ;9 C5: 74@>4Mµµ6;6 '!/K<6RC<4LQ@5;6< CWLB@D 67J K9µJB<6 ? <K<P;<EM <K4T-µ6;6 RP4LA 56 67@E8CL@5;6< ;6 µC<E;M BDB;?µ6;6.

0<6 ;@DA 8J>@DA 6D;@TA E6< 65;67@E4<5JµC59 ;JB@B;@ ECLµC5@ K<6S@T8CDB9A ;9A !! ><6 ;95 656=C:-49B9 ;9A !$ 36/2005, JB@ E6< B;@ 6L;9µ6 ><6 74@-;MBC<A ;@D *7@D4>CL@D 36<KCL6A ><6 ;@5 E6=@4<BµJ;P5 C8MR<B;P5 74@Z7@=IBCP5 E6;M4;<B9A ;P5 5@B9-

8CD;:5, 9 !.! 74J;C<5C ;6 CW?A: 0<6 ;9 K<6BNM8<B9;9A K<6;?49B9A ;P5 CE76<KCD;<E:5 676<;?BCP5 BRC-;<EM µC ;95 MBE9B9 ;@D 5@B98CD;<E@T C76>>I8µ6;@A,67646L;9;9 CL56< 9 MµCB9 BT5KCB? ;9A µC ;95 '!/µC J4@DA E6< 74@Z7@=IBC<A 7@D =6 656NI4@5;6<49;:A (7R 7<B;P;<EIA µ@5MKCA – credits) B;95 656-=CP49µI59 !D4P76XE? $K9>L6. & '!/ =6 74I7C< 56CL56< D7@R4CP;<E? ><6 ;95 C76>>C8µ6;<E? CWI8<W9 ?><6 ;95 6565IPB9 ;9A MKC<6A MBE9B9A C76>>I8µ6-;@A C5:, 74@>4Mµµ6;6 '!/ =6 74I7C< 56 @4>65:5@-5;6< E6< 56 µ@4<@K@;@T5;6< 67J ;95 !.! ? 56 @4>6-5:5@5;6< 67J M88@DA CE76<KCD;<E@TA N@4CLA D7J ;956<>LK6 E6< ;9 µ@4<@KJ;9B9 ;9A !.!. /WLQC< 56 B9µC<-P=CL J;< @< 76467M5P 74@;MBC<A 65;656E8:5;6< E6<B;@ !D4P76XEJ 'DµS@T8<@ ;P5 )D=µ<B;:5 ;@D .@B9-8CD;<E@T !76>>I8µ6;@A, (European Council of NursingRegulators - FEPI), @< @7@LCA E6;6;I=9E65 C7<B?-µPA B;95 !D4P76XE? !7<;4@7?.

!7JµC5@ S?µ6 ;9A !.! E6< BC BD5C4>6BL6 µC ;9FEPI, ;@ @7@L@ ?K9 S4LBEC;6< B;9 K<6K<E6BL6 ;9AD8@7@L9B9A, CL56< 9 E6=<I4PB9 C5JA !D4P76XE@TN@4I6 656>5:4<B9A E6< µ@4<@KJ;9B9A ;9A BD5CR<-QJµC59A 5@B98CD;<E?A CE76LKCDB9A B;6 74J;D76?K9 D764RJ5;P5 @4>65<Bµ:5 J7PA 7.R. ;@ EuropeanAccreditation Council for Continuing MedicalEducation (EACCME). ';95 E6=<I4PB9 ;@D N@4I6µ@4<@KJ;9B9A =6 BDµSM8C< 9 ;CR5@>5PBL6 E6< 9BD5C4>6BL6 ><6 ;95 CE6;I4P=C5 656>5:4<B9 ;9A '!/µC R:4CA J7PA @< &3/ E6< @ "656KMA @< @7@LCA CL56<?K9 BD5KCKCµI56 µI89 ;9A FEPI.

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 4

Page 6: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [5]

& 67@;C8CBµ6;<EJ;9;6 ;9A K<6RCL4<B9A ;@D 7J5@D B;@ %µ?µ6 !7C<>J5;P5 3C4<B;6;<E:5E6< @ S6=µJA 65;67JE4<B?A ;9A B;<A 65M>ECA

;P5 6B=C5:5

00<<::44>>@@AA UU<<88<<7777MM;;@@AA,,

.@B98CD;?A %!, MSc, 0C5<EJ .@B@E@µCL@ !8CDBL56A

*2345676

!!<<BB66>>PP>>??:: $ 7J5@A 67@;C8CL ;95 ED4<J;C49 6<;L6 74@BI8CDB9A ;P5 6B=C5:5 B;6 %µ?µ6;6 !7C<>J5;P5 3C4<-B;6;<E:5. & =C467CL6 ;@D JµPA ;<A 7C4<BBJ;C4CA N@4IA CL56< 65C764E?A µC ET4<@ R646E;94<B;<EJ ;95 D7@-CE;Lµ9B9 E6< ;95 D7@=C467CL6.''EE@@77JJAA:: .6 74@BK<@4<B;@T5 @< 746E;<EIA K<6RCL4<B9A ;@D 7J5@D E6< 56 6W<@8@>9=CL 9 67@;C8CBµ6;<EJ;9;6 ;@DAB;95 656E@TN<B9 ;@D 6B=C5?. !7LB9A 56 E6=@4<B;CL 9 C7<=Dµ9;? K<6RCL4<B9 E6< 656E@TN<B9 BTµNP56 µC ;<A74@BK@ELCA ;P5 6B=C5:5 ><6 µCLPB9 ;9A I5;6B9A ;@D 7J5@D ;@DA E6< ;95 C7<=DµL6 R@4?>9B9A 6568>9BL6A.**88<<EEJJ--µµII==@@KK@@AA:: /56K4@µ<E? 7C4<>46N<E? µC8I;9 7@D 746>µ6;@7@<?=9EC B;@ %µ?µ6 !7C<>J5;P5 3C4<B;6-;<E:5 C5JA 0C5<E@T .@B@E@µCL@D /;;<E?A E6;M ;95 K<M4EC<6 >C5<E:5 CN9µC4<:5 ,@D5L@D-,@D8L@D 2009. &BD88@>? ;P5 KCK@µI5P5 I><5C µC BDµ78?4PB9 C4P;9µ6;@8J><P5 (CLB@K@A-IW@K@A) E6< µC C76EJ8@D=9 65M-8DB9 K<6>46µµM;P5. & I5;6B9 ;@D 7J5@D 6D;@6W<@8@>?=9EC µC ;95 11-S6=µ<6 64<=µ9;<E? E8Lµ6E6. %@ D8<-EJ 67@;I8CB65 J8@< @< 6B=C5CLA 98<EL6A 14 C;:5 E6< M5P µC <E65J;9;6 E6;65J9B9A C4P;9µ6;@8J><@D E6<6B=I5C<CA µ9 67C<89;<EIA ><6 ;95 QP?.//77@@;;CC88IIBBµµ66;;66:: ';95 µC8I;9 BDµµC;CLR65 247 6B=C5CLA 98<EL6A 38.5±15.3 C;:5. & µIB9 I5;6B9 7J5@D E6;M;95 CLB@K@ ?;65 7.2±1.9 E6< E6;M ;95 IW@K@ 5.0±2. & I5;6B9 ;@D 7J5@D IµC<5C 6µC;MS89;9 ><6 ;@ 35,5% ;P56B=C5:5. & µIB9 I5;6B9 7J5@D 7@D C7<=Dµ@TB65 56 67@RP4?B@D5 @< 6B=C5CLA ?;65 2.5±1.3 9 @7@L6 67I-E8<5C 7C4<BBJ;C4@ ;P5 KD@ µ@5MKP5 ><6 ;@ 90% ;P5 6B=C5:5 BC BRIB9 µC ;95 I5;6B9 CWJK@D. ';@ 68% ;P56B=C5:5 7@D C7<=Dµ@TBC ;95 8?V9 6568>9;<E@T KC5 R@49>?=9EC. "65I56A 6B=C5?A KC5 CLRC ;CEµ94<PµI-59 CE;Lµ9B9 I5;6B9A 7J5@D B;@ K<M>46µµ6 ;@D E6< µJ8<A 6% CLRC I>>46N9 R@4?>9B9 6568>9;<E@T. ''DDµµ77CC44MMBBµµ66;;66:: $< C7<E46;@TBCA 746E;<EIA K<6RCL4<B9A ;@D 7J5@D B;@ %µ?µ6 !7C<>J5;P5 3C4<B;6;<E:5 IR@D57C5<R4M 67@;C8IBµ6;6 B;95 656E@TN<B9 ;@D 6B=C5? E6< 67IR@D5 67J ;<A 65M>ECA E6< ;<A 74@BK@ELCA ;@D.

++IIWWCC<<AA--EE88CC<<KK<<MM:: #<6RCL4<B9 7J5@D, @8<>@6568>9BL6, %µ?µ6 !7C<>J5;P5 3C4<B;6;<E:5, 74@BK@ELCA 6B=C5:5,<E65@7@L9B9 6B=C5:5.

+"+&'*(,-H +".!%/A

)89:;<;=$ 7J5@A 67@;C8CL ;95 74P;64R<E? 6<;L6 656Q?;9B9A<6;4<E?A S@?=C<6A B;6 %µ?µ6;6 !7C<>J5;P5 3C4<B;6-;<E:5 (%!3) ><6 I565 B;@DA KD@ 6B=C5CLA (Cordell etal 2002, Pletcher et al 2008) E6< ;95 BD59=IB;C49C5JR89B9/BDµ7;Pµ6 ><6 ;@ 78% ;P5 C7<BEIVCP5 7@<-

EL89A 6<;<@8@>L6A (Tanabe and Buschmann 1999,Karwowski-Soulie et al 2006). "6=@8<E? CL56< 9 764@D-BL6 ;@D 7J5@D BC EI5;46 ;46Tµ6;@A (Berben et al 2008)C5: 6W<@B9µCLP;9 CL56< 9 BDR5J;9;6 ;@D 7J5@D B;95C7CL>@DB6 74@5@B@E@µC<6E? N4@5;LK6 (McLean et al2002, Galinski et al 2010).

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 5

Page 7: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[6] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

+"+&'*(,-H +".!%/A

& K<6RCL4<B9 ;@D 7J5@D B;6 %!3 µC ET4<@ R646-E;94<B;<EJ ;95 67@DBL6 ? ;95 C88<7? CE;Lµ9B9 E6< ;957C4<@4<BµI59 R4?B9 µC=JKP5 6568>9BL6A 67@KC<-E5TC;6< 65C764E? B;95 656E@TN<B9 ;P5 6B=C5:5 (Toddet al 2002, Karwowski-Soulie F et al 2006, Todd etal 2007). $< 7C4<BBJ;C4CA I4CD5CA CB;<MQ@5;6< B;6R6µ98M 7@B@B;M 6568>9BL6A (Kozlowski et al 2002,Johnston et al 2005), ;95 D7@K@B@8@>L6 (Goldman etal 2008), E6< ;<A 6W<@B9µCLP;CA E6=DB;C4?BC<A (Grant2006). HB;JB@ ;@ N6<5JµC5@ ;9A @8<>@6568>9BL6A(Wilson and Pendleton 1989) KC5 7646;94?=9EC BC;JB@ µC>M89 IE;6B9 BC %!3 6>4@;<E?A 7C4<@R?A (Vlahakiand Milne 2008) E6< BC EI5;46 ;46Tµ6;@A (Probst etal 2005, Mader et al 2006, Chisholm et al 2008).

$< 764M>@5;CA 7@D IR@D5 C5@R@7@<9=CL ><6 ;95 C7<-E46;@TB6 E6;MB;6B9 ;9A D7@=C467CL6A ;@D 7J5@DK<6E4L5@5;6< BC Cµ7JK<6 7@D BRC;LQ@5;6< µC ;@DA C76>->C8µ6;LCA D>CL6A, µC ;@ D>C<@5@µ<EJ BTB;9µ6 E6< ;@DA6B=C5CLA (Duignan and Dunn 2008). ';@ 5@B98CD;<-EJ 74@BP7<EJ K<67<B;:5@5;6< µC>M86 >5PB;<EM C88CLµ-µ6;6 BRC;<EM µC ;<A B;46;9><EIA K<6RCL4<B9A ;@D 7J5@D(Tanabe and Buschmann 2000, Jastzab et al 2003,Van Hulle Vincent 2005, Tsai et al 2007) E6< D7@CE;L-µ9B9 ;@D S6=µ@T I5;6B9A ;@D 7J5@D ;@D 6B=C5?(Puntillo at al 2003, Duignan and Dunn 2008, Davoudiet al 2008).

';95 764@TB6 µC8I;9 C7<RC<4CL;6< 9 E6;6>46N?;9A DN<B;MµC59A 746E;<E?A K<6RCL4<B9A ;@D 7J5@DB;@ %!3 E6< 9 6W<@8J>9B9 ;9A 67@;C8CBµ6;<EJ;9;6A;9A B;9 656E@TN<B9 ;@D 6B=C5?. !7LB9A 67@;D7:5@-

5;6< @< 74@BK@ELCA ;P5 6B=C5:5 ><6 ;95 µCLPB9 ;9AI5;6B9A ;@D 7J5@D ;@DA E6< ;95 C7<=DµL6 6568>9;<E?AK<6RCL4<B9A BC µ<6 74@B7M=C<6 56 74@BK<@4<B;CL ;@µI>C=@A ;9A 67JE8<B9A 65MµCB6 B;95 746>µ6;<E? E6<;95 C764E? K<6RCL4<B9 7J5@D.

"58>?--2@ABAC0<6 ;<A 65M>ECA ;9A µC8I;9A BRCK<MB;9EC µ<6 656-K4@µ<E? 7C4<>46N<E? I4CD56 S6B<QJµC59 B;95 K<C-=5? S<S8<@>46NL6 (Karwowski-Soulie et al 2006,Todd et al 2007, Fosnocht et al 2004) 9 @7@L6 7C4<C-8MµS65C ;95 BDµ78?4PB9 C4P;9µ6;@8J><@D E6;M ;95CLB@K@ E6< ;95 IW@K@ 67J ;6 %!3 E6< ;95 C76EJ8@D-=9 65M8DB9 ;@D <6;4@5@B98CD;<E@T <B;@4<E@T. %@KCL>µ6 67@;I8CB65 J8@< @< 6B=C5CLA µC 7J5@ 7@D74@B?8=65 B;@ %!3 C5JA 0C5<E@T .@B@E@µCL@D #D;<-E?A /;;<E?A E6< KC5 M59E65 B;6 E4<;?4<6 67@E8C<-Bµ@T (3L56E6A 1). & BD88@>? ;P5 B;@<RCLP5 WCEL59-BC E6;J7<5 I>E4<B9A ;@D C4CD59;<E@T 74P;@EJ88@D67J ;95 C7<B;9µ@5<E? C7<;4@7? ;@D 5@B@E@µCL@D E6<746>µ6;@7@<?=9EC E6;M ;95 K<M4EC<6 >C5<E:5 CN9-µC4<:5 ,@D5L@D-,@D8L@D 2009.

& K<6K<E6BL6 7C4<C8MµS65C 64R<EM ;95 C59µI4P-B9 ;P5 6B=C5:5 ><6 ;@5 BE@7J ;9A I4CD56A B;@5 R:4@K<68@>?A ;P5 7C4<B;6;<E:5 E6< B;95 BD5CRCL6 ;95 K<6-5@µ? ;@D C4P;9µ6;@8J><@D E6;J7<5 I>>46N9A BD>E6-;M=CB9A BDµµC;@R?A ;P5 C5K<6NC4@µI5P5 6B=C5:5.& BDµ78?4PB9 ;@D C4P;9µ6;@8J><@D 746>µ6;@7@<-@T;65 BC KD@ R4@5<EIA B;<>µIA: ;95 CLB@K@ E6< ;95IW@K@ 67J ;6 %!3. $< C4P;?BC<A 7C4<C8MµS6565 6D;@-

!I"#$#% 1: !"#$%µ&'"(") "**"*'+µµ&,-, +./",0,

!!""##$$%%$$ &&''(())##**## ++$$,, ++--$$''..%%((&&## ''//&& 001122 4587!!""##$$%%$$ &&''(())##**## µµ)) ++33##$$ 2949 (64%)!!""##$$%%$$ &&''(())##**## ++$$,, 44))## //55--$$""''&&## //&& 66--77//..--77&& 2127 (72%)

I. 8%769&:14 )/*# 394 (18,5%)II. ;%*''& 288 (13,6%)

III. <,'76. 6&7 47&#$5/76. &#76&#3/5/& 27 (1,3%) IV. =,>7&/-76?@ 47&/&-&>?@ 38 (1,8%) V. 23#$@ 7'>&7µ76.@ &7/7$%$A9&@ 204 (9,6%)

VI. 1A6,µ$'"#5 269 (12,6%) VII. GCS <15 115 (5,5%)

VIII. B&6$+$95'5 16 (0,7%) IX. B-&/$"µ)#$7 35 (1,6%) X. C-#5'5 ',µµ)/$>.@ 741 (34,8%)

!!""##$$%%$$ &&''(())##**## ++$$,, //55--$$""''&&## //&& 66--77//..--77&& 822 (28%)I. D#)+&-6. '/$7>)7E )-F/5µ&/$%$A9$, 208(25,3%)

II. D#)+&-6. '/$7>)7E 7'/$-76$" 182 (22,1%) III. D+$>*-5'5 +-7# /5# $%$6%.-F'5 /5@ )G?/&'5@ 68(7,4%)IV. H)# &#),-?(56&# 117 (14,2%)

!!""##$$%%$$ ))AAAA))AA--&&µµµµ??##FF## '',,µµµµ))//))>>33##//FF## 247 (30%)

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 6

Page 8: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [7]

+"+&'*(,-H +".!%/A

6W<@8@>?BC<A ;9A I5;6B9A ;@D 7J5@D, 6D;@656N@4IA><6 ;95 6568>9;<E? K<6RCL4<B9 E6< ;@5 S6=µJ <E65@-7@L9B9A 67J ;95 K<6RCL4<B9 ;@D 7@5@D B;6 %!3.

& K<6K<E6BL6 @8@E894P5J;65 µC BDµ78?4PB9 67J;@5 C4CD59;? ;P5 K9µ@>46N<E:5 R646E;94<B;<E:5;@D 6B=C5?, ;P5 R646E;94<B;<E:5 ;@D 7J5@D, ;9A K<6-RCL4<B9A ;@D 7J5@D (CE;Lµ9B9-=C467CL6) E6< ;9A K<M->5PB9A BDµN:56 µC ;@ <6;4@5@B98CD;<EJ K<M>46µµ6;@D 6B=C5?.

& 6W<@8J>9B9 ;9A I5;6B9A ;@D 7J5@D I><5C µC ;9511-S6=µ<6 64<=µ9;<E? E8Lµ6E6 (11-NRS) E6< @ S6=-µJA <E65@7@L9B9A µC ;95 5-S6=µ<6 E8Lµ6E6 Likert(E6=J8@D-8L>@-64EC;M-7@8T-7646 7@8T). & K<M>5P-B9 E6;M ;95 IW@K@ E6;9>@4<@7@<?=9EC µC SMB9 ;95K<C=5? ;6W<5Jµ9B9 ICD-10 E6< ;6 6568>9;<EM @µ6K@-7@<?=9E65 BC ;4C<A µC>M8CA E6;9>@4LCA (7646EC;6-µJ89-('/U-@7<@C<K?). HA C8MR<B;6 E8<5<EM B9µ65;<-E? K<MN@46 @4LB;9EC µ<6 6886>? B;95 I5;6B9 ;@D7J5@D LB9 ? µC>68T;C49 ;P5 2 µ@5MKP5 (Todd et al2007). $ R4J5@A 6568>9BL6A BD>E4L=9EC BTµNP56 µC;<A E6;CD=D5;?4<CA @K9>LCA ;@D 'D88J>@D !7CL>@DB6A,6;4<E?A ;@D !5PµI5@D 16B<8CL@D.

!D:D89D8>= 2E2F23;:94:';95 7C4<>46N<E? B;6;<B;<E? R49B<µ@7@<?=9E65 BDR5J-;9;CA ><6 ;95 67C<EJ5<B9 R646E;94<B;<E:5 E6< µIB9

;<µ?, ;D7<E? 67JE8<B9 E6< CT4@A ><6 ;95 67C<EJ5<B9;P5 C5;MBCP5. $ I8C>R@A ;9A E6;65@µ?A ;P5 BDR5@-;?;P5 K<6NJ4P5 E6;9>@4<E:5 µC;6S89;:5 65M E6;9->@4LCA M88P5 µC;6S89;:5 746>µ6;@7@<?=9EC µC I8C>-R@ 22 . $< K<6N@4IA B;95 I5;6B9 ;@D 7J5@D 65M C7L7CK6KL;@µ9A E6;9>@4<E?A µC;6S89;?A 746>µ6;@7@<?=9ECµC t-test E6< Mann-Whitney test J;65 6D;IA 6E@8@D-=@T5 ? JR< ;95 E65@5<E? E6;65@µ? 65;LB;@<R6. $ I8C>-R@A ;9A E6;65@µ?A I5;6B9A 7J5@D 65MµCB6 BC @µM-KCA 6B=C5:5 746>µ6;@7@<?=9EC µC one-way ANOVA.

!I"#$#% 2: 1+$2*%'3") 4(+*,0."-, "564%7 +#6 $+ 89: .;µ<-,+ µ" ICD-10

0-&"µ& 99 (40,1%)2&(.')7@ µ,$'6)%)/76$" ','/.µ&/$@ 41 (16,6%)2&(.')7@ #),-76$" ','/.µ&/$@ 23 (9,3%)!,µ+/*µ&/&-I,'76& '5µ)9& 22 (8,9%)2&(.')7@ +)+/76$" ','/.µ&/$@ 17 (6,9%)2&(.')7@ /$, $,-$+$7$A)##5/76$" ','/.µ&/$@ 14 (5,6%)2&(.')7@ $I(&%µ$"-F/$@ 9 (3,7%)2&(.')7@ 6,6%$I$-7&6$" ','/.µ&/$@ 6 (2,4%)C%%)@ +&(.')7@ 16 (6,5%)

0

5

10

15

20

25

30!"#$%$& '($%$& !)*+,µ-./

1 2 3 4 5 6 7 8 9 100

EIKONA 1: 1+$+,%µ= #6,%7 +,> ?+/µ6 &,$+.2)

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 7

Page 9: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[8] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

+"+&'*(,-H +".!%/A

!7L7CK@ B;6;<B;<E?A B9µ65;<EJ;9;6A @4LB;9EC ;@ 5%.& B;6;<B;<E? 65M8DB9 746>µ6;@7@<?=9EC µC R4?B9B;6;<B;<E@T 76EI;@D SPSS v16.

%EAD25G9µ:D:';95 µC8I;9 C>>4MN;9E65 247 6B=C5CLA 7@D 65;<74@-BP7CTC< ;@ 30% ;P5 6B=C5:5 7@D ;94@TB65 ;6 E4<-;?4<6 C7<8@>?A (3L56E6A 1). & µIB9 98<EL6 ;@D KCL>-µ6;@A ?;65 38.5±15,3 I;9 E6< ;@ 54% ;P5 BDµµC;CRJ5;P5?;65 M5;4CA. & 78C<@V9NL6 ;P5 6B=C5:5 (87%) ?;65C8895<E?A E6;6>P>?A. $ 7J5@A ?;65 9 ET4<6 6L;<6 74@-BI8CDB9A ><6 ;@ 80% ;P5 6B=C5:5 E6< CLRC 74@E89-=CL CW6<;L6A ;46Dµ6;<Bµ@T ><6 ;@ 40,1% (3L56E6A 2).

& µIB9 I5;6B9 7J5@D E6;M ;95 CLB@K@ ?;65 7.2±1.9µC ;@ 50% ;P5 6B=C5:5 56 656NI4C< µI;4<@ E6< ;@ 46%<BRD4J 7J5@. ';95 IW@K@ 9 µIB9 I5;6B9 7J5@D ?;655.0±2.1 µC ;@ 60% ;P5 6B=C5:5 56 67@RP4CL µC µI;4<@E6< ;@ 14% µC <BRD4J 7J5@ (!<EJ56 1). & I5;6B9 7J5@D764IµC<5C 6µC;MS89;9 ><6 ;@ 33% ;P5 6B=C5:5 C5:6DW?=9EC ><6 ;@ 2,5% ;P5 6B=C5:5. (J5@ 33% ;P56B=C5:5 SLPBC E8<5<EM B9µ65;<E? µCLPB9 ;9A I5;6-B9A ;@D 7J5@D ;@D (NRS[2).

$< 6B=C5CLA 74@BK@E@TB65 56 67@RP4?B@D5 67J;@ %!3 65 9 78?49 656E@TN<B9 KC5 ?;65 CN<E;? µCµIB9 I5;6B9 7J5@D 2.5±1.3 (!<EJ56 1) E6< µIB@ R4J-5@ ><6 ;95 C7L;CDW9 ;@D 59±47 8C7;M. & µIB9 C7<=D-µ9;? I5;6B9 7J5@D E6;M ;95 IW@K@ KC5 K<6N@4@7@<-

@T;65 BTµNP56 µC ;@ NT8@ (p=0.098) ? ;95 ;46Dµ6;<-E? ? JR< 6<;<@8@>L6 ;@D 7J5@D (p=0.094). $< 74@BK@-ELCA ;P5 6B=C5:5 CE7894:=9E65 µC 67JE8<B9 PA 2µ@5MKCA (NRS\2) µJ8<A B;@ 10,3% 6D;:5.

"65I56A 67J ;@DA 6B=C5CLA KC5 CLRC ;CEµ94<PµI-59 CE;Lµ9B9 ;9A I5;6B9A ;@D 7J5@D µC R4?B9 E8<µM-EP5 B;@ <6;4@5@B98CD;<EJ ;@D K<M>46µµ6. (J8<A 6%CLRC E6;6>C>46µµI59 R4?B9 6568>9;<E@T (!<EJ56 2)RP4LA R4@5<EJ 74@BK<@4<BµJ R@4?>9B9A ;@D. & 7<@BDR5M R49B<µ@7@<@TµC59 E6;9>@4L6 6568>9;<E:5 ?;65;6 ('/U µC 63% C5: 9 @7<@C<K? 6568>9BL6 7C4<@4<-QJ;65 B;@ 1%. 'C J8@DA BRCKJ5 ;@DA 6B=C5CLA (99%)74@;<µ?=9EC 9 C5K@µDXE? R@4?>9B9 6568>9BL6A.

'TµNP56 µC ;95 656N@4M ;@D 6B=C5? E6;M ;95 IW@-K@ ;@ 7@B@B;J R@4?>9B9A 6568>9BL6A 65C4RJ;65 B;@25% (!<EJ56 2) µC µIB@ 65;<897;J R4J5@ 55±22 8C7;M."65I56A 67J ;@DA 6B=C5CLA µC µI;4<@ 7J5@ KC5 I86-SC 67J ;@D B;Jµ6;@A 6568>9BL6 B;95 K<68@>? E6< µJ8<A5,5% ;P5 6B=C5:5 µC <BRD4J 7J5@ I86SC 6568>9BL6(C5K@µDXEM) C5;JA 20 8C7;:5 67J ;95 MN<W9 ;@DA BTµ-NP56 µC ;<A E6;CD=D5;?4<CA @K9>LCA ;@D 'D88J>@D!7CL>@DB6A ,6;4<E?A ;9A (C>M89A 14C;M5<6A.

& 78C<@V9NL6 ;P5 6B=C5:5 BC 7@B@B;J 70% C7<-=Dµ@TBC ;95 8?V9 6568>9;<E@T ><6 ;95 656E@TN<B9;@D 7J5@D ;@D (!<EJ56 2). %@ 24% ;P5 6B=C5:5 C7<-=Dµ@TBC ;95 8?V9 6568>9;<E@T 67J ;@ 5@B98CD;<EJ74@BP7<EJ E6;M ;95 K<68@>? 74<5 ;95 <6;4<E? CWI;6-

0

5

10

15

20

25

30

!)*+,µ"0 1*2340µµ0 5,.$0607$42

4 5 6 7 8 9 103

EIKONA 2: @%'=*2.2 +,+A*2$(B0, +,> ?+/µ6 &,$+.2) #6,%7

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 8

Page 10: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [9]

+"+&'*(,-H +".!%/A

B9. & C7<=DµL6 R@4?>9B9A 6568>9;<E@T C794C6QJ;6567J ;95 I5;6B9 ;@D 7J5@D E6;M ;95 CLB@K@ (p<0.001).(J5@ 32% ;P5 6B=C5:5 7@D C7<=Tµ9B65 ;95 R@4?>9-B9 6568>9;<E@T E6< 7% ;P5 6B=C5:5 7@D KC5 C7<=D-µ@TB65 ;C8<EM I86S65 6568>9;<EJ.

364M ;95 7C4<@4<BµI59 656E@TN<B9 9 @7@L6 KC565;67@E4<5J;65 B;<A 74@BK@ELCA ;P5 6B=C5:5 ;@ 63%?;65 <E65@7@<9µI5@< ? 7@8T <E65@7@<9µI5@< 67J ;95K<6RCL4<B9 ;@D 7J5@D ;@DA. !86N4:A DV98J;C46 BC7@B@B;J 69% 6W<@8J>9B65 ;95 BD5@8<E? N4@5;LK6 ;@D74@S8?µ6;@A ;@DA B;@ %!3 (!<EJ56 3).

!HI=D696';95 764@TB6 µC8I;9 656KC<E5TC;6< J;< 9 K<6RCL4<B9;@D 7J5@D B;@ %!3 CL56< 65C764E? E6=:A BDµN:56µC ;95 6D;@656N@4M ;P5 6B=C5:5 ;6 ? 67@RP4@T5 µCµI;4<@ 9 <BRD4J 7J5@. %@ LK<@ 6E4<S:A 7@B@B;J (74%)K<67<B;:=9EC BC 6B=C5CLA µC µI;4<@ IPA <BRD4J 7J5@(NRS>3), 98<EL6A 8 C;:5 E6< M5P @< @7@L@< 74@B?8-=65 BC 17 %!3 ;P5 &3/ E6< C 3 %!3 ;@D "656KM (Toddet al 2007). 'C 764Jµ@<6 I4CD56 ;@ 78% ;P5 6B=C5:5S<:5C< µI;4<6A ? <BRD4?A C5;MBCPA 7J5@ E6;M ;95 IW@-K@ 67J %!3 ;9A 0688L6A (Karwowski-Soulie et al 2006)E6< @< µ<B@L 67J ;@DA 6B=C5CLA 2 765C7<B;9µ<6E:55@B@E@µCLP5 ;P5 &3/ (Todd et al 2002).

& 64R? ;9A E6E@K<6RCL4<B9A ;@D 7J5@D B;6 %!3N6L5C;6< 56 CL56< 9 67@DBL6 ;CEµ94<PµI59A CE;Lµ9-B9A ;9A I5;6B9A ;@D 7J5@D. 34M>µ6;< BC E65I56 <6;4@-5@B98CD;<EJ K<M>46µµ6 KC5 D7?4RC CE;Lµ9B9 ;9A I5;6-B9A ;@D 7J5@D ;@D 6B=C5? @T;C E6;M ;95 K<68@>? @T;CE6;M ;95 IW@K@ 67J ;6 %!3 >C>@5JA 7@D CW9>CL;6< 67J;95 67@DBL6 C5BPµ6;PµI5P5 E8<µMEP5 CE;Lµ9B9A7J5@D. %@ 67@;I8CBµ6 6D;J CL56< BDµS6;J µC 2 74@9->@TµC5CA I4CD5CA J7@D B;95 74:;9 KC5 D7?4RC E6µ<MCE;Lµ9B9 7J5@D B;@ <6;4<EJ <B;@4<EJ E6< µJ8<A 7% B;@5@B98CD;<EJ <B;@4<EJ (Guru and Dubinsky 2000) C5:B;95 KCT;C49 ;@ 7@B@B;J CE;Lµ9B9A KC5 WC7C45@TBC;@ 23% ;P5 6B=C5:5 (Eder et al 2003). & K<67LB;PB9><6 ;95 CE;Lµ9B9 ;@D 7J5@D 67J ;@ 5@B98CD;<EJ 74@-BP7<EJ B;6 %!3 CL56< J;< ;<A 7C4<BBJ;C4CA N@4IA7C4<@4LQC;6< B;@ ME@DBµ6 ;9A 7C4<>46N?A ;@D 7J5@D67J ;@5 6B=C5? E6;M ;95 74@BI8CDB9 ;@D C5: C76EJ-8@D=CA C765CE;<µ?BC<A >L5@5;6< µJ5@ E6;J7<5 7646-7J5P5 ;@DA ><6 65C764E? 656E@TN<B9 (Blank et al2001).

%@ KCT;C4@ E@µS<EJ B9µCL@ ;9A D7@=C467CL6A ;@D7J5@D B;@ %!3 ;9A µC8I;9A CL56< 9 674@=DµL6 R@4?->9B9A 6568>9BL6A J7@D 9 BD5;6>@>4MN9B9 B;@ K<M->46µµ6 ;@D 6B=C5? CL56< 64EC;M 7C4<@4<BµI59 C5: BC65M8@>CA I4CD5CA ;6 7@B@B;M ;CEµ94<PµI59A R@4?-

1*089"4*#- ):6$,

;,6$<*=/ 74$6."%0

>0+:<$, ?"3$ @$<A54=9.2 @240 )$<A

0

5

10

15

20

25

30

35

40

EIKONA 3: CB+,%#%32.2 +./",0, +#6 $2, 4(+D"3'(.2 $%7 #6,%7 B+( $2, .7,%A(B= <'%,$34+ .$% 89:

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 9

Page 11: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[10] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

+"+&'*(,-H +".!%/A

>9B9A 6568>9BL6A BC 6B=C5CLA µC 7J5@ 7@<EL89A 6<;<@-8@>L6A EDµ6L5C;6< µC;6WT 27-60% (Todd et al 2002,Karwowski-Soulie et al 2006, Todd et al 2007). ,K<-6L;C46 9 @7<@C<K? 6568>9BL6 ?;65 BRCKJ5 65T764E;9µC 8<>J;C4@ 67J 1% ;@ @7@L@ 67IRC< 67J ;@ 7,6% ;P56B=C5:5 7@D I86S65 764C5;C4<EM @7<@C<K? BC %!3;9A /DB;468L6A (Arendts and Fry 2006) E6< ;@ 8,2%;P5 6B=C5:5 7@D I86SC µ@4NL59 BC %!3 ;9A />>8L6A(Forero et al 2008).

& B;6;<B;<EM B9µ65;<E? K<MN@46 (p<0.001) 65MµC-B6 B;95 6D;@656N@46 ;@D 6B=C5? E6< ;@ <B;@4<EJ ;@D><6 ;95 8?V9 6568>9;<E@T E6;M ;95 7646µ@5? ;@D B;6%!3 KC5 SC8;LPBC ;@ N6<5JµC5@ ;9A @8<>@6568>9BL6A./D;? 9 6BDµNP5L6 CLRC K<67<B;P=CL 74@>C5IB;C46 BCµC>68T;C49 IE;6B9 µC ;@DA ><6;4@TA 56 R@49>@T56568>9BL6 B;@ 79,9% ;P5 6B=C5:5 688M 56 ;@ E6;6->4MN@D5 B;@ 31,7% ;P5 <B;@4<E:5 ;@DA >C>@5JA 7@D;@DA @K?>9BC B;@ BDµ7I46Bµ6 J;< 9 656K4@µ<E? 65M-8DB9 K<6>46µµM;P5 KC5 67@;C8CL C764E? 65;<74@B:-7CDB9 ;9A 6568>9;<E?A K<6RCL4<B9A B;6 %!3 (Chisholmet al 2008).

!7LB9A 9 7C4<@4<BµI59 R4?B9 6568>9;<E:5 KC5K<E6<@8@>CL;6< 67J ;95 674@=DµL6 ;P5 6B=C5:5 568MS@D5 6568>9;<EJ ;95 @7@L6 K<67LB;PB65 BC 3926B=C5CLA %!3 J7@D @< µ<B@L 6B=C5CLA µC µIB9 64R<-E? I5;6B9 7J5@D 7.1 (SD=2) KC5 C7<=Dµ@TB65 ;95 8?V96568>9;<E@T ><6 ;95 65;<µC;:7<B9 ;@D 7J5@D ;@DA C5:BC 6D;@TA 7@D C7<=Dµ@TB65 ;@ 81% (95% CI 75% to86%) I86SC 6568>9;<EJ. & 74@B=?E9 E6< ;9A 74@BP-7<E?A CD=T59A ;@D 6B=C5? ><6 ;@5 ;4J7@ K<6RCL4<B9A;@D 7J5@D ;@D BRC;<EM µC ;95 8?V9 6568>9;<E:5 ?;659 M7@V9 7@D 74@;M=9EC 67J 6D;?5 ;95 C4CD5M (Singeret al 2008).

(<6 M889 K<MB;6B9 ;9A 6568>9;<E?A K<6RCL4<B9ACL56< 9 K<M4EC<6 656µ@5?A 67J ;95 K<68@>? µIR4< ;95R@4?>9B9 6568>9;<E:5 N64µMEP5 J7@D BDµN:56 µC;95 6D;@656N@4M ;@D 6B=C5? ?;65 7C4L7@D µ<6 :46.%@ R4@5<EJ 6D;J K<MB;9µ6 CL56< BDµS6;J µC 74@9>@T-µC5CA I4CD5CA B;<A J7@<CA EDµ6L5C;6< 67J 46-1168C7;M (Todd et al 2002, Karwowski-Soulie et al 2006,Todd et al 2007). HB;JB@ 67IRC< 67J ;<A E6;CD=D5;?-4<CA @K9>LCA ;@D 14C;65<E@T 'D5KIBµ@D !7CL>@DB6A,6;4<E?A BTµNP56 µC ;<A J7@<CA 74I7C< 56 R@49>CL-;6< E6;M88989 6568>9BL6 C5;JA 20 8C7;:5 BC 6B=C-5CLA µC <BRD4J 7J5@ E6< E6;M ;95 K<68@>? BC 6B=C5CLAµC µI;4<@ 7J5@, J7@D ;T>R6565 CN64µ@>?A µJ8<A B;@1% ;P5 6B=C5:5 ;9A µC8I;9A. 'C C4CD5M BC %!3 ;9A/>>8L6A 9 µIB9 K<M4EC<6 656µ@5?A ><6 R@4?>9B9 6568->9BL6A BC 6B=C5CLA µC µI;4<@ ? <BRD4J 7J5@ ?;65 1068C7;M E6< @< E6;CD=D5;?4<CA @K9>LCA CN64µJB;9E65µJ8<A B;@ 32% ;P5 6B=C5:5 (Grant 2006).

& C7M4EC<6 ? JR< ;9A =C467CL6A ;@D 7J5@D B;6 %!3KC5 74I7C< 56 7C4<@4LQC;6< µJ5@ BC 6886>IA B;95 I5;6-B9 ;@D 7J5@D ? B;95 R@4?>9B9 N64µMEP5 688M =674I7C< 56 CB;<MQC;6< B;95 CE78?4PB9 ;P5 656>E:5

;P5 6B=C5:5 ><6 656E@TN<B9 67J ;@5 7J5@. (<6 I5;6-B9 7J5@D 2.5 µ@5MKP5 B;95 64<=µ9;<E? E8Lµ6E6 E6;M;95 IW@K@ 67J ;6 %!3 ?;65 65CE;? ><6 ;@DA 6B=C5CLA;9A µC8I;9A 74@BNI4@5;6A C764E? 656E@TN<B9. (C;95 100mm 6568@><E? E8Lµ6E6, 9 65CE;? E6;M ;@56B=C5? I5;6B9 7J5@D CL56< 33mm (Blank et al 2001)C5: 9 µIB9 C7<=Dµ9;? 656E@TN<B9 B;95 <KL6 E8Lµ6-E6, J7@D ;@ 64<B;C4J ME4@ (0mm) 65;<B;@<RCL BC 67@D-BL6 656E@TN<B9A E6< ;@ KCWL ME4@ (100mm) BC 67J-8D;9 656E@TN<B9, CL56< 72mm (95% CI 70-74). (Fosnochtet al 2004).

';95 764@TB6 µC8I;9 @< 6B=C5CLA 67@RP4@TB65µC K<786BL6 I5;6B9 7J5@D 67J ;95 @7@L6 C7<=Dµ@T-B65 65 KC5 ?;65 CN<E;? 9 78?49 656E@TN<B9 C5: 9K<6N@4M 65MµCB6 B;95 746>µ6;<E? E6< ;95 C7<=Dµ9-;? 656E@TN<B9 ?;65 µC>68T;C49 ;P5 2 µ@5MKP5 B;9564<=µ9;<E? E8Lµ6E6 ><6 B;95 BD5;4<7;<E? 78C<@V9NL6;P5 6B=C5:5. /5;LB;@<R6 BC 6B=C5CLA µC E@<8<6EJM8>@A µJ8<A ;@ 14,6% ;P5 6B=C5:5 SLPBC ;95 656E@T-N<B9 7@D C7<=Dµ@TBC B;6 %!3 (Yee et all 2006).

364M ;95 65C764E? 656E@TN<B9 K<67<B;:=9EC J;<@< 6B=C5CLA ?;65 <E65@7@<9µI5@< µC ;95 K<6RCL4<B9;@D 7J5@D ;@DA E6< µC ;95 BD5@8<E? 65;<µC;:7<B9 ;@D74@S8?µ6;@A ><6 ;@ @7@L@ 74@B?8=65. %@ 764MK@W@6D;J N6<5JµC5@ ;@ @7@L@ IRC< K<67<B;P=CL E6< BC 74@9->@TµC5CA I4CD5CA (Todd et al 2002, Todd et al 2007)@K?>9BC B;95 6µN<BS?;9B9 ;9A 67@E8C<B;<E? BDµS@-8? ;9A 656E@TN<B9A ;@D 7J5@D B;95 <E65@7@L9B9 ;@D6B=C5? (<6 7<=65? CW?>9B9 CL56< J;< 9 656E@TN<B9;@D 7J5@D 656NI4C;6< B;95 K<6ETµ65B9 ;9A I5;6B9A;@D BDµ7;:µ6;@A C5: 9 <E65@7@L9B9 B;95 74@BP7<-E? CE;Lµ9B9 ;P5 D794CB<:5 D>CL6A E6< ;<A K<674@BP-7<EIA BRIBC<A (Dawson et al 2002).

/7J ;6 67@;C8IBµ6;6 ;9A 764@TB6A C4>6BL6A >C5-5<I;6< 9 65M>E9 ><6 ;95 8?V9 µI;4P5 7@D IR@D5 ?K974@;6=CL E6< CN64µ@B;CL BC M88CA R:4CA J7PA 9 @4>M-5PB9 CE76<KCD;<E:5 74@>46µµM;P5 (Augarten et al2006, Decosterd et al 2007), 9 C5BPµM;PB9 µ<6A E8L-µ6E6A 7J5@D KL786 67J ;6 D7J8@<76 QP;<EM B9µCL6(Nelson et al 2004, Silka et al 2004, Thomas andAndruszkiewicz 2004) E6< 9 CN64µ@>? E6;CD=D5;9-4LP5 @K9><:5 67J K<C=5CLA @4>65<Bµ@TA J7PA 9 "@<-5? !7<;4@7? 3<B;@7@L9B9A ;@D $4>65<Bµ@T *>C<@5@-µ<E?A 3C4L=68V9A (JCAHO 2001 guidelines), E6< @'T88@>@A !7CL>@DB6A ,6;4<E?A ;9A (C>M89A 14C;M-5<6A (CEM 2004 guidelines).

';95 656B;4@N? ;9A C7<E46;@TB6A E6;MB;6B9A µC;95 65C764E? 65;<µC;:7<B9 ;@D 7J5@D B9µ65;<EJ 4@8JN6L5C;6< 56 K<6K46µ6;LQC< ;@ 5@B98CD;<EJ 74@BP7<-EJ B;@ @7@L@ CERP4CL;6< 9 CD=T59 ><6 ;95 CN64µ@>?74P;@EJ88P5 65;<µC;:7<B9A ;@D 7J5@D (Fry andHoldgate 2002, Fry et al 2004, Kelly et al 2005, Tamchèset al 2007, Viallon et al 2007). Y88PB;C 9 74@ET7;@D-B6 BTB;6B9 67J ;95 E6E@K<6RCL4<B9 ;@D 7J5@D B;6%!3 CL56< J;< ;@ 5@B98CD;<EJ 74@BP7<EJ IRC< E6=?-

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 10

Page 12: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [11]

+"+&'*(,-H +".!%/A

E@5 56 C7<SCS6<:5C< J;< 9 656E@TN<B9 ;@D 7J5@D KJ=9-EC B;@DA 6B=C5CLA (Teanby 2003).

*238A389µA4 µ25GD6C';95 µC8I;9 KC5 BDµ7C4<C8?N=9EC I56A µC>M8@A 64<=-µJA 6B=C5:5 7@D KC5 ;94@TB65 ;6 E4<;?4<6 C5: BCBD5KD6BµJ µC ;@ R6µ98J 7@B@B;J BDµµC;@R?A E6=<-B;@T5 KTBE@89 ;95 >C5LECDB9 ;P5 67@;C8CBµM;P5. ';<A746E;<EIA K<6RCL4<B9A ;@D 7J5@D KC5 E6;6>4MN9EC 9BD5;6>@>4MN9B9 6568>9;<E:5 B;95 IW@K@ E6=:A C7L-B9A E6< 9 8?V9 6568>9;<E:5 74<5 ;95 74@BI8CDB9 B;6%!3 ;@ @7@L@ =6 µ7@4@TBC 56 C794CMBC< ;95 C7<=D-µL6 ;P5 6B=C5:5 ><6 8?V9 6568>9;<E@T E6< ;95 67J-N6B9 ;@D <6;4<E@T 74@BP7<E@T ><6 R@4?>9B9 6568>9-;<E@T. ]56A C7<78I@5 7C4<@4<BµJA ?;65 9 67@DBL6 :46AR@4?>9B9A 6568>9BL6A B;@ K<M>46µµ6 ;@D 6B=C5? ;@@7@L@ LBPA KC5 µ6A C7<;4I7C< ;95 6E4<S? µI;49B9 ;@DR4J5@D 656µ@5?A ><6 R@4?>9B9 6568>9BL6A ;@ @7@L@74@BK<@4<B;<EI µC SMB9 ;@5 65;<897;J 67J ;@5 6B=C-

5? R4J5@ 656µ@5?A. 0<6 ;@ 8J>@ 6D;J KC5 BD>E4L56µC;@5 746>µ6;<EJ µC ;@5 C7<=Dµ9;J R4J5@ ><6 R@4?>9B96568>9BL6A. %I8@A KC5 C4CD5?=9EC 9 R4?B9 ;@7<E:5656<B=9;<E:5 E6< M88P5 µ9 N64µ6E@8@><E:5 764Cµ-SMBCP5 ><6 ;95 µCLPB9 ;@D 7J5@D C7C<K? KC5 E6;6->4MN@5;6< B;@ K<M>46µµ6 ;@D 6B=C5?

!HµE23J9µ:D:H K<6RCL4<B9 ;@D 7J5@D B;@ %!3 R646E;94LQC;6< 67J765;C8?A I88C<V9 CE;Lµ9B9A ;9A I5;6B9A ;@D 7J5@D,67J 7C4<@4<BµI59 R4?B9 6568>9;<E:5 E6< 7646;C;6-µI59 656µ@5? ><6 ;95 R@4?>9B9 ;@DA. $< C7<E46;@T-BCA 6D;IA 746E;<EIA K<6RCL4<B9A ;@D 7J5@D IR@D5 7C5<-R4M 67@;C8IBµ6;6 B;95 656E@TN<B9 ;@D 6B=C5? E6< ;6@7@L6 KC5 65;67@E4L5@5;6< B;<A 65M>ECA E6< ;<A 74@B-K@ELCA ;@D. $< µC88@5;<EIA 74@B7M=C<CA =6 74I7C< 56656KCLW@D5 ;@ =Iµ6 E6< 56 ;@7@=C;?B@D5 ;95 K<6RCL4<-B9 ;@D 7J5@D B;6 %!3 BC 7<@ 74@CWIR@DB6 =IB9 µC7C46<;I4P 6886>IA B;95 K@µ? E6< ;95 8C<;@D4>L6 ;@D.

ABSTRACT

OORRIIGGIINNAALL AARRTTIICCLLEETThhee eeffffeeccttiivveenneessss ooff ppaaiinn mmaannaaggeemmeenntt iinn tthhee EEmmeerrggeennccyy DDeeppaarrttmmeenntt aanndd tthhee ddeeggrreeee ooff rreessppoonnssiivveenneessssttoo tthhee ppaattiieenntt’’ss nneeeeddss..GGeeoorrggee FFiilliippppaattooss,, RRNN,, MMSScc,, GGeenneerraall HHoossppiittaall ooff EElleeffssiinnaa ‘‘TThhrriiaassssiioo’’..

IInnttrroodduuccttiioonn:: Pain is the main reason for out patients visitation to the Emergency Department. Painmanagement however in most cases is inadequate due to underestimation and inefficient treatment. AAiimm:: Identifying pain management practices and assess their effectiveness in pain relief. We also desireto identify the best pain management care plan to effectively reduce the patient’s pain and need foranalgesic drugs.MMeetthhoodd:: A study was conducted at the General Hospital of Attica, Emergency department during Juneand July of 2009. Data was completed by the collection of questionnaires (arrival / discharge) of all patientsaged 14 and over whose illness was not life threatening and had the ability to understand and answerthe questionnaire, and also with the patients analysis charts. Pain intensity was evaluated with an 11point numerical pain scale. RReessuullttss:: 247 patients participated in the study with a mean age 38.5 ± 15.3 years. The mean pain intensity onarrival was 7.2 ± 1.9 and at discharge 5.0 ± 2. Pain intensity was unchanged for 35.5% of patients during theirvisit to the ED. Patients were expected to leave the emergency department with a mean pain intensity of 2.5± 1.3, which deviates more than 2 points for 90% of the patients concerning pain intensity on discharge. In 68%of patients who should have been administered analgesics, they were not administered. Not one of the patientshad their pain intensity documented and less than 6% were recorded to have been administered pain relief. CCoonncclluussiioonnss:: The results showed a poor response in pain relief due to prevailing practice of pain managementin the Emergency Department and a lack of assessment of the needs and expectations of the patient.

KKeeyy wwoorrddss:: Pain management, oligoanalgesia, emergency department, patient expectation, patientsatisfaction

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 11

Page 13: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[12] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

+"+&'*(,-H +".!%/A

18K58A;3:L8>GC %M:LA3GC1. Arendts G, Fry M., 2006. Factors associated with delay to opiate

analgesia in emergency departments. The Journal of pain 7 (9),682-6

2. Augarten A, Zaslansky R, Matok Pharm I, Minuskin T, Lerner-Geva L, Hirsh-Yechezkel G, Ziv A, Shavit I, Yativ N, Keidan I., 2006.The impact of educational intervention programs on painmanagement in a pediatric emergency department. BiomedicinePharmacotherapy 60 (7), 299-302.

3. Berben SA, Meijs TH, van Dongen RT, van Vugt AB, Vloet LC,Mintjes-de Groot JJ, van Achterberg T., 2008. Pain prevalenceand pain relief in trauma patients in the Accident & Emergencydepartment. Injury 39 (5), 578-85

4. Blank FS, Mader TJ, Wolfe J, Keyes M, Kirschner R, Provost D.,2001. Adequacy of pain Assessment and Pain Relief and Correlationof Patient Satisfaction in 68 ED fast-track Patients. Journal ofEmergency Nursing 27 (4), 327-334

5. Campbell P, Dennie M, Dougherty K, Iwaskiw O, Rollo K., 2004.Implementation of an ED protocol for pain management at triageat a busy Level I trauma center. Journal of Emergency Nursing30 (5), 431-8.

6. Chisholm CD, Weaver CS, Whenmouth LF, Giles B, BrizendineEJ., 2008. A Comparison of Observed Versus Documented PhysicianAssessment and Treatment of Pain: The Physician Record DoesNot Reflect the Reality. Annals of Emergency Medicine 52 (4),383-389

7. Cordell WH, Keene KK, Giles BK, Jones JB, Jones JH, BrizentineEJ., 2002. The high prevalence of pain in emergency medicalcare. The American Journal of Emergency Medical 20 (3), 165-169

8. Davoudi N, Afsharzadeh P, Mohammadalizadeh S, HaghdoostAA., 2008. A comparison of patients' and nurses' assessmentsof pain intensity in patients with coronary artery disease. Internationaljournal of nursing practice 14 (5), 347-56.

9. Dawson R, Spross JA, Jablonski ES, Hoyer DR, Sellers DE, SolomonMZ., 2002. Probing the paradox of patients' satisfaction withinadequate pain management. Journal of pain and symptomManagement 23 (3), 211-20.

10. Decosterd I, Hugli O, Tamchès E, Blanc C, Mouhsine E, GivelJC, Yersin B, Buclin T., 2007. Oligoanalgesia in the emergencydepartment: short-term beneficial effects of an educationprogram on acute pain. Annals of Emergency Medicine 50 (4),462-71.

11. Duignan M, Dunn V., 2008. Barriers to pain management inemergency departments. Emergency Nurse 15 (9), 30-34

12. Duignan M, Dunn V., 2008. Congruence of pain assessmentbetween nurses and emergency department patients: a replication.International emergency nursing 16 (1), 23-8.

13. Eder SC, Sloan EP, Todd K., 2003. Documentation of ED patientpain by nurses and physicians. The American journal of emergencymedicine 21 (4), 253-7.

14. Forero R, Mohsin M, McCarthy S, Young L, Ieraci S, Hillman K,Santiano N, Bauman A, Phung H., 2008. Prevalence of morphineuse and time to initial analgesia in an Australian emergencydepartment. Emergency medicine Australasia 20 (2), 136-43.

15. Fosnocht DE, Heaps ND, Swanson ER., 2004. Patient expectationsfor pain relief in the ED. The American journal of emergencymedicine 22 (4), 286-8.

16. Fry M, Holdgate A., 2002. Nurse-initiated intravenous morphinein the emergency department: efficacy, rate of adverse eventsand impact on time to analgesia. Emergency Medicine 14 (3),249-54

17. Fry M, Ryan J, Alexander N., 2004. A prospective study of nurse

initiated panadeine forte: expanding pain management in theED. Accident and emergency nursing 12 (3), 136-40

18. Galinski M, Ruscev M, Gonzalez G, Kavas J, Ameur L, Biens D,Lapostolle F, Adnet F, 2010. Prevalence and management ofacute pain in prehospital emergency medicine. PrehospitalEmergency Care 14 (3), 334-9.

19. Goldman RD, Narula N, Klein-Kremer A, Finkelstein Y, RogovikA., 2008. Predictors for opioid analgesia administration in childrenwith abdominal pain presenting to the emergency department.Clinical Journal of Pain 24 (1), 11-15

20. Grant PS., 2006. Analgesia delivery in the ED. The AmericanJournal of Emergency Medicine 24 (7), 806-809

21. Guru V, Dubinsky I., 2000. The patient vs. caregiver perceptionof acute pain in the emergency department. The Journal ofemergency medicine 18 (1), 7-12.

22. Jastzab G, Fairbrother G, Kerr S, Mclnerney M., 2003. Profilingthe pain aware nurse, acute care nurses’ attitudes and knowledgeconcerning adult pain management. Australian journal ofadvanced nursing 21 (3), 27-33

23. Johnston CC, Gagnon AJ, Pepler CJ, Bourgault P., 2005. Painin the emergency department with one-week follow-up of painresolution. Pain research & management 10 (2), 67-70

24. Karwowski-Soulie F, Lessenot-Tcherny S, Lamarche-Vadel A,Bineau S, Ginsburg C, Meyniard O, Mendoza B, Fodella P,Vidal-Trecam G, Brunet F., 2006. Pain in an emergency department:an audit. European Journal of Emergency Medicine 13 (4), 218-224

25. Kelly AM, Brumby C, Barnes C., 2005. Nurse-initiated, titratedintravenous opioid analgesia reduces time to analgesia forselected painful conditions. Canadian journal of emergencymedical care 7 (3), 149-54.

26. Kozlowski MJ, Wiater JG, Pasqual RG, Compton S, Swor RA,Jackson RE., 2002. Painful discrimination: the differential useof analgesia in isolated lower limb injuries. The American journalof emergency medicine 20 (6), 502-5.

27. Mader TJ, Ames A, Letourneau P., 2006. Pain management inpediatric trauma patients with long bone fracture. Injury 37 (1),61-65

28. McLean SA, Maio RF, Domeier RM., 2002. The epidemiology ofpain in the prehospital setting. Prehospital emergency care 6(4), 402-5.

29. Nelson BP, Cohen D, Lander O, Crawford N, Viccellio AW, SingerAJ., 2004. Mandated pain scales improve frequency of EDanalgesic administration. The American journal of emergencymedicine 22 (7), 582-5.

30. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R., 2008. Trendsin opioid prescribing by race/ethnicity for patients seeking carein US emergency departments. The journal of the AmericanMedical Association 299 (1), 70-8.

31. Probst BD, Lyons E, Leonard D, Esposito TJ., 2005. Factorsaffecting emergency department assessment and managementof pain in children. Pediatric emergency care 21 (5), 298-305

32. Puntillo K, Neighbor M, O'Neil N, Nixon R., 2003. Accuracy ofemergency nurses in assessment of patients' pain. Painmanagement nursing 4 (4), 171-5.

33. Silka PA, Roth MM, Moreno G, Merrill L, Geiderman JM., 2004.Pain scores improve analgesic administration patterns fortrauma patients in the emergency department. Academicemergency medicine 11 (3), 264-70.

34. Singer AJ, Garra G, Chohan JK, Dalmedo C, Thode HC Jr., 2008.Triage pain scores and the desire for and use of analgesics.Annals of emergency medicine 52 (6), 689-95.

35. Tamchès E, Buclin T, Hugli O, Decosterd I, Blanc C, Mouhsine

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 12

Page 14: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [13]

+"+&'*(,-H +".!%/A

E, Givel JC, Yersin B., 2007. Acute pain in adults admitted to theemergency room: development and implementation of abbreviatedguidelines. Swiss medical weekly 137 (15-16), 223-7.

36. Tanabe P, Buschmann M., 1999. A prospective study of ED painmanagement practices and the patient’s perspective. Journalof emergency nursing 25 (3), 171–7

37. Tanabe P, Buschmann M., 2000. Emergency nurses’ knowledgeof pain management principles. Journal of Emergency Nursing26 (4), 299-305

38. Teanby S., 2003. A literature review into pain assessment attriage in accident and emergency departments. Accident andEmergency Nursing 11 (1), 12-17

39. The College of Emergency Medicine. Clinical EffectivenessCommittee: Guideline for the Management of Pain in Adults/Children 2004 http://www.collemergencymed.ac.uk/

40. Thomas SH, Andruszkiewicz LM., 2004. Ongoing visual analogscore display improves Emergency Department pain care. Thejournal of emergency medicine 26 (4), 389-94.

41. Todd HK, Duchrame J, Choiniere M, Crandall SC, Fosnocht ED,Homel P,Tanabe P., 2007. Pain in the emergency department:Results of the Pain and Emergency Medicine Initiative (PEMI)Multicenter Study. The Journal of Pain 6 (8), 460-466

42. Todd KH, Sloan EP, Chen C, Eder S, Wamstad K., 2002. Survey

of pain etiology, management practices and patient satisfactionin two urban emergency departments. Canadian journal ofemergency medical care 4 (4), 252-6.

43. Tsai FC, Tsai YF, Chien CC, Lin CC., 2007. Emergency nurses'knowledge of perceived barriers in pain management in Taiwan.Journal of clinical nursing 16 (11), 2088-95.

44. Van Hulle Vincent C., 2005. Nurses' knowledge, attitudes, andpractices: regarding children's pain. The American journal ofmaternal child nursing 30 (3), 177-83.

45. Viallon A, Marjollet O, Guyomarch P, Robert F, Berger C,Guyomarch S, Navez ML, Bertrand JC., 2007. Analgesic efficacyof orodispersible paracetamol in patients admitted to theemergency department with an osteoarticular injury. Europeanjournal of emergency medicine 14 (6), 337-42.

46. Vlahaki D, Milne WK., 2008. Oligoanalgesia in a rural emergencydepartment. Canadian journal of rural medicine 13 (2), 62-67

47. Wilson JE, Pendleton JM., 1989. Oligoanalgesia in the emergencydepartment. American journal of emergency medicine 7 (6),620-3.

48. Yee AM, Puntillo K, Miaskowski C, Neighbor ML., 2006. Whatpatients with abdominal pain expect about pain relief in theemergency department. Journal of emergency nursing 32 (4),281-7.

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 13

Page 15: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[14] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

Death Attitude Profile-Revised (DAP-R)-!4P;9µ6;@8J><@ K<C4CT59B9A B;MB9A

67I565;< B;@ =M56;@. ';M=µ<B9 ;9A C8895<E?ACEK@R?A ;@D C4P;9µ6;@8@>L@D

((668888<<6644@@TT ((6644LL6611,, ''6644MMNN99AA 3366TT88@@AA22,, ""664466==6655MMBB99 ""PPBB;;6655;;<<55<<MM33,, ''CC4466NNCCLLµµ %%66;;<<MM556644,, ''PP;;9944<<MMKK@@DD ""DD44<<66EE??55,, --CC@@KK@@BB@@77@@TT88@@DD !!88II559966

1. +@R6>JA .@B98CT;4<6 ^DR<E?A *>CL6A, M.Sc 3894@N@4<E? *>CL6A, (C;67;DR<6E? N@<;?;4<6 #<@LE9B9A(@5MKP5 *>CL6A /5@<E;@T 365C7<B;9µL@D "T74@D, *7@V?N<6 #<KME;P4 .@B98CD;<E?A !"3/, 404 0'.,

!7<B;9µ@5<E? BD5C4>M;9A %!, +M4<B6A/;µ?µ6 .@B98CD;<E?A.2. *7@78@L64R@A (*.) 3., ../, PhD, !7<B;9µ@5<EJA 'D5C4>M;9A !"3/,

,6;4CL@ %6W<K<P;<E?A ,6;4<E?A !D>C5LKC<@5 -C467CD;?4<@.3. %6>µ6;M4R9A .@B98CT;4<6, !WC<K<ECD=CLB6 B;9 5@B98CD;<E? RC<4@D4>CL@D AMEDD,

TEXAS USA, (C;67;DR<6E? N@<;?;4<6 #<@LE9B9A (@5MKP5 *>CL6A /5@<E;@T 365C7<B;9µL@D "T74@D,34@XB;6µI59 2C<4@D4>CL@D 404 0'..

4. %6>µ6;M4R9A .@B98CT;4<6 ^DR<E?A *>CL6A, 424 0'.!.5. %6>µ6;M4R9A .@B98CT;4<6, 0!'/#*0/!$#.

6. /567894:;4<6 "6=9>?;4<6 2C<4@D4><E?A .@B98CD;<E?A, !=5<EJ E6< "67@K<B;4<6EJ 365C7<B;?µ<@ /=95:5, ;µ?µ6 .@B98CD;<E?A.

33!!))II++&&^̂&&

''EE@@77JJAA:: H µC;MN46B9 C5JA C4P;9µ6;@8@>L@D CE;Lµ9B9A ;9A B;MB9A ;P5 5@B98CD;:5 67I565;< B;@ =M56;@E6< 9 B;M=µ<B9 ;@D.((II==@@KK@@AA:: 150 5@B98CD;IA BDµ78?4PB65 ;@ C4P;9µ6;@8J><@ ><’ 6D;J ;@ BE@7J. %@ 64R<EJ DAP-R N;<MR;9-EC 67J ;@DA Wong, P.T.P., Reker, G.T., E6< Gesser, G ;@ 1994. 3C4<IRC< 32 C4P;?BC<A, RP4LQC;6< BC 5 D7@-E8Lµ6ECA J7@D @< C4P;:µC5@< 6765;@T5 BC µ<6 C7;6SM=µ<6 Likert scale (BDµNP5: 67J8D;6 IPA K<6NP5:67J8D;6). & E8Lµ6E6 DAP-R µC;6N4MB;9EC B;6 C8895<EM E6< B;9 BD5IRC<6 I><5C VDR@µC;4<EJA I8C>R@A ;@DC4>68CL@D. 0<6 ;9 µC;MN46B9 E6< R4?B9 ;P5 C4>68CLP5/C4P;9µ6;@8@>LP5 K<6BN68LB;9EC 64R<EM I>>46N9MKC<6 µC;MN46B9A 67J ;@DA BD>>46NCLA. & K<6K<E6BL6 ;9A µC;MN46B9A B;6 C8895<EM I><5C BTµNP56 µC ;9K<6K<E6BL6 7@D 74@;CL5C;6< 67J ;95 “Trust Scientific Advisory Committee” SAC: (K<78? 65;LB;4@N9 µC;M-N46B9) E6< 7@8<;<Bµ<E? 74@B64µ@>?, B;M=µ<B9 ;@D C4P;9µ6;@8@>L@D. 0<6 ;95 B;M=µ<B9 ;@D C4P;9µ6;@8@->L@D K<C5C4>?=9E65 BD>ECE4<µI5CA VDR@µC;4<EIA K@E<µ6BLCA ><6 ;95 CE;Lµ9B9 ;9A 6W<@7<B;L6A (reliability);@D C4P;9µ6;@8@>L@D, ;9A C>ED4J;9;6A (validity), C5: 764M88986 I><5C I8C>R@A ;9A K@µ?A ;@D (factor analysis).//77@@;;CC88IIBBµµ66;;66:: $ 764M>@5;6A «/7@ND>? =65M;@D» BDµ7L7;C< µC ;9 K<MB;6B9 «Death avoidance». !7LB9A,@ 764M>@5;6A «UJS@A =65M;@D» 67@;C8CL;6< 6E4<S:A 67J ;<A LK<CA C4P;?BC<A µC ;9 K<MB;6B9 «Fear ofdeath». $ 764M>@5;6A «$DKI;C49 67@K@R?» BDµ7L7;C< µC ;9 K<MB;6B9 «Neutral acceptance». $< C4P;?-BC<A 4,8,13,16 E6< 31 µC ;95 76467M5P 65M8DB9 7C4<IR@5;6< B;@5 764M>@5;6 «(IB@ K<6ND>?A» 65;L 56 7C4<I-R@5;6< B;9 K<MB;6B9 «Approach acceptance».''DDµµ77CC44MMBBµµ66;;66:: H C8895<E? CEK@R? ;@D DAP-R 67@;C8CL I56 6W<J7<B;@ E6< I>ED4@ C4>68CL@ ><6 ;95 CE;Lµ9-B9 ;9A B;MB9A ;P5 5@B98CD;:5 67I565;< B;@ =M56;@.

++IIWWCC<<AA EE88CC<<KK<<MM:: =M56;@A, 5@B98CD;?A, B;M=µ<B9.

+"+&'*(,-H +".!%/A

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 14

Page 16: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [15]

+"+&'*(,-H +".!%/A

)89:;<;=: $ =M56;@A ;P5 6B=C5:5 B;@5 C4>6B<6EJ R:4@ ;@D 5@B@-E@µCL@D C794CMQC< ;95 VDR@8@>L6 ;P5 5@B98CD;:5K9µ<@D4>:5;6A BD56<B=?µ6;6 NJS@D –M>R@DA =65M-;@D. & CE76LKCDB9 7@D 86µSM5@D5 @< 5@B98CD;IA 74I-7C< 56 E68T7;C< =Iµ6;6 K<6RCL4<B9A 67:8C<6A ><6 56µ7@4@T5 56 65;67CWI4R@5;6< B;95 E6=9µC45? C76N?µC ;@5 =M56;@, µC ;@ BD>>C5<EJ 7C4<SM88@5 ;P5 6B=C-5:5 E6< 56 K<6RC<4LQ@5;6< ;<A K<EIA ;@DA 656KDJµC5CABEIVC<A E6< BD56<B=?µ6;6. $< C76>>C8µ6;LCA 5@B9-8CD;IA 74I7C< 56 µ7@4@T5 56 K<@RC;CT@D5 ;@ M>R@A=65M;@D µIB6 BC @µMKCA VDR@8@><E?A D7@B;?4<W9A.!L56< B9µ65;<EJ 56 >5P4LQ@D5 E6< 56 656>5P4LQ@D5 @<5@B98CD;IA ;95 B;MB9 ;@DA 67I565;< B;@5 =M56;@ ><656 µ7@4IB@D5 ;C8<EM 56 ;@ K<6RC<4<B;@T5 (Kubler-Ross, 1969).

-2@ABA5A;4::150 5@B98CD;IA BDµ78?4PB65 ;@ C4P;9µ6;@8J><@ ><’6D;J ;@ BE@7J. %@ 64R<EJ DAP-R N;<MR;9EC 67J ;@DAWong, P.T.P., Reker, G.T., E6< Gesser, G ;@ 1964. 3C4<I-RC< 32 C4P;?BC<A, RP4LQC;6< BC 5 D7@E8Lµ6ECA J7@D@< C4P;:µC5@< 6765;@T5 BC µ<6 C7;6SM=µ<6 Likertscale (BDµNP5: 67J8D;6 IPA K<6NP5: 67J8D;6).

$< D7@E8Lµ6ECA CL56< 6) Fear of death - UJS@A=65M;@D (1, 2, 7, 18, 20, 21, 32) S) death avoidance -/7@ND>? =65M;@D (3, 10, 12, 19, 26) >) neutral acceptance- $DKI;C49 /7@K@R? (6, 14, 24, 17, 30) K) approachacceptance - /7@K@R? =65M;@D (4, 8, 13, 15, 16, 22,25, 27, 28, 31) C) escape acceptance - #<6ND>? (5, 9,11, 23, 29). ';95 764@TB6 µC8I;9, 9 E8Lµ6E6 DAP-RµC;6N4MB;9EC B;6 C8895<EM E6< B;9 BD5IRC<6 I><5CVDR@µC;4<EJA I8C>R@A ;@D C4>68CL@D. 0<6 ;95 B;M=µ<-B9 ;@D C4P;9µ6;@8@>L@D K<C5C4>?=9E65 BD>ECE4<µI-5CA VDR@µC;4<EIA K@E<µ6BLCA ><6 ;95 CE;Lµ9B9 ;9A6W<@7<B;L6A (reliability) ;@D C4P;9µ6;@8@>L@D, ;9AC>ED4J;9;6A (validity), C5: 764M88986 I><5C I8C>R@A;9A K@µ?A ;@D (factor analysis).

0<6 ;9 µC;MN46B9 E6< R4?B9 ;P5 C4>68CLP5/C4P-;9µ6;@8@>LP5 K<6BN68LB;9EC 64R<EM I>>46N9 MKC<6µC;MN46B9A 67J ;@DA BD>>46NCLA ;P5 C4P;9µ6;@8@->LP5 E6< ;@DA E6;JR@DA ;P5 K<E6<PµM;P5 IEK@B9A.

& K<6K<E6BL6 ;9A µC;MN46B9A B;6 C8895<EM I><-5C BTµNP56 µC ;9 K<6K<E6BL6 7@D 74@;CL5C;6< 67J ;95“Trust Scientific Advisory Committee” SAC (MedicalOutcomes Trust Bulletin 1997 E6< MAPI ResearchInstitute, 2002): 6) K<>8PBB<E? µC;MN46B9 74@A KT@ E6;CD=T5BC<A(forward translation, backward translation) S) 7@8<;<Bµ<E? 74@B64µ@>? (cultural adaptation) µC7<8@;<E? CN64µ@>? ;P5 E8<µMEP5 B;@DA C4P;:µC5@DAµC R4?B9 ;9A >5PB;<E?A 74@BI>><B9A C765674@BK<@-4<Bµ@T (cognitive debriefing process/interview). &µC;MN46B9 E6< 9 74@B64µ@>? CL56< 7<=65J 56 688M-W@D5 ;95 CBP;C4<E? K@µ?, ><’ 6D;J R4C<MQC;6< 56 K<6-BN68<B;CL 9 6W<@7<B;L6 E6< C>ED4J;9;6 ;@D 656=CP-

49µI5@D C4>68CL@D. & µC;6N46B=CLB6 CEK@R? =CP-4CL;6< <BJ;<µ9 ;@D 74P;@>C5@TA C4>68CL@D µJ5@5 J;659 6W<@7<B;L6, 9 C>ED4J;9;6 E6< @ K@µ<EJA 764M>@5;6ACL56< 764Jµ@<6 µC ;@ 74P;@>C5IA C4>68CL@.

//WW<<@@77<<BB;;LL66HA 6W<@7<B;L6 C5JA C4CD59;<E@T C4>68CL@D @4LQC;6< 9IE;6B9 B;95 @7@L6 ;@ C4>68CL@ KL5C< ;6 LK<6 67@;C8I-Bµ6;6 BC C765C<89µµI5CA µC;4?BC<A E6< 656NI4C;6<B;95 6568@>L6 6E4LSC<6A E6< 656E4LSC<6A B;9 µI;49B9.

$< ;4C<A ED4<J;C4CA <K<J;9;CA ;9A 6W<@7<B;L6A CL56<9 B;6=C4J;9;6, K986K? 9 <E65J;9;6 µ<6A E8Lµ6E6A 56KL5C< ;6 LK<6 67@;C8IBµ6;6 BC C765C<89µµI5CA µC;4?-BC<A, 9 @µ@<@>I5C<6, 7@D B9µ6L5C< J;< J86 ;6 B9µCL6BC I56 C4>68CL@ µC;4@T5 ;95 LK<6 I55@<6 ? R646E;9-4<B;<EJ, E6< ;95 <B@KD56µL6, K986K? ;95 <E65J;9;6 ;@DC4>68CL@D 56 764M>C< ;6 LK<6 67@;C8IBµ6;6 J;65 R49-B<µ@7@<@T5;6< 764M88986 C4>68CL6 ? K<6K<E6BLCA.';<A CE;<µ?BC<A CBP;C4<E?A BD5@R?A R49B<µ@7@<CL-;6< @ BD5;C8CB;?A 6 ;@D Cronbach, µC ;@5 @7@L@ D7@-8@>LQC;6< 9 CBP;C4<E? BD5I7C<6 ? 9 @µ@<@>I5C<6 C5JAC4>68CL@D. !<K<EJ;C46, @ 6 67@;C8CL ;@ R6µ98J;C4@J4<@ ><6 ;95 689=<5? 6W<@7<B;L6 @8JE8949A ;9A I4CD-56A. (6=9µ6;<EM, 9 6W<@7<B;L6 E6=@4LQC;6< PA 9 656-8@>L6 ;9A µC;6S89;J;9;6A ;P5 65;67@E4LBCP5 ;9AµC8I;9A, 7@D CL56< ;@ 67@;I8CBµ6 ;P5 K<6N@4:5 65M-µCB6 B;@DA BDµµC;IR@5;CA. 'D5C7:A, @< 65;67@E4L-BC<A BC µ<6 6W<J7<B;9 µC8I;9 =6 K<6NI4@D5 8J>P ;@DJ;< ;6 M;@µ6 7@D BDµµC;IR@D5 IR@D5 K<6N@4C;<EIA67JVC<A E6< JR< K<J;< 9 I4CD56 CL56< BD>RD;<E? ? 74@-E68CL K<MN@4CA C4µ95CLCA. (C M886 8J><6, JB@ V98J-;C4@A CL56< @ 6, K986K? JB@ 7<@ E@5;M B;@ 1, ;JB@µC>68T;C49 CL56< 9 6W<@7<B;L6.

!!>>EEDD44JJ;;99;;66& C>ED4J;9;6 656NI4C;6< B;@ E6;M 7JB@ I56 C4CD59-;<EJ C4>68CL@ µC;4M µC 6E4LSC<6 6D;J 7@D D7@;L=C;6<J;< µC;4M. (<6 E8Lµ6E6 µ7@4CL 56 CL56< 6W<J7<B;9 688M56 µ95 CL56< I>ED49, E6< 9 V98? 6W<@7<B;L6 KC5 67@-;C8CL 67646L;9;9 I5KC<W9 ;9A C>ED4J;9;6A, C5: ;@I>ED4@ C4>68CL@ CL56< 7M5;@;C 6W<J7<B;@. ';9 S<S8<@->46NL6 7C4<>4MN@5;6< ;4L6 CLK9 C>ED4J;9;6A: 7C4<C-R@µI5@D, K986K? 9 IE;6B9 B;95 @7@L6 ;@ 7C4<CRJµC-5@ ;9A E8Lµ6E6A 65;<74@BP7CTC< BN6<4<EM µ<6 I55@<6,E4<;94L@D, 9 @7@L6 KCLR5C< ;@ S6=µJ ;9A BRIB9A 65M-µCB6 B;95 67JK@B9 BC µ<6 E8Lµ6E6 E6< B;95 746>µ6-;<E? BDµ7C4<N@4M ;@D D7@EC<µI5@D, E6< K@µ<E?, 9@7@L6 S6BLQC;6< B;95 IE;6B9 B;95 @7@L6 µ<6 E8Lµ6E6µC;4M EM7@<6 =CP49;<E? K@µ? ? I56 R646E;94<B;<EJ.

//55MM88DDBB99 77664466>>JJ55;;PP55& 65M8DB9 7646>J5;P5 (factor analysis) 67@;C8CL µ<674@BI>><B9 6W<@8J>9B9A ;9A K@µ<E?A C>ED4J;9;6A,7@D KL5C< B;@5 C4CD59;? 7894@N@4LCA BRC;<EM µC ;95IE;6B9 B;95 @7@L6 µ<6 @µMK6 B9µCLP5 µC;4M ;95 LK<6K<MB;6B9 µ<6A I55@<6A. %6 B9µCL6 6D;M N@4;LQ@D5 BC

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 15

Page 17: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[16] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

+"+&'*(,-H +".!%/A

K<6N@4C;<E@TA 764M>@5;CA E6< 9 65M8DB9 CL56< C7L-B9A C5KC<E;<E? ;@D E6;M 7JB@ ;6 B9µCL6 C5JA C4>6-8CL@D 65;656E8@T5 µL6 µ@56K<E? ? 7C4<BBJ;C4CA I55@<-CA. & K<C4CD59;<E? 65M8DB9 7646>J5;P5 «B;@RCTC<B;95 6W<@8J>9B9 ;9A C>ED4J;9;6A ;@D ;4J7@D K<6RCL-4<B9A µ<6A @µMK6A KC<E;:5, µC ;4J7@ 7@D 56 65;656-E8@T5 ;95 LK<6 I55@<6». (C M886 8J><6, 9 µI=@K@A 6D;?6568TC< ;@5 ;4J7@ µC ;@5 @7@L@ @µ6K@7@<@T5;6< @<65;67@E4LBC<A, I;B< :B;C 56 KL5@D5 5J9µ6 ><6 ;9 BRI-B9 7@D D7M4RC< 65MµCBM ;@DA. $< 6568TBC<A 6D;IACWC;MQ@D5 ;6 B9µCL6 ;P5 E8<µMEP5 WCRP4<B;M ><6 K@µ<-E? C>ED4J;9;6.

&& KK<<66KK<<EE66BBLL66 µµCC;;MMNN4466BB99AA ;;99AA EE88LLµµ66EE66AA & E8Lµ6E6 R49B<µ@7@<?=9EC µC;M 67J >467;? MKC<6;@D C5JA CE ;P5 ;P5 BD>>46NIP5 E. Reker, G.T ><6µC;MN46B? ;9A B;6 C8895<EM. & K<6K<E6BL6 ;9A µC;M-N46B9A B;6 C8895<EM I><5C BTµNP56 1C ;9 K<6K<E6-BL6 7@D 74@;CL5C;6< 67J ;95 «Trust Scientific AdvisoryCommittee» (Medical Outcomes Trust., 1997). ';J-R@A ?;65 9 µC;MN46B9 ;@D C4P;9µ6;@8@>L@D 67J ;6/>>8<EM B;6 !8895<EM, K<6;94:5;6A ;6 ET4<6 R646E;9-4<B;<EM ;@D C4P;9µ6;@8@>L@D. "6;64R?5, I><5C µC;M-N46B9 B;6 C8895<EM E6< E6;J7<5 µC;6N4MB;9EC 65;L-B;4@N6 B;6 6>>8<EM KL>8PBB@ 5@B98CD;? 74@EC<µI5@D56 CW6BN68<B;CL 9 6E4<S?A 67JK@B9 ;P5 C4P;9µ6;@-8@>LP5 B;6 C8895<EM. %6 KT@ M;@µ6 7@D IE6565 ;9µC;MN46B9 C4>MB;9E65 65CWM4;9;6 E6< @ ET4<@A B;J-R@A ;9A 65;LB;4@N9A µC;MN46B9A ?;65 56 K<6BN68<-B;CL J;< @< C4P;?BC<A B;<A KT@ >8:BBCA =6 CLR65 ;95LK<6 I55@<6. ';9 BD5IRC<6, ;6 C4P;9µ6;@8J><6 BDQ9-;?=9E65 µC 65CWM4;9;@ 765C7<B;9µ<6EJ E6=9>9;? ;9A.@B98CD;<E?A, >5:B;9 ;@D =Iµ6;@A, ><6 ;95 6W<@8J->9B9 ;@D 8CE;<E@T, ;@D >46µµ6;<E@T E6< ;@D C55@<@-8@><E@T 7C4<CR@µI5@D ;P5 µC;6N4MBCP5. /E@8@T=9-BC BR@86B;<EJA I8C>R@A E6< BDQ?;9B9 67J ;95 C4CD59;<E?@µMK6 E6<, ;I8@A, I><565 @4<BµI5CA 6886>IA E6< C8M-R<B;CA >8PBB<EIA SC8;<:BC<A, :B;C 56 ;C8C<@7@<9=CL9 67JK@B9 B;6 C8895<EM. 0<6 56 E4<=CL 9 7@8<;<Bµ<E?E6;68898J;9;6 E6< BRC;<EJ;9;6 ;9A µC;MN46B9A ><6;@5 789=DBµJ-B;JR@, ;@ µC;6N46BµI5@ C4>68CL@ KJ=9-EC BC µ<6 @µMK6 6;JµP5 E6;M ;9 K<M4EC<6 7<8@;<E?AµC8I;9A. $ I56A 67J ;@DA E6;6BECD6B;IA ;@D C4P;9-µ6;@8@>L@D @ E. Reker, G.T., 67J ;@5 @7@L@ 8MS6µC ;95I>E4<B9 ><6 ;95 µC;MN46B9 ;@D, KC5 IE65C E6µL6 ;4@-7@7@L9B9 C7L ;@D µC;6N46BµI5@D C4P;9µ6;@8@>L@D.

33@@88<<;;<<BBµµ<<EE?? 7744@@BB6644µµ@@>>?? ;;@@DD CC44PP;;99µµ66;;@@88@@>>LL@@DD ((ccuullttuurraallaaddaappttaattiioonn)) 0<6 ;95 7@8<;<Bµ<E? 74@B64µ@>? (cultural adaptation)R49B<µ@7@<?=9EC ;@ C4P;9µ6;@8J><@ BC I56 ;DR6L@KCL>µ6 7I5;C 5@B98CD;:5, J7PA 74@;CL5C;6< B;95 K<6-K<E6BL6 >5PB;<E?A 656BEJ79B9A (cognitive debriefingprocess) (Medical Outcomes Trust., 1997). /N@T 74:-;6 C4P;?=9E65 ;6 M;@µ6 BD5@8<EM ><6 56 BDµ7894P-=CL ;@ C4P;9µ6;@8J><@, B;9 BD5IRC<6 4P;?=9E65 ><6

EM=C C4:;9B9 RP4<B;M 65 ?;65 E6;65@9;? E6< 65 R4C<-6QJ;65 56 ;95 656K<6;D7:B@D5 µC K<EM ;@DA 8J><6 ?74@;<µ@TB65 56 6886R;CL EM7@<6 BD>ECE4<µI59 8IW9BC EM7@<6 C4:;9B9 I;B< :B;C 56 >L5C< 7<@ E6;65@9;?9 C4:;9B9 (cognitive debriefing interview). %@ C4P-;9µ6;@8J><@ E6;M ;95 K<M4EC<6 ;9A 7@8<;<Bµ<E?A 74@-B64µ@>?A (cultural adaptation), ?;65 >C5<EM E6;65@9-;J E6< CTE@8@ BTµNP56 µC ;6 BRJ8<6 ;P5 5@B98CD;:5.#C5 D7?4W65 74@;MBC<A ;P5 C4P;:µC5P5 :B;C 56C5BPµ6;P=@T5 BC 5I6 KCT;C49 CEK@R? ;@D C4P;9µ6-

!&"#$#% 1. E2µ%*'+<(B> .$%(D"3+ $-, .7µµ"$"D6,$-,

N %

<<""%%$$;,#&96)@ 123 82,0C#4-)@ 27 18,088%%776699&&,, µµ??''55 //77µµ..±±SSDD 35,5±7,255%%776699&&<32 36 24,032-40 78 52,0>40 36 24,0JJ7766$$AA))##))77&&66.. 66&&//EE''//&&''55CA&µ$@/5 48 32,0KAA&µ$@/5 87 58,0H7&L),Aµ?#$@/>.-$@ 15 10,011++99++))44$$ ))66++&&9944)),,''55@@21 24 16,001 63 42,0H1 63 42,0MM??''55 ''//$$ >>**--$$ ))--AA&&''99&&@@2-$N'/Eµ)#$@ 6 4,0D#&+%5-F/.@ +-$N'/Eµ)#$@ 9 6,0O$'5%),/.@ 72 48,0P$5(3@ #$'5%),/. 60 40,00-&,µ&/7$I$-?&@ 3 2,022--$$QQ++55--))''99&&,, µµ??''55 //77µµ..±±SSDD 12,1±8,100µµ..µµ&& ))--AA&&''99&&@@D#&7'(5'7$%$A763 18 12,01GF/)-76E 7&/-)9& 3 2,0B&-47$%$A76. 6%7#76. 12 8,0R1M 3 2,0R$#E4& /)>#5/$" #)I-$" 3 2,0O),-$>)7-$,-A76. 3 2,0J-($+)476. 6%7#76. 3 2,02&($%$A76. 6%7#76. 42 28,0012 6 4,0S)7-$,-A)9$ 30 20,0S)7-$,-A76. 6%7#76. 15 10,0=,>7&/-76. 6%7#76. 12 8,0SS--$$##776633 4477EE''//55µµ&& ''//$$ //µµ..µµ&&,, µµ??''55 //77µµ..±±SSDD 5,4±6,0

TOMOS4_TEFXOS1 5/11/11 11:21 AM Page 16

Page 18: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"!#$%&'(H !")*+,A

!"#"$%"&, "'(!) *+, '+-+µ)%.+µ) /!0. +-1,*2 µ)!3-4-+/2 !"&, 0 "'"%+ +'"!)#)% *+, !0. !)#,*2 5##0.,-*2 µ)!34-+/0 (final version) !"& )-6!0µ+!"#"$%"&('67 '+-"&/,38)!+, /!" 9+-3-!0µ+.

99##00::&&//µµ((77 µµ))##;;!!0077 **++,, µµ;;::""<<"",, //!!++!!,,//!!,,**2277 ++..33##&&//0077H /!3:µ,/0 *+, 0 '-"!='6/0 !"& )-6!0µ+!"#"$%"&;$,.) /) 150 ."/0#)&!;7 $).,*>. ."/"*"µ)%6. !07

!"µ#$ 4 - !%&'#$ 1 [17]

!I"#$#% 2. !"µ#$%&'(%) *+, -"µµ$*$./,*+, 0#1,0,*& -$ 0-2$,$34 #%(.+%5µ1,(" -*063("

N %

!!""##$$%% &&''(())%% **++,, $$--..''µµ//..00 ))((11$$##**$$ ##$$ $$2200&&33 µµ$$ 22$$((4422**55##++ 00((((66##**''77 22''77 8800**009933::$$;;,, µµ))##++ **;;µµ33±±SSDD 0,6±1,0<<11$$**$$ 99//--$$;; ##77::88$$88((;;µµ)),,++ $$88220044..$$77##++ ##**++ ##11''9933 &&''44**++##++%% ::;;00 ..;;0011$$44((;;##++ ==00,,//**''77>0; 69 46,0?1; 81 54,0>>''##++99$$@@$$**00;; 00##==$$,,$$44%% µµ$$ 22((''1155((++µµ)),,++ ,,""##'' **++,, 2200((''@@##00 ##**;;::µµ33>0; 63 42,0?1; 87 58,0<<11$$**$$ ##77AA++**33##$$;; µµ$$ 00##==$$,,$$44%% µµ$$ 22((''1155((++µµ)),,++ ,,""##'' ::;;00 **'' ==))µµ00 **''77 ==00,,//**''77>0; 69 46,0?1; 81 54,0BB,, ##77AA++**//**$$ µµ$$ 00##==$$,,$$44%% µµ$$ 22((''1155((++µµ)),,++ ,,""##'' ::;;00 **'' ==//,,00**'' 22""##'' //--''9900 ##00%% 88//,,$$;; 0077**"" ,,00 00;;##==//,,$$##**$$??C$, #7A+*6 60 40,0!/(0 2'9@ 24 16,0!'9@ 33 22,0D)*(;0 12 8,0B.;0&'(6 3 2,0E9/1;#*0 9 6,0F4:' 6 4,0G0="9'7 3 2,0!!'';;00 $$((66**++##++ **''77 00##==$$,,33 ##00%% ))8800,,$$ ,,00 00;;##==00,,==$$44**$$ //--''9900??:;0*4 + :(0µµ3 A53% #*' 1)(; µ'7 $4,0; µ;8("*$(+? 3 2,0:;0*4 #$ $µ),0 3 2,0.$, .4,$; 02/,*+#+ 72 48,0.$, )15 $(5*+=$4 3 2,0)15 *$9$;6#$; µ$ *;% $88($µ"*+*$% µ$ *'7% #7::$,$4% 3 2,0=0 A3#5 3 =0 2$=/,5 12 8,080µ40 6 4,0µ2'($4*$ ,0 µ$ -'+=3#$*$ 3 2,0"9$% 6 4,02';'% 2)=0,$ 1=$%? 3 2,02"#'% 80;("% µ'7 µ),$; 18 12,02"*$ =0 $4µ0; )*';µ'% ,0 2$=/,5? 3 2,0*; 08(;-6% )15 3 2,0*; =0 02':4,$; + ';8':),$;0 µ'7 3 2,0*; 72/(1$; µ$*/ *' =/,0*' 6 4,0*' =)µ0 =0,/*'7 3 2,0DD;;99//**$$ 00,,'';;88**// µµ$$ **''77%% 00##==$$,,$$44%% ##00%% ::;;00 **'' ==))µµ00 **''77 ==00,,//**''77??>0; 18 12,0?1; 132 88,0GG//,,$$**$$ 22$$((;;22''44++##++ ,,$$88((''@@??>0; 99 66,0?1; 51 34,0

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 17

Page 19: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[18] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

!I"#$#% 5. !",*$7$-*14 -"-.1*&-54 *+, 6&0-*)-$+, *(" $%+*5µ0*(7(83(" DAP-R

death neutral approach escapeavoidance acceptance acceptance acceptance

fear of death rr 0,35 -0,43 0,23 0,20 PP <<00,,000011 <<00,,000011 00,,002211 00,,004422

death avoidance rr 0,03 0,29 0,07 PP 0,801 00,,000044 0,514

neutral acceptance rr 0,03 0,01 PP 0,768 0,959

approach acceptance rr 0,46 PP <<00,,000011

!I"#$#% 4. 9&0-*)-$&4 *(" $%+*5µ0*(7(83(" DAP-R

:7).&-*5 *&µ; <18&-*5 *&µ; <1-5 *&µ; SD Cronbach's a

fear of death 1,9 14,4 4,9 1,9 0,71death avoidance 1,2 7,0 4,9 1,5 0,85neutral acceptance 4,0 7,0 5,6 0,9 0,65approach acceptance 1,0 6,0 4,2 1,2 0,82escape acceptance 1,0 6,4 2,9 1,6 0,86

!I"#$#% 3. E#&%%(; #(" 0-=$3 *( #$%&-*0*&=/ *(" 20,)*("

N %

HH77AA++**//**$$ ##**'' **µµ33µµ00 ##00%% ::;;00 **'' 22$$((;;##**00**;;88"" **''77 ==00,,//**''77 ""**00,, 0077**"" ##77µµ--$$44??>0; 126 84,0?1; 24 16,0BB,, ##77AA++**//**$$ ,,''µµ44AA$$**$$ 2255%% 0077**"" **$$99;;88// ##00%% 00,,0088''77&&44AA$$;;??>0; 78 52?1; 72 48EE//,, ..$$,, ##77AA++**//**$$ ##**'' **µµ33µµ00 ##00%% ::;;00 **'' 22$$((;;##**00**;;88"" **''77 ==00,,//**''77 22""##'' 0077**"" ##00%% $$22++(($$//AA$$;; 00((,,++**;;88//??!/(0 2'9@ 18 12B.;0&'(6 18 12G0="9'7 114 76,0!!'';;'' **((""22'' ==00 $$22;;99))::00**$$ ::;;00 ,,00 00,,0088''77&&;;##**$$44**$$ 0022"" **00 ##77,,00;;##==33µµ00**00 22''77 00,,00..@@'',,**00;; 0022"" **'' 22$$((;;##**00**;;88"" **''77 ==00,,//**''77??B2'µ',6,'µ0; 6 4,0B2'&$@:5 ,0 *' #7A+*3#5 µ$ #7,0.)9&'7% 3 2,0G9045 :;0 ,0 I$#2/#5 18 12,0J' #8)2*'µ0; #*' #24*; µ'7 72 48,0B.;0&'(6 293(5% 18 12,0J42'*0 02" *0 20(02/,5 33 22,0KK44,,'',,**00;; ''µµ//..$$%% 22((''##5522;;88''@@ ::;;00 **++,, ..;;0011$$44((;;##++ ##77,,00;;##==++µµ//**55,, ##**'' ,,''##''88''µµ$$44'' 22''77 ..''7799$$@@$$**$$??>0; 6 4,0?1; 144 96,0!!55%% $$22++(($$//AA$$;; **++,, 22((''##5522;;8833 ##00%% AA5533 )),,00 **))**'';;'' ##77µµ--//,,??!/(0 2'9@ 12 8,0!'9@ 30 20,0D)*(;0 45 30,0E9/1;#*0 39 26,0F4:' 9 6,0G0="9'7 15 10,0

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 18

Page 20: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [19]

!"!#$%&'(H !")*+,A

!I"#$#% 6. !",*$7$-*14 -"-.1*&-54 *+, 6&0-*)-$+, *(" $%+*5µ0*(7(83(" DAP-R µ$ *5, 57&=30 *+, -"µµ$*$./,*+,

>7&=30fear of death r 0,11

P 0,257death avoidance r 0,27

P 0,006neutral acceptance r 0,03

P 0,760approach acceptance r 0,07

P 0,513escape acceptance r -0,02

P 0,828

!I"#$#% 7. ?,)7"-54 #0%08/,*+, µ$ *5 µ12(6( principal components<1-( ?#('"8; ?#(6(.; @/A(4 B"61*$%56&0'"8;4 20,)*(" 20,)*(" 20,)*(" 0#(6(.;

44 !;#*$@5 "*; =0 $4µ0; #*', 20(/.$;#' µ$*/ 02" *' =/,0*" µ'7 00,,445555 L =/,0*'% =0 $4,0; ),0 *)9'% :;0 "90 µ'7 *0 2('-93µ0*0 00,,772288 L =/,0*'% $4,0; + $4#'.'% #$ ),0 16(' 02"97*+% ;80,'2'4+#+% 00,,449999 L =/,0*'% 2('#&)($; µ40 .;0&7:3 02" *', 0204#;' 8"#µ' 00,,77221111 L =/,0*'% $4,0; 02$9$7=)(5#+ 02" *', 2",' 80; *0 -/#0,0 00,,77771133 !;#*$@5 "*; ' 20(/.$;#'% =0 $4,0; ),0% 809@*$('% *"2'%

02" 07*" *', 8"#µ' 00,,55111166 L =/,0*'% 02'*$9$4 µ;0 72"#1$#+ :;0 µ;0 809@*$(+ A53 00,,66992233 M9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 $:8"#µ;0 -/#0,0 00,,66992299 M9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 -/(+ 07*3% *+% A53% 00,,88223311 B,72'µ',6 :;0 *+ A53 µ$*/ *' =/,0*' 00,,770033 B2'&$@:5 *;% #8)N$;% =0,/*'7 µ$ 8/=$ 8"#*'% 00,,77111100 ?2'*$ + #8)N+ *'7 =0,/*'7 )(1$*0; #*' µ709" µ'7,

2('#20=6 ,0 *+ .;6I5 µ08(;/ 00,,77991122 !('#20=6 2/,*0 ,0 µ+, #8)&*'µ0; *' =/,0*' 00,,77771199 B2'&$@:5 ,0 #8)&*'µ0; *' =/,0*' 02" 8/=$ /2'N+ 00,,77992266 !('#20=6 ,0 µ+, )15 *42'*0 ,0 8/,5 µ$ *' =)µ0 *'7 =0,/*'7 00,,77001155 L =/,0*'% $4,0; ),5#+ µ$ *' =$" 80; 0;6,;0 $7.0;µ',40 00,,88442222 !('#-9)25 #$ µ;0 $20,),5#+ µ$ *'7% 0:02+µ),'7% µ'7

µ$*/ *' =/,0*" µ'7 00,,66332255 M9)25 *' =/,0*' 5% *' 2)(0#µ0 #$ ),0 0;6,;' 80; $79':+µ),' *"2' 00,,66222277 L =/,0*'% 2('#&)($; µ40 72)('1+ 0,08'@&;#+ *+% N713% 00,,44112288 <,0 2(/:µ0 2'7 µ'7 .4,$; /,$#+ #*' ,0 0,*;µ$*524#5

*' =/,0*' $4,0; + 24#*+ µ'7 #*+, µ$*0=/,0*' A53 00,,774411 L =/,0*'% $4,0; 15(4% 0µ&;-'940 µ40 µ08/-(;0 $µ2$;(40 00,,445522 O 2(''2*;83 *'7 .;8'@ µ'7 =0,/*'7 µ'7 .+µ;'7(:$4 /:1'% 00,,882277 E,'19'@µ0; 02" *+, '(;#*;8"*+*0 *'7 =0,/*'7 00,,88001188 <15 ),*',' &"-' :;0 *' =/,0*' 00,,77112200 J' =)µ0 *+% A53% µ$*/ *' =/,0*' µ$ 2('-9+µ0*4A$; ),*',0 00,,66552211 J' :$:',"% "*; ' =/,0*'% #+µ04,$; *' *)9'% "95, *5, 2(0:µ/*5,

"25% *0 :,5(4A5 µ$ &'-4A$; 00,,66553322 O 0-$-0;"*+*0 *'7 *; #7µ-04,$; µ$*/ *' =/,0*' µ$ 0,+#71$4 00,,443366 L =/,0*'% =0 2()2$; ,0 0,*;µ$*524A$*0; 5% 8/*; &7#;'9':;8",

0,0µ&;#-3*+*' 80; 0,02"&$78*' :$:',"% 00,,66001144 L =/,0*'% $4,0; &7#;83 .;/#*0#+ *+% A53% 00,,44661177 L@*$ &'-/µ0; '@*$ 8095#'(4A5 *' =/,0*' 00,,55442244 L =/,0*'% $4,0; 029/ ),0 *µ3µ0 *+% .;0.;80#40% *+% A53% 00,,44443300 L =/,0*'% .$, $4,0; '@*$ 809"% '@*$ 808"% 00,,4422

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 19

Page 21: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[20] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

1>-+7. ?,+ !0. /!3:µ,/0 !"& )-6!0µ+!"#"$%"& <,)-.)-$2:0*+. /&$*)*-,µ;.)7 @&1"µ)!-,*;7 <"*,µ+/%)7$,+ !0. )*!%µ0/0 !07 +A,"',/!%+7 (reliability) !"& )-6-!0µ+!"#"$%"&, !07 )$*&-(!0!+7 (validity), ).> '+-3#-#0#+ ;$,.) ;#)$1"7 !07 <"µ27 !"& (factor analysis).B&$*)*-,µ;.+ 0 +A,"',/!%+ )*!,µ2:0*) µ) !0 µ;!-0-/0 !07 )/6!)-,*27 /&.34),+7 (internal consistency)$,+ !". ;#)$1" !6. /!",1)%6. !"& )-6!0µ+!"#"$%"& !";.+ ).3.!,+ /!" 3##", µ;!-0/0 !"& <)%*!0 Cronbach’salpha (Cronbach, 1951). C,µ;7 µ)$+#=!)-)7 2 %/)7 !"&0,7 :)6-"=.!+, +'"<)*!;7. D, /&.!)#)/!;7 /&/1;!,-/07 !"& Pearson (r) 1-0/,µ"'",2:0*+. $,+ !0. /&/1;-!,/0 !6. <,+/!3/)6. !"& )-6!0µ+!"#"$%"& /!+ '#+%-/,+ !07 )$*&-(!0!+7 <"µ27. E +.3#&/0 '+-+$(.!6.1-0/,µ"'",2:0*) $,+ .+ <,)-)&.0:)% 0 <"µ2 !"& )-6-!0µ+!"#"$%"& DAP-R *+, $,+ .+ /&$*-,:)% µ) !0. +&:)-

.!,*2 <"µ2. E <,)-)=.0/0 !07 <"µ27 !"& )-6!0µ+!"-#"$%"& (exploratory factor analysis) ;$,.) µ) !0 1-2-/0 !07 µ):(<"& Principal Components Analysis µ)Varimax with Kaiser Normalization (rotation method),µ) !0. "'"%+ +.+80!"=.!+. ", ,<,+%!)-", '+-3$".!)7'"& /&.:;!"&. !" )-6!0µ+!"#($,". C+ )'%')<+ /0µ+-.!,*(!0!+7 )%.+, +µ4%'#)&-+ *+, 0 /!+!,/!,*2 /0µ+-.!,*(!0!+ !;:0*) /!" 0,05. ?,+ !0. +.3#&/0 1-0/,µ"-'",2:0*) !" /!+!,/!,*( '-($-+µµ+ SPSS 17.0.

!"#$%&'(µ)$)B!". ''%%..++**++ 11 <%.".!+, !+ <0µ"$-+4,*3 /!",1)%+ !6./&µµ)!)1(.!6. *+:>7 *+, /!",1)%+ '"& +4"-"=. /!0.)-$+/%+ !"&7.B!". ''%%..++**++ 22 <%.".!+, /!",1)%+ '"& +4"-"=. /!0./&µ')-,4"-3 !6. /&µµ)!)1(.!6. +';.+.!, /) +/:)-

!I"#$#% 8. O& 0#/C$&4 *+, -"µµ$*$./,*+, -.$*&=) µ$ *( 2),0*(

<1-5 *&µ; SD

L =/,0*'% $4,0; 15(4% 0µ&;-'940 µ40 µ08/-(;0 $µ2$;(40 5,5 1,9O 2(''2*;83 *'7 .;8'@ µ'7 =0,/*'7 µ'7 .+µ;'7(:$4 /:1'% 5,2 2,0B2'&$@:5 *;% #8)N$;% =0,/*'7 µ$ 8/=$ 8"#*'% 5,1 1,8!;#*$@5 "*; =0 $4µ0; #*', 20(/.$;#' µ$*/ 02" *' =/,0*" µ'7 3,8 1,7L =/,0*'% =0 $4,0; ),0 *)9'% :;0 "90 µ'7 *0 2('-93µ0*0 2,5 1,9L =/,0*'% =0 2()2$; ,0 0,*;µ$*524A$*0; 5% 8/*; &7#;'9':;8", 0,0µ&;#-3*+*' 80; 0,02"&$78*' :$:',"% 6,2 1,1E,'19'@µ0; 02" *+, '(;#*;8"*+*0 *'7 =0,/*'7 5,9 8,2L =/,0*'% $4,0; + $4#'.'% #$ ),0 16(' 02"97*+% ;80,'2'4+#+% 3,4 2,0L =/,0*'% 2('#&)($; µ40 .;0&7:3 02" *', 0204#;' 8"#µ' 2,9 1,9?2'*$ + #8)N+ *'7 =0,/*'7 )(1$*0; #*' µ709" µ'7, 2('#20=6 ,0 *+ .;6I5 µ08(;/ 5,2 1,9L =/,0*'% $4,0; 02$9$7=)(5#+ 02" *', 2",' 80; *0 -/#0,0 3,1 2,0!('#20=6 2/,*0 ,0 µ+, #8)&*'µ0; *' =/,0*' 4,5 2,1!;#*$@5 "*; ' 20(/.$;#'% =0 $4,0; ),0 809@*$(' µ)('% 02" 07*" *', 8"#µ' 4,4 2,2L =/,0*'% $4,0; &7#;83 .;/#*0#+ *+% A53% 6,2 1,0L =/,0*'% $4,0; ),5#+ µ$ *' =$" 80; 0;6,;0 $7.0;µ',40 5,1 1,8L =/,0*'% 02'*$9$4 µ;0 72"#1$#+ :;0 µ;0 809@*$(+ A53 3,4 1,8L@*$ &'-/µ0; '@*$ 8095#'(4A5 *' =/,0*' 5,1 1,7<15 ),*',' &"-' :;0 *' =/,0*' 4,0 2,1B2'&$@:5 ,0 #8)&*'µ0; *' =/,0*' 02" 8/=$ /2'N+ 4,9 1,9J' =)µ0 *+% A53% µ$*/ *' =/,0*' µ$ 2('-9+µ0*4A$; ),*',0 5,0 1,9J' :$:',"% "*; ' =/,0*'% #+µ04,$; *' *)9'% "95, *5, 2(0:µ/*5, "25% *0 :,5(4A5 µ$ &'-4A$; 4,7 1,9!('#-9)25 #$ µ;0 $20,),5#+ µ$ *'7% 0:02+µ),'7% µ'7 µ$*/ *' =/,0*" µ'7 4,9 2,1M9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 $:8"#µ;0 -/#0,0 3,1 2,0L =/,0*'% $4,0; 029/ ),0 *µ3µ0 *+% .;0.;80#40% *+% A53% 5,7 1,3M9)25 *' =/,0*' 5% *' 2)(0#µ0 #$ ),0 0;6,;' 80; $79':+µ),' *"2' 4,5 1,8!('#20=6 ,0 µ+, )15 *42'*0 ,0 8/,5 µ$ *' =)µ0 *'7 =0,/*'7 4,7 1,8L =/,0*'% 2('#&)($; µ40 72)('1+ 0,08'@&;#+ *+% N713% 4,3 1,9<,0 2(/:µ0 2'7 µ'7 .4,$; /,$#+ #*' ,0 0,*;µ$*524#5 *' =/,0*' $4,0; + 24#*+ µ'7 #*+, µ$*0=/,0*' A53 4,8 2,0M9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 -/(+ 07*3% *+% A53% 2,9 1,8L =/,0*'% .$, $4,0; '@*$ 809"% '@*$ 808"% 4,9 2,1B,72'µ',6 :;0 *+ A53 µ$*/ *' =/,0*' 3,0 1,9O 0-$-0;"*+*0 *'7 *; #7µ-04,$; µ$*/ *' =/,0*' µ$ 0,+#71$4 4,4 1,9

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 20

Page 22: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [21]

!"!#$%&'(H !")*+,A

.)%7 '-"16-0µ;."& /!+<%"&.B!". ''%%..++**++ 33 <%.)!+, 0 )',--"2 '"& +/*)% !" ')-,-/!+!,*( !"& :+.3!"& /!"&7 /&µµ)!;1".!)7.F0µ,"&-$2:0*+. ", +-1,*;7 ';.!) <,+/!3/),7 !"& )-6-!0µ+!"#"$%"& DAP-R (as defined by Wong et al., 1994).B!". ''%%..++**++ 44 ')-,$-34".!+, +&!;7 ", <,+/!3/),7 !"&)-6!0µ+!"#"$%"& DAP-R.

G'"<)*!2 +A,"',/!%+ H3/0 !"& <)%*!0 Cronbach'sa (internal consistency Reliability of the DAP-R) ;1"&-

µ) /!,7 <,+/!3/),7 death avoidance, approach acceptance,escape acceptance. B!0 <,3/!+/0 neutral acceptance0 +A,"',/!%+ <). ;4!+/) !" +'"<)*!( (-," 0.7.B!". ''%%..++**++ 55 <%.".!+, ", /&.!)#)/!;7 /&/1;!,/07 !6.<,+/!3/)6. !"& )-6!0µ+!"#"$%"& DAP-R.

I'2-A) /0µ+.!,*2 :)!,*2 /&/1;!,/0 !07 <,3/!+-/07 «fear of death» µ) !,7 <,+/!3/),7 «death avoidance»,«approach acceptance» *+, «escape acceptance».G.!%:)!+, &'2-A) /0µ+.!,*2 +-.0!,*2 /&/1;!,/0 !07

!I"#$#% 9. @(%) *+, 0#0,*;-$+, *(" $%+*5µ0*(7(83("

9",0*14 0#0,*;-$&4

L =/,0*'% $4,0; 15(4% 0µ&;-'940 µ40 µ08/-(;0 $µ2$;(40 SD D MD U MA A SAO 2(''2*;83 *'7 .;8'@ µ'7 =0,/*'7 µ'7 .+µ;'7(:$4 /:1'% SA A MA U MD D SDB2'&$@:5 *;% #8)N$;% =0,/*'7 µ$ 8/=$ 8"#*'% SA A MA U MD D SD!;#*$@5 "*; =0 $4µ0; #*', 20(/.$;#' µ$*/ 02" *' =/,0*" µ'7 SD D MD U MA A SAL =/,0*'% =0 $4,0; ),0 *)9'% :;0 "90 µ'7 *0 2('-93µ0*0 SD D MD U MA A SAL =/,0*'% =0 2()2$; ,0 0,*;µ$*524A$*0; #0 8/*; &7#;'9':;8", 0,0µ&;#-3*+*' 80; 0,02"&$78*' :$:',"% SA A MA U MD D SDE,'19'@µ0; 02" *+, '(;#*;8"*+*0 *'7 =0,/*'7 SA A MA U MD D SDL =/,0*'% $4,0; + $4#'.'% #$ ),0 µ)('% 02"97*+% ;80,'2'4+#+% SD D MD U MA A SAL =/,0*'% 2('#&)($; µ40 .;0&7:3 02" *', 0204#;' 8"#µ' SA A MA U MD D SD?2'*$ + #8)N+ *'7 =0,/*'7 )(1$*0; #*' µ709" µ'7, 2('#20=6 ,0 *+ .;6I5 µ08(;/ SD D MD U MA A SAL =/,0*'% $4,0; 02$9$7=)(5#+ 02" *' 2",' 80; *0 -/#0,0 SD D MD U MA A SA!('#20=6 2/,*0 ,0 µ+, #8)&*'µ0; *' =/,0*' SA A MA U MD D SD!;#*$@5 "*; ' 20(/.$;#'% =0 $4,0; ),0 809@*$(' µ)('% 02" 07*" *', 8"#µ' SA A MA U MD D SDL =/,0*'% $4,0; &7#;83 .;/#*0#+ *+% A53% SA A MA U MD D SDL =/,0*'% $4,0; ),5#+ µ$ *' =$" 80; 0;6,;0 $7.0;µ',40 SD D MD U MA A SAL =/,0*'% 02'*$9$4 µ;0 72"#1$#+ :;0 µ;0 809@*$(+ A53 SA A MA U MD D SDL@*$ &'-/µ0; '@*$ 8095#'(4A5 *' =/,0*' SA A MA U MD D SD<15 ),*',' &"-' :;0 *' =/,0*' SD D MD U MA A SAB2'&$@:5 ,0 #8)&*'µ0; *' =/,0*' 02" 8/=$ /2'N+ SD D MD U MA A SAJ' =)µ0 *+% A53% µ$*/ *' =/,0*' µ$ 2('-9+µ0*4A$; ),*',0 SA A MA U MD D SDJ' :$:',"% "*; ' =/,0*'% #+µ04,$; *' *)9'% "95, *5, 2(0:µ/*5, "25% *0 :,5(4A5 µ$ &'-4A$; SA A MA U MD D SD!('#-9)25 #$ µ;0 $20,),5#+ µ$ *'7% 0:02+µ),'7% µ'7 µ$*/ *' =/,0*" µ'7 SD D MD U MA A SAM9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 $:8"#µ;0 -/#0,0 SA A MA U MD D SDL =/,0*'% $4,0; 029/ ),0 *µ3µ0 *+% .;0.;80#40% *+% A53% SA A MA U MD D SDM9)25 *' =/,0*' 5% *' 2)(0#µ0 #$ ),0 0;6,;' 80; $79':+µ),' *"2' SA A MA U MD D SD!('#20=6 ,0 µ+, )15 *42'*0 ,0 8/,5 µ$ *' =)µ0 *'7 =0,/*'7 SD D MD U MA A SAL =/,0*'% 2('#&)($; µ40 72)('1+ 0,08'@&;#+ *+% N713% SD D MD U MA A SA<,0 2(/:µ0 2'7 µ'7 .4,$; /,$#+ #*' ,0 0,*;µ$*524#5 *' =/,0*' $4,0; + 24#*+ µ'7 #*+, µ$*0=/,0*' A53 SD D MD U MA A SAM9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 -/(+ 07*3% *+% A53% SD D MD U MA A SAL =/,0*'% .$, $4,0; '@*$ 809"% '@*$ 808"% SA A MA U MD D SDB,72'µ',6 :;0 *+ A53 µ$*/ *' =/,0*' SA A MA U MD D SDO 0-$-0;"*+*0 *'7 *; #7µ-04,$; µ$*/ *' =/,0*' µ$ 0,+#71$4 SD D MD U MA A SA

SD=strongly disagree .;0&5,6 02"97*0, D=disagree .;0&5,6, MD= moderately disagree .;0&5,6 µ)*(;0, U= undecided0,02'&/#;#*'%/+, MA= moderately agree #7µ&5,6 µ)*(;0, A=agree #7µ&5,6, SA=strongly agree #7µ&5,6 02"97*0

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 21

Page 23: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

<,3/!+/07 «fear of death» µ) !0 <,3/!+/0 «neutralacceptance». G*(µ+, &'2-A) /0µ+.!,*2 :)!,*2 /&/1;-!,/0 !07 <,3/!+/07 «death avoidance» µ) !0 <,3/!+-/0 «approach acceptance». C;#"7, &'2-A) /0µ+.!,-*2 :)!,*2 /&/1;!,/0 !07 <,3/!+/07 «escape acceptance»µ) !0 <,3/!+/0 «approach acceptance».B!". ''%%..++**++ 66 <%.".!+, ", /&.!)#)/!;7 /&/1;!,/07 !6.<,+/!3/)6. !"& )-6!0µ+!"#"$%"& DAP-R µ) !0. 0#,-*%+ !6. /&µµ)!)1(.!6..

I'2-A) /0µ+.!,*3 1+µ0#2 :)!,*2 /&/1;!,/0 !07<,3/!+/07 «death avoidance» µ) !0. 0#,*%+ !6. /&µ-µ)!)1(.!6.. D'(!) (/" +&A3.)!+, 0 0#,*%+ !6. /&µ-µ)!)1(.!6. !(/" +&A3.)!+, *+, 0 +'"4&$2 !"& :+.3-!"&. F). H-;:0*) /0µ+.!,*2 /&/1;!,/0 !07 0#,*%+7µ) !"&7 &'(#",'"&7 '+-3$".!)7.B!". ''%%..++**++ 77 <%.".!+, !+ +'"!)#;/µ+!+ !07 +.3#&-/07 '+-+$(.!6. (factor analysis) µ) !0 µ;:"<" principalcomponents.

E /&."#,*2 µ)!+H#0!(!0!+ '"& )')A0$)%!) +'(!"&7 +.6!;-6 5 '+-3$".!)7 )%.+, 58%. D '+-3$".!+7«G'"4&$2 :+.3!"&» /&µ'%'!), µ) !0 <,3/!+/0 «Deathavoidance». 5'%/07, " '+-3$".!+7 «J(H"7 :+.3!"&»+'"!)#)%!+, +*-,H>7 +'( !,7 %<,)7 )-6!2/),7 µ) !0<,3/!+/0 «Fear of death». D '+-3$".!+7 «D&<;!)-0+'"<"12» /&µ'%'!), µ) !0 <,3/!+/0 «Neutral acceptance».D, )-6!2/),7 4,8,13,16 *+, 31 µ) !0. '+-+'3.6 +.3-#&/0 ')-,;1".!+, /!". '+-3$".!+ «K;/" <,+4&$27»+.!% .+ ')-,;1".!+, /!0 <,3/!+/0 «Approach acceptance».

L!/, *+!+#2$"&µ) /!" (!, !" )-6!0µ+!"#($," )%.+,;$*&-" )-$+#)%" $,+ !0. )*!%µ0/0 !07 /!3/07 !6.."/0#)&!>. +';.+.!, /!" :3.+!" +##3 &'3-1), µ,+<,+4"-"'"%0/0 /!" '",)7 )-6!2/),7 /&µ')-,#+µH3-

.), " *3:) '+-3$".!+7 /!0. )##0.,*2 )*<"12 !"& DAP-R.B!!". ''%%..++**++ 88 ')-,$-34".!+, ", +'(@),7 !6. /&µµ)-!)1(.!6. /1)!,*3 µ) !" :3.+!", ('67 +&!;7 H+:µ"-#"$2:0*+. *+!3 µ;/" (-" +'( !"&7 )-$+8(µ)."&7.B!". ''%%..++**++ 99 ')-,$-34)!+, 0 4"-3 !6. +'+.!2/)6.!"& )-6!0µ+!"#"$%"&.B!". ''%%..++**++ 1100 '"& +*"#"&:)% ')-,$-34".!+, ", .;)7<,+/!3/),7 !"& )-6!0µ+!"#"$%"& DAP-R.

G'"<)*!2 +A,"',/!%+ H3/0 !"& <)%*!0 Cronbach'sa (internal consistency Reliability of the DAP-R) ;1"&-µ) /!,7 ')-,//(!)-)7 <,+/!3/),7. B!0 <,3/!+/0 D&<;-!)-0 +'"<"12 0 +A,"',/!%+ <). ;4!+/) !" +'"<)*!((-," 0.7.B!". ''%%..++**++ 1111 <%.".!+, ", /&.!)#)/!;7 /&/1;!,/07!6. .;6. <,+/!3/)6. !"& )-6!0µ+!"#"$%"& DAP-R.

I'2-A) /0µ+.!,*2 µ;!-,+ :)!,*2 /&/1;!,/0 !07<,3/!+/07 «K;/" <,+4&$27» µ) !0 <,3/!+/0 «G'"-<"12 :+.3!"&». 5'%/07, &'2-A) /0µ+.!,*2 1+µ0#2:)!,*2 /&/1;!,/0 !07 <,3/!+/07 «K;/" <,+4&$27»µ) !0 <,3/!+/0 «J(H"7 :+.3!"&». 5'%/07, &'2-A)/0µ+.!,*2 µ;!-,+ :)!,*2 /&/1;!,/0 !07 <,3/!+/07«G'"4&$2 :+.3!"&» µ) !,7 <,+/!3/),7 «G'"<"12 :+.3-!"&» *+, «J(H"7 :+.3!"&». I'2-A) /0µ+.!,*2 1+µ0-#2 :)!,*2 /&/1;!,/0 !07 <,3/!+/07 «G'"<"12 :+.3-!"&» µ) !0 <,3/!+/0 «J(H"7 :+.3!"&» *+, D&<;!)-0+'"<"12. C;#"7, &'2-A) /0µ+.!,*2 µ;!-,+ +-.0!,*2/&/1;!,/0 !07 <,3/!+/07 «D&<;!)-0 +'"<"12» µ) !0<,3/!+/0 «J(H"7 :+.3!"&».B!". ''%%..++**++ 1122 <%.".!+, ", /&.!)#)/!;7 /&/1;!,/07!6. .;6. <,+/!3/)6. !"& )-6!0µ+!"#"$%"& DAP-R µ)!0. 0#,*%+ !6. /&µµ)!)1(.!6..

[22] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

!I"#$#% 10. D1$4 6&0-*)-$&4 *(" $%+*5µ0*(7(83(" DAP-R

:7).&-*5 *&µ; <18&-*5 *&µ; <1-5 *&µ; SD Cronbach's a

D)#' .;0&7:3% 10,0 61,0 32,4 12,9 0,86G'"4&$2 :+.3!"& 6,0 35,0 24,4 7,5 0,85B2'.'13 =0,/*'7 5,0 34,0 23,6 6,9 0,76J(H"7 :+.3!"& 13,0 101,0 34,6 13,6 0,71L7.)*$(+ 02'.'13 20,0 35,0 28,1 4,3 0,65

!I"#$#% 11. !",*$7$-*14 -"-.1*&-54 *+, ,1+, 6&0-*)-$+, *(" $%+*5µ0*(7(83(" DAP-R

?#('"8; ?#(6(.; @/A(4 B"61*$%5 20,)*(" 20,)*(" 20,)*(" 0#(6(.;

DD))##'' ..;;00&&77::33%% rr 0,14 0,41 0,23 -0,01PP 0,168 <<00,,000011 00,,002244 0,930

BB22''&&77::33 ==00,,//**''77 rr 1,00 0,31 0,35 0,03PP 00,,000022 <<00,,000011 0,801

BB22''..''1133 ==00,,//**''77 rr 1,00 0,21 0,20PP 00,,003399 00,,004488

PP""--''%% ==00,,//**''77 rr -0,43PP <<00,,000011

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 22

Page 24: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [23]

!"!#$%&'(H !")*+,A

!I"#$#% 12. !",*$7$-*14 -"-.1*&-54 *+, ,1+, 6&0-*)-$+, *(" $%+*5µ0*(7(83(" DAP-R µ$ *5, 57&=30 *+, -"µµ$*$./,*+,

>7&=30DD))##'' ..;;00&&77::33%% r 0,00

P 0,990BB22''&&77::33 ==00,,//**''77 r 0,27

P 00,,000066BB22''..''1133 ==00,,//**''77 r 0,09

P 0,365PP""--''%% ==00,,//**''77 r 0,11

P 0,257LL77..))**$$((++ 0022''..''1133 r 0,03

P 0,760

9&0'+,E 9&0'+,E 9&0'+,E ?,0#(- !"µ'+,E !"µ'+,E !"µ'+,E0#/7"*0 D(%) <1*%&0 ')-&-*(4 µ1*%&0 D(%) 0#/7"*0D(%) D(%) D(%) D(%) D(%)

L =/,0*'% $4,0; 15(4% 0µ&;-'940 µ40 µ08/-(;0 $µ2$;(40 12(8%) 9(6 %) 6(4%) 18(12%) 54(36%) 51(34%)O 2(''2*;83 *'7 .;8'@ µ'7 =0,/*'7 µ'7 .+µ;'7(:$4 /:1'% 15(10%) 15(10%) 9(6%) 21(14%) 42(28%) 48(32%)B2'&$@:5 *;% #8)N$;% =0,/*'7 µ$ 8/=$ 8"#*'% 3(2%) 27(18%) 6(4%) 6(4%) 21(14%) 54(36%) 33(22%)!;#*$@5 "*; =0 $4µ0; #*', 20(/.$;#' µ$*/ 02" *' =/,0*" µ'7 24(16%) 12(8%) 9(6%) 69(46%) 12(8%) 15(10%) 9(6%)L =/,0*'% =0 $4,0; ),0 *)9'% :;0 "90 µ'7 *0 2('-93µ0*0 66(44%) 36(24%) 6(4%) 15(10%) 12(8%) 3(2%) 12(8%)L =/,0*'% =0 2()2$; ,0 0,*;µ$*5-24A$*0; #0 8/*; &7#;'9':;8", 0,0µ&;#-3*+*' 80; 0,02"&$78*' :$:',"% 3(2%) 6(4%) 3(2%) 6(4%) 66(44%) 66(44%)E,'19'@µ0; 02" *+, '(;#*;8"*+*0 *'7 =0,/*'7 15(10%) 21(14%) 6(4%) 21(14%) 54(36%) 33(22%)L =/,0*'% $4,0; + $4#'.'% #$ ),0 µ)('% 02"97*+% ;80,'2'4+#+% 39(26%) 21(14%) 15(10%) 24%) 6(4%) 21(14%) 12(8%)L =/,0*'% 2('#&)($; µ40 .;0&7:3 02" *', 0204#;' 8"#µ' 60(40%) 18(12%) 18(12%) 18(12%) 15(10%) 15(10%) 6(4%)?2'*$ + #8)N+ *'7 =0,/*'7 )(1$*0; #*' µ709" µ'7, 2('#20=6 ,0 *+ .;6I5 µ08(;/ 9(6%) 15(10%) 6(4%) 9(6%) 21(14%) 42(28%) 48(32%)L =/,0*'% $4,0; 02$9$7=)(5#+ 02" *' 2",' 80; *0 -/#0,0 54(36%) 15(10%) 15(10%) 27(18%) 15(10%) 15(10%) 9(6%)!('#20=6 2/,*0 ,0 µ+, #8)&*'µ0; *' =/,0*' 15(10%) 18(12%) 24(16%) 6(4%) 24(16%) 30(20%) 33(22%)!;#*$@5 "*; ' 20(/.$;#'% =0 $4,0; ),0 809@*$(' µ)('% 02" 07*" *', 8"#µ'. 30(20%) 6(4%) 9(6%) 36(24%) 3(2%) 33(22%) 33(22%)L =/,0*'% $4,0; &7#;83 .;/#*0#+ *+% A53% 3(2%) 9(6%) 9(6%) 60(40%) 69(46%)L =/,0*'% $4,0; ),5#+ µ$ *' =$" 80; 0;6,;0 $7.0;µ',40 12(8%) 6(4%) 6(4%) 30(20%) 12(8%) 42(28%) 42(28%)L =/,0*'% 02'*$9$4 µ;0 72"#1$#+ :;0 µ;0 809@*$(+ A53 33(22%) 30(20%) 6(4%) 39(26%) 18(12%) 21(14%) 3(2%)

B&.;1),+ /!0. '%/6 /)#.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 23

Page 25: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[24] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

I'2-A) /0µ+.!,*3 1+µ0#2 :)!,*2 /&/1;!,/0 !07<,3/!+/07 «G'"4&$2 :+.3!"&» µ) !0. 0#,*%+ !6. /&µ-µ)!)1(.!6.. D'(!) (/" +&A3.)!+, 0 0#,*%+ !6. /&µ-µ)!)1(.!6. !(/" +&A3.)!+, *+, 0 +'"4&$2 :+.3!"&.

*+,-$.(.D /!(1"7 !07 µ)#;!07 2!+. 0 /!3:µ,/0 !"& )-6!0µ+-!"#($,"& )*!%µ0/07 !07 /!3/07 !6. ."/0#)&!>. +';-.+.!, /!" :3.+!" DAP-R, µ)!3 +'( µ)!34-+/2 !"&)-6!0µ+!"#"$%"& *+, '"#,!,/M,*2 '-"/+-µ"$2. ?,+!0. /!3:µ,/0 !"& )-6!0µ+!"#"$%"& <,).)-$2:0*+./&$*)*-,µ;.)7 @&1"µ)!-,*;7 <"*,µ+/%)7 $,+ !0. )*!%-µ0/0 !07 +A,"',/!%+7 (reliability) !"& )-6!0µ+!"#"-$%"&, !07 )$*&-(!0!+7 (validity), ).> '+-3##0#+ ;$,-.) ;#)$1"7 !07 <"µ27 !"& (factor analysis). B&$*)*-,µ;.+0 +A,"',/!%+ )*!,µ2:0*) M) !0 µ;!-0/0 !07 )/6!)-,-*27 /&.34),+7 (internal consistency) $,+ !". ;#)$1"

!6. /!",1)%6. !"& )-6!0µ+!"#"$%"& !" ;.+ ).3.!,+ /!"3##", (µ) !0. µ;:"<" <"*,µ+/%+7-)'+.+<"*,µ+/%+7),µ;!-0/0 !"& <)%*!0 Cronbach’s alpha.

C+ +'"!)#;/µ+!+ !07 ;-)&.+7 !6. Clements *+,Rooda (2000) &'"/!2-,A+. ). µ;-), !0. +-1,*2 <"µ2!"& )-6!0µ+!"#"$%"& !6. )-)&.0!>., )'+.+#+µH3."-.!+7 !+ +'"!)#;/µ+!+ !6. &'"*#,µ3*6. µ) µ,*-;7<,+4"-;7. D, &'"*#%µ+*)7 J(H"7 N+.3!"&, G'"4&$2N+.3!"&, K;/" <,+4&$27, G'"<"12 N+.3!"& H-;:0-*) .+ µ)!-3.) <,+4"-)!,*"=7 '+-3$".!)7 *+, .+ )%.+,+A,(',/!)7. D, %<,", H-2*+.) (!, ", )-6!2/),7 '"& <,+-µ"-4>."&. !0. &'"*#%µ+*+ "&<;!)-0 +'"<"12 µ'"--)% .+ µ0. µ)!-3.) *3!, ).,+%" +##3 µ'"-"=. .+ <,+-µ"-4>/"&. *+, 60 &'"*#%µ+*+ +'"!)#"=µ).0 +'( !,7)-6!2/),7 17 *+, 30.

K)!3 +'( !0. '+-+$".!,*2 +.3#&/0 0 '+-"=/+;-)&.+ +.;<),A) !"&7 A)16-,/!"=7 '+-3$".!)7 '"&

9&0'+,E 9&0'+,E 9&0'+,E ?,0#(- !"µ'+,E !"µ'+,E !"µ'+,E0#/7"*0 D(%) <1*%&0 ')-&-*(4 µ1*%&0 D(%) 0#/7"*0D(%) D(%) D(%) D(%) D(%)

L@*$ &'-/µ0; '@*$ 809'#5(4A5 *' =/,0*' 9(6%) 3(2%) 12(8%) 33(22%) 9(6%) 45(30%) 39(26%)<15 ),*',' &"-' :;0 *' =/,0*' 27(18%) 30(20%) 3(2%) 21(14%) 21(14%) 27(18%) 21(14%)B2'&$@:5 ,0 #8)&*'µ0; *' =/,0*' 02" 8/=$ /2'N+ 6(4%) 24(16%) 3(2%) 12%) 24(16%) 42(28%) 33(22%)J' =)µ0 *+% A53% µ$*/ *' =/,0*' µ$ 2('-9+µ0*4A$; ),*',0 9(6%) 15(10%) 3(2%) 24(16%) 27(18%) 30(20%) 42(28%)J' :$:',"% "*; ' =/,0*'% #+µ04,$; *' *)9'% "95, *5, 2(0:µ/*5, "25% *0 :,5(4A5 µ$ &'-4A$; 8%) 12%) 9(6%) 15(10%) 30(20%) 36(24%) 30(20%)!('#-9)25 #$ µ;0 $20,),5#+ µ$ *'7% 0:02+µ),'7% µ'7 µ$*/ *' =/,0*" µ'7 15(10%) 18(12%) 27(18%) 9(6%) 39(26%) 42(28%)M9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 $:8"#µ;0 -/#0,0 45(30%) 30(20%) 18(12%) 15(10%) 12(8%) 24(16%) 6(4%)L =/,0*'% $4,0; 029/ ),0 *µ3µ0 *+% .;0.;80#40% *+% A53% 3(2%) 9(6%) 15(10%) 12(8%) 69(46%) 42(28%)M9)25 *' =/,0*' 5% *' 2)(0#µ0 #$ ),0 0;6,;' 80; $79':+µ),' *"2' 21(14%) 9(6%) 30(20%) 30(20%) 54(34%) 9(6%)!('#20=6 ,0 µ+, )15 *42'*0 ,0 8/,5 µ$ *' =)µ0 *'7 =0,/*'7 9(6%) 15(10%) 12(8%) 36(24%) 12(8%) 42(28%) 24(16%)L =/,0*'% 2('#&)($; µ;0 72$('13 0,08'@&;#+ *+% N713% 21(14%) 12(8%) 9(6%) 30(20%) 30(20%) 30(20%) 18(12%)<,0 2(/:µ0 2'7 µ'7 .4,$; /,$#+ #*' ,0 0,*;µ$*524#5 *' =/,0*' $4,0; + 24#*+ µ'7 #*+, µ$*0=/,0*;' A53 21(14%) 12(8%) 18(12%) 21(14%) 54(36%) 24(16%)M9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 -/(+ 07*3% *+% A53% 54(36%) 15(10%) 21(14%) 33(22%) 9(6%) 12(8%) 6(4%)L =/,0*'% .$, $4,0; '@*$ 809"% '@*$ 808"% 24(16%) 3(2%) 30(20%) 12(8%) 39(26%) 42(28%)B,72'µ',6 :;0 *+ A53 µ$*/ =/,0*' 54(36%) 18(12%) 9(6%) 30(20%) 21(14%) 12(8%) 6(4%)O 0-$-0;"*+*0 *'7 *; #7µ-04,$; µ$*/ *' =/,0*' µ$ $,'19$4 12(8%) 27(18%) 3(2%) 36(24%) 21(14%) 24(16%) 27(18%)

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 24

Page 26: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [25]

!"!#$%&'(H !")*+,A

/&.:;!"&. !" )-6!0µ+!"#($,". D '+-3$".!+7 «G'"-4&$2 :+.3!"&» /&µ'%'!), µ) !0 <,3/!+/0 «Deathavoidance». 5'%/07, " '+-3$".!+7 «J(H"7 :+.3!"&»+'"!)#)%!+, +*-,H>7 +'( !,7 %<,)7 )-6!2/),7 µ) !0<,3/!+/0 «Fear of death». D '+-3$".!+7 «D&<;!)-0+'"<"12» /&µ'%'!), µ) !0 <,3/!+/0 «Neutral acceptance».D, )-6!2/),7 4,8,13,16 *+, 31 µ) !0. '+-+'3.6 +.3-#&/0 ')-,;1".!+, /!". '+-3$".!+ «K;/" <,+4&$27»+.!% .+ ')-,;1".!+, /!0 <,3/!+/0 «Approach acceptance».

*+µ"%/0(µ)$):E )##0.,*2 )*<"12 !"& DAP-R +'"!)#)% ;.+ +A,(',-/!" *+, ;$*&-" )-$+#)%" $,+ !0. )*!%µ0/0 !07 /!3/07!6. ."/0#)&!>. +';.+.!, /!" :3.+!".

O/" +4"-3 /!+ +'"!)#;/µ+!+ +'( !0. +.3#&/0!6. +'+.!2/)6. !6. )-6!>µ).6., <)%1."&. (!,, $,+.+ !-"'"'",0:)% 0 /!3/0 !6. ."/0#)&!>. /) /1;/0µ) !". :3.+!", <,+4+%.)!+, 0 +.3$*0 <,+1)%-,/07 !"&<,*"= !"&7 3$1"&7 *+, !6. +.0/&1,>. !"&7, !+ "'"%+/1)!%8".!+, µ) H,6µ+!,*;7 *+!+/!3/),7, +'( !,7 "'"%-)7 <). µ'"-"=. .+ +'+##+$"=. *+, !"&7 )'0-)38"&.*+, /!". )-$+/,+*( !"&7 1>-". C" *#),<% )µ4+.%8)!+,/!0. )*'+%<)&/0 !"&7 (/" +4"-3 !0. <,+1)%-,/0 !;!",-6. :)µ3!6.. G. *+, ", '-"/6',*;7 )µ'),-%)7 '+%8"&./0µ+.!,*( -(#" /!0 <,+µ(-46/0 /!3/)6. *+, +'(-@)6., 0 )*'+%<)&/0 )%.+, +&!2 '"& !)#,*3 :+ *+:"--%/), *+, !0. /&."#,*2 /&µ')-,4"-3 !6. ."/0#)&!>.+';.+.!, /) 3!"µ+ '"& '):+%."&..

ABSTRACT

OORRIIGGIINNAALL AARRTTIICCLLEEDDEEAATTHH AATTTTIITTUUDDEE PPRROOFFIILLEE--RREEVVIISSEEDD ((DDAAPP--RR))--VVAALLIIDDAATTIIOONN OOFF GGRREEEEKK VVEERRSSIIOONN MM.. KKaalllliiaarroouu11,, PP.. SSaarraaffiiss22,, KK.. KKaarraatthhaannaassii33,, TT.. SSeerraaffiimm44,, KK.. SSoottiirriiaaddoouu55,, EE.. TThheeooddoossooppoouulloouu66

[[11.. CCaappttaaiinn RRNN,, MMSScc oonn HHeeaalltthh IInnffoorrmmaattiiccss,, GGrraadduuaattee SSttuuddeenntt ooff HHeeaalltthh CCaarree MMaannaaggeemmeenntt,, OOppeenn UUnniivveerrssiittyy ooff CCyypprruuss,,PPhhDDcc NNuurrssiinngg FFaaccuullttyy,, NNaattiioonnaall CCaappooddiissttrriiaann UUnniivveerrssiittyy ooff AAtthheennss,, 440044 GGeenneerraall MMiilliittaarryy HHoossppiittaall,, SScciieennttiiffiicc ccoollllaabboorraattoorrTTeecchhnnoollooggiiccaall IInnssttiittuuttiioonn ooff LLaarriissaa//NNuurrssiinngg DDeeppaarrttmmeenntt,, 22.. LLiieeuutteennaanntt RRNN,, HHeell.. NNaavvyy,, AAtthheennss NNaavvaall && VVeetteerraannssHHoossppiittaall,, PPhhDD,, SScciieennttiiffiicc ccoollllaabboorraattoorr NNCCUUAA,, TTrraavveell MMeeddiicciinnee ooff EEvvggeenniiddeeiioonn HHoossppiittaall,, 33.. MMaajjoorr RRNN,, SSppeecciiaalliizzeedd oonnSSuurrggeerryy NNuurrssiinngg AAMMEEDDDD,, TTeexxaass UUSSAA,, GGrraadduuaattee SSttuuddeenntt ooff HHeeaalltthh CCaarree MMaannaaggeemmeenntt,, OOppeenn UUnniivveerrssiittyy ooff CCyypprruuss,,HHeeaadd NNuurrssee,, 440044 GGeenneerraall MMiilliittaarryy HHoossppiittaall,, 44.. MMaajjoorr,, MMeennttaall HHeeaalltthh RRNN,, 442244 GGeenneerraall MMiilliittaarryy HHoossppiittaall,, 55.. MMaajjoorr RRNN,,HHeelllleenniicc AArrmmyy GGeenneerraall SSttaaffff,, 66.. AAssssoocciiaattee PPrrooffeessssoorr,, NNuurrssiinngg FFaaccuullttyy,, NNaattiioonnaall CCaappooddiissttrriiaann UUnniivveerrssiittyy ooff AAtthheennss]]

AAiimm:: To translate a questionnaire that evaluates and validates the attitude of nurses’ attitudes towards death.MMeetthhoodd:: 150 nurses completed this questionnaire. The initial DAP-R was constructed by Wong, P.T.P., Reker, G.T.,and Gesser, G in 1994. It contains 32 questions and is separated in 5 sub levels where the participants are asked toanswer a seven-level Likert scale (I absolutely agree to I absolutely disagree).The DAP-R was translated in Greek and a psychometric evaluation of the tool was made. Prior translating and usingthe tools/questionnaires, permission was guaranteed by the authors. Translation was based on “Trust ScientificAdvisory Committee” SAC: (double reversed translation) cultural adjustment, validation of the questionnaire. In orderto validate the questionnaire certain psychometric tests were conducted to estimate the reliability and validity of thequestionnaire, in addition control of factor analysis was also made. RReessuullttss:: The factor «apofigi thanatou (G'"4&$2 :+.3!"&)» overlaps with the aspect «Death avoidance». Moreover,the factor «fovos thanatou (J(H"7 :+.3!"&)» consists of the same questions as the aspect «Fear of death». The factor«oudeteri apodoxi (D&<;!)-0 +'"<"12)» overlaps with the aspect «Neutral acceptance». Questions 4, 8, 13, 16 and31 based on the above analysis are included in factor «meso diafigis (K;/" <,+4&$27)» instead of aspect «Approachacceptance».CCoonncclluussiioonn:: The Greek version of DAP-R is a reliable and valid tool to estimate nurses' attitude towards death.

KKeeyy wwoorrddss:: death, nurse, validation.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 25

Page 27: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[26] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

1!2A2345!F$7&=; $775,&=; µ$*)'%0-5 *(" $%+*5µ0*(7(83("

1. L =/,0*'% $4,0; 15(4% 0µ&;-'940 µ40 µ08/-(;0 $µ2$;(40 CB C CD B HD H HB 2. O 2(''2*;83 *'7 .;8'@ µ'7 =0,/*'7 µ'7 .+µ;'7(:$4 /:1'% CB C CD B HD H HB3. B2'&$@:5 *;% #8)N$;% =0,/*'7 µ$ 8/=$ 8"#*'% CB C CD B HD H HB4. !;#*$@5 "*; =0 $4µ0; #*', 20(/.$;#' µ$*/ 02" *' =/,0*" µ'7 CB C CD B HD H HB5. L =/,0*'% =0 $4,0; ),0 *)9'% :;0 "90 µ'7 *0 2('-93µ0*0 CB C CD B HD H HB6. L =/,0*'% =0 2()2$; ,0 0,*;µ$*524A$*0; #0 8/*; &7#;'9':;8", 0,0µ&;#-3*+*' 80; 0,02"&$78*' :$:',"% CB C CD B HD H HB7. E,'19'@µ0; 02" *+, '(;#*;8"*+*0 *'7 =0,/*'7 CB C CD B HD H HB8. L =/,0*'% $4,0; + $4#'.'% #$ ),0 µ)('% 02"97*+% ;80,'2'4+#+% CB C CD B HD H HB9. L =/,0*'% 2('#&)($; µ40 .;0&7:3 02" *', 0204#;' 8"#µ' CB C CD B HD H HB10. ?2'*$ + #8)N+ *'7 =0,/*'7 )(1$*0; #*' µ709" µ'7, 2('#20=6 ,0 *+ .;6I5 µ08(;/ CB C CD B HD H HB11. L =/,0*'% $4,0; 02$9$7=)(5#+ 02" *' 2",' 80; *0 -/#0,0 CB C CD B HD H HB12. !('#20=6 2/,*0 ,0 µ+, #8)&*'µ0; *' =/,0*' CB C CD B HD H HB13. !;#*$@5 "*; ' 20(/.$;#'% =0 $4,0; ),0 809@*$(' µ)('% 02" 07*" *', 8"#µ'. CB C CD B HD H HB14. L =/,0*'% $4,0; &7#;83 .;/#*0#+ *+% A53% CB C CD B HD H HB15. L =/,0*'% $4,0; ),5#+ µ$ *' =$" 80; 0;6,;0 $7.0;µ',40 CB C CD B HD H HB16. L =/,0*'% 02'*$9$4 µ;0 72"#1$#+ :;0 µ;0 809@*$(+ A53 CB C CD B HD H HB17. L@*$ &'-/µ0; '@*$ 809'#5(4A5 *' =/,0*' CB C CD B HD H HB18. <15 ),*',' &"-' :;0 *' =/,0*' CB C CD B HD H HB19. B2'&$@:5 ,0 #8)&*'µ0; *' =/,0*' 02" 8/=$ /2'N+ CB C CD B HD H HB20. J' =)µ0 *+% A53% µ$*/ *' =/,0*' µ$ 2('-9+µ0*4A$; ),*',0 CB C CD B HD H HB21. J' :$:',"% "*; ' =/,0*'% #+µ04,$; *' *)9'% "95, *5, 2(0:µ/*5, "25% *0 :,5(4A5 µ$ &'-4A$; CB C CD B HD H HB22. !('#-9)25 #$ µ;0 $20,),5#+ µ$ *'7% 0:02+µ),'7% µ'7 µ$*/ *' =/,0*" µ'7 CB C CD B HD H HB23. M9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 $:8"#µ;0 -/#0,0 CB C CD B HD H HB24. L =/,0*'% $4,0; 029/ ),0 *µ3µ0 *+% .;0.;80#40% *+% A53% CB C CD B HD H HB25. M9)25 *' =/,0*' 5% *' 2)(0#µ0 #$ ),0 0;6,;' 80; $79':+µ),' *"2' CB C CD B HD H HB26. !('#20=6 ,0 µ+, )15 *42'*0 ,0 8/,5 µ$ *' =)µ0 *'7 =0,/*'7 CB C CD B HD H HB27. L =/,0*'% 2('#&)($; µ40 72)('1+ 0,08'@&;#+ *+% N713% CB C CD B HD H HB28. <,0 2(/:µ0 2'7 µ'7 .4,$; /,$#+ #*' ,0 0,*;µ$*524#5 *' =/,0*' $4,0; + 24#*+ µ'7 #*+, µ$*0=/,0*' A53 CB C CD B HD H HB29. M9)25 *' =/,0*' 5% 0,08'@&;#+ 02" *0 -/(+ 07*3% *+% A53% CB C CD B HD H HB30. L =/,0*'% .$, $4,0; '@*$ 809"% '@*$ 808"% CB C CD B HD H HB31. B,72'µ',6 :;0 *+ A53 µ$*/ *' =/,0*' CB C CD B HD H HB32. O 0-$-0;"*+*0 *'7 *; #7µ-04,$; µ$*/ *' =/,0*' µ$ 0,+#71$4 CB C CD B HD H HB

678&7#9/):;)1. Cronbach. 1951. http://www.joe.org/joe/1999april/tt3.php2. Clements R, Rooda LA. Factor structure, reliability, and validity of

the death attitude profile-revised. Omega 1999-2000; 40(3): 453-463.3. Kubler-Ross E. Death and Dying Macmillan. New York. 1969.4. Medical Outcomes Trust Bulletin 1997 http://www.outcomes-

trust.org/bulletin/0797blltn.htm5. Trust Scientific Advisory Committee” SAC http://www.outcomes-

trust.org/monitor/nov98/8.html6. Wong TP, Gesser G, Reker GT. Death attitudes across the life-

span: The development and validation of the Death Attitude Profile(DAP). Omega 1987; 18: 104-124.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 26

Page 28: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

5µH"#,+/!,*2 *3#&@0 µ+:0!>. 0#,*%+7 6-16 )!>. /) ')-,"12

!07 )##0.,*27 )'+-1%+7

55&&++$$$$))##%%++ KK++//!!--++''3311,, PP--0077 II44++..!!227722,, FF;;//''"",,..++ QQ++..,,>>!!0033,, 55##;;..00 BB,,++µµ33$$**++44,, RR6633....0077 99--;;////++7755,, ??))66--$$%%++ SS33''!!0033,, BB""44%%++ CC//,,--%%$$**++11

1. 5',/*;'!-,+ I$)%+7 TE ,M.Sc, T;.!-" I$)%+7 B!&#%<+7, 2. U"/0#)&!27 TE, M.Sc, ?.U. V+µ%+7, 3. U"/0#)=!-,+ C5, 4. 5'%*"&-"7 T+:0$2!-,+, C5R V+µ%+7, 5. J",!0!27 U"/0#)&!,*27 C5R V+µ%+7.

1<2I=4>4

BB**""''((77:: W!+. 0 +A,"#($0/0 !07 )µH"#,+/!,*27 *3#&@07 !6. µ+:0!>. !07 ')-,"127 )&:=.07 T;.!-"& I$)%-+7 B!&#%<+7 !"& U"µ"= J:,>!,<+7 *+!3 !+ ;!0 2006 -2008, ('67 +&!2 *+!+$-34)!+, *+!3 !0 /&µ'#2-6/0!"& G!"µ,*"= F)#!%"& I$)%+7.II##,,**(( **++,, µµ;;::""<<""77:: C" <)%$µ+ !07 ;-)&.+7 +'"!;#)/+. 611 µ+:0!;7 *+, !6. <=" 4=#6. (319 +$(-,+) 0#,-*%+7 6-16 )!>., !6. GX, ?X, *+, 5X !3A07 F0µ"!,*>. B1"#)%6. !07 ')-,"127 )&:=.07 T;.!-"& I$)%+7 B!&#%-<+7 !"& U"µ"= J:,>!,<+7, *+:>7 )'%/07 *+, !07 GX ?&µ.+/%"& *+, !07 GX V&*)%"&, +.!%/!",1+, !6. "'"%6.*+, +A,"#"$2:0*+. !+ G!"µ,*3 F)#!%+ I$)%+7 (GFI). C" )'%')<" /!+!,/!,*27 /0µ+.!,*(!0!+7 "-%/!0*) /!"p=0,05, ).> 1-0/,µ"'",2:0*) 0 /!+!,/!,*2 <"*,µ+/%+ 12.GG''""!!))##;;//µµ++!!++:: 19 '+,<,3 (52,20%) 2!+. +$(-,+ *+, 292 (47,80%) 2!+. *"-%!/,+. 9#2-67 )µH"#,+/µ;.+ $,+!" /=."#" !6. )µH"#%6. 2!+. 139 +$(-,+ *+, 132 *"-%!/,+, '"/"/!( 43,57% *+, 44,1% +.!%/!",1+. F). <,+-',/!>:0*+. /!+!,/!,*3 /0µ+.!,*;7 <,+4"-;7 µ)!+A= +$"-,>. *+, *"-,!/,>.. C" µ)$+#=!)-" '"/"/!( )##,-'"=7 )µH"#,+/µ"= +4"-3 /!" )µH(#," ;.+.!, !"& µ0.,$$,!,<(*"**"& (45,51%) *+, ;'".!+, +&!( !07 +.)µ)&-#"$,37 *+, !" MMR µ) '"/"/!( 14,42%.BB&&µµ'';;--++//µµ++:: B0µ+.!,*( '"/"/!( '+,<,>. /1"#,*27 0#,*%+7 *+, !6. <=" 4=#6. '+-"&/,38)!+, )##,'>7 )µH"-#,+/µ;.". D, µ)$+#=!)-)7 )##)%@),7 ).!"'%8".!+, /) )µH(#,+ '"& ),/21:0/+. !+ !)#)&!+%+ /!" 5:.,*( '-(-$-+µµ+ )µH"#,+/µ>..

VV;;AA)),,77 TT##)),,<<,,33:: G!"µ,*( F)#!%" I$)%+7, )µH(#,+, 9-"+$6$2 &$)%+7 .

!"µ#$ 4 - !%&'#$ 1 [27]

!"!#$%&'(H !")*+,A

<7()9?9- 9+-3 !,7 '-"/'3:),)7 '"& *+!+H3##".!+, +'( !,7&$),"."µ,*;7 +-1;7 '+$*"/µ%67, !+ #",µ><0 ."/2-µ+!+ )A+*"#"&:"=. .+ '-"/H3##"&. )*+!"µµ=-,+'+,<,3 µ) /&1.3 :+.+!04(-+ *+!3#0A0. U"/2µ+!+('67 0 )#"."/%+, ", '.)&µ".%)7 +'( '.)&µ".,(*"*-*", 0 ,#+-3, +##3 *+, " *"**=!07, 0 <,4:)-%!,<+ *+," !;!+."7 )&:=.".!+, $,+ µ)$3#" µ;-"7 !07 '+,<,*27:.0/,µ(!0!+7. 235 1-(.,+ µ)!3 !0. +.+*3#&@0 !"&'->!"& )µH"#%"& !" 1775, <,+:;!"&µ) /2µ)-+ 30

')-%'"& )µH(#,+. *+, 0 1>-+ µ+7 ;1), )',<)%A), /0µ+-.!,*( ;-$" /!". !"µ;+ !6. )µH"#,+/µ>.(T3/,µ"7,2003, T6./!+.!('"&#"7 2005). U(/", ('67 0 <,4:)--%!,<+ *+, 0 '"#,"µ&)#%!,<+ <). ;1"&. *3.), !0. )µ43-.,/2 !"&7 )<> *+, 1-(.,+ *+, 3##)7 !)%."&. .+ )*#)%-@"&.. Y/!(/", ", µ)!+*,.2/),7 '#0:&/µ"= !6.!)#)&!+%6. <)*+)!,>., /) /&.<&+/µ( µ) !". '#0µ-µ)#2 ;#)$1" *+, !0. *+!+$-+42 !6. ."/0µ3!6. <).)',!-;'"&. !". )40/&1+/µ( !6. &$),"."µ,*>.+-1>.(Philalithis,1995). E 5##3<+ <). <,+:;!), 5:.,-

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 27

Page 29: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[28] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

*( K0!->" T+!+$-+427 5µH"#,+/µ>., ).> µ(#,7 !+!)#)&!+%+ 1-(.,+ ;1), '-+$µ+!"'",2/), 9+.)##2.,)75:.,*;7 K)#;!)7 5µH"#,+/µ"= !" 1997, !" 2001 *+,!" 2006. (9+.+$,6!('"&#"7, M+#3//0-G<3µ 1998,9+.+$,6!('"&#"7 *+, /&.. 2002+, 9+.+$,6!('"&#"7*+, /&.. 2002H). B2µ)-+ /!0. 5##3<+ !" '"/"/!( !6.)µH"#,+8(µ).6. '+,<,>. &'"#"$%8)!+, µ) H3/0 !+/!",1)%+, '"& &'3-1"&. /!0. I'0-)/%+ T",.6.,*27B!+!,/!,*27 !"& I'"&-$)%"& I$)%+7 *+, 9-(.",+7 (II9)*+, /!" Cµ2µ+ 9+-+*"#"=:0/07 !07 T+!+.3#6/07*+, 5'3-*),+7 9-"Z(.!6. !"& 5:.,*"= D-$+.,/µ"=J+-µ3*6. (5DJ) (T"&-;+-T-)µ+/!,."=, 2006). Y/!(-/", !" 0 *).!-,*2 *&H;-.0/0 /&##;$), /!",1)%+ $,+!"&7 )µH"#,+/µ"=7, '"& $%.".!+, µ(." /!"&7 *-+!,-*"=7 4"-)%7, 4,6% !"& R.T.G. *+, ')-%'"& 18% /!+T;.!-+ I$)%+7, ).> )%.+, $.6/!( (!, ", &'(#",'",$%.".!+, +'( !"&7 ,<,>!)7 '+,<%+!-"&7, ", "'"%", <).)%.+, &'"1-)6µ;.", .+ ).0µ)->."&. !" I'"&-$)%",).> 0 +.!,'-"/6')&!,*(!0!+ /!,7 *+!+$-+4;7 !6.9+,<,+!-,*>. T#,.,*>. *+, !6. T;.!-6. I$)%+7 )#;$-1)!+, +4"= +&!;7 +4"-"=. /) ."/0#)&(µ).+ '+,<,32 /) )*)%.+ '"& '-"/;-1".!+, /!+ )A6!)-,*3 ,+!-)%+(U"=#+ *+, /&. 2008).

B*"'(7 !07 '+-"=/07 ;-)&.+7 2!+. 0 *+!+$-+42*+, 0 +A,"#($0/0 !6. )&-0µ3!6. /1)!,*3 µ) !0. !2-0-/0 !"& '-"$-3µµ+!"7 )µH"#,+/µ>. !+ "'"%+ '-";*&-@+. *+!3 !0. /&µ'#2-6/0 !"& G!"µ,*"= F)#!%"& I$)%-+7 !6. µ+:0!>. !07 ')-,"127 )&:=.07 T;.!-"& I$)%+7B!&#%<+7 !"& U"µ"= J:,>!,<+7 *+!3 !+ ;!0 2006 -2008.

@&7AB A)7 5'C#D#EC" &#,*( !07 ;-)&.+7 +'"!;#)/+. 611 µ+:0!;7 *+,!6. <=" 4=#6., +$(-,+ 52,20% (319), *"-%!/,+ 47,80%(292), 0#,*%+7 6-16 )!>., !6. GX, ?X, *+, 5X !3A07 F0µ"-!,*>. B1"#)%6. !07 ')-,"127 )&:=.07 T;.!-"& I$)%-

+7 B!&#%<+7 !"& U"µ"= J:,>!,<+7, *+:>7 )'%/07 *+,!07 GX?&µ.+/%"& *+, !07 GXV&*)%"&, +.!%/!",1+, !6."'"%6. *+, +A,"#"$2:0*+. !+ G!"µ,*3 F)#!%+ I$)%+7(GFI). B0µ),>.)!+, (!, 0 '-"#0'!,*2 )A;!+/0 !"& G!"-µ,*"= F)#!%"& I$)%+7 µ+:0!2 *+!’ ).!"#2 !"& I'"&--$)%"& I$)%+7 *+, !"& I'"&-$)%"& 9+,<)%+7 <,)A3$)-!+, *+, /&µ'#0->.)!+, µ)!3 +'( )',µ)#2 )A;!+/0 !6.µ+:0!>. *3:) 1-(.". E )A;!+/0 !6. µ+:0!>. !07µ)#;!07 ;$,.) /!" T;.!-" I$)%+7 B!&#%<+7 +'( ,+!-"=7$).,*27 ,+!-,*27, '+,<%+!-", '+:"#($", "<".!%+!-",)',/*;'!-,)7 &$)%+7, ."/0#)=!-,)7 *+, *",.6.,*"=7#),!"&-$"=7, +.+#($67 !07 &'( ;#)$1" '3:0/07 *+,!07 +.!%/!",107 '-"#0'!,*27 '+-;µH+/07. C+ )&-2-µ+!+ !07 *3:) )A;!+/07 *+!+$-34".!+, /!" G!"µ,*(F)#!%" I$)%+7 *+, /) ')-%'!6/0 ).!(',/07 '-"H#2-µ+!"7 &$)%+7 <%.)!+, ;.!&'" '+-+'"µ'27 $,+ '," ),<,-*( ;#)$1" !"& µ+:0!2 *+, 0 '+-+'"µ'2 *+!+$-34)-!+, *+, /!" GFI. B!0. '+-"=/+ µ)#;!0 '+-"&/,38".!+,!+ )&-2µ+!+ '"& +4"-"=. /!". )µH"#,+/µ( !6. µ+:0-!>.. Y7 '#2-67 )µH"#,+/µ;.+ $,+ *3'",+ +/:;.),+:)6-2:0*+. )*)%.+ !+ '+,<,3 '"& )%1+. '-+$µ+!"-'",2/), !" /=."#" !6. '-"H#)'"µ;.6. <(/)6. !"&)µH"#%"& ;.+.!, !07 /&$*)*-,µ;.07 +/:;.),+7. Y7/&."#,*3 '#2-67 )µH"#,+/µ;.+ :)6-2:0*+. )*)%-.+ !+ '+,<,3 '"& )%1+. '-+$µ+!"'",2/), !" /=."#"!6. <(/)6. (#6. !6. '-"H#)'"µ;.6. )µH"#%6. $,+!0. 0#,*%+ !"&7.

?,+ !0. *+!+$-+42 !6. +'"!)#)/µ3!6. *+, !0 /!+-!,/!,*2 !"&7 )')A)-$+/%+ 1-0/,µ"'",2:0*) !" /!+!,-/!,*( '+*;!" SPSS 17.0. C" )'%')<" /!+!,/!,*27 /0µ+-.!,*(!0!+7 "-%/!0*) /!" p=0,05, ).> 1-0/,µ"'",2:0*)0 /!+!,/!,*2 <"*,µ+/%+ 12.

!"#$%&'(µ)$) 319 '+,<,3 (52,20%) 2!+. +$(-,+ *+, 292 (47,80%) 2!+.*"-%!/,+ ('%.+*+7 1). 9#2-67 )µH"#,+/µ;.+ $,+ !"/=."#" !6. )µH"#%6. '"& ')-,#+µH3.".!+, /!" )',-*+,-"'",0µ;." '-($-+µµ+ )µH"#,+/µ>. 2!+. 139 +$(--,+ *+, 132 *"-%!/,+, '"/"/!( 43,57% *+, 44,1% +.!%-/!",1+. Q6-%7 H,H#,3-," 2!+. 18 +$(-,+ (5,65%) *+, 16*"-%!/,+ (5,39%), ).> ;.+ µ(." +$(-, 2!+. +.)µH"#%+-/!". F). <,+',/!>:0*+. /!+!,/!,*3 /0µ+.!,*;7 <,+-4"-;7 µ)!+A= +$"-,>. *+, *"-,!/,>. ('%.+*+7 2). C"

!&"#$#% 1. !G,2$-5 *(" 6$38µ0*(4 =0*) 'G7(

@G7( D %

B:"(;0 319 52,20G'(4*#;0 292 47,80H@,'9' 611 100

!&"#$#% 2. H0*0,(µ; $µA(7&0-*&=;4 =)7"C54 *+, $I$*0-21,*+, µ025*E, =0*) 'G7(

@G7( ?8/%&0 % H(%3*-&0 %

!93($;% 139 43,57 132 44,10E99;2$4% 161 50,47 151 50,51B,$µ-'940#*0 1 0,31 - -B,$7 -;-9;0(4'7 $µ-'9;0#µ6, 18 5,65 16 5,39H@,'9' 319 100 292 100

Q2, p>0,05

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 28

Page 30: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [29]

!"!#$%&'(H !")*+,A

µ)$+#=!)-" '"/"/!( )##,'"=7 )µH"#,+/µ"= +4"-3 /!")µH(#," ;.+.!, !"& µ0.,$$,!,<(*"**"& (45,51%) *+,;'".!+, +&!( !07 +.)µ)&#"$,37 *+, !" MMR µ) '"/"-/!( 14,42% ('%.+*+7 3).

*+,-$.(.B=µ46.+ µ) !+ +'"!)#;/µ+!+ !07 '+-"=/07 µ)#;-!07, µ)$3#" '"/"/!( '+,<,>. <). )%1+. '-+$µ+!"-'",2/), !" /=."#" !6. '-"H#)'"µ;.6. )µH"#,+/µ>.,).> /0µ+.!,*(7 +-,:µ(7 '+,<,>. <). )%1) '-+$µ+-!"'",2/), (#)7 !,7 +'+,!"=µ).)7 <(/),7, +*(µ+ *+,/!+ )µH(#,+ '"& )%1+. ).!+1:)% /!" 5:.,*( 9-($-+µ-µ+ 5µH"#,+/µ>. '-,. +'( !" 1990. B0µ),>.)!+, (!,;-)&.+ <,)A21:0 /) 0µ,+/!,*2 ')-,"12 !07 B!)-)375##3<+7, ;.+ $)6$-+4,*( <,+µ;-,/µ+, !"& "'"%"& ",)',<(/),7 /!" 82!0µ+ !"& )µH"#,+/µ"= )%.+, +'( !,71+µ0#(!)-)7 /!0. 5##3<+. 9-3$µ+!,, /=µ46.+ µ);-)&.+ '"& ;$,.) !" 2006 /) (#0 !0. 5##3<+, /) ):.,-*( +.!,'-"/6')&!,*( <)%$µ+ µ+:0!>. *+, /!0. "'"%+)*!,µ2:0*) 0 )µH"#,+/!,*2 *3#&@0 !6. '+,<,>.,;40H6. *+, '-"*='!), (!, µ) )A+%-)/0 !+ µ)$3#++/!,*3 *;.!-+ *+, !07 ')-,4;-),)7 !07 K+*)<".%+7,!07 N)//+#%+7 *+, !" ."µ( G!!,*27, ", &'(#",')7')-,"1;7 &'"#)%'".!+, (5-10%) /!0. '-+$µ+!"'"%-0/0 +*(µ+ *+, !6. '->!6. <(/)6. !"& )µH"#%6.. C+'"/"/!3 +&!3 ;1"&. 1),-(!)-0 ),*(.+ (!+. '-(*),-!+, $,+ !0. ;$*+,-0 '-+$µ+!"'"%0/0 !6. <(/)6. 2$,+ !0. !)#)&!+%+ +.+µ.0/!,*2 <(/0. Y7 '+-3<),$-µ+ +.+4;-)!+, 0 ')-%'!6/0 !"& )µH"#%"& DTP, ('"&!" '"/"/!( '-+$µ+!"'"%0/07 !07 507 <(/07 *+!;--1)!+, /!" 56% $,+ !" '+.)##+<,*( <)%$µ+. (9+.+$,6-!('"&#"7 *+, /&.., 2006). B&.)'>7 +. *+, !" )'%')-<" )µH"#,+/µ"= /!0 1>-+ µ+7 *-%.)!+, ,*+."'",0!,*(($,+ !+ «*#+/,*3» )µH(#,+ *+, µ) )#31,/!)7 )A+,-;-/),7 *&µ+%.)!+, 3.6 !"& 70% $,+ !" /=."#" !6. '+,-<,>.), '"##3 +'"µ;."&. +*(µ+ .+ $%."&. +'( !,7 &'0--)/%)7 &$)%+7 $,+ !0. '#2-0 &$),"."µ,*2 *3#&@0/!". !"µ;+ !6. #",µ6<>. ."/0µ3!6.. G7 /0µ),6:)%(!, *3'",)7 µ),"."!,*;7 "µ3<)7 &/!)-"=. /0µ+.!,-*3 /!" )'%')<" )µH"#,+/µ( !"&7, $)$".(7 '"& *+:,-

/!3 )',!+*!,*2 !0. +.3$*0 '+-)µH3/)6. /!,7 +.!%-/!",1)7 ')-,'!>/),7. C"',*27 *#%µ+*+7 µ)#;!)7 )',-H)H+,>."&. (!, ),*(.+ /!0. )##0.,*2 ='+,:-" +42-.), '"##3 ')-,:>-,+ '+-)µH3/)6.. B=µ46.+ µ);-)&.+ /) +$-"!,*2 ')-,"12 !07 V3-,/+7, µ(." !"22,71% )%1) "#"*#0->/), !"&7 '-"H#)'(µ)."&7 $,+!0. 0#,*%+ )µH"#,+/µ"=7, ).> (#+ /1)<(. !+ '+,<,3)%1+. '-+$µ+!"'",2/), 4 <(/),7 DTP. O/". +4"-3/!" MMR !" 50% !6. '+,<,>. !07 G’ !3A07 ?&µ.+/%-"& <). )%1+. )µH"#,+/!)% µ) !0. )'+.+#0'!,*2 <(/0,).> $,+ !0. 0'+!%!,<+ M /!0. G’ !3A0 ?&µ.+/%"& !"19,6% !6. '+,<,>. <). )%1) )µH"#,+/!)% µ;1-, !(!).(M2.0 2000). B) 3##0 µ)#;!0 '-" 15)!%+7 /!0. ')-,"-12 !07 B!&#%<+7, " '#0µµ)#27 )µH"#,+/µ(7 !6. '+,-<,>. +.)-1(!+. /!" 45%. D, µ+:0!;7 !"& ?&µ.+/%"&*+, V&*)%"& )µ4+.%8".!+. '#0µµ)#>7 )µH"#,+/µ;-.", /) '"/"/!( 69,8% ;.+.!, 10,2% !6. µ+:0!>. !6.F0µ"!,*>. /1"#)%6. (K+/!-+'3 1996). 9+-3 !0.'3-"<" !6. )!>., !+ '-"H#2µ+!+ µ) !0. '#0µµ)#2)µH"#,+/!,*2 *3#&@0 '+-+µ;."&..

E /&."#,*2 +.+#($,+ +'(*-,/07 /!+ '+,<,3 G’<0µ"!,*"= )%.+, /1)!,*3 &@0#2 (88%), 0 +'(*-,/0/) ),<,*;7 "µ3<)7 !"& '#0:&/µ"= *+, /!"&7 )42-H"&7 (?’ $&µ.+/%"&) )%.+, 1+µ0#(!)-0. ?,+ !+ )µH(-#,+ '"& )%1+. ).!+1:)% /!" 5:.,*( 9-($-+µµ+ 5µH"-#,+/µ>. '-,. +'( !" 1990 (DTP, 9"#,"µ&)#%!,<+7,MMR) )',!&$13.".!+, '"#= &@0#3 )'%')<+ )µH"#,+-/µ"= /!+ '+,<,3 !"& <0µ"!,*"=, DTP 3 <(/),7 99%,4 <(/),7 98%, 5 <(/),7 90%. MMR 1 <(/0 98%. Y/!(-/" (/". +4"-3 +&!3 !+ )µH(#,+, !" '," /0µ+.!,*('-(H#0µ+ '+-"&/,38)!+, µ) !0 <)=!)-0 <(/0 !"&)µH"#%"& MMR µ) '"/"/!( 77% !6. '+,<,>. !071>-+7 '"& ;1), #3H), !0 <)=!)-0 <(/0, ).> $,+ !+'+,<,3 µ)!+.+/!>. !" '"/"/!( +&!( )%.+, 52% *+,+-*)!3 1+µ0#(!)-" $,+ !"&7 +:%$$+."&7. Q+µ0#2*3#&@0 µ) 2 <(/),7 )µH"#%"& $,+ ,#+-3 H-;:0*) $,+!+ '+,<,3 !07 ?’ $&µ.+/%"& (80%). B0µ),>.)!+, (!, "/!(1"7 '"& ;1), :;/), " 9DI /!" '#+%/," !07 /!-+-!0$,*27 !07 )A3#),@07 !07 )$1>-,+7 ,#+-37 +'( !0.5&->'0 )%.+, .+ )',!)&1!)% " )µH"#,+/µ(7 !"& 95%!"& '+,<,*"= '#0:&/µ"= µ) <&" <(/),7 MMR. C" )'%-')<" )µH"#,+/!,*27 *3#&@07 $,+ ,#+-3 '"& H-;:0-*) /!0. µ)#;!0 )%.+, /&µH+!( µ) !" $)$".(7 (!, /&.)-1%8"&. .+ )*<0#>.".!+, )',<0µ%)7 ,#+-37 /!0. 5##3<+,('67 0 )',<0µ%+ '"& ;$,.) !" 2006 – 2006, 0 ('",+'-"/;H+#) *+!3 *=-," #($" '+,<,3 !07 !/,$$3.,*07µ),".(!0!+7 *+:>7 *+, µ)!+.3/!)7, +##3 *+, )42-H"&7 *+, .;"&7 !"& $).,*"= '#0:&/µ"= (9+.+$,6!(-'"&#"7 *+, /&.., 2006).

?,+ !+ )µH(#,+ '"& ).!31:0*+. /!" 5:.,*( 9-(-$-+µµ+ 5µH"#,+/µ>. ;67 !0. +-12 !07 <)*+)!%+7!"& 2000 (0'+!%!,<+7 M !" 1998 *+, !"& +,µ(4,#"&,.4#"&;.!/+7 !='"& b !" 2002) &'3-1), &@0#2 *3#&-@0 µ) !0. '-6!"$).2 /),-3 )µH"#,+/µ"=: 95% µ)!,7 +'+,!"=µ).)7 3 <(/),7 )µH"#%"& $,+ 0'+!%!,<+

!I"#$#% 3. H0*0,(µ; $77&#E, $µA(73+, *+,$I$*0-2$,*+, µ025*E, =0*) =0*58(%30 $µA(73("

:36(4 $µA(73(" D %

D.T.P. SABIN 4 1.30D.T. E,+948'7 50 16B.C.G. 4 1,30O20*4*;.0% M 22 7,05D+,;::4*;.0% C 142 45,51B,$µ$79':;/% 45 14,42M.M.R. 45 14,42H@,'9' 312 100

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 29

Page 31: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

6F6=FGH2!IF!

1. M3,+ C., R0-"% Q., F;/2+ B., H;6µ'7 J., H8$,*)(+% >. (2000). E7(3-µ0*0 02" *' B*'µ;8" C$9*4' S:$40% *'7 D0=+*3 80; !$(0;*)(5

BI;'9":+#3 *'7%. 38' !0,$993,;' !0;.;0*(;8" H7,).(;', #$9.277.2. G/#;µ'% Q (2003). !('&7908*;8'4 Eµ-'9;0#µ'4. >)0 !0;.;0*(;8/Q(',;8/. 3 (1):21-25.

3. G'7()0 - G($µ0#*;,'@ JA., (2006). M0#;8/ T)µ0*0 C+µ"#;0% S:$4-

[30] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

M *+, 90% $,+ +,µ(4,#" ,.4#"&;.!/+7 !='"& b (Hib). ?,+ !+ )µH(#,+ '"& ).!31:0*+. /!" 5:.,*( 9-(-

$-+µµ+ 5µH"#,+/µ>. !" 2006, <0#+<2 ')-%'"& !"<,3/!0µ+ '"& <,)A+$(!+. 0 µ)#;!0, 0 )µH"#,+/!,*2*3#&@0 '",*%#),. K) /&8)&$µ;." )µH(#," $,+ µ0.,$-$,!,<(*"**" "-""µ3<+7 C (MCVC)- '"& 2!+. <,+:;-/,µ" /!" )µ'(-," +'( !" 2001- )%1+. )µH"#,+/!)%')-%'"& 7 /!+ 10 '+,<,3 (72%). O'67 )%.+, +&!"-.(0!", /1)<(. $,+ !" /=."#" !6. )µH"#,+/µ>. +&!>.!" *(/!"7 !"& )µH"#%"& )%1) *+!+H#0:)% +'( !0.",*"$;.),+ *+, 0 µ)$3#0 '#),"@04%+ !"&7 (87%) )%1)$%.), /!". ,<,6!,*( !"µ;+. K) /&8)&$µ;." 7<=.+µ")µH(#," *+!3 !"& '.)&µ".(*"**"& (PCV7) *+, µ))µH(#," +.)µ)&#"$,37 (Var)- '"& *&*#"4(-0/+./!0. 5##3<+ !" 2005- <0#+<2 #%$" µ(." *+,-( '-,.!0 <,)A+$6$2 !07 µ)#;!07, !+ '"/"/!3 *3#&@07 2!+.1+µ0#3 (5% *+, 13% +.!,/!"%167), ('67 +.+µ).(!+.(9+.+-$,6!('"&#"7 *+, /&. , 2006).

C+ '+,<,3 !07 ?’ $&µ.+/%"& )µ4+.%8"&. 1+µ0#(-!)-+ )'%')<+ )µH"#,+/!,*27 *3#&@07 +'( +&!3 !6.µ,*-(!)-6. '+,<,>.. R<,+%!)-0 /0µ+/%+ ;1), !" +.)-'+-*;7 )'%')<" *3#&@07 µ) <&" <(/),7 )µH"#%"&MMR (80%), !" /1)!,*3 1+µ0#( )'%')<" )µH"#,+-/µ"= $,+ 0'+!%!,<+ M (85%) *+, 0 '"#= 1+µ0#(!)-0*3#&@0 µ) )µH(#," µ0.,$$,!,<(*"**"& "-""µ3<+7C (43%). B0µ),>.)!+, (!, ;.+ '"/"/!( 5,5% ')-%-'"& !6. '+,<,>. <). '-"/*(µ,/+. H,H#,3-,", +42-.".!+7 )-6!0µ+!,*3 $,+ !0 /6/!2 *+!+$-+42 *+,'+-+*"#"=:0/0 !07 +.3'!&A07 !"& '+,<,"=.E ).%-/1&/0 !6. <0µ"/%6. )µH"#,+/!,*>. *;.!-6. >/!).+ +&A0:"=. ", <&.+!(!0!)7 !6. $".;6. .+ '-"/4)=-$"&. /) +&!3 +'"!)#)%, )'"µ;.67, +*-"$6.,+%" #%:"$,+ !0. +=A0/0 !07 )µH"#,+/!,*27 *3#&@07 /!0 1>-+µ+7, ,<%67 $,+ '+,<,3 +'( ),<,*;7 '#0:&/µ,+*;7"µ3<)7 *+, +'( ",*"$;.),)7 µ) 1+µ0#;7 ",*"."µ,-*;7 <&.+!(!0!)7.

ABSTRACT

OORRIIGGIINNAALL AARRTTIICCLLEETTHHEE VVAACCCCIINNEE CCOOVVEERRAAGGEE OOFF SSCCHHOOOOLLCCHHIILLDDRREENN ((66--1166 YYEEAARRSS OOLLDD)) IINN AA GGRREEEEKK PPRROOVVIINNCCEEEE.. KKaassttrraappaa11,, AA.. IIffaannttiiss22,, DD.. HHaanniioottii33,, EE.. SSiiaammaannggaa44,, II.. PPrreessssaass55,, GGeeoorrggiiaa RRaappttii33,, SS.. TTssiirriinnggaa11

[[11.. MM..SScc..,, HHeeaalltthh VViissiittoorr ooff HHeeaalltthh CCeenntteerr aatt SSttyylliiddaa,, 22.. RRNN,, MM..SScc..,, GGeenneerraall HHoossppiittaall ooff LLaammiiaa,, 33..RRNN,, 44.. AAssssiissttaannttPPrrooffeessssoorr ooff TTEEII LLaammiiaa,, 55.. NNuurrssiinngg ssttuuddeenntt ooff TTEEII LLaammiiaa]]

AAiimm:: To assess the vaccine coverage of schoolchildren in the responsibility area of a Health Center, as recordedduring Personal Health Card ( PHC) fill-in procedure.MMaatteerriiaall aanndd mmeetthhooddss:: The sample consisted of 611 pupils( boys: 319), aged 6-16 years old of the 1st, 3rd and 5thgrade of Elementary School as well of 1st Junior High School class and 1st High School class, in the responsibilityarea of Stylida Health Center. Their PHC records were evaluated. X2 was used for comparison and statistical significancewas set at p=0,05.RReessuullttss:: 319 children ( 51.20%) were boys and 292(47.80%) were girls. Fully vaccinated for all the recommendedvaccines were 139 boys and 132 girls, 43.57% and 44.1% respectively. No statistical differences were observed betweenboys and girls. Most low vaccination coverage refers to meningococcus vaccine ( 45,51%) followed by MMR andvaricella –zoster vaccine (14.42%. CCoonncclluussiioonnss:: A considerable percentage of school children of both sexes s presented with vaccination coveragedeficits. Most deficits occur in vaccines lately introduced in The National Vaccination Program.

KKeeyy wwoorrddss:: Personal Health Card (PHC), vaccine, Health Promotion.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 30

Page 32: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [31]

!"!#$%&'(H !")*+,A

0%. E.H.C.S., 296-7, 359-360, 362-4.4. G'7()0-G($µ0#*;,'@ JA., JA0,08/8+ J., (2004). E=,;8" G),*(' B,0-&'(/% D+,;::4*;.0%, :15.

5. G5,#*0,*"2'79'% K.B., (2005). EI$94I$;% #*+, !0;.;0*(;83, C;0-:,5#*;83 80; T$(02$7*;83. D$*$820;.$7*;8" H$µ;,/(;' !0;.;0-*(;83%. M’ !0;.;0*(;83 G9;,;83 !0,$2;#*+µ4'7 B=+,6,.

6. D0#*(02/ E., M)99;'% C., Q0*A"2'79'% >., 80; #7,. (1996). >'#+-("*+*0 20;.;6, +9;840% 5-15 $*6, #*+, 2$(;'13 H*794.0% F0µ40%.!(08*;8/ 8'7 !0,$99+,4'7 H7,$.(4'7 K$,;83% U0*(;83%, Q098;.;83.

7. >'@90 D., K8$#'@9+ E., D0#*(':;/,,+% C., 80; #7,. (2008).Vaccination coverage in primary school children of urban andsuburban population in central Greece. U0*(;8/ Q(',;8/. GBV (10):486-90.

8. !0,0:;5*"2'79'% J., M09/##+–B./µ E (1998). !0,$990.;83 µ$9)-*+ 80*/#*0#+% $µ-'9;0#µ'@. U,#*;*'@*' 7:$40% *'7 20;.;'@, C;$@-=7,#+ G';,5,;83% !0;.;0*(;83%, B=3,0

9. !0,0:;5*"2'79'% J., M09/##+–B./µ E., H0(0&4.'7 E. 80; #7,.(2002). E=,;83 µ$9)*+ Eµ-'9;0#µ6, 2001: G/97N+ µ$ $µ-"9;' :;0

+20*4*;.0 M, 0;µ'&;9' ;,&9'7),*A0% *@2'7 b 80; µ+,;::;*;."8'88',40o !0,$993,;' !0;.;0*(;8" H7,).(;', T$##09',48+ (2$(49+N+).

10. !0,0:;5*"2'79'% J., M09/##+–B./µ E., H0(0&4.'7 E. 80; #7,.(2002). E=,;83 µ$9)*+ Eµ-'9;0#µ6, 2001: G/97N+ µ$ DTP 80;MMR, 4o !0,$993,;' H7,).(;' C+µ"#;0% 7:$40% 80; S2+($#;6,7:$40% , B=3,0 ( 2$(49+N+).

11. !0,0:;5*"2'79'% J. 80; 'µ/.0 µ$9)*+%, E=,;83 H1'93 C+µ"#;0%S:$40% *'7 20;.;'@, U,#*;*'@*' S:$40% *'7 20;.;'@, G),*(' E9):-1'7 80; !("9+N+% >'#+µ/*5, (*µ3µ0 E2;.+µ;'9':;83% $2;*3-(+#+%), B(;#*'*)9$;' !0,$2;#*3µ;' T$##09',48+% (U0*(;8" *µ3-µ0), !0,$2;#*3µ;' G(3*+% (*'µ)0% 8';,5,;83% U0*(;83%), S2'7(:$4'S:$40% 80; G';,5,;83% B99+9$::@+, (2006). E=,;83 µ$9)*+ 80*/-#*0#+% $µ-'9;0#µ'@ 80; #71,"*+*0% &7µ0*;83% 9'4µ5I+% #*020;.;/, #$9. 6, 8, 15-23, 32-35.

12. Philalithis AE (1995). Health Service Reforms in Bulgaria:Constraints and Opportunities, #*': Oealth Challenges forCountries of Central and Eastern Europe and the Newly IndependentStates, Harrington P., Ritsatakis A. ( Eds), Copenhagen, Denmark.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 31

Page 33: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

5*!%µ0/0 !6. G.+$*>. 5*'+%<)&/07 *+, T+!3-!,/07 !6. G.:->',.6. 9(-6. I$)%+7

/!0 Q>-+ µ+7 /!" 9#+%/," !"& 5:.,*"=B!-+!0$,*"= B1)<%"& G.3'!&A07 2007-2013

FF;;//''"",,..++ GG..<<--,,>>!!0011,,FF00µµ22!!--0077 TT""µµµµ++!!337722,,GG##))AA33..<<--++ BB**%%!!//""&&33,, ??,,>>--$$""77 QQ++--++##33µµ''""&&7744,, QQ--==//++ KK''++--((55

1. D,*"."µ"#($"7 !07 I$)%+7, BA, MSc, PhD, 5',/!0µ".,*(7 B&.)-$3!07, C5R G:2.+7, 2. 9"#,!,*(7 5',/!2µ6., MA, MSc, 9-"Z/!3µ)."7 F,)=:&./07 5*'+%<)&/07 I'"&-$)%" I$)%+7

*+, T",.6.,*27 G##0#)$$=07, 3. U"µ,*(7, BA, MSc, PhD, T+:0$2!-,+ 9+.)',/!0µ%"& Frederick, T='-"7,

4. I')=:&."7 Cµ2µ+!"7 5'),$(.!6. 9)-,/!+!,*>., ?.U.G. R''"*-3!),", MD, MSc, PhD,5. U"/0#)=!-,+, MA, MSc, I'"&-$)%" I$)%+7 *+, T",.6.,*27 G##0#)$$=07

9955SSIIVVEE[[EE

55,,//++$$66$$22:: E )*'+%<)&/0 *+, *+!3-!,/0 H"0:3), /!0 H)#!%6/0 !6. <)A,"!2!6. !6. )'+$$)#µ+!,>. &$)%-+7 *+, /&µH3##), /!0. +=A0/0 !07 +'"<"!,*(!0!+7 !"&7. D, *+!3##0#+ )*'+,<)&µ;.", )-$+8(µ).",, µ'"--"=. .+ +.!+'"*-%.".!+, /!,7 !-;1"&/)7 *+, µ)##".!,*;7 +.3$*)7 !"& '#0:&/µ"=. C" 5:.,*( B!-+!0$,-*( 9#+%/," G.3'!&A07 (5B9G) 2007-2013 +'"!)#)% µ".+<,*2 )&*+,-%+ $,+ !" /1)<,+/µ( /=$1-".07)*'+%<)&/07 *+, *+!3-!,/07 !"& +.:->',."& <&.+µ,*"= !"& &$),"."µ,*"= !"µ;+ '-"7 +&!2 !0. *+!)=-:&./0BB**""''((77:: B*"'(7 !07 )-$+/%+7 +&!27 2!+. 0 )*!%µ0/0 !6. +.+$*>. )*'+%<)&/07 *+, *+!3-!,/07 !6. )'+$-$)#µ+!,>. &$)%+7 !07 1>-+7 µ+7 µ) H3/0 !" &$),"."µ,*( '-(!&'" !"& '#0:&/µ"=. G'"!)#)% )',*+,-"'",0-µ;.0 )*<"12 !"& *),µ;."& '"& 1-0/,µ"'",2:0*) $,+ <,+H"=#)&/0 /!" :;µ+ !07 +.3'!&A07 +.:->',."&<&.+µ,*"= /!" '#+%/," !"& 5:.,*"= G.+'!&A,+*"= B1)<%"& 2007-2013, !"& I'"&-$)%"& I$)%+7 *+, T",.6.,-*27 G##0#)$$=07II##,,**((--KK;;::""<<""77:: B&$*).!->:0*+. <0µ"$-+4,*3 *+, )',<0µ,"#"$,*3 <)<"µ;.+ !"& )##0.,*"= '#0:&/µ"= !+"'"%+ /&.<&3/!0*+. µ) /&.+4)%7 '"#,!,*;7 +.:-6'%.6. '(-6. +'( <,):.)%7 "-$+.,/µ"=7 µ;/6 H,H#,"$-+-4,*27 +.+82!0/07 /!,7 ,/!"/)#%<)7 !"&7. BB&&µµ''))--33//µµ++!!++:: D -(#"7 !07 '"#,!)%+7 )%.+, *+:"-,/!,*(7 /!0 <,+µ(-46/0 *+!3##0#07 '"#,!,*27 *+, /!0:;/',/0 /!(16. *+, /!-+!0$,*>. $,+ !0. )'%!)&A0 !07 +.3'!&A07 !"& +.:->',."& <&.+µ,*"=. M+/,*3 :;µ+-!+ '"& '-;'), .+ +.!,µ)!6',/!"=. '-"7 +&!2 !0. *+!)=:&./0 )%.+, 0 #)'!"µ)-27 *+!+$-+42 !"& &'3-1"-.!"7 <&.+µ,*"= (+-,:µ"% *+, 1+-+*!0-,/!,*3), 0 '-(H#)@0 $,+ µ)##".!,*;7 &'0-)/%)7, 0 H)#!%6/0 !07 '",-(!0!+7 *+, !6. <)A,"!2!6. !"&, µ;/6 )').<=/)6. /) '-"$-3µµ+!+ )*'+%<)&/07 *+, *+!3-!,/07 ')-,#+µH+."µ;.07!07 <,+ H%"& )*'+%<)&/07 *+, !07 )*'+%<)&/07 /!,7 .;)7 !)1."#"$%)7.

VV;;AA)),,77--**##)),,<<,,33:: F,+-H%"& )*'+%<)&/0 *+!3-!,/0, )'+$$)#µ+!%)7 &$)%+7, )'+$$)#µ+!,*3 '-"/(.!+, <)A,(!0!)7

[32] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 32

Page 34: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [33]

!"!#$%&'(H !")*+,A

1.1 !"#$%&%'! "#$%&'"()* #%+ #%,-.,+)* ,/( %01.2$+0/( '(0%µ+-#/3 "&0%+ /()+2'*4 $%.-µ",./4 ),*0 %0-$,(5* ,60%01.2$+060 $7.60 ,/( )(),8µ%,/4 (9"&%4 (Cedefop2009). ! "#$%&'"()* "$"+'8 :/*1- ),*0 %$7#,*)*902)"60 #%+ '"5+/,8,60 #%+ * #%,-.,+)* "$"+'8 :/*-1- ),* '+%,8.*)* #%+ %0%0;6)8 ,/(4. <0% #%=- "#$%+-'"(µ;0/ %01.2$+0/ '(0%µ+#7 $%.;>"+ $/+/,+#;4 ($*-.")&"4 $/( %0,%$/#.&0/0,%+ ),+4 $./)'/#&"4 #%+%$%+,8)"+4 ,/( $=*1()µ/3 #%+ )(µ:-=="+ ),*0 %)?--="+% ,60 %)1"020. @$+$=;/0 "&0%+ µ+% %$7 ,+4 ,."+4$%.%µ;,./(4 ,*4 $/=+,+#84 ,60 %01.2$+060 $7.60,* /$/&% )(0/A&B",%+ 64 "584: «,% #%,-==*=% "#$%+-'"(µ;0% -,/µ%, ),+4 )6),;4 %0%=/9&"4 #%+ ),+4 #%,-=-=*="4 1;)"+4 ".9%)&%4» (WHO 2006).

C" %?/.µ8 ,/ @10+#7 D,.%,*9+#7 D>;'+/ E0-$,(-5*4 2007-2013 "$+>"+."&,%+ * )#+%9.-?*)* ,60 )39->./060 %0%9#20 "#$%&'"()*4 #%+ #%,-.,+)*4 ,/('(0%µ+#/3 (9"&%4 µ" :-)* ,/ (9"+/0/µ+#7 $./?&= ,/($=*1()µ/3 #%+ ),7>/ ,*0 %0%'+/.9-06)* #%+ µ",%.-.31µ+)* ,/( @10+#/3 D(),8µ%,/4 F9"&%4 ,*4 >2.% µ%4),*0 #%,"31(0)* ,*4 $/+7,*,%4 #%+ %$/'/,+#7,*,%4(F$/(.9"&/ F9"&%4 #%+ G/+060+#84 E==*="993*4 2005)

' ()*+,-. !µ/*)012H I%9#7)µ+/4 H.9%0+)µ74 F9"&%4 #%+ * @(.6$%J#8<06)*, µ" *9",+#8 1;)* ),* '+%µ7.?6)* $/=+,+#84(9"&%4, ;>/(0 1;)"+ )" (A*=8 $./,".%+7,*,% ,/ 1;µ%,*4 %0-$,(5*4 ,/( %01.2$+0/( '(0%µ+#/3 ,/ /$/&/%$/,"="& #.&)+µ/ $%.-9/0,% 9+% ,* µ",%..31µ+)* ,60)(),*µ-,60 (9"&%4 2)," 0% %0,%$/#.&0/0,%+ ),+4%0-9#"4 ,/( $=*1()µ/3, 7$64 ?%&0",%+ #%+ %$7 ,+4)>",+#;4 "#1;)"+4. (Commission of the EuropeanCommunities 2008, European Commission 2010).K%)+#8 $./L$71")* %(,84 ,*4 %0-$,(5*4 "&0%+ *"$+=/98 #%+ (+/1;,*)* %$/,"=")µ%,+#20 #%+ )39->./060 "#$%+'"(,+#20 $./9.%µµ-,60, ,% /$/&% 1%;>/(0 ),7>/ ,* :"=,&6)* ,60 '"5+/,8,60 #%+ ,% $/+-/,+#- >%.%#,*.+),+#- ,*4 ".9%)&%4, %?/3 /+ '"5+7-,*,"4 /+ /$/&"4 %$%+,"&,%+ 0% %0%$,35/(0 /+ "$%9-9"=µ%,&"4 (9"&%4, "&0%+ #-1" ?/.- )(0'"'"µ;0"4 µ",/ (9"+/0/µ+#7 $./?&=, ,*0 #/+060+#//+#/0/µ+#8 %0--$,(5*, ,+4 %5&"4 #%+ ,+4 $./,".%+7,*,"4 ,*4 #/+06-0&%4 (WHO 2006, European Commission 2010).

34 *556,)78 /5219)4 D,* >2.% µ%4 * %$/()&% "10+#84 $/=+,+#84 %01.2-$+060 $7.60 '()#/="3"+ ,/0 $./9.%µµ%,+)µ7 #%,-=-=*=60 ($*.")+20 9+% ,*0 %$/,"=")µ%,+#8 #-=(A*,/( $=*1()µ/3. ! #%,-),%)* 9&0",%+ %#7µ% '()#/-=7,".* "5’ %+,&%4 ,*4 ;=="+A*4 )(),8µ%,/4 #%,%-9.%?84 #%+ $%.%#/=/31*)*4 ,60 µ"9"120 #%+ ,60>%.%#,*.+),+#20 ,/( '(0%µ+#/3 (9"&%4. <0% ,;,/+/)3),*µ% $=*./?7.*)*4 %$/,"="& %$%.%&,*,* $./-L$71")*, 9+% ,* '*µ+/(.9&% "$+,(>*µ;0*4 "10+#84$/=+,+#84 %01.2$+060 $7.60 (European Commission2009). ! $/=+,+#8 %(,8 1% $.;$"+ 0% 1;,"+ )%?"&4-5/0"4 ),/0 ,/µ;% ,*4 $./)?/.-4 ("#$%&'"()* #%+#%,-.,+)*), ,*4 B8,*)*4 ($.7)=*A* #%+ %$%)>7=*-)*) #%+ ,*4 '+/&#*)*4 (%0-$,(5*, 9"69.%?+#8 #%,%-0/µ8, $%.%969+#7,*,%) #%+ µ",.8)+µ/(4 ),7>/(4(E0'.+2,* 1998)

@+'+#7,".%, * :"=,&6)* ,*4 $/+7,*,%4 ,60 $%."->/µ;060 ($*.")+20, $./L$/1;,"+ ,*0 %0%'+/.9-06-)* ,60 $./9.%µµ-,60 )$/('20, ,*4 "#$%&'"()*4,#%,-.,+)*4 #%+ '+% :&/( "#$%&'"()*4 #%+ ,* '+%#.&-:6)* ,/(4 (accreditation), ,/0 #%1/.+)µ7 ,60 "+'+-#/,8,60 (licensing) #%+ ,/ )(0%?;4 $".+">7µ"0/ ,60)$/('20 (Mladovsky et al 2009).

D" %0%?/.- µ" ,% $./9.-µµ%,% '+% :&/( "#$%&-'"()*4 #%+ #%,-.,+)*4, ),/0 I&0%#% 1 ?%&0",%+ '+%->./0+#- 7,+, * )(µµ",/>8 ,60 @==8060 *=+#&%4 25-64 ",20 8,%0 )*µ%0,+#- >%µ*=7,".* ,7)/ %$7 ,/0µ;)/ 7./ ,60 $%=%+20 @@15 7)/ #%+ %$7 ,/ µ;)/7./ ,60 #.%,20 µ"=20 ,*4 @@25 8 @@27 %0,&),/+->%. D(9#"#.+µ;0%, $".&$/( 2 ),/(4 ';#% $%.%#/-=/31*)%0 #-$/+%4 µ/.?84 "#$%&'"()* #%+ #%,-.-,+)* ),* >2.% µ%4 #%,- ,*0 $".&/'/ 1993-2007;0%0,+ $".&$/( 8 ),+4 >2."4 @@15 (@DF@ 2009,Boateng 2009). M/ 9"9/074 %(,7 ($/'*=20"+ ,*>%µ*=8 %5+/$/&*)* ,;,/+60 $.6,/:/(=+20, $/( %$/-,"=/30 µ/0%'+#8 '(0%,7,*,% 9+% %0%0;6)* ,60 902-)"60 ,/( ".9%,+#/3 '(0%µ+#/3. ! %0-=()* ,/( @10+-#/3 µ%4 D(),8µ%,/4 @#$%&'"()*4 #%+ G%,-.,+)*4(@&G) µ" ,* :/81"+% '"+#,20 (D%..84 #%+ )(0 2006)"µ?%0&B"+ #%1%.-, %?’ "074 ,*0 (),;.*)* %(,20,60 #.&)+µ60 µ*>%0+)µ20 ),* >2.% µ%4 )" )>;)*µ" ,/( @(.6$%J#/34 µ;)/(4 7./(4 (EUROSTAT2009) (D>8µ% 1), %?’ ",;./( ,* '()#/=&% )39#=+)*4

!I"#$#% 1. !"µµ#$%&' $% #(()*+,%- ,.+ $%" /()0"1µ%- $)2 3"45/.6,'2 7*51)2 3315 ,.+ 3325 1# ,8/%+%" #9:%"2 #,/.9:#"1) ,.$8 $. ;$) 1993-2007

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2007

!""#$% 1.1 1.0 0.9 0.9 0.9 1.0 1.3 1.1 1.4 1.2 2.7 2.0 2.1!! (25) : : : : : : : 7.9 7.8 7.9 9.2 9.9 9.7*E! (15) : : : 5.7 5.7 : 8.2 8.4 8.3 8.5 9.9 10.6 8.4&'(): Boateng 2009*EU-27 member states

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 33

Page 35: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[34] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

,7)/ $/)/,+#- (%$%&,*)* (A*=20 .(1µ20) 7)/ #%+$/+/,+#- (;=="+A* ),.%,*9+#20 «#.&#60») (OECD2010).

! %5+/=79*)* $/( ;9+0" ),% $./9.-µµ%,% #%,-.-,+)*4 $/( (=/$/+81*#%0 %$7 ?/."&4 ,/( F$/(.9"&/(F9"&%4 #%+ G/+060+#84 E==*="993*4, ),/ $=%&)+/ ,/($./*9/3µ"0/( D,.%,*9+#/3 I=%&)+/ E0-$,(5*4 2000-2006 ;'"+5" %'(0%µ&% )30'")*4 ,*4 #%,-.,+)*4 µ",*0 #%1*µ".+08 -)#*)* ,/( ;.9/( ,/(4, #%124 #%+%'(0%µ&% "#,&µ*)*4 ,*4 "$&$,6)*4 ,*4 "$%99"=µ%-,+#84 "#$%&'"()*4 ),*0 "$%99"=µ%,+#8 ,/(4 #/(=-,/3.% (D%..84 #%+ )(0 2006).

!:;5):6 72) !/)<6µ)454=)78 >04?15 @4A >56+A9µ4BM/ "$+'*µ+/=/9+#7 $./?&= ,/( "==*0+#/3 $=*1()µ/3,)3µ?60% µ" ,/0 IHF #%+ ,*0 @==*0+#8 D,%,+),+#8 E.>8(@NDMEM), "&0%+ $%.7µ/+/ µ" "#"&0/ $/( $".+9.-?"-,%+ 9+% ,+4 %0%$,(9µ;0"4 >2."4. ! #(.+7,"."4 %+,&"41%0-,/( ,/( $=*1()µ/3 "&0%+ ,% 0/)8µ%,% ,/( #(#=/-?/.+#/3 (48%), ,% #%#/81* 0"/$=-)µ%,% (25%), ,%0/)8µ%,% ,/( %0%$0"(),+#/3 (7%) #%+ /+ "56,".+#;4#%#2)"+4 #%+ '*=*,*.+-)"+4 (5%). M% ,./>%&% %,(>8-µ%,% "&0%+ * #(.+7,".* %+,&% 1%0-,/( 9+% ,+4 *=+#&"4µ;>.+ 44 ",20 #%+ "&0%+ (A*=7,".* ),* >2.% µ%4 )")>;)* µ" ,/ µ;)/ 7./ ,*4 @@ (27). E5&B"+ 0% )*µ"+6-1"& 7,+ ,% ,"="(,%&% >.70+% '"&>0"+ 0% µ"+20",%+ #%+%(,7 ?%&0",%+ 7,+ /?"&=",%+ ),/(4 "=;9>/(4 #%,%0--

=6)*4 /+0/$0"3µ%,/4 ),/(4 /'*9/34 #%124 #%+ ),*0%9698 (9"&%4 ),% )>/="&%. M% #%#/81* 0"/$=-)µ%,%"$*."-B/(0 #(.&64 ,% -,/µ% µ;)*4 *=+#&%4, "02 ,%0/)8µ%,% ,/( #(#=/?/.+#/3 "&0%+ * #(.+7,".* %+,&%1%0-,/( ),+4 *=+#&"4 60+

D" 7,+ %?/.- ,* 9"00*,+#7,*,% %(,8 $%.%µ;0"+ ),%-1".8 )" 1,3 $%+'+- %0- 9(0%&#% %$7 ,+4 %.>;4 ,*4'"#%",&%4 ,/( ’90 "(.+)#7µ"0* )*µ%0,+#- #-,6 ,/("$+$;'/( %0,+#%,%),-)"64. <,)+, )3µ?60% µ" ,+4 "#,+-µ8)"+4 ,/( Eurostat 2008 #%+ ,*4 @NDMEM 2010, / $=*-1()µ74 ,*4 >2.%4 1% %.>&)"+ 0% µ"+20",%+ %$7 ,/2020, "02 ,/ $/)/),7 ,60 *=+#+6µ;060 65+ 1% %(5*-1"& #%+ 1% %0;=1"+ )" 21% ,/ &'+/ ;,/4 #%+ )" 32% ,/2050.

<>"+ "(.3,%,% ,"#µ*.+61"& )" µ"9-=/ %.+1µ7 µ"="-,20, 7,+ ,% %,/µ+#- $.7,($% )(µ$".+?/.-4, #%124#%+ ,/ #/+060+#7 #%+ /+#/0/µ+#7 $".+:-==/0, "0/>/-$/+/30,%+ )" µ"9-=/ :%1µ7 9+% ,% >.70+% 0/)8µ%,%.<,)+ ),/ D>8µ% 2 ?%&0",%+ * %35*)* ,/( %.+1µ/3 ,60$%>3)%.#60 #%+ ($;.:%.60 ),* >2.% µ%4, "02 )" 7,+%?/.- ,/ #-$0+)µ%, * >2.% µ%4 ;>"+ ,/ (A*=7,"./$/)/),7 ),*0 @@ %?/3 ,/ 46,8% ,60 %0'.20 #%+ ,/29% ,60 9(0%+#20 *=+#&%4 -06 ,60 15 ",20 #%$0&B"+.

! 98.%0)* ,/( $=*1()µ/3 #%+ * )(µµ",/>8 ),*0%0%=/9+#8 0/)*.7,*,% #%+ 10*)+µ7,*,% ,60 #%.'+%9-9"+%#20 0/)*µ-,60, 0"/$=%)µ-,60, %,(>*µ-,60, A(>+-#20 '+%,%.%>20 #%+ ,/( '+%:8,* 1% :%&0"+ )(0">24

0

10

20

30

40

50

60

70

80%

!"#

#$%&$

'(()

*$

+,(

-.&$

/0$(

&$

+,%

0,#$

(&$

1,%

2$

/34$

.&$

5$((

&$

6378&$

9"3

0%$(

&$

:2(#

;,

<(,=

7.&$

9"3

0%&$

'3>,

.&$

1$.

$*)?

<(,=

$@&$

A$.

&$

!((

$.*&$

57%µ

$.&$

B+9

B..

:$3

&(7;,

C,%

=D#&$

E;.($

.*&$

'(=70&$

C2$

FD(

$.*&$

<,"D

*&$

OECD average

!"#$: OECD (2010), %ducation at a Glance 2010, Table A5, 1a, available at http://dx.doc.org/10.1787/888932310168.

%&H'# 1. !"µµ#$%&' $%" /()0"1µ%- )(+,9.2 25-64 #$<* 1# /4%=48µµ.$. ,.$84$+1)2, 1$+2 &<4#2 $%" >>!?, 2007

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 34

Page 36: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [35]

!"!#$%&'(H !")*+,A

%(5%07µ"0*, ($/'*=20/0,%4 #%+ ,*0 %0-9#* 9+% $%./->8 "5"+'+#"(µ;060 ($*.")+20 $.7=*A*4, $".&1%=-A*4, ?./0,&'%4 #%+ %$/#%,-),%)*4 ),/0 $=*1()µ7.@# $%.%==8=/( * µ"&6)* ,*4 9"00*,+#7,*,%4 #%+ *µ",%:/=8 ,/( $./?&= ,*4 "==*0+#84 /+#/9;0"+%4 )*µ%-,/'/,"& ,*0 %0-9#* 9+% "$;#,%)* ,60 '/µ20 :/81"+-%4 #%+ ?./0,&'%4 9+% ,*0 M.&,* *=+#&% #%+ ,*0 %0,&),/+->* "$;0'()* )" ($/'/µ;4 #%+ $./)6$+#7 2)," 0%µ$/."& 0% %0,%$/#.+1"& )’ %(,;4 ,+4 µ",%:/=;4 (E0'.+2-,* #%+ O/(µ"=+2,* 2007).

D" 7,+ %?/.- ),* 9"00*,+#7,*,% "$"+'8 1% :%&0"+)(0">24 µ"+/3µ"0*, %0%µ;0",%+ 0% µ"+61"& * B8,*)*9+% µ%+"(,8.+% #%+ µ%+"(,+#- #.":-,+%, #%124 #%+ )"%0,&),/+>/ '(0%µ+#7 )(0%?20 "+'+#/,8,60. ! B8,*)*7µ64 9+% 0/)*="&% 0"/9020 (A*=/3 #+0'30/( %0%µ;-0",%+ 0% %(5*1"&, µ" ),7>/ ,* µ"&6)* ,*4 $".+9"00*-,+#84 #%+ 0"/90+#84 10*)+µ7,*,%4, /+ /$/&"4 %0 #%+;>/(0 :"=,+61"& 1"%µ%,+#- µ",%53 ,60 ",20 1971-

2007 ;>/(0 $".+12.+/ $".%+,;.6 :"=,&6)*4. D,*0#%,"31(0)* %(,8 1% :/*18)"+ * /.18 "?%.µ/98 ,/($./9%µ+%&/( $+),/$/+*,+#/3 )" )(0'(%)µ7 µ" ,* '(0%-,7,*,% $./9"00*,+#84 '+-906)*4. I%.-==*=% * %0,+-µ",2$+)* ,*4 ($/9/0+µ7,*,%4 1% %$%+,8)"+ %0,&),/+->"4 "$"0'3)"+4 )" (A*=8 ,">0/=/9&% #%+ "#$%+'"(µ;0/$./)6$+#7 (E0'.+2,* #%+ O/(µ"=+2,* 2007).

C) >044/@)7;.M/ $=%&)+/ ,*4 $/=+,+#84 9+% ,/ )>"'+%)µ7 #%+ ,*0 %0--$,(5* ,/( %01.2$+0/( '(0%µ+#/3, =%µ:-0/0,%4 ($7-A* ,+4 +'+%+,".7,*,"4 ,*4 >2.%4 µ%4, "&0%+ %$%.%&,*-,/ 0% :%)+),"& ),* ';)µ"()* ,*4 #"0,.+#84 '+/&#*)*49+% ,+4 %0%9#%&"4 µ",%..(1µ&)"+4, ),* 1;)$+)* #%+"?%.µ/98 )>",+#84 0/µ/1")&%4, ,*0 %0-$,(5* )(),*-µ-,60 #%,%9.%?84, $=*./?7.*)*4 #%+ %0-=()*4 ,60'"'/µ;060 ,*4 >2.%4 (Commission of the EuropeanCommunities 2008).

'(()*$*

B.. :$3&(7;,

/34$.&$

+,%0,#$(&$

E;.($.*&$

57%µ$.&$**

/%($.*&$

9"30%&$

A$.&$

<,"D*&$

:2(#;,

/0$(&$

!(($.*&$

5$((&$

!"#$: European Association for the Study of Obesity.

*Restricted age group **Germany overweight figures derived from WHO MONICA studies

0 10 20 30 40 50 60 70 80

!"#$%&'(

57%µ$.&$**

'(()*$*

E;.($.*&$

/%($.*&$

B.. :$3&(7;,

:2(#;,

9"30%&$

/34$.&$

A$.&$

+,%0,#$(&$

<,"D*&$

/0$(&$

!(($.*&$

5$((&$

0 10 20 30 40 50 60 70 80

$#)*'(

%

BMI 25-29.9BMI ! 30

%&H'# 2. 3,$9µ)1) $%" #/+/%(.1µ%- "/;[email protected]* ,.+ /.&-1.4,5* ,.$8 A-(% 1# #/+(#=µ;*#2 &<4#2 $)2 3"45/.6,'2 7*51)2 $% 2010

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 35

Page 37: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

C" :-)* ,*0 %0-=()* $/( $./*981*#" $./,"&0/-0,%+:! ! '*µ+/(.9&% $/=+,+#84 %01.6$&060 $7.60. D,/$=%&)+/ ,*4 %0%B8,*)*4 µ+%4 µ",%..31µ+)*4 ,/( (9"+-/0/µ+#/3 ,/µ;% ),*0 @==-'%, / )>"'+%)µ74 #%+ * '+%->"&.+)* ,60 %01.6$&060 $7.60 %$/,"="& (A*=8 $./-,".%+7,*,% $./#"+µ;0/( 0% %0,+µ",6$+),/30 /+'+%9.%?7µ"0"4 $./#=8)"+4 %$7 ,*0 #/+060&% ,*4 902-)*4 #%+ ,+4 ,">0/=/9+#;4 "5"=&5"+4 7$64 ;>/(0 $".+-9.%?"& ),* )>",+#8 :+:=+/9.%?&% (Cedefop 2008)! P*µ+/(.9&% )(),8µ%,/4 ,"#µ*.&6)*4 #%+ ;."(0%4,60 "$%99"=µ%,+20 (9"&%4. @&0%+ $./?%0;4 7,+ 9+%,*0 (=/$/&*)* ,*4 )>",+#84 $/=+,+#84 ),/0 ,/µ;%,60 %01.6$&060 $7.60 >."+-B",%+ * 1;)$+)* ),%-1"./3 )(),8µ%,/4 )(==/984 #%+ "$"5".9%)&%4 ),%-,+),+#20 '"'/µ;060 9+% ,*0 $%.%#/=/31*)* ,*4 "5;-=+5*4 ,/(4, ,*4 )(µ:/=84 ,/(4 ),*0 $/+7,*,% ,60($*.")+20 #%+ ,* µ;,.*)* ,*4 $%.%969+#7,*,%4.E(,7 µ$/."& 0% 9&0"+ µ;)6 ,*4 &'.()*4 I%.%,*.*-,8.+/( E01.2$+060 I7.60, 1")µ74 / /$/&/4 $./-,"&0",%+ #%+ %$7 ,/0 IHF (Rechel et al 2006)! E0-$,(5* %01.6$&060 $7.60 )" %.+1µ/34, "+'+#7-,*,"4 #%+ * $/+7,*,% ,/(4. ! '+%.1.6,+#8 #%+ ,">0/-=/9+#8 %==%98 $/( 1% $./#3A/(0 %$7 ,/(4 $(=20"4,/( %0%$./)%0%,/=+)µ/3 ,/( @10+#/3 D(),8µ%,/4F9"&%4 1% ?;./(0 ),/ "$&#"0,./ ,+4 0;"4 902)"+4 #%+,">0/=/9&"4 (e-health #%+ health intelligence, :+/-0%0/-MI@) (F$/(.9"&/ E0-$,(5*4 2005) #%+ 1% $.;-$"+ 0% =*?1/30 ($7A* ),/ µ"==/0,+#7 )>"'+%)µ7. D,/$=%&)+/ %(,7, #.&0/0,%+ %$%.%&,*,"4 /+ "$"0'3)"+4 )"($/'/µ;4 (C@Q, M@I), µ" $%.-==*=* "#$%&'"()* #%+#%,-.,+)* %0-=/9/( %.+1µ/3 %01.2$+0/( '(0%µ+#/3$/( 1% "&0%+ )" 1;)* 0% >"+.&B",%+ ,*0 (A*=8 ,">0/-=/9&% (Kachur and Krajic 2006)! E0%1"2.*)* ,*4 "#$%&'"()*4, #%,-.,+)*4 #%+ '+%:&/( "#$%&'"()*4 #%124 #%+ #%1+;.6)* #%+ "$;-#,%)* ,*4 "#$%&'"()*4 )" (?+),-µ"0"4 #%+ 0;"4,">0/=/9&"4. D,* >2.% µ%4 ($-.>"+ )/:%.7 $.7:=*-µ% "#$%&'"()*4 +'+%&,".% )" 7,+ %?/.- 1;µ%,% $./-9.%µµ-,60 )$/('20, '+%'+#%)&%4 #%+ %5+/=79*)*4,/(4. ! &'.()* @10+#/3 G;0,./( P+%#.&:6)*4 %0%-µ;0",%+ 0% :/*18)"+ )*µ%0,+#- $./4 %(,8 ,*0 #%,"3-1(0)*. ! ),.%,*9+#8 )*µ%)&% ,60 %01.6$&060 $7.60,$/( 1% (=/$/+8)/(0 ,*0 $/=+,+#8 ,*4 #"0,.+#84 '+/&-#*)*4 9+% ,*0 (9"&% #-0"+ "$+,%#,+#8 ,*0 %0-9#*'*µ+/(.9&%4 "$%99"=µ%,+20 '+"$+?-0"+%4, %0%'"+-#03/0,%4 )" #.&)+µ/ $%.-9/0,% ,/(4 "#$%+'"(,+-#/34 #%+ ($/),*.+#,+#/34 µ*>%0+)µ/34 #-1" "&'/(4(McKee et al 2006). D,/(4 µ*>%0+)µ/34 %(,/34 $".+-=%µ:-0/0,%+ ,/ 1")µ/1",*µ;0/ @#$%+'"(,+#7 D3),*-µ% (D>/="&%, I%0"$+),8µ+%, M@R, %.>+#8 "$%99"=µ%-,+#8 #%,-.,+)*), * '+% :&/( "#$%&'"()* ("0*=&#60,"+'+#20 /µ-'60, -,($"4 µ/.?;4), %==- #%+ ,% D(),8-µ%,% I+),/$/&*)*4 ,60 902)"60 #%+ ,60 '"5+/,8-,60, /+ "$%99"=µ%,+#;4 /.9%02)"+4, * '*µ7)+% '+/&-

#*)* #%+ ,;=/4 ,/ %01.2$+0/ #"?-=%+//%$71"µ%(902)"60 '"5+/,8,60), $/( "&0%+ )())6."(µ;0/ )"µ+% #/+060&% ! <="9>/4 ,*4 $./)?/.-4 +%,.+#/3 '(0%µ+#/3, "01-.-.(0)* ,/( 9+% ,*0 #%,-=*A* µ* #/.")µ;060 "+'+#/-,8,60. ! '+%,3$6)* %(,8 ($/'*=20"+ ,*0 %0-9#* 9+%"#$%&'"()*, #%,-.,+)* #%+ '+% :&/( "#$%&'"()* +#%-0/3 %.+1µ/3 9+%,.20 #(.&64 ),* 9"0+#8 +%,.+#8, '*µ7-)+% (9"&%, 9*.+%,.+#8, /9#/=/9&%, A(>+%,.+#8, "$"+-9/0,/=/9&%, +%,.+#8 ,*4 ".9%)&%4, 0"/90/=/9&%, =/+$20"$%99"=µ%,+20 ),/(4 %06,;.6 ,/µ"&4 #%124 #%+ "#$%&-'"()* 7=60 ,60 "$%99"=µ%,+20 (9"&%4 ),+4 0;"4 ,">0/-=/9&"4 #%+ ,+4 ,">0/=/9&"4 %+>µ84 (G(.+7$/(=/4 #%+)(0 1996). E$/,;=")µ% ,60 "5"=&5"60 1% "&0%+ * µ"&-6)* ,60 %0%9#20 )" µ%+"(,+#- #.":-,+% #%+ )" %01.2-$+0/ '(0%µ+#7 )(0%?20 "+'+#/,8,60 (µ%+"(,8."4, µ%&-"4), µ" $%.-==*=* %0-9#* 9+% "$;0'()* )" 0"/90/=/9+#-,µ8µ%,% #%+ µ/0-'"4 0/)*="&%4 $./2.60 0"/9020(A*=/3 #+0'30/(, $/( 1% :/*18)"+ #%+ ),* µ"&6)*,*4 $".+9"00*,+#84 #%+ 0"/90+#84 10*)+µ7,*,%4! I.7)=*A* #%+ /.1/=/9+#8 ),"=;>6)* ,60 ($*."-)+20 µ" +#%07 %.+1µ7 0/)*="(,20 #%+ =/+$20 "$%9-9"=µ%,+20 (9"&%4. ! %0%=/9&% 0/)*="(,20 $./4 #%,/&-#/(4 "&0%+ %#7µ% $/=3 >%µ*=8 ),* >2.% µ%4 )" )>;)*µ" ,+4 -=="4 >2."4 ,*4 @@. H %.+1µ74 ,60 =/+$20"$%99"=µ%,+20 (9"&%4 $/( %$%)>/="&,%+ ),/0 (9"+/-0/µ+#7 ,/µ;4 "&0%+ -906),/4 #%+ "$+:-==",%+ 0% µ"="-,*1"& '+"5/'+#- #%+ 0% :"=,+61"&, 9"9/074 ,/ /$/&/1% )(0,"=;)"+ ),* :"=,&6)* ,*4 $/+7,*,%4 ,60 $%."->/µ;060 ($*.")+20 (I+"..-#/4 #%+ )(0 2006)! F+/1;,*)* )39>./060 µ"17'60 '+/&#*)*4 #%+ 9"6-9.%?+#84 +)/#%,%0/µ84. @+'+#7,".% * "#$%&'"()* #%+#%,-.,+)* )" )39>./0"4 µ"17'/(4 '+/&#*)*4 #%+ '+%->"&.+)*4 %$/,"="& $-9+/ "$%0%=%µ:%07µ"0/ %&,*µ%,60 "$%99"=µ%,+20 (9"&%4. H )(0'(%)µ74 ,60 '3/%(,20 $%.%µ;,.60 1% )(µ:-="+ )*µ%0,+#- ),* :"=-,&6)* ,*4 $%.%969+#7,*,%4, ,*4 $.7):%)*4 %==- #%+,*4 $/+7,*,%4 ,60 $%.">/µ;060 ($*.")+20 !G+0*,+#7,*,% #%+ “brain drain” D,/ $=%&)+/ ,*4 "="3-1".*4 µ",%#&0*)*4 ,60 ".9%B/µ;060, "01%..30",%+* #+0*,+#7,*,% ,60 "$%99"=µ%,+20 (9"&%4, µ",%53 ,60>6.20 ,*4 @(.6$%J#84 <06)*4 #%+ #%,%:-==",%+$./)$-1"+% '+"(#7=(0)*4 ,/(4, µ;)6 ,*4 '+%µ7.?6-)*4 #%+ %0%1"2.*)*4 ,*4 )>",+#84 "10+#84 0/µ/1"-)&%4 ,60 #.%,20 µ"=20. M/ “brain drain” 1"6."&,%+µ"&B/0 1;µ% 9+% ,*0 %0-$,(5* ,/( %01.2$+0/( '(0%-µ+#/3, ;>"+ ,* µ/.?8 ,*4 "#./84 $7.60 #%+ %$/,;="-)µ% %(,/3 "&0%+ * )(µµ",/>8 ,60 >6.20 %0%>2.*)*4),/ )>*µ%,+)µ7 $=/3,/( ),+4 >2."4 ($/'/>84. M/1;µ% "."(0-,%+ )" "$&$"'/ P+"1020 H.9%0+)µ20 #%+?/.;60 (European Union 2005)

#Aµ/*0D9µ2@2! /.9-06)* ($*.")+20 $.7=*A*4, * :"=,&6)* ,*4$./)$"=%)+µ7,*,%4 #%+ * "?%.µ/98 ),.%,*9+#20

[36] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 36

Page 38: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [37]

!"!#$%&'(H !")*+,A

E)F5)4=02?121. European centre for the development of VET (Cedefop) (2009).

Future Skill Supply in Europe. Medium-term forecast up to 2020synthesis report. Luxembourg: Publications Office, *+,-*."#-

-/'0. 10/4/10 http://www.cedefop.europa.eu/etv/Upload/Information_resources/Bookshop/546/4086_en.pdf

2. World Health Organization (2006). Working Together for Health.The World Health Report. WHO Geneva http://www.who.int/hrh/

9+% ,/0 "$*."%)µ7 ,/( ,.7$/( B684 (lifestyles) ,/($=*1()µ/3 ;>/(0 1"µ"=+2'* )*µ%)&%, %?/3 * "$;0-'()* ),*0 (9"&% ;>"+ %$/'"+>,"& 7,+ "&0%+ -5/0%4%0-$,(5*4 µ+%4 >2.%4 #%+ '"0 µ$/./30 0% "?%.µ/-),/30 >6.&4 #%,-==*=% "#$%+'"(µ;0/ %01.2$+0/'(0%µ+#7. H+ "$"0'3)"+4 )" 0;% "#$%+'"(,+#- $./-9.-µµ%,% #%+ ,">0/=/9&"4, )" )(0'(%)µ7 µ" ,*0 %0--$,(5* ,60 "$%99"=µ%,+20 (9"&%4 )3µ?60% µ" ,+4%0-9#"4 ,/( $=*1()µ/3 #%+ ,*4 %9/.-4 ".9%)&%4,%$/,"=/30 ,* :-)* ,*4 (9"+/0/µ+#84 µ",%..31µ+-)*4, '"'/µ;0/( 7,+ * (9"+/0/µ+#8 #.&)* ),*0 @==--'% "&0%+ #(.&64 $.7:=*µ% %01.2$+0/( '(0%µ+#/3.! $".+9.%?8 ,60 1;)"60 ".9%)&%4 2)," 0% %0,+#%-,/$,.&B/(0 ,+4 '"5+7,*,"4 ,/( $./)6$+#/3, "&0%+1;µ% $./,".%+7,*,%4. E(,7 1% ,/(4 '2)"+ ,*0 '(0%-,7,*,% 0% "?%.µ7B/(0 ,+4 0;"4 902)"+4 $/( ;>/(0

%$/#,*1"& µ;)6 ,*4 "#$%&'"()*4 #%+ #%,-.,+)*4),*0 #%1*µ".+08 ,/(4 $.%#,+#8 #%+ 1% )(µ:-="+),*0 %$/,"=")µ%,+#7,*,% ,60 )>",+#20 "$"0'3)"-60 9+% ,/ %01.2$+0/ '(0%µ+#7 ,/( (9"+/0/µ+#/3,/µ;%. I%.-==*=%, * %)?-="+% ,/( %)1"0/34 $./-L$/1;,"+ #%,-==*=% "#$%+'"(µ;0/ %01.2$+0/ '(0%-µ+#7 ,/( /$/&/( /+ '"5+7,*,"4 "#)(9>./0&B/0,%+)(0">24 #%,- ,* '+-.#"+% ,*4 "$%99"=µ%,+#84 ,/(B684. ! "$+,(>&% %(,20 ,60 $/=+,+#20, $./L$/1;-,"+ ,*0 "?%.µ/98 )39>./060 #%07060 '+/&#*)*4 ),/0(9"+/0/µ+#7 ,/µ;%. M;=/4 "&0%+ %$%.%&,*,* * "$&-,"(5* "(."&%4 )(0%&0")*4, ,*4 $/=+,"&%4 µ" ,/(4"$%99"=µ%,&"4 (9"&%4, '"'/µ;0/( 7,+ %(,/& #%=/3-0,%+ 0% (=/$/+8)/(0 ,*0 $/=+,+#8 (9"&%4 ,*4 >2.%4.H+ µ",%..(1µ&)"+4 /'*9/30,%+ )" %$/,(>&% >6.&4,*0 "0*µ;.6)*, )(0".9%)&% #%+ ($/),8.+5* ,/(4.

ABSTRACT

OORRIIGGIINNAALL AARRTTIICCLLEEHHUUMMAANN RREESSOOUURRCCEESS FFOORR HHEEAALLTTHH NNEEEEDDSS AASSSSEESSSSMMEENNTT OOFF LLIIFFEE--LLOONNGG LLEEAARRNNIINNGG IINN TTHHEE FFRRAAMMEEWWOORRKK OOFF TTHHEESSTTRRAATTEEGGIICC NNAATTIIOONNAALL DDEEVVEELLOOPPMMEENNTT PPLLAANN 22000077--22001133DD.. AAnnddrriioottii11,, DD.. KKoommmmaattaass22,, AA.. SSkkiittssoouu33,, GG.. CChhaarraallaammbboouuss44,, CC.. BBaarroo55

[[11.. BBAA,, MMSScc,, PPhhDD,, HHeeaalltthh EEccoonnoommiisstt,, SScciieennttiiffiicc CCoollllaabboorraattee ooff TTEEII ooff AAtthheennss,, 22.. BBAA,, MMSScc,, PPoolliittiiccaall SScciieennttiisstt,, CChhiieeff ooffEEdduuccaattiioonnaall DDiirreeccttoorraattee ooff MMiinniissttrryy ooff HHeeaalltthh aanndd SSoocciiaall SSoolliiddaarriittyy,, 33.. BBAA,, MMSScc,, PPhhDD,, LLaawwyyeerr,, PPrrooffeessssoorr ooff FFrreeddeerriiccUUnniivveerrssiittyy,, CCyypprruuss,, 44.. CChhiieeff ooff EEmmeerrggeennccyy DDeeppaarrttmmeenntt,, IIppppookkrraatteeiioonn GGeenneerraall HHoossppiittaall ooff AAtthheennss,, 55.. RRNN,, MMiinniissttrryy ooffHHeeaalltthh aanndd SSoocciiaall SSoolliiddaarriittyy]]

BBaacckkggrroouunndd:: Education and training contribute to better responsiveness and performance. Relevant policies shouldbe based on the population health needs assessment. The National Strategic Development Plan (NSDP) 2007-2013is a unique opportunity for planning modern education and training so that human resources for health meet currentand future needs of the population AAiimm:: The aim of this study was to assess health professionals’ training needs and life-long learning in our country,based on population profiles, and was one of the consultation documents under the National Strategic DevelopmentPlan (NSDP) 2007-2013MMeetthhoodd:: Demographic and epidemiological data of the Greek population were combined with relevant human resourcespolicies described by international organizations CCoonncclluussiioonn:: Leadership is crucial in shaping the appropriate policy and establishing goals and strategies to achievehuman resource development. Key issues to be addressed to this direction is detailed inventory of existing capacity(numbers and characteristics), the provision for future services, improving the quality and skills, through investmentin education and training, including lifelong learning and education in new technologies.

KKeeyy wwoorrddss:: Life long learning, health professional, skills, competencies.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 37

Page 39: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

whr06_consultation/en/index.html *+,-*."#-/'0. 10/4/103. 1*,2+(.3, 1(.3%4 0%5 6,578750)4 9""'".((:'4 (2005). ;."</' -/,

*"%3-5, /,2 !=750,: >/+%/'(50,: >?.$3,2 97#*/2@'4-1(.3% 0%5 6,5-78750) 9""'".((:' !>&9 2007-2013. 1169, 9=)7%

4. Commission of the European Communities (2008). On the EuropeanWorkforce for Health. Green Paper. COM725 final. Brussels

5. European Commission. New Skills for New Jobs (2010). Anticipatingand matching labour market and skills needs 2009, Luxembourg:Office for official publications of the European Communities

6. European Commission (2009). New skills for new jobs: Actionnow. Expert Group Luxembourg: Office for official publicationsof the European Communities, http://ec.europa.eu/social/main.jsp?catId=568&langId=en accessed 12/3/2010

7. 97$+5A/' B (1998). C% !*%((<"µ%/% 1(.3%4 -/'7 !""#$%. !@#7/%4,9=)7%

8. Mladovsky Ph., Merkur S., Mossialos E., McKee M (2009). Lifelong learning and physician revalidation in Europe. Euro Observer,11(2):1-5

9. !>1! (2009). D+.27% !0*%3$.2-'4 !7'"3087. B."/3, C:*,2, ;#+-/5,4 http://www.statistics.gr/portal/page/portal/ESYE/BUCKET/A0102/PressReleases/A0102_SJO18_DT_AH_00_2007_01_F_GR.pdf*+,-*."#-/'0. 5/ 4/10

10. Boateng S (2009). Significant country differences in adult learning.Population and Social Conditions, Statistics in focus 44, Eurostat,Brussels http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-SF-09-044/EN/KS-SF-09-044-EN.PDF

11. >%++)4 ;. &5.++#0,4 E. 9µ3/-'4 E. 62+5F*,2",4 E. >,:"'4 >(2006). 9@5,"F('-' $,µA7 -27.?5GFµ.7'4 0%/#+/5-'4 -/54 2*'-+.-3.4 2(.3%4. H,-'".2/50) 45(1):118-128

12. OECD (2010). Highlights from education at a glance OECD 201013. EUROSTAT (2009). Lifelong learning statistics http://epp.eurostat.ec.

europa.eu/statistics_explained/index.php/Lifelong_learning_statistics*+,-*."#-/'0. 5/ 4/10

14. Eurostat (2008). Ageing characterises the demographic perspectives

of the European Societies. Population and social conditions.Statistic in focus. 72

15. 97$+5A/' 0%5 I,2µ."5A/' (2007). B'µ,(+%J3%, B'µF-5% 1(.3% 0%5&,"5/50) 1(.3%4. !0$F-.54 &%*%G)-', 9=)7%

16. European centre for the development of VET, (Cedefop) (2008).Future Skill Needs in Europe. Medium-term forecast: synthesisreport. Luxembourg: Publications Office, *+,-*."#-/'0. 10/4/10http://www.cedefop.europa.eu/EN/Files/4078_en.pdf

17. Rechel B., Dubois C-A., McKee M (eds) (2006). The Health CareWorkforce in Europe: Learning from Experience. WHO/Europe

18. 1*,2+(.3, 97#*/2@'4 (2005). C.?7,",(50) &+,,*/50) B5.+.:7'--' -/'7 !""#$% >27=./50) D0=.-'. B5.:=27-' >?.$5%-µ,: 0%5&+,(+%µµ%/5-µ,:, 9=)7%

19. Kachur E., Krajic K (2006). Structures and Trends in healthprofession Education in Europe. In: Dubois C-A., McKee M.,Nolte E (eds) Human Resources for Health 5n Europe. EuropeanObservatory on Health Systems and Policies. Open UniversityPress pp 79-97

20. McKee M., Dubois C-A., Sibbald B (2006). Changing professionalboundaries. In: Dubois C-A., McKee M., Nolte E (eds) HumanResources for Health 5n Europe. European Observatory on HealthSystems and Policies. Open University Press pp 63-78

21. 62+5F*,2",4 E. >,:"'4 >. 97$+5A/' B. K+2-#0'4 ; (1996). ;."<-/' 6%=,+5-µ,: /87 97%(0A7 !*%((."µ%/50)4 6%/#+/5-'4 (!+(%-G,µ<787 0%5 97<+(87) %7# &.+5J<+.5% 0%5 !5$50F/'/% -/,7 C,µ<%/'4 1(.3%4. C,µ<%4 L50,7,µ3%4 /'4 1(.3%4 !>B1, 0%5 Cµ)µ% B5,3-0'-'4 ;,7#$87 1(.3%4, >?,") !*%((."µ#/87 1(.3%4 0%5 &+F7,5-%4, C!M 9=)7%4. 1169, 9=)7%

22. &5.++#0,4 E. >%++)4 ; 9µ3/-'4 E. 62+5F*,2",4 E. >,:"'4 >.(2006) !0*%5$.2/50<4 %7#(0.4 0%5 -27.?5GFµ.7' 0%/#+/5-' %7=+A-*57,2 $27%µ50,: /,µ<% 2(.3%4. H,-'".2/50), 45(4):543-551

23. European Union (2005). The Contribution of Health to the Economyin the European Union. Health &Consumer Protection Directorate-General.

[38] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 38

Page 40: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [39]

!"!#$%&'(H !")*+,A

Q".%$"&% ,*4 >.70+%4 0"?.+#84 %0"$-.#"+%4: µ"=;,* #7),/(4

,60 µ"17'60 %+µ/#-1%.)*4 µ" ?3)+99% #%+ '+,,%01.%#+#7 '+-=(µ% #%+ ,*4 %+µ/'+%'+81*)*4

II%%..%%))##""((88 QQ""//??&&==//((

P.. S(>/=/9&%4 F9"&%4, @10+#8 D>/=8 P*µ7)+%4 P+/&#*)*4, Mµ8µ% P+/&#*)*4 F$*.")+20 F9"&%4, E180%

DD##//$$7744:: ! /+#/0/µ+#8 %$/,&µ*)* ,*4 %+µ/#-1%.)*4 (EG) )" C/0-'% M">0*,/3 T"?./3 (CMT) +'+6,+#84#=+0+#84. @+'+#7,".%, 9&0",%+ )(9#.+,+#8 %0-=()* ,/( #7),/(4 %+µ/#-1%.)*4 µ",%53 ,*4 µ"17'/( µ" '+,-,%01.%#+#- #%+ ,*4 %+µ/'+%'+81*)*4.

II==**11(())µµ7744 µµ""==;;,,**44:: 120 %)1"0"&4 µ" UTE ,"=+#/3 ),%'&/(, /+ /$/&/+ ($/:-==/0,%0 )" %+µ/#-1%.)* ),*CMT ,*4 #=+0+#84 9+% ,/ ;,/4 2006.

FF==++##77 ##%%++ CC;;11//''//44:: G%,"9.-?*)%0 ,% '*µ/9.%?+#-, #=+0+#- #%+ /+#/0/µ+#- ),/+>"&% %$7 ,/(4 ?%#;-=/(4 ,60 %)1"020. E$7 ,*0 /+#/0/µ+#8 '+"31(0)* ,*4 #=+0+#84 )(==;>,*#%0 '"'/µ;0% )>",+#- µ" ,*µ+)1/'/)&% ,/( $./)6$+#/3, ,/0 #"?%=%+/(>+#7 #%+ ,">0/=/9+#7 "5/$=+)µ7, %$/):;)"+4, '%$-0"4 9+%$-9+% #%+ =/+$- %0%=2)+µ%. U.*)+µ/$/+81*#%0 ,+µ;4 ,/( 2006 #%+ 64 µ/0-'% #7),/(4 1"6.81*#" *)(0"'.&%.

EE$$//,,""==;;))µµ%%,,%%:: I%./()+-B",%+ ,/ #7),/4 )(0"'.&%4 "#-),*4 µ"17'/( %+µ/#-1%.)*4. M/ )(0/=+#7 #7),/4,*4 )(0"'.&%4 %+µ/#-1%.)*4 µ" %+µ/'+%'+81*)* ($".;>"+ #%,- 30% $".&$/( ,*4 µ"17'/( µ" '+,,%01.%#+#7'+-=(µ%. ! )*µ%0,+#8 %(,8 %35*)* ,/( #7),/(4 /?"&=",%+ ),/ "$+$=;/0 (9"+/0/µ+#7 (=+#7 $/( %$%+,"&,%+ ),*)(9#"#.+µ;0* µ;1/'/ ()-#/+ #%+ 9.%µµ;4 %+µ/'+%'+81*)*4).

DD((µµ$$""..--))µµ%%,,%%:: ! %+µ/#-1%.)* %$/,"="& µ&% +'+%&,".% %#.+:8 µ;1/'/ %0,+µ",2$+)*4 ,60 $%)>70,60 %$7UTE, '"'/µ;0/( 7,+ :%)&B",%+ #(.&64 ),* >.8)* #%+0/,7µ60 ,">0/=/9+20. E0-=/9"4 %0%=3)"+4 /+#/0/µ+-#84 %5+/=79*)*4 '" 1"6./30,%+ $=8.64 ,"#µ*.+6µ;0"4, 7,%0 '" =%µ:-0/(0 ($7A* ,/(4 ,*0 #=+0+#8 ($"-./>8 #%+ '"0 ,*0 %$/'&'/(0 )" 7./(4 #7),/(4-%$/,"=")µ%,+#7,*,%4.

NN;;55""++44--##==""++''++--:: /+#/0/µ+#8 %5+/=79*)*, >.70+% 0"?.+#8 %0"$-.#"+%, %+µ/#-1%.)*, %+µ/'+%'+81*)*.

!)92=G=-D,*0 R%,.+#8, ),+4 '(,+#;4 #(.&64 #/+060&"4, /+,"="(,%&"4 '"#%",&"4 >%.%#,*.&B/0,%+ %$7 µ"9-=%"$+,"39µ%,% ),*0 %0,+µ",2$+)* ,60 '+%?7.60 0/)*-µ-,60. ! )39>./0* ,">0/=/9&% #%+ +'+%&,".% / #=--

'/4 ,*4 :+/,">0/=/9&%4, $/( ;>"+ "$"#,%1"& )*µ%-0,+#- ),% $"'&% ,*4 %0,+µ",2$+)*4 $/==20 $%1/-=/9+#20 #%,%),-)"60 #%124 #%+ ,*4 +%,.+#84 ?./-0,&'%4 %)1"020 , $./)?;."+ $=;/0 %(5*µ;0"4'(0%,7,*,"4 '+%,8.*)*4 #%+ "$+µ8#(0)*4 ,*4 B684

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 39

Page 41: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[40] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

9+% µ"9-="4 #%,*9/.&"4 %..2),60, $/( #-$/," %?8-0/0,%0 ),*0 ,3>* ,/(4 (E$/),7=/(, 2000). <,)+, $;.%0$=;/0 ,*4 "$+:&6)*4, / ,.7$/4 $/( #%0"&4 "$+:+2-0"+, * '(0%,7,*,% $=8./(4 8 µ".+#84 %$/#%,-),%-)*4, #%124 #%+ * %5+/=79*)8 ,*4, ;9+0%0 $.7)1"-,/+ +%,.+#/& ),7>/+. ! )*µ".+08 #/+060&% ,/( '(,+#/3#7)µ/( "&0%+ µ&% #/+060&% $/( 9".0- $".+))7,"./%$’ 7,+ $%=+-, µ" )(0;¬$"+% ,*0 %35*)* #%+ "$+#.--,*)* ,60 >.70+60 0/)*µ-¬,60. @5 /.+)µ/3, µ&%1".%$"&% $/( %$"(130",%+ )" >.7¬0+/(4 %)1"0"&4'"0 %$/)#/$"& ),*0 &%)* %==- #(.&64 ),*0 %35*-)* ,/( $./)'7#+µ/( "$+:&6)*4 #%+ ,* '+%,8¬.*)*µ&%4 %5+/$."$/34 $/+7,*,%4 ,*4 ($7=/+$*4 B684,/(4.

@&0%+ 9"9/074 7,+ %$7 ,/ ,;=/4 ,*4 '"#%",&%4 ,/(’70, 9&0",%+ µ&% )(0">84 $./)$-1"+% 9+% ,*0 %0,+-µ",2$+)* ,*4 U.70+%4 T"?.+#84 E0"$-.#"+%4 (UTE)µ" %$/,;=")µ% ,*0 "µ?-0+)* 7=/ #%+ $+/ #%+0/3.-9+60 µ*>%0*µ-,60 %+µ/#-1%.)*4, =+97,"./ '%$%-0*.20 #%+ =+97,"./ #/(.%),+#20 9+% ,/0 &'+/ ,/0%)1"08. V3.6 %$7 %(,- ,% B*,8µ%,% -.>+)" 0% %0%-$,3))",%+ ;0,/0/4 $./:=*µ%,+)µ74 %0-µ")% ),/(4/+#/0/µ/=79/(4 ,*4 (9"&%4 µ" %0,+#"&µ"0/ ,*0 "$&-,"(5* ,/( >%µ*=7,"./( '(0%,/3 #/+060+#/3 #%+/+#/0/µ+#/3 #7),/(4 )" )(0'(%)µ7 µ" ,*0 %$/,"-=")µ%,+#7,".* µ;1/'/ 1".%$"&%4, ;,)+ 2)," 0% $./-)?;.",%+ ),/ 0"?./$%18 * #%=3,".* '(0%,8 $/+7-,*,% B684.

W=% ,% $%.%$-06, ),+4 %0"$,(9µ;0"4 >2."4,=8?1*#%0 )/:%.- ($’ 7A* ),* >-.%5* ,*4 $/=+,+-#84 (9"&%4 ),/0 ,/µ;% ,60 %)1"020 µ" UTE, µ" %$/-

,;=")µ% ,*0 (+/1;,*)* ,*4 µ",%µ7)>"()*4 0"?./3)%0 #(.&%.>*4 µ/.?84 1".%$"&%4.

D,* >2.% µ%4, /3," * $/=+,"&% /3," /+ %)?%=+),+-#/& ?/."&4 '"0 ;>/(0 %)>/=*1"& µ" ,* )39#.+)*#7),/(4-/?;=/(4 µ",%53 ,60 "0%==%#,+#20 µ/.?201".%$"&%4, $%.’ 7,+ 5/'"3/0,%+ µ"9-=% $/)- 9+% ,*)(9#"#.+µ;0* /µ-'% %)1"020, µ" %$/,;=")µ% 0%$%.%µ;0"+ )% :%)+#8 µ/.?8 1".%$"&%4 * %+µ/#--1%.)* ),/ 0/)/#/µ"&/.

! %0%9#%+7,*,% =/+$70 9+% ,/0 $".+/.+)µ7 ,/(#7),/(4 )" )(0'(%)µ7 µ" ,*0 3$%.5* ,60 "$+=/920)" #-1" $.-5* 8 ="+,/(.9&% $/( %$%+,"& /+#/0/µ+#;41()&"4 #%1+),/30 ,*0 /+#/0/µ+#8 %5+/=79*)* 64 ;0%%$%.%&,*,/ µ"1/'/=/9+#7 ".9%="&/, ,/ /$/&/ )(µ:-=-="+ ),* =8A* /.1/=/9+#20 %$/?-)"60 (G(.+7$/(=/4,T+-#%4, 1994). E$7 ,*0 -==* $="(.-, ),*0 $".&$,6-)* ,60 +'+6,+#20 "$"0'3)"60, * "?%.µ/98 ,*4 /+#/-0/µ+#84 %5+/=79*)*4 ),/0 +'+6,+#7 ,/µ;% ;>"+ 64 ),7->/ ,/ 0% '+#%+/=/98)"+ ,*0 "$+=/98 )(9#.+µ;060%$/?-)"60, µ" #.+,8.+% #%1%.- /+#/0/µ+#- #%+ µ"),7>/ ,/ ,"=+#7 #;.'/4.

G.&0",%+ "$/µ;064 "$+,%#,+#8 * '+"0;.9"+% /+#/-0/µ+#20 µ"=",20 µ" )#/$7 ,*0 #%,%9.%?8 ,60 $%.%-970,60 $/( "$*."-B/(0 -µ")% 8 ;µµ")% ,o #7),/4,;,)+ 2)," * ;."(0% 0% ),.%?"& $./4 )(9#"#.+µ;0%µ;,.% µ" ),7>/ ,*0 "=%>+),/$/&*)8 ,/(.

! )(9#"#.+µ;0* ".9%)&% µ;)% %$7 ,*0 /+#/0/µ+-#8 %5+/=79*)* µ&%4 %$7 ,+4 '3/ µ"17'/(4 "560"?.+-#84 #-1%.)*4, ,*4 %+µ/#-1%.)*4, ?+=/'/5"& 0% )(µ-:-=="+ 8 ,/(=->+),/0 0% #"0,.&)"+ ,/ "0'+%?;./0 9+%,*0 %0-$,(5* $".%+,;.6 $./:=*µ%,+)µ/3 #%+ µ"=;-,*4 µ&%4 "0%==%#,+#84 µ/.?84 >.*µ%,/'7,*)*4. @$+-$=;/0, / ($/=/9+)µ74 ,/( #7),/(4 ,*4 )(9#"#.+µ;-0*4 1".%$"&%4 µ$/."& 0% %$/,"=;)"+ ,*0 %?",*.&%9+% ,*0 $.%9µ%,/$/&*)* µ"=",20 #7),/(4-%$/,"="-)µ%,+#7,*,%4, '&0/0,%4 ,* '(0%,7,*,% )(9#.+,+#84%5+/=79*)*4 ,*4 %$/,"=")µ%,+#7,*,%4 #%+ ,*4 %$/-'/,+#7,*,%4 %(,20.

H5)78 72) I;+4<4.D,* )(9#"#.+µ;0* µ"=;,*, / ($/=/9+)µ74 %?/.- ,/#7),/4 ,*4 %+µ/#-1%.)*4 )" +'+6,+#8 #=+0+#8 ,/ 2006.! 7=* $./)$-1"+% :%)&),*#" ),% ),/+>"&% %$7 ,/(4?%#;=/(4 ,60 %)1"020 $/( )(==;>1*#%0 %$7 ,* C/0--'% M">0*,/3 T"?./3 (CMT) ,*4 +'+6,+#84 #=+0+#84«G(%0/34 D,%(.74». X4 µ/0-'% µ;,.*)*4, >.*)+µ/-$/+81*#" * )(0"'.&% %+µ/#-1%.)*4.

V+% ,*0 "#,&µ*)* ,/( #7),/(4 ,*4 %+µ/#-1%.)*4,"?%.µ7),*#" * µ;1/'/4 %0-=()*4 #7),/(4 (costanalysis), #%,- ,*0 /$/&% ;9+0" #%,%9.%?8 ,60 $%.%-970,60 $/( )(µ:-==/(0 ),* '+%µ7.?6)* ,/( ,"=+-#/3 #7),/(4 ,*4 1".%$"(,+#84 µ"17'/( ($/#%,--),%)*4 ,*4 0"?.+#84 ="+,/(.9&%4. @+'+#7,".%, 9+% ,*0"#,&µ*)* #-1" )(),%,+#/3 $/( %?/.- >.8)* $7.60($.>. $%.%#=+0+#;4 "5",-)"+4, ?-.µ%#%, (9"+/0/µ+#7

9;µ,@)>$%3D µ7 $;µ,*;$*;G>D3D

9;µ,@)>$%3D µ7 *;00$.>%$@;@H*;)("µ$ @$; IJ3;##$ *;00$.>%$@;@K.

70%

30%

()#*+'# 1. B4.=µ.$%/%+)0#91#2 1"*#:49#2 .*8 $-/% .+µ%,80.41)2 =+. $% ;$%2 2006

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 40

Page 42: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [41]

!"!#$%&'(H !")*+,A

(=+#7 #.=$.), %#/=/(181*#" * µ+#./#/),/=79*)*(Drummond, 1997).

M/0 ($7 µ"=;,* $=*1()µ7 9+% ,/0 $./)'+/.+)µ7,/( #7),/(4 %$/,;=")%0 /+ 120 µ70+µ/+ %)1"0"&4 µ"UTE ,"=+#/3 ),%'&/(, /+ /$/&/+ ($/:-==/0,%0 )" %+µ/-#-1%.)* ),* CMT ,*4 #=+0+#84 9+% ,/ ;,/4 2006.

! µ/0-'% ="+,/(.9"& 6 *µ;."4 ,*0 ":'/µ-'% (P"(-,;.%-D-::%,/) "02 ($-.>/(0 21 ),%1µ/& %+µ/#-1%.-)*4. D,* '+-.#"+% ,/( 2006, $.%9µ%,/$/+81*#%0 )(0/-=+#- 18.801 )(0"'.&"4 %+µ/#-1%.)*4. D,* µ/0-'%,">0*,/3 0"?./3 ,*4 +'+6,+#84 #=+0+#84 «G(%0/34D,%(.74», $.%9µ%,/$/+/30,%+ /+ $%.%#-,6 '3/ ,3$/+%+µ/#-1%.)*4:! E+µ/#-1%.)* µ" '+,,%01.%#+#7 '+-=(µ% #%+ ?3)+9-9% '+,,%01.%#+#20,

! E+µ/'+%'+81*)* (HDF) µ" ,* >.*)+µ/$/&*)* µ"µ-:.%020 (A*=84 '+%$".%,7,*,%4. E$7 ,/ )30/=/ ,60 )(0"'.+20 %+µ/#-1%.)*4, /+

/$/&"4 $.%9µ%,/$/+81*#%0 ,/ 2006 (18.801), /+13.161 (70%) ;9+0%0 µ" '+,,%01.%#+#7 '+-=(µ% #%+?3)+99% '+,,%01.%#+#20 "02 /+ ($7=/+$"4 5.640 ;9+-0%0 µ" ,* µ;1/'/ ,*4 %+µ/'+%'+81*)*4 (30%) (9.--?*µ% 1).

W$64 ?%&0",%+, ),* )(9#"#.+µ;0* #=+0+#8 9&0",%+"(."&% "?%.µ/98 ,*4 %+µ/#-1%.)*4 µ" '+,,%01.%#+-#7 '+-=(µ% #%+ ?3)+99% '+,,%01.%#+#20 )" )39#.+)*µ" ,*0 %+µ/'+%'+81*)* (HDF) µ" ,* >.*)+µ/$/&*)*µ"µ:.%020 (A*=84 '+%$".%,7,*,%4.

V+% ,/0 ($/=/9+)µ7 ,/( #7),/(4, µ"=",81*#%0 /+$%.%#-,6 $%.-9/0,"4: ! ,/ #7),/4 µ+)1/'/)&%4 9+% ,/ $./)6$+#7, ,/ /$/&/%$%)>/="&,%+ ),* C/0-'% M">0*,/3 T"?./3.

! ,/ #7),/4 ,60 ?%.µ-#60 $/( =%µ:-0/(0 /+ %+µ/#%-1%+.7µ"0/+ %)1"0"&4 #%+ $/( )>",&B/0,%+ µ" ,* 1".%-$"&% ,*4 >.70+%4 0"?.+#84 %0"$-.#"+%4.

! ,/ #7),/4 "5/$=+)µ/3 (%9/.- - %$7):")* - )(0,8-.*)*).

! ,/ #7),/4 ,60 #,+.+%#20 "9#%,%),-)"60.! ,/ #7),/4 ,60 ".9%),*.+%#20 "5",-)"60.

! ,/ #7),/4 ,/( (9"+/0/µ+#/3 (=+#/3 (9"0+#/3 #%+ "+'+-#/3) $/( >.*)+µ/$/+"&,%+ 9+% ,* '+"#$".%&6)* µ&%4)(0"'.&%4 %+µ/#-1%.)*4, %0-=/9% µ" ,/0 ,3$/ ,*4%+µ/#-1%.)*4.

! ,/ #7),/4 ,60 ($/),*.+#,+#20 ($*.")+20 #%+ =/+-$20 %0%=6)&µ60 (0".7, ,*=;?60/, 1;.µ%0)* #.,.=.).

$/4@*5;9µ2@2D,/0 $&0%#% 1, $%./()+-B",%+ ,/ )(0/=+#7 #7),/4 )(0"-'.&%4 "#-),*4 µ"17'/( %+µ/#-1%.)*4. @+'+#7,".%,

!I"#$#% 1: !"*%(+,C ,C1$%2 1"*#:49.2 #,81$)2 µ#0C:%" .+µ%,80.41)2

?D µ# E+$$.*04.,+,8 ?+µ%:+.:+'0)1)

66%%//%%77,,µµ)) ""..55//,,22++((5500,,:: 00FF--//,,2244;5-=,$,-3% 43.00 43.00N#+µ%0% 151.87 151.87!@,*"5-µF4 (-27/)+'-' - %*F-O.-') 21.46 21.466/5+5%0<4 .(0%/%-/#-.54 5.32 5.32!+(%-/'+5%0<4 .@./#-.54 7.53 7.531(.5,7,µ50F 2"50F 97.08 189.141*,-/'+50/50<4 2*'+.-3.4 & ",5*# %7%"A-5µ% 3.35 3.35>>11HHLLPPLL 332299..6611ee 442211..6677ee

L;3>,*,3&$'%#$30D%;$@2? 7M70)37;?10;%;$@2? 7#@$0$30)37;?N#7;,.,µ;@H "(;@H

70% 1%

2%2%

E)%µ$@$ 'M,4(;3µH? (3".0G%D3D-$4H3=73D)N4,30D%;@0;@2?"4D%73&7? & (,;4)$.$(K3;µ$

7%

46%13%

29%

()#*+'# 2. !"*%(+,C ,C1$%2 µ9.2 1"*#:49.2 .+µ%,80.41)2 µ# A-1+==.

,.+ :+$$.*04.,+,C :+8("µ.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 41

Page 43: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[42] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

,/ )(0/=+#7 #7),/4 µ&%4 )(0"'.&%4 %0;.>",%+ ),%329.61 "(.2 9+% ,*0 %+µ/#-1%.)* µ" ?3)+99% #%+ '+,-,%01.%#+#7 '+-=(µ%.

M/ µ"9%=3,"./ µ;./4 %$7 ,/ #7),/4 ,*4 )(0"'.&%4#%,%=%µ:-0/(0 ,% ?-.µ%#% µ" 46% µ+%4 #%+ * ".(-1./$/+*,&0* $/( =%µ:-0",%+ %$7 ,/(4 %)1"0"&4 #/),&-B"+ $/=3 %#.+:-. E#/=/(1/30 ,/ (9"+/0/µ+#7 (=+#7 µ"29%, %?/3 ,% (=+#-, ,% /$/&% >.*)+µ/$/+/30,%+ ($.>.?&=,.%) "&0%+ "$&)*4 +'+%&,".% %#.+:- #%+ ),* )(0;->"+% * µ+)1/'/)&% ,/( $./)6$+#/3 µ" $/)/),7 13%"$& ,/( )(0/=+#/3 #7),/(4 (9.-?*µ% 2).

E$7 ,*0 -==* $="(.-, ,/ )(0/=+#7 #7),/4 µ&%4)(0"'.&%4 %0;.>",%+ ),% 421.67 "(.2 9+% ,*0 %+µ/-#-1%.)* µ" ,* µ;1/'/ ,*4 %+µ/'+%'+81*)*4 ($&0%-#%4 1).

! %35*)* %(,8 #%,- 30% $".&$/( )" )39#.+)*µ" ,*0 %+µ/#-1%.)* µ" ?3)+99% #%+ '+,,%01.%#+#7'+-=(µ% /?"&=",%+ ),% "$+$=;/0 (=+#- $/( >.*)+-µ/$/+/30,%+ ),* )(9#"#.+µ;0* µ;1/'/ #%+ ,% /$/&%"&0%+ +'+%&,".% %#.+:- ()-#/+ #%+ 9.%µµ;4 %+µ/'+%-'+81*)*4). @$/µ;064, ),*0 %+µ/'+%'+81*)* %(5--0",%+ ,/ $/)/),7 )(µµ",/>84 ,/( (9"+/0/µ+#/3 (=+-#/3 #%+ %0;.>",%+ ),/ 45% "$& ,/( )(0/=+#/3 #7),/(4%+µ/#-1%.)*4 "02 %#/=/(1/30 ,/ #7),/4 ,60 ?%.-µ-#60 µ" 36% #%+ ,*4 µ+)1/'/)&%4 µ" 10% (9.-?*-µ% 3).

D,/0 $&0%#% 2, $%./()+-B",%+ ,/ #7),/4 %0- %)1"-08 9+% ,/ 2006, / /$/&/4 $%.%#/=/(1"& $.79.%µµ%%+µ/#-1%.)*4 µ" '+,,%01.%#+#-. M/ #7),/4 %0;.>"-,%+ ),% 51.419.16 "(.2.

M/ µ"9%=3,"./ µ;./4 #%,%=%µ:-0/(0 ,% ?-.µ%#%µ" 46%. E#/=/(1/30 ,/ (9"+/0/µ+#7 (=+#7 µ" 29% #%+),* )(0;>"+% * µ+)1/'/)&% ,/( $./)6$+#/3 µ" $/)/-),7 13% "$& ,/( )(0/=+#/3 #7),/(4.

E0%?/.+#- µ" ,/ ",8)+/ #7),/4 %0- %)1"08, / /$/&-/4 $%.%#/=/(1"& $.79.%µµ% %+µ/#-1%.)*4 µ" ,*µ;1/'/ ,*4 %+µ/'+%'+81*)*4, %(,7 %0;.>",%+ ),%65.780.52 "(.2 9+% ,/ 2006 ($&0%#%4 3).

D,*0 %+µ/'+%'+81*)* %(5-0",%+ ,/ $/)/),7 )(µ-µ",/>84 ,/( (9"+/0/µ+#/3 (=+#/3 #%+ %0;.>",%+ ),/45% "$& ,/( )(0/=+#/3 #7),/(4 %+µ/#-1%.)*4 %0-%)1"08 "02 %#/=/(1/30 ,/ #7),/4 ,60 ?%.µ-#60 µ"36% #%+ ,*4 µ+)1/'/)&%4 µ" 10%.

#AJ-@696@&0%+ %'+%µ?+):8,*,/ 7,+ * :"=,&6)* ,*4 902)*4 )"1;µ%,% %$/,"=")µ%,+#7,*,%4 #%+ #7),/(4 ,60 '+%-?7.60 (9"+/0/µ+#20 $%."µ:-)"60 1% "$+,.;A"+ ,*0"$&,"(5* ,/( ,"=+#/3 ),7>/( $/( "&0%+ * )6),8 #%+* /+#/0/µ+#- %$/,"=")µ%,+#8 '+%>"&.+)* ,*4 %..2-),+%4 (disease management) (N+%.7$/(=/4, 1996%).

!I"#$#% 2. 3$'1+% ,C1$%2 .*8 .10#*' (.+µ%,80.41) µ# A-1+==. ,.+ :+$$.*04.,+,C :+8("µ.)

D.$.*%µ' (#+$%"4=+,%- ,C1$%"2 DC1$%2 .*8 .10#*' (1# e) % (B%1%1$C)

;5-=,$,-3% 6708.00 13%N#+µ%0% 23691.72 46%!@,*"5-µF4 (-27/)+'-' - %*F-O.-') 3347.76 7%6/5+5%0<4 .(0%/%-/#-.54 829.92 2%!+(%-/'+5%0<4 .@./#-.54 1174.68 2%1(.5,7,µ50F 2"50F 15144.48 29%1*,-/'+50/50<4 2*'+.-3.4 & ",5*# %7%"A-5µ% 522.60 1%>>11HHLLPPLL 5511..441199..1166 110000%%

L;3>,*,3&$'%#$30D%;$@2? 7M70)37;?10;%;$@2? 7#@$0$30)37;?N#7;,.,µ;@H "(;@H

70%

1%

2%1%

E)%µ$@$ 'M,4(;3µH? (3".0G%D3D-$4H3=73D)N4,30D%;@0;@2?"4D%73&7? & (,;4)$.$(K3;µ$

5%

36%

45%

10%

()#*+'# 3. !"*%(+,C ,C1$%2 µ9.2 1"*#:49.2 .+µ%,80.41)2 µ# $) µ;0%:%

$)2 .+µ%:+.:+'0)1)2

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 42

Page 44: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [43]

!"!#$%&'(H !")*+,A

E$%.%&,*,/ ".9%="&/ )" %(,8 ,* '+%'+#%)&% %$/,"-=/30 /+ µ"=;,"4 #/+060+#//+#/0/µ+#84 %$/,&µ*)*4,/+ /$/&"4 ),*.&B/0,%+ ),% %$/,"=;)µ%,% ,/( +%,.+-#/3 ;.9/( 9+% 0% %$%.+1µ8)/(0 "&," ,/ #7),/4 ,/()(9#"#.+µ;0/( ;.9/( 8 0% )(9#.&0/(0 "0%==%#,+#;41".%$"(,+#;4 $%."µ:-)"+4 $/( ;>/(0 '+%?/.",+#7#7),/4 #%+ )(0;$"+"4 (G(.+7$/(=/4, T+-#%4, 1994,V"&,/0%, 1996).

! %+µ/#-1%.)* %$/,"="& µ&% +'+%&,".% %#.+:8µ;1/'/ %0,+µ",2$+)*4 ,60 $%)>70,60 %$7 UTE, '"'/-µ;0/( 7,+ :%)&B",%+ #(.&64 ),* >.8)* #%+0/,7µ60,">0/=/9+20.

M/ #7),/4 %(5-0",%+ µ" ,* >.*)+µ/$/&*)* 0;60µ"17'60 %+µ/#-1%.)*4, 7$64 %(,8 ,*4 %+µ/'+%'+8-1*)*4 $/( "5",-),*#". M% %#.+:7,".% (=+#- $/( >.*-)+µ/$/+/30,%+ %(5-0/(0 #%,- 30% $".&$/( ,/ #7),/4)" )>;)* µ" ,*0 %+µ/#-1%.)* µ" ?3)+99% #%+ '+-=(-µ% '+,,%01.%#+#20.

M% ?-.µ%#% %$/,"=/30 ,/ )*µ%0,+#7,"./ $%.--9/0,% ),* '+%µ7.?6)* ,/( #7),/(4 %?/3 #%,%=%µ-:-0/(0 ,/ 46% %$7 ,/ )(0/=+#7 #7),/4 ,*4 µ"17'/(,*4 %+µ/#-1%.)*4 µ" '+,,%01.%#+#- "5%+,&%4 ,*4 ".(-1./$/+*,&0*4 $/( %$/,"="& ;0% +'+%&,".% %#.+:7 ?-.-µ%#/.

@$+$.7)1",%, ;0%4 %$7 ,/(4 :%)+#7,"./(4 $%.--9/0,"4 $/( '+%µ/.?20/(0 ,/ (A*=7 #7),/4 "&0%+ #%+,/ (9"+/0/µ+#7 (=+#7, ,/ /$/&/ ),*0 %+µ/#-1%.)* µ"?3)+99% #%+ '+,,%01.%#+#7 '+-=(µ% #%=3$,"+ ,/ 29%%$7 ,/ )(0/=+#7 #7),/4 ,*4 µ"17'/(. D" %(,7 )(µ-:-=="+ ,/ (A*=7 #7),/4 ,60 ?&=,.60 $/( >.*)+µ/-$/+/30,%+ µ&% µ70/ ?/.- 9+% #-1" )(0"'.&%.

M/ #7),/4 µ+)1/'/)&%4 %$/,"="& ,/0 ,.&,/ )*µ%-0,+#7 $%.-9/0,% '+%µ7.?6)*4 ,/( ,"=+#/3 #7),/(4µ" $/)/),7 )(µµ",/>84 13% "$& ,/( )(0/=+#/3 #7),/(4,*4 %+µ/#-1%.)*4 µ" ?3)+99% #%+ '+-=(µ% '+,,%01.%-#+#20.

I".020,%4 ),*0 %+µ/#-1%.)* µ" ,* µ;1/'/ ,*4%+µ/'+%'+81*)*4, /+ #(.+7,"./+ $%.-9/0,"4 $/( '+%-µ/.?20/(0 ,/ )(0/=+#7 #7),/4 "&0%+ /+ &'+/+. X),7-)/, ,% $/)/),- %==-B/(0 =796 ,60 %#.+:20 (=+#20

$/( >.*)+µ/$/+/30,%+ ),* µ;1/'/ %(,8, µ" %$/,;="-)µ% ,*0 %35*)* ,/( $/)/),/3 ,/( (9"+/0/µ+#/3 (=+-#/3 (45% %$7 29% µ" ?3)+99% #%+ '+-=(µ% '+,,%01.%-#+#20) ),/ )(0/=+#7 #7),/4 ,*4 %+µ/#-1%.)*4 µ" ,*)(9#"#.+µ;0* µ;1/'/.

M% %$/,"=;)µ%,% ,*4 )(9#"#.+µ;0*4 µ"=;,*4 %0%-?/.+#- µ" ,* )(9#.+,+#8 %$/,&µ*)* ,60 '3/ $%.%-$-06 µ"17'60 %+µ/#-1%.)*4 )(µ?60/30 µ" ,% %$/-,"=;)µ%,% $%.7µ/+60 "."(020 (Tediosi et al., 2001,Piccoli et al., 1997, Rodriguez-Carmona et al., 1996),:-)"+ ,60 /$/&60 * %+µ/#-1%.)* µ" ,* µ;1/'/ ,*4%+µ/'+%'+81*)*4 %$/,"="& $+/ %#.+:8 µ/.?8 1".%-$"&%4 )" )39#.+)* µ" ,*0 %+µ/#-1%.)* µ" '+,,%01.%-#+#-.

@$/µ;064, 9&0",%+ )%?;4 7,+ * #%,%9.%?8 ,/(#7),/(4 ,*4 %+µ/#-1%.)*4 µ%4 '&0"+ ,* '(0%,7,*,%%$7 ,* µ&% $="(.- 0% "),+-)/(µ" ),/(4 $%.-9/0,"4,/+ /$/&/+ '+%µ/.?20/(0 ,/ )(0/=+#7 #7),/4 ("?7)/0* )(9#"#.+µ;0* µ;1/'/4 %$/,"="& ,*0 $+/ '+%'"'/-µ;0* ),*0 @==-'%), ;,)+ 2)," 0% µ$/.;)/(µ" 0% )(µ-:-=/(µ" ),/0 ;="9>7 ,/( #%+ %$7 ,*0 -==* ,* '(0%-,7,*,% )39#.+)*4, %0%?/.+#- µ" ,/ #7),/4, µ" ,+4"0%==%#,+#;4 1".%$"&"4 ($/#%,-),%)*4 ,*4 0"?.+-#84 ="+,/(.9&%4, '*=%'8 ,*4 $".+,/0%J#84 #-1%.)*4#%+ ,*4 µ",%µ7)>"()*4 0"?./3.

E(,7 -==6)," '"&>0/(0 #%+ µ&% )"+.- %$7 ;."(-0"4, 7,+ * %+µ/#-1%.)* "&0%+ $+/ %#.+:8 %$7 ,*0 $".+-,/0%J#8 #-1%.)* #%,- 20% (Kontodimopoulos et al.,2005, Rozenbaum et al., 1985, Goeree et al., 1995,Rodriguez-Carmona et al., 1996), 60% %#.+:7,".*,)" -=="4 ;."(0"4, µ" '+-=(µ% '+,,%01.%#+#20 #%+'+$=-)+% µ" ,* µ;1/'/ ,*4 %+µ/'+%'+81*)*4 (Tediosiet al., 2001). E(,7 :%)&B",%+ ),/ 9"9/074 7,+ * 1".%-$"&% 9&0",%+ ),/ 0/)/#/µ"&/ µ" %$/,;=")µ% 0% %$/-?;."+ )*µ%0,+#- #7),* $./)6$+#/3 )" %0,&1")* µ",*0 $".+,/0%J#8 '+-=()* $/( $.%9µ%,/$/+"&,%+ ),/)$&,+. D,*0 $".&$,6)* %(,8 7µ64 ,/ #7),/4 ,/( 0%"#$%+'"3)"+ #%0"&4 ;0%0 %)1"08 0% "?%.µ7B"+ ,*1".%$"&% / &'+/4 ),/ )$&,+ 1% $.;$"+ 0% =*?1"& ($7-A* (Kontodimopoulos et al., 2005).

!,"#$#% 3: 3$'1+% ,C1$%2 .*8 .10#*' (.+µ%,80.41) µ# $) µ;0%:% $)2 .+µ%:+.:+'0)1)2)

D.$.*%µ' (#+$%"4=+,%- ,C1$%"2 DC1$%2 .*8 .10#*' (1# e) % (B%1%1$C)

;5-=,$,-3% 6708.00 10%N#+µ%0% 23691.72 36%!@,*"5-µF4 (-27/)+'-' - %*F-O.-') 3347.76 5%6/5+5%0<4 .(0%/%-/#-.54 829.92 1%!+(%-/'+5%0<4 .@./#-.54 1174.68 2%1(.5,7,µ50F 2"50F 29505.84 45%1*,-/'+50/50<4 2*'+.-3.4 & ",5*# %7%"A-5µ% 522.60 1%>>11HHLLPPLL 6655778800..5522 110000%%

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 43

Page 45: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[44] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#$%&'(H !")*+,A

@$+$.7)1",%, ,/ #7),/4 %0- %)1"08 9+% ,/ 2006%0;.>",%+ ),% 51.419.16 "(.2 9+% ,*0 %+µ/#-1%.)*µ" '+,,%01.%#+#-. E$7 ,*0 -==* $="(.-, ,/ ",8)+/#7),/4 %0- %)1"08 %0;.>",%+ ),% 65.780.52 "(.2 9+%,*0 %+µ/'+%'+81*)*. ! '+%?/.- %(,8 "5*9"&,%+, 7$64%0%?;.1*#" #%+ $.6,3,".%, =796 ,60 %#.+:7,".60(=+#20, ,% /$/&% >.*)+µ/$/+/30,%+ ),*0 %+µ/#-1%.-)* µ" ,* µ;1/'/ ,*4 %+µ/'+%'+81*)*4.

C" '"'/µ;0/ =/+$70 ,/ )(0">24 %(5%07µ"0/#7),/4 %0,+µ",2$+)*4 ,*4 UTE #%+ ,* )$%0+7,*,%,60 '+%1;)+µ60 $7.60, ,% '"'/µ;0% %$7 ,;,/+"4;."(0"4 µ$/."& 0% %$/'"+>1/30 >.8)+µ% )" "$&$"-'/ =8A*4 %$/?-)"60 "$+=/984 µ"17'60 1".%$"&-%4 ,*4 0"?.+#84 %0"$-.#"+%4. M* '(0%,7,*,% %(,8/?"&="+ 0% %5+/$/+8)"+ * >2.% µ%4 #%+ ($7 ,*0;00/+% %(,8 $.;$"+ 0% '/1"& µ"9-=* :%.3,*,% ),*>.8)* ,60 ,">0+#20 /+#/0/µ+#84 %5+/=79*)*4 %0,&,*4 )(>0- "?%.µ/B7µ"0*4 )+6$*.84 =8A*4 %$/-?-)"60, 7$/( /+ "$+=/9;4 #%+ * $/=3 )$/('%&% ($7-1")* ,*4 #%,%0/µ84 ,60 $7.60 ),*.&B",%+ )" )(08-

1"+4 +%,.+#;4 $.%#,+#;4 #%+ +),/.+#- '"'/µ;0% >6.&40% )(0($/=/9&B/0,%+ /+ $%./3)"4 %0-9#"4 #%+ ?()+-#- /+ $./,+µ8)"+4 #%+ * $/+7,*,% B684 ,60 %)1"-020. F$7 %(,;4 ,+4 )(018#"4, %$/?"39/0,%4 '*=%-'8 ,*0 "?%.µ/98 "$+),*µ/0+#20 µ"17'60 %5+/=79*)*4,%?"074 '"0 #%1&),%,%+ "?+#,8 * /.1/=/9+#8 #%,%-0/µ8 ,60 $7.60 #%+ * /+#/0/µ+#8 %$/,"=")µ%,+#7-,*,% ,60 $./9.%µµ-,60 (9"&%4 #%+ %?",;./( µ$/-."& 0% '*µ+/(.9/30,%+ $./:=8µ%,% +)7,*,%4 #%+#/+060+#84 '+#%+/)30*4 9+%,& * #%#8 >.8)* ,60$7.60 &)64 /'*9"& )" %$/#="+)µ/34 $%./>84 0;60($*.")+20 (9"&%4 )" )*µ%0,+#- ,µ8µ%,% ,/( $=*-1()µ/3.

!AK20)9@1*.! )(99.%?;%4 /?"&="+ "(>%.+),&"4 ),* '+/&#*)* ,*4#=+0+#84 «GFETHFD DMEFOHD», #%+ +'+%&,".% ),/0'+/+#*,+#7 '+"(1(0,8 #/ G2),% I%$%=%B-./( 9+% ,*0$/=3,+µ* :/81"+- ,/( ),* )(==/98 ,60 /+#/0/µ+#20),/+>"&60.

ABSTRACT

OORRIIGGIINNAALL AARRTTIICCLLEETTRREEAATTMMEENNTT OOFF CCHHRROONNIICC KKIIDDNNEEYY DDIISSEEAASSEE:: CCOOSSTT AANNAALLYYSSIISS OOFF BBIICCAARRBBOONNAATTEE DDIIAALLYYSSIISS AANNDDHHAAEEMMOODDIIAAFFIILLTTRRAATTIIOONNPPaarraasskkeevvii TThheeooffiilloouu,, PPhhDD PPssyycchhoollooggiisstt,, NNaattiioonnaall SScchhooooll ooff PPuubblliicc AAddmmiinniissttrraattiioonn,, DDeeppaarrttmmeenntt ooff MMaannaaggeemmeenntt ooffHHeeaalltthh SSeerrvviicceess,, AAtthheennss

AAiimm:: The economic assessment of haemodialysis (HD) in a Unit of Artificial Kidney of a private clinic. More specifically,cost analysis of bicarbonate dialysis and haemodiafiltration is used.

PPooppuullaattiioonn SSttuuddyy:: 120 patients with end - stage renal disease, undergoing HD in the Unit of Artificial Kidney of theclinic in 2006.

MMaatteerriiaall aanndd MMeetthhoodd:: The demographic, clinical and economic characteristics were recorded from the files ofpatients. Data were collected by the finance management of the clinic with regards to the payroll of personnel,the capital and technological equipment, dampings, fixed costs and other consumables. Prices of 2006 were usedand one HD session was considered as the unit of cost.

RReessuullttss:: The total cost of an HD session with haemodiafiltration surpasses by 30% of the method of bicarbonatedialysis. This important increase of cost is due to the additional sanitary material that is required in the particularmethod (bags and lines of haemodiafiltration).

CCoonncclluussiioonnss:: HD is an especially expensive method regarding the treatment of end - stage renal diseasepatients, based on the use of innovative technologies. Similar analyses of economic evaluation are not fullydocumented, if they do not take into account of the clinical superiority and they do not attribute in terms ofcost -effectiveness.

KKeeyy wwoorrddss:: Economic Assessment, chronic Kidney disease, bicarbonate dialysis, haemodiafiltration

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 44

Page 46: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [45]

!"!#$%&'(H !")*+,A

E)F5)4=02?121. 9*,-/F",2, Q., (2000). «&,5F/'/% G8)4: ;3% *%+%µ."'µ<7' *%+#-

µ./+,4 %@5,"F('-'4 =.+%*.2/50A7 %*,J#-.87». >/,: !""'750)H.J+,",(3%. 12 (1): 28-33.

2. E.3/,7%, ;., (1996). «&,"5/50) 0%5 L50,7,µ50# /'4 1(.3%4». 9=)7%:!@#7/%4.

3. Drummond, M., O’ Brien, B., Stoddart, G., Torrance, G., (1997).«;<=,$,5 ,50,7,µ50)4 %@5,"F('-'4 /87 *+,(+%µµ#/87 2(.3%4».;/J+. I,:--,4, H., 9=)7%: 6+5/50).

4. Goeree, R., Manalich, J., Grootendorst, P., Beecroft, M. L., Churchill,D. N., (1995). «Cost analysis of dialysis treatments for end-stagerenal disease». In: Clin Invest Med, 18: 455-464.

5. Kontodimopoulos, N., Niakas, D., Mylonakis, J., (2005). «A socio-economic comparison of haemodialysis and peritoneal dialysisin Greece». In: Int J Health Care Tech Manag, 6: 296-306.

6. 62+5F*,2",4, E., H5#0%4, B., (1994). «Q<µ%/% L50,7,µ50A7 0%5 &,"5-/50)4 1(.3%4». 9=)7%: 6<7/+, 6,578750A7 !*5-/'µA7 /'4 1(.3%4.

7. P5%+F*,2",4, P., (1996%). «N%+µ%0,,50,7,µ50<4 µ."</.4 0%5 µ.=,-

$,",(50# =<µ%/% 0,-/,"F('-'4». >/,: N%+µ%0.2/50), 9 (MMM): 97-105.

8. Piccoli, G., Formica, M., Mangiarotti, G., Pacitti, A., Piccoli, GB.,Bajardi, P., Cavagnino, A., Ghezzi, P., Rangi, R., Ramello, A.,Verzetti, G., Cesano, G., Quarello, F., Vercellone, A., (1997). «Thecost of dialysis in Italy». In: Nephrol Dial Transplant, 12 (Suppl.1): 33-44.

9. Rodriguez-Carmona, A., Perez Fontan, M., Bouza, P., GarciaFalcon, T., Valdes, F., (1996). «The economic cost of dialysis: acomparison between peritoneal dialysis and in-center haemodialysisin a Spanish unit». In: Adv Perit Dial, 12: 93-96.

10. Rozenbaum, A. E., Pliskin, J. S., Barnoon, S., Chaimovitz, C.,(1985). «Comparative study of costs and quality of life of chronicambulatory peritoneal dialysis and haemodialysis patients inIsrael». In: Israel Journal of Medical Sciences, 21: 335-339.

11. Tediosi, F., Bertolini, G., Parazzini, F., Mecca, G., Garattini, L.,(2001). «Cost analysis of dialysis modalities in Italy». In: HealthServ Manag Res, 14: 9-17.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 45

Page 47: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[46] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

D(0%+)1*µ%,+#8 0/*µ/)30*-1"6.&% #%+ "?%.µ/9;4 ),* 0/)*="(,+#8 '+/&#*)*

YY6688 KK77....**

T/)*="3,.+% I@, CSc ),* S(>+#8 F9"&% IVT «EMMRGHT»@.9%),*.+%#74 D(0".9-,*4 M@R E1*020 T/)*="(,+#8 KZ

>!L"M'N'

@@++))%%99669988:: ! D(0%+)1*µ%,+#8 T/*µ/)30* (DT) %0%?;.",%+ ),* :+:=+/9.%?&% )%0 ;0% )*µ%0,+#7 >%.%#,*-.+),+#7 ,/( "$+,(>*µ;0/( *9;,*. G%124 ,/ )3),*µ% (9"&%4 %==-B"+ µ" ,%>"&4 .(1µ/34 /+ *9;,"4 ,/( )(),8-µ%,/4 %(,/3 >."+-B",%+ 0% "?%.µ7B/(0 #%+0/,7µ% µ/0,;=% *9")&%4 "$+#"0,.6µ;0% ),* '*µ+/(.9&% '")µ20#%+ )>;)"60 "µ$+),/)30*4. H+ *9;,"4 0/)*="(,;4 $/( '+%1;,/(0 %(,- ,% >%.%#,*.+),+#- ,*4 DT "0+)>3/(0,+4 /.9%06,+#;4 +#%07,*,"4 ,/( $./)6$+#/3 #%+ ,*0 %$/,"=")µ%,+#7,*,% ,/( /.9%0+)µ/3 $/( '+/+#/30.DD##//$$7744:: ! $%./3)% ".9%)&% ),7>/ ;>"+ 0% $%./()+-)"+ ,*0 :+:=+/9.%?&% $/( "&0%+ )>",+#8 µ" ,* )(0%+)1*-µ%,+#8 0/*µ/)30* #%+ ,+4 )(0;$"+;4 ,*4 ),* 0/)*="(,+#8 '+/&#*)*.EE00%%))##77$$**))** KK++::==++//99..%%??&&%%44:: ! %0%)#7$*)* ,*4 :+:=+/9.%?&%4 ;9+0" >.*)+µ/$/+20,%4 ,+4 '+"10"&4 :-)"+4'"'/µ;060 (MEDLINE, PUBMED) #%=3$,/0,%4 µ+% $".&/'/ %$7 ,/ 1998 ;64 ,/ 2008. @$+$=;/0 )(µ$".+"-=8?1*)%0 µ+% )"+.- %$7 )>",+#- -.1.%.DD((µµ$$""..--))µµ%%,,%%:: H+ )(0%+)1*µ%,+#- ;5($0/+ *9;,"4 0/)*="(,;4 '+%1;,/(0 %(,/906)&%, "$/$,+#;4 +#%07,*-,"4, '+%>"+.&B/0,%+ ,7)/ ,% '+#- ,/(4 )(0%+)18µ%,% 7)/ #%+ %(,- ,/( $./)6$+#/3 ,/(4 µ" %$/,;=")µ% 0%'*µ+/(.9/30 /µ-'"4 +#%0;4 0% "$+B8)/(0 ),/ )(0">24 µ",%:%==7µ"0/ $".+:-==/0 ,*4 (9"&%4.

NN;;55""++44 GG==""++''++--:: )(0%+)1*µ%,+#8 0/*µ/)30*, 0/)*="(,+#8 '+/&#*)*, *9",+#;4 +#%07,*,"4

!"!#"$%&'(")* '+',)$-*,*

!"#$%&%'! D(0%+)1*µ%,+#8 T/*µ/)30* (D.T) "&0%+ ;0%4 7./4$/( %$%0,-,%+ /=/;0% #%+ )(>07,".% ),* :+:=+/9.%-?&% ,*4 #/+060+#84 A(>/=/9&%4 (Cherniss, 2002),#%124 #%+ ),% 0/)*="(,+#- $".+/'+#- (Cadman &Brewer 2001). M% )(),8µ%,% (9"&%4 µ",%:-==/0,%+9.89/.% #%+ "$+#"0,.20/0,%+ $".+))7,"./ ),+4 )>;-)"+4 .H+ *9;,"4 9+% 0% "$+,3>/(0 $.;$"+ 0% '/(="3/(0$".+))7,"./ µ" ,*0 #%.'+- ,/(4 #%+ 0% '+%1;,/(0 %(,7$/( "&0%+ 906),7 '+"1024 64 “soft skills”(Kerfoot,1996). D(9#"#.+µ;0% /?"&=/(0 0% ;>/(0 "0)(0%&)1*-)* (empathy) $./4 ,/(4 ".9%B7µ"0/(4 , 0% "01%..3-0/(0 %,/µ+#;4 #%+ /µ%'+#;4 )>;)"+4, 0% %0%906.&B/(0,* )(0"+)?/.- ,/( #-1" µ;=/(4 ,*4 /µ-'%4, 0% %0%-=3/(0 ,* )(0%+)1*µ%,+#8 $="(.- ,/( #-1" 1;µ%,/4#%+ 0% $./:=;$/(0 ,+4 %0,+'.-)"+4 ,/( $./)6$+#/3.

! )(0%+)1*µ%,+#8 $="(.- ,*4 *9")&%4 %$%+,"&µ/0%'+#;4 +#%07,*,"4. D(9#"#.+µ;0% %$%+,"& /+ *9;-

,"4 0% %0%906.&B/(0 ,7)/ ,% '+#- ,/(4 7)/ #%+ ,%)(0%+)18µ%,% ,60 -==60, 0% >.*)+µ/$/+/30 ,% )(0%+-)18µ%,% ),/ ,.7$/ ,*4 )#;A*4 ,/(4, 0% #%,%0//30#%+ 0% %+,+/=/9/30 µ" )(0%&)1*µ% #%+ 0% '+%>"+.&B/-0,%+ ,% )(0%+)18µ%,- ,/(4, %==- #%+ %(,- ,/( $./)6-$+#/3 ,/(4 . M% -,/µ% $/( ?;./0,%+ µ" %(,7 ,/0 ,.7-$/ %0%?;./0,%+ 64 )(0%+)1*µ%,+#- "(?(8 -,/µ% #%,-,/(4 Mayer #%+ Salovey (Mayer & Salovey, 1997).

3) *1,2) 6 #A,2)9+6µ2@)7- O46µ49B,6 (#.O.);! D(0%+)1*µ%,+#8 T/*µ/)30* /.&B",%+ 64 * +#%07-,*,% ,/( %,7µ/( 0% %0%906.&B"+ ,% '+#- ,/( )(0%+)18-µ%,%, ,% )(0%+)18µ%,% ,60 -==60, 0% '*µ+/(.9"& #&0*-,.% 9+% ,/0 "%(,7 ,/( #%+ 0% >"+.&B",%+ )6),- ,%)(0%+)18µ%,% #%+ ,+4 )>;)"+4 ,/( (Goleman, 1998).H.&B",%+ %#7µ* 64 * +#%07,*,% %0,&=*A*4, %5+/=79*-)*4, ;#?.%)*4 #%+ '+%>"&.+)*4 ,60 )(0%+)1*µ-,60((Mayer & Salovey , 1997).

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 46

Page 48: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [47]

!"!#"$%&'(")* '+',)$-*,*

I".+9.%?;4 ,*4 D.T. ($-.>/(0 %$7 ,7," $/( "µ?%-0&B/0,%+ %0%?/.;4 )>",+#- µ" ,*0 %01.2$+0* )(µ$"-.+?/.-. E$7 ,/(4 %.>%&/(4 <==*0"4 ?+=/)7?/(4 ;64,*0 I%=%+- #%+ ,*0 G%+08 P+%18#* , %$7 ,/0 D%&5$*.;64 ,/0 Thomas Jefferson #%+ ,* )39>./0* A(>/=/-9&%, * )(0%+)1*µ%,+#8 '+-),%)* ,*4 =/9+#84 1"6."&-,%+ 1"µ"=+2'"4 ),/+>"&/ ,*4 %01.2$+0*4 ?3)*4(T.Bradberry &J.Greeaves ,2006 ) . I%.%'/)+%#- /7./4 0/*µ/)30* )>",+B7,%0 µ" ,*0 %$7'/)* ),/ ,"),0/*µ/)30*4 (IQ test), ($8.5%0 6),7)/ "."(0*,;4 $/('+%$&),6)%0 9.89/.% #%+ $64 /+ µ* 906),+#;4 $="(-.;4 "&0%+ "5&)/( )*µ%0,+#;4, 7$64 / Wechsler $/(7.+)" ,* 0/*µ/)30* 64 ,*0 +#%07,*,% ,/( %,7µ/( 0%'.% )#/$&µ64 #%+ 0% )(0%==-))",%+ %$/,"=")µ%,+#-µ" ,/ $".+:-==/0 ,/((Wechsler, 1958), / Garner $/(;9.%A" 9+% ,*0 «$/==%$=8 0/*µ/)30*» #.%. (Garrdner,1983).Wµ64 µ7=+4 ,/ 1990 /+ Salovey #%+ Mayer %0;$,(5%09+% $.2,* ?/.- ,/0 7./ D(0%+)1*µ%,+#8 T/*µ/)30*.E==- #%+ %(,8 * $./);99+)* ;µ"+0" %?%084 64 ,/ 1995$/( 9&0",%+ * ;#'/)* ,/( :+:=&/( ,/( Daniel Goleman“Emotional Intelligence : Why it can matter morethan IQ”, /$7," $%.;>",%+ µ+% $=*.;),".* "+#70% ,*4+#%07,*,%4 $/( )>",&B",%+ µ" ,*0 "$+,(>&% ,7)/ ),*B68 7)/ #%+ ),*0 ".9%)&% )" )>;)* µ" ,* 906),+#8

0/*µ/)30*. ! ;00/+% ,*4 D.T "589*)" 9+%,& '(/ -01.6-$/+ $/( ;>/(0 ,/0 &'+/ '"&#,* 0/*µ/)30*4 "0';>",%+0% ?,-)/(0 )" '+%?/.",+#- "$&$"'% "$+,(>&%4.

D,* '+"108 :+:=+/9.%?&% ($-.>/(0 '(/ $./)"99&-)"+4 ,*4 D(0%+)1*µ%,+#84 T/*µ/)30*4 ,/( DanielGoleman #%+ ,60 John Mayer, Peter Salovey $/( %0#%+ '+%1;,/(0 $/==- #/+0- ),/+>"&% 64 $./4 ,+4 ($/-1;)"+4 #%+ ,+4 $./)'/#&"4 9+% ,*0 "$&'.%)* ,*4 D(0%+-)1*µ%,+#84 T/*µ/)30*4 '+%?;./(0 ),/ 9"9/074 7,+/ $.2,/4 $./,"&0"+ ;0%0 $+/ 9"0+#7 #/+060+#7-)(0%+-)1*µ%,+#7 /.+)µ7 "02 /+ '"3,"./+ $".+9.-?/(0 ,*D.T. 64 906),+#7-)(0%+)1*µ%,+#8 +#%07,*,% $%.-)%0 >%.%#,*.+),+#7 ,*4 $./)6$+#7,*,%4.

34 µ4,@;54 #.O. @G, P. Salovey 72) J. Mayer' #A,2)9+6µ2@)7- O46µ49B,6 G. )72,8@6@2D,/ $%.%#-,6 )>8µ% %$"+#/0&B",%+ ,/ µ/0,;=/ ,60Salovey&Mayer, ,/ /$/&/ $".+9.-?"+ ,+4 ,;))".+4 +#%-07,*,"4 ,*4 D.T. #%+ ,+4 %0,&),/+>"4 )(0%+)1*µ%,+#;4'+%'+#%)&"4, /+ /$/&"4 "&0%+ ),/+>"+/1",*µ;0"4 µ",;,/+/ ,.7$/ 2)," #-1" #%,*9/.&% %$7 #-,6 $./4 ,%$-06 0% %0,+),/+>"& )" $+/ %$=;4 +#%07,*,"4 ,*4 %0,&-=*A*4 #%+ ;#?.%)*4 ,/( )(0%+)18µ%,/4, )" %0,&1"-)* µ" ,*0 %02,".* #%,*9/.&% $/( $".+=%µ:-0"+ ,*

%&H'#1: F% µ%*$;(% !"*.+10)µ.$+,'2 G%)µ%1-*)2 $5* John Mayer,Peter Salovey( Mayer& Salovey, 1997)

!$%&.1$+,' H-0µ+1) $%" !"*.+10'µ.$%2 =+. $)* /4%.=5=' $)2 1"*.+10)µ.$+,'2 ,.+ /*#"µ.$+,'2 .*8/$"I)2

M0%7F/'/% 7% .3-%5 %7,5?/F4 -. -27%5-=)µ%/%M0%7F/'/% 7% *+,-0,""#-%5 ) 7% %*,-*#-%5 -/,?%-/50# %*F <7% -27%3-='µ%M0%7F/'/% 7% 0%/%(+#J.54 -/,?%-/50# -27%5-=)µ%/%M0%7F/'/% 7% $5%?.5+3G.-%5 -27%5-=)µ%/% ?8+34 7% µ./%O#""./%5 ' F*,5% *"'+,J,+3% *.+5<?,27

D.$.*C)1) ,.+ ?*8("1) $5* 1"*.+10)µ8$5* /"+%0;$)1) 1"*.+10)µ.$+,'2 =*<1)2

M0%7F/'/% 7% ?%+%0/'+3G.54 -27%5-=)µ%/% 0%5 7% %7%(78+3G.54 /54 -?<-.54 µ./%@: /,24M0%7F/'/% 7% %*,$3$.54 /54 -'µ%-3.4 *,2 .µ*.+5<?,27 /% -27%5-=)µ%/% -?./50# µ. -2-?./3-.54M0%7F/'/% 7% 0%/%7,.34 -:7=./% -27%5-=)µ%/%M0%7F/'/% 7% %7%(78+3G.54 *5=%7<4 µ./%O#-.54 µ./%@: /87 -27%5-='µ#/87

!"*.+10)µ.$+,' E+#",C("*1) $)2 1,;J)2

R -0<S' %0,",2=.3 /87 -27%5-='µ#/87 *,2 0%/.2=:7,27 /'7 *+,-,?)C% -27%5-=)µ%/% .37%5 .*%+0A4 <7/,7% 0%5 $5%=<-5µ% *,2 µ*,+,:7 7% %7%*%+%?=,:7L5 -27%5-='µ%/50<4 %""%(<4 /'4 $5#=.-'4 /+,*,*,5,:7 /54 *+,,*/50<4 /,2 %/Fµ,2>27%5-='µ%/50<4 0%/%-/#-.54 .7=%++:7,27 $5%J,+./50<4 *+,-.((3-.54 -. -2(0.0+5µ<7% *+,O")µ%/%

?*$9()J), ?I+%(C=)1) ,.+ 7,A4.1) $%" 1"*.+10'µ.$%2

M0%7F/'/% 7% %7%(78+3G.54 -27%5-=)µ%/%M0%7F/'/% 7% %7%(78+3G.54 -27%5-=)µ%/% #""87 µ<-% %*F /' ("A--%, /'7 .µJ#75-', /' -2µ*.+5J,+#M0%7F/'/% 7% .0J+#G.54 %0+5OA4 /% -27%5-=)µ%/% -,2M0%7F/'/% 7% $5%0+37.54 µ./%@: /'4 .5"50+57)4 0%5 µ' .5"50+57)4 <0J+%-'4 /,2 -27%5-=)µ%/,4

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 47

Page 49: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[48] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")* '+',)$-*,*

)(0"+'*,8 #%+ $%.-==*=% ),/>%),+#8 .31µ+)* ,/()(0%+)18µ%,/4.

! %0,&=*A*, * %5+/=79*)* #%+ ;#?.%)* ,/( )(0%+-)18µ%,/4 %$/,"=/30 ,*0 #%,2,".* #%,*9/.&% ,/()>8µ%,/4 1 #%+ %?/./30 ),*0 %#.&:"+% µ" ,*0 /$/&%,% -,/µ% µ$/./30 0% %0,+=*?1/30, 0% %5+/=/98)/(0#%+ 0% "#?.-)/(0 ,% )(0%+)18µ%,% ,/(4. ! '"3,".*#%,*9/.&% %?/.- ),* )(0%+)1*µ%,+#8 '+"(#7=(0)*,60 906),+#20 '+%'+#%)+20. E(,8 "),+-B"+ ),/ $64,/ )(0%&)1*µ% "$*."-B"+ ,/ 906),+#7 )3),*µ% 2),"0% ,/ "5/$=&B"+ 9+% $+/ %$/,"=")µ%,+#8 "$&=()* $./-:=*µ-,60, %+,+/=79*)*, =8A* %$/?-)"60 #%+ $+/'*µ+/(.9+#;4 $./)$-1"+"4. (Palfai& Salovey,1993).!,.&,* #%,*9/.&% ,/( )>8µ%,/4 %?/.- ),*0 +#%07,*-,% ,*4 #%,%07*)*4 ,60 )(0%+)1*µ-,60 #%+ ,*4 >.*-)+µ/$/&*)*4 ,*4 )(0%+)1*µ%,+#84 902)*4. ! %02-,".* #%,*9/.&% ,/( µ/0,;=/( D.T. ,60 Mayer #%+Salovey %?/.- ),* )(0"+'*,8 .31µ+)* ,60 )(0%+-)1*µ-,60 2)," 0% $./-9",%+ * )(0%+)1*µ%,+#8 #%+$0"(µ%,+#8 %0-$,(5* ,/( %,7µ/( #%+ $".+=%µ:-0"+,* .31µ+)* ,*4 "µ$"+.&%4 #%+ ,*4 ;#?.%)*4 ,60)(0%+)1*µ-,60 %$/)#/$20,%4 ),*0 "$&,"(5* ,60),7>60 ,/( %,7µ/(.

34 µ4,@;54 #.O. @4A Daniel Goleman' #A,2)9+6µ2@)7- O46µ49B,6 G. K2027@60)9@)78 @6. /049G/)78@[email protected]/ µ/0,;=/ ,*4 D.T ,/( Goleman $/( %$"+#/0&B",%+),/ $%.%#-,6 )>8µ% '&0"+ ;µ?%)* )" %,/µ+#;4 '+%-?/.;4 ),*0 /.9-06)* #%+ ;#?.%)* ,60 )(0%+)1*µ--,60 #%+ )(0%?20 #/+060+#20 '"5+/,8,60 7$64 * "0)(-0%&)1*)*, ,% #&0*,.%, * $./)%.µ/),+#7,*,% #%+ 9"0+#8)(9#+0*)+%#8 #%,-),%)*.

I;@0696 @6. #.O.H+ Petrides #%+ Furnham (Petrides & Furnham, 2001)$.7,"+0%0 ;0%0 +'"/=/9+#7 '+%>6.+)µ7 µ",%53 ,60 '3/$./)"99&)"60 ,*4 D(0%+)1*µ%,+#84 T/*µ/)30*4 :-)"+,*4 >.*)+µ/$/+/3µ"0*4 µ"1/'/=/9&%4 µ;,.*)84 ,/(4.! $./);99+)* ,*4 D.T. 64 +#%07,*,% µ",.-,%+ µ" ,"),µ;9+),*4 %$7'/)*4 "02 * $./);99+)8 ,*4 64 >%.%-#,*.+),+#7 ,*4 $./)6$+#7,*,%4 µ",.-,%+ µ" ".6,*-µ%,/=79+% %(,/%0%?/.-4.

! µ;,.*)* ,*4 D.T 64 +#%07,*,% "&0%+ $./:=*µ%-,+#8 "$"+'8 * )(µ?(84 ($/#"+µ"0+#8 ?3)* ,*4 )(0%+-)1*µ%,+#84 "µ$"+.&%4 ($/0/µ"3"+ ,*0 $./)$-1"+%%0-$,(5*4 ,"), µ;9+),*4 %$7'/)*4, $%.7µ/+% '*=%-'8 µ" ,% IQ tests. V+% ,*0 $%.-#%µA* %(,/3 ,/( $./-:=8µ%,/4 (+/1",81*#%0 '+%'+#%)&"4 :%1µ/=79*)*4$/( $./)$%1/30 0% '*µ+/(.98)/(0 )6),;4 "$+=/9;4µ",%53 $/==20 "0%==%#,+#20.

H+ $+/ '+%#"#.+µ;0"4 #=&µ%#"4 µ;,.*)*4 %(,84,*4 $./);99+)*4 ,*4 D.T. "&0%+ ,/ Multifactor Emotionaland Intelligence Scale (MEIS, Mayer, Caruso, Salovey,1999)#%+ ,/ Mayer-Salovey-Caruso Emotion andIntelligence Test CMSCEIT; Mayer , Salovey, Caruso2002). H+ $+/ >.*)+µ/$/+/3µ"0"4 #=&µ%#"4 µ;,.*)*4,*4 D.T 64 >%.%#,*.+),+#7 ,*4 $./)6$+#7,*,%4 "&0%+:Emotional Quotient Inventory EQ-i(Bar-On,1997),Emotional Competence Inventory ECI (Boyatzis,Goleman, Hay/McBer,1999), Trait Emotional IntelligenceQuestionnaire TEIQue (Petrides&Furnham,2003).

$,D/@A:6 @6. #.O.I.7)?%,"4 0"(./)(µ$".+?/.+#;4 ;."(0"4 %$/'"+-#03/(0 7,+ * D.T µ$/."& 0% %0%$,(>1"& µ;)% %$7 $%.%-#&0*)*, -)#*)* #%+ %0%,./?/'7,*)*. H Goleman ($/-

%&H'#2: F% µ%*$;(% !"*.+10)µ.$+,'2 G%)µ%1-*)2 $%" D. Goleman (Daniel Goleman, 1998)

BH>!KBLDM LD?G>FMF?

?"$#/9=*51) ?"$%4-0µ+1) D9*)$4. !"µ/#4+A%482

! !*3(78-' /87 -27%5-='µ#/87 ! 92/,<".(?,4 ! C#-' *+,4 .*3/.2@' ! 92/,%@5,"F('-' ! 9@5,*5-/3% ! B<-µ.2-'! 92/,*.*,3='-' ! !2-27.5$'-3% ! &+8/,O,2"3%

! &+,-%+µ,-/50F/'/% ! 95-5,$,@3%! 6%57,/,µ3%

D>LGKGLDM LD?G>FMF?

3*1"*.910)1) D%+*5*+,;2 E#I+C$)$#2

! 6%/%7F'-' /87 #""87 ! !*5++,)! &+,-%7%/,"5-µF4 -/'7 *%+,?) 2*'+.-5A7 ! !*50,57873%! !73-?2-' /'4 %7#*/2@'4 /87 #""87 ! R(.-3%! &,"5/50) 97/3"'S' ! !*3"2-' /87 -2(0+,:-.87

! 6%""5<+(.5% $.-µA7! >27.+(%-3%! Lµ%$50<4 50%7F/'/.4

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 48

Page 50: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [49]

!"!#"$%&'(")* '+',)$-*,*

!"#$%&'( )"( *(+ ,+ +-./!'( 0123(34 "# 5.6. 2$72'( ,+8(+0)9'( 2+:(74 !-µ2'$(;3$74 0+( ,+ 8#µ(3-$*/!'(,7'4 +2):-"+ '.+"3µ(0'-µ7,'4 «5.6.» 8', µ23$'% ,+-21$.'( <=$%4 "# >+?(1 '2(?-µ%+ 0+( "# !-,'(8#"/2$3!21?'(+ "3- +")µ3- (Goleman,1998).

!.". #$% &'(% )(*+#,+-@ >+?µ)4 !"3, 323%3 # 5.6. !-µ>1::'( !"#, 2$3!=-2(0/ 0+( '2+**':µ+"(0/ '2("-<%+ 2+$+µ7,'( 1*,=-!"34. A%,+( )µ=4 +,+µ;%>3:# # !-µ>3:/ "#4 !"#, '2(-"-<%+ '%"' )"+, +-"/ 3$%&'"+( =4 (0+,)"#"+ "3- +")µ3-*(+ +-"'2%*,=!#, +-"30-$(+$<%+, +-"37:'*<3, '-!--,'(8#!%+ 0+( 8-,+")"#"+ ,+ µ2+%,'( !"# ?7!# "=,1::=,, ,+ "3-4 0+"+,3'%, ,+ "3-4 +!0'% '2($$3/, ,+'2(03(,=,'% 0+( ,+ !-,'$*1&'"+( )2=4 2+$3-!(1!"#-0' +2) "3, Daniel Goleman ,'%"' )"+, 3$%&'"+( =4 #(0+,)"#"+ +,"%:#9#4, +.(3:)*#!#4, 70;$+!#4 0+( 8(+-<'%$(!#4 "=, !-,+(!?#µ1"=, )2=4 2+$3-!(1!"#0'+2) "3-4 Mayer 0+( Salovey

B-") !-µ>+%,'( *(+"% "+ !-,+(!?#µ+"(01 ,3/µ3,+1"3µ+ 0+"+;7$,3-, ,+ µ'"+8%83-, 0+:C"'$+ "(4 (87-'4 0+( "3-4 !")<3-4 "3-4 µ' "$)23 23- 8', '2(87<'-"+( +µ;(!>#"/!'(4, 01,3,"+4 "3-4 1::3-4 ,+ +(!?1-,3,"+( 0+"1::#:3( !"3 '$*+!(+0) "3-4 2'$(>1::3,(Goleman,1998), 0+?D4 0+( *(+"% # 5.6. !<'"%&'"+( µ'"(4 03(,=,(074 (0+,)"#"'4 23- +2+("3C,"+( *(+ !-,'$-*+!%+ 0+( '23µ7,=4 +) '%,+( <$/!(µ# *(+ "# 8#µ(3-$-*%+ 3µ+:1 !-,'$*+&)µ',=, 3µ18=,, >)3( #*7"'4 µ'5.6. !' !-,'$*+!%+ µ' "3 '$*+"(0) 8-,+µ(0) µ23$3C,,+ '2(8$1!3-, !"(4 !<7!'(4 "=, +")µ=, 0+( ,+ !-µ->1::3-, !"#, +C.#!# "#4 +"3µ(0/4 0+( 3µ+8(0/4 !-,+(-!?#µ+"(0/4 ,3#µ3!C,#4 0+( !"#, 3$*+,=!(+0/ 87!µ'--!# (Cherniss, 2001)

!.". .+/ 0%#12)3$/.4 5/%,.1#1E 2+$3-!%+ "#4 5.6. !"3-4 '2+**':µ+"%'4 ,3!#:'--"74 (8(+%"'$+ µ'"1 "#, µ'"+>3:/ "3- !-!"/µ+"34 2+$3-</4 ;$3,"%8+4 2$34 µ(+ 3:(!"(0/ ?'D$#!# "3- +!?'-,3C4 '%,+( +2+$+%"#"#. 5"$+"#*(074 )2=4 # !-,'$*+!%+,# +,3(<"/ '2(03(,=,%+ ,3!#:'-"/ – +!?',/ , # +,+-*,D$(!# "=, 8(0D, "3- !-,+(!?#µ1"=, , "=, !-,+87:-;=,, "=, +!?',D,, # 8(+<'%$(!# "=, !-,+(!?#µ1"=,")!3 '!="'$(01 )!3 0+( µ7!+ !"(4 !<7!'(4 "3- (,3!#-:'-"/ – 2$3F!"1µ',3, ,3!#:'-"/ – ,3!#:'-"/ – ,3!#-:'-"/- ,3!#:'-"/ – *(+"$), ,3!#:'-"/ – +!?',/ / 0+(3(03*7,'(+), +23"':3C, !#µ+,"(01 !"3(<'%+ "#4 ,7+4,3!#:'-"(0/4 2$+*µ+"(0)"#"+4.

G8(+%"'$+ 3 $):34 "3- ,3!#:'-"/ – #*7"# '%,+( 0$%-!(µ34 !"# 8#µ(3-$*%+ ?'"(03C 0+( -23!"#$(0"(03C2'$(>1::3,"34 D!"' ,+ >3#?/!'( "3-4 ,3!#:'-"74 ,++,"(µ'"=2%!3-, "3 !"$'4 "=, 8(0D, "3-4 !-,+(!?#-µ1"=, 0+( "=, +!?',D, / "=, !-,+87:;=, "3-4 .HI+-") "3, "$)23 +-.1,'"+( # (0+,323%#!# ")!3 "=,+!?',D, )!3 0+( "=, ,3!#:'-"D,.

A%,+( !#µ+,"(0) 3( ,3!#:'-"74 – #*7"'4 ,+ 8#µ(-3-$*3C, 0:%µ+ (0+,323%#!#4 "3- 2$3!=2(03C 0+( "=,

+!?',D,, ,+ ',(!<C3-, "# !-,+8':;(0/ +::#:'**C#,,+ ':+<(!"323(3C, "(4 !-*0$3C!'(4 µ'"+.C "=, 3µ1-8+4 D!"' +-"/ ,+ '%,+( +23"':'!µ+"(0/ 0+( ,+ +23-;'C*'( "#, '2+**':µ+"(0/ '.3-?7,=!# (burnout).B-"1 )µ=4 !#µ+%,3-, )"( 3( #*7"'4 !"3<'C3-, !' 7,+-9#:) '2%2'83 !-,+(!?#µ+"(0/4 ,3#µ3!C,#4 D!"',+ +,+*,=$%&3-, 0+( ,+ <$#!(µ323(3C, "# !-,+(!?#-µ+"(0/ 2:#$3;3$%+ !"(4 03(,=,(074 !<7!'(4 "3-4 µ'"3 2$3!=2(0) 0+( "3-4 +!?','%4.

@( ,3!#:'-"74 #*7"'4 µ' 5.6. 0+"+,33C, "+ !-,+(-!?/µ+"+ 0+( '2#$'1&3-, "+ !-,+(!?/µ+"+ "=, 1::=,.B, "3 !-,+%!?#µ+ "3- +,?$D2(,3- 8-,+µ(03C 38#*'%-"+( 2$34 "3 ;1!µ+ "3- ',?3-!(+!µ3C, ")"' # +2383-"(0)"#"+ +-.1,'"+(, ',D +,"%?'"+ +, "+ !-,+(!?/µ+-"+ 38#*3C,"+( 2$34 "3 1*<34 / "#, +23*3/"'-!# ")"'2$30+:'%"+( +23!-,"3,(!µ)4 0+( 8-!+$µ3,%+ -23!01-2"3,"+4 "+ !-,+(!?#µ+"(01 ?'µ7:(+ 23- '2("$723-,!"3-4 +,?$D23-4 ,+ 2$338'C!3-,.

5Cµ;=,+ µ' "3, Ryback (Ryback, 1998) 3 !-,+(-!?#µ+"(01 ,3/µ=, #*7"#4 '08#:D,'( 870+ >+!(074!-µ2'$(;3$74:11.. J', 0$+"1 '2(0$("(0/ !"1!# !"3-4 -;(!"+µ7,3-4

"3-22.. J(+?7"'( 0+"+,)#!# *(+ "+ !-,+(!?/µ+"+ "=, 1::=,33.. A%,+( '(:(0$(,/4 *(+ "(4 2$3?7!'(4 "3-44.. B,+:+µ>1,'( "(4 '-?C,'4 "3-55.. J%,'( !#µ+!%+ !"# :'2"3µ7$'(+66.. A%,+( '0;$+!"(0)4 77.. A%,+( -23!"#$(0"(0)488.. A%,+( +23;+!(!"(0)4 0+( '2(:C'( !-*0$3C!'(499.. J(+?7"'( &/:31100.. A<'( +-"32'23%?#!# 0+( +;/,'( "3-4 *C$= "3- ,+

+,+8'%.3-, "(4 (0+,)"#"74 "3-4

@ Goleman !' 1$?$3 "3- (2000) 01,'( :)*3 *(+ 7.( 8(+-;3$'"(03C4 "C23-4 (!"-:) #*'!%+4 23- !-,873,"+( 1µ'-!+ µ' "(4 8(+!"1!'(4 "#4 !-,+(!?#µ+"(0/4 ,3#µ3!C-,#4. @( "C23( +-"3% '%,+(: 3 0+"+2('!"(0)4 (coercive),3 3$+µ+"(!"/4 (visionary), 3 +,?$=2(!"(0)4 (affiliative),3 8#µ30$+"(0)4 (democratic), 3 0+?38#*#"(0)4(pacesetting) 0+( 3 !-µ>3-:'-"(0)4 (coaching). @(2$+*µ+"(01 '2("-<#µ7,3( 0+( +23"':'!µ+"(03% #*7"'48', <$#!(µ323(3C, µ),3 7,+ "C23 #*'!%+4 ,+::1 ',+:-:1!!3-, !"-: +,1:3*+ µ' "(4 +,1*0'4 "#4 '$*+!%+4.

@( !-,+(!?#µ+"(01 ,3/µ3,'4 ,3!#:'-"74 #*7"'4'µ2,73-, !"3-4 1::3-4 ',?3-!(+!µ) *(+ 7,+ )$+µ+0+( µ(+ 03(,/ +23!"3:/, 2+%$,3-, 2$="3>3-:%+ 0+(8$3-, =4 #*7"'4 +,'.1$"#"+ +2) "# ?7!# "3-4, >3#-?3C, "3-4 1::3-4 ,+ 7<3-, 0+:/ '2%83!#.

H' 8'83µ7,# "# <+3"(0/ ;C!# "3- !-!"/µ+"34-*'%+4 3( #*7"'4 ,3!#:'-"74 23- 7<3-, +-"74 "(4 (0+-,)"#"'4 µ23$3C, ,+ +23"':7!3-, 23:C"(µ# 2#*/ *(+"3-4 3$*+,(!µ3C4 -*'%+4.

K!")!3, +.()2(!"'4 0+( 7*0-$'4 7$'-,'4 *C$= +2)"# 5.6. !"3 <D$3 "#4 -*'%+4 !"+ 2:+%!(+ "#4 '::#,(-0/4 '2(0$1"'(+4 2$72'( +0)µ# ,+ 2$+*µ+"323(#?3C,.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 49

Page 51: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[50] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")* '+',)$-*,*

6/72/%*(+8,+1. Bar-On,(2006). The Bar-On model of emotional- social intelligence(ESI).

Psicothema,18, supl.,13-25.2. Bradberry T., Greaves(2006).!"#$%&'(µ$)%*+ ,-(µ-&.#(, /'+#$,01%)%*+.

3. Cadman C. & BrewerJ. (2001): a vital prerequisite for recruitmentin nursing. Journal of Nursing Management 9(6), 321-324.

4. Cherniss C,(2001). Emotional Intelligence: What it is and why itmatters(online from

5. http://www.eiconsortium.org/research/what is emotionalintelligence.htm

6. Cherniss C,(2002) Emotional Intelligence and the good community.American Journal of Community Psychology 30(1), 1-11.

7. Gardner H.,(1983).Frames of mind: The theory of multipleintelligence.NY:Basic Books.

8. Goleman D.(1998). Working with emotional intelligence. London:Bloomsbury.

9. Goleman D.(1998). What makes a leader? Harvard Business

Review, November-December ,93-102 .10. Kerfoot K(1996). The emotional side of leadership:t he nurse

manager’s challenge. Nurs. Economics, 14(1) :59-6211. Mayer J., Salovey P. (1997). What is emotional intelligence? In

P. Salovey & D. Sluyter, eds Emotional Development and EmotionalIntelligence :Educational Implications. New York :Basic Books;1-31

12. Palfai, Salovey (1993). The influence of depressed and elatedmood on deductive and inductive reasoning. Imagination, Cognitionand Personality.

13. Petrides K., Furnham A. (2001) Trait Emotional Intelligence:psychometric investigation with reference to established traittaxonomies. European Journal of Personality, 15, 425-448.

14. Ryback D. (1998). Putting emotional intelligence to work.Successful leadership is more than IQ. Butterworth-Heinemann.

15. Wechsler D. (1958) T HE MEASUREMENT AND APPRAISAL OFADULT INELLIGENCE. Baltimore, MD: Williams and Wilkins.

ABSTRACT

RREEVVIIEEWWEEMMOOTTIIOONNAALL IINNTTEELLLLIIGGEENNCCEE:: TTHHEEOORRYY AANNDD TTHHEE IIMMPPLLIICCAATTIIOONNSS IINN TTHHEE NNUURRSSIINNGG LLEEAADDEERRSSHHIIPPZZooii VVoorrrrii RRNN,, BBSScc,, MMSScc MMeennttaall HHeeaalltthh

BBaacckkggrroouunndd:: Emotional intelligence is popular in literature as an important characteristic for successful leaders.Health care is changing rapidly and leaders should use modern models of leadership focused on creating relationshipsbased on trust. Nurse leaders who exhibit characteristics of emotional intelligence enhance staff organizationalskills and effectiveness of their work.AAiimm:: This paper aims to present an analysis of the literature on Emotional Intelligence and explore the implicationsof it for the nursing leadership.MMeetthhoodd:: A literature search was undertaken using international databases (MEDLINE, PUBMED) covering the period1998 to 2008. A hand-search of relevant journals added to the data.CCoonncclluussiioonnss:: Emotionally intelligent nurse leaders who are self-aware, supervisory skillful, capable of address theemotional side of their staff can develop strong synergized teams, necessary for the survival during this changinghealthcare landscape.

KKeeyy wwoorrddss:: Emotional intelligence, nursing administration, competence, leadership

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 50

Page 52: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [51]

@ $):34 "=, '2+**':µ+"(D, -*'%+4 0+( # >':"%=!# "#4 23()"#"+4 -2#$'!(D,

!"+ ,3!303µ'%+

JJ$$.. LL((11,,,,##44 HH11$$0033>>((""4411,, 5533;;%%++ HH33,,++!!""##$$%%8833--22

1. Ph.D. Aston Business School, Aston University, Birmingham, UK – A02+(8'-"/4 !"3 A?,(0) M7,"$3J#µ)!(+4 J(3%0#!#4 0+( B-"38(3%0#!#4, 2. 63!#:'C"$(+, L.6.N. «@ O*(34 J#µ/"$(34»

9:;I<=>=

E 23()"#"+ !"(4 2+$'<)µ','4 -2#$'!%'4 -*'%+4 '%,+( !#µ+,"(0/ *(+ "#, 2+$3</ ;$3,"%8+4 -*'%+4 !"3-4+!?','%4. P+ >+!(01 !"3(<'%+ "#4 !<'"%&3,"+( µ' "3 +,?$D2(,3 8-,+µ(0), "#, 3$*1,=!# 0+( "(4 8(+8(0+!%'40+( "+ +23"':7!µ+"+ µ' "(4 2+$'<)µ','4 -2#$'!%'4. @( µ7?383( 23- -21$<3-, *(+ "# >':"%=!# "#4 23()"#-"+4 7<3-, ,+ 01,3-, µ' "# J(3%0#!# @:(0/4 Q3()"#"+4, "+ !-!"/µ+"+ 8(+!;1:(!#4 23()"#"+4 0+( "(4 23!3-"(074 µ'"$/!'(4 23- +;3$3C, !"#, 23()"#"+ 0+( "#, !<7!# 0)!"3-4-=;7:'(+4. @ $):34 "3- +,?$D2(,3-2+$1*3,"+ !"# >':"%=!# "#4 23()"#"+4 µ7!+ +2) "#, ';+$µ3*/ "3- ?'=$#"(03C -238'%*µ+"34 "3- Donabedian'%,+( 3-!(+!"(0)4, 0+?D4 'µ2:70'"+( 0+( !"(4 "$'(4 2+$+µ7"$3-4 23- +;3$3C, !"#, 23()"#"+ -2#$'!(D,-*'%+4. P7:34, )!3, +;3$1 !"#, -:323%#!# 2$3*$+µµ1"=, >':"%=!#4 "#4 23()"#"+4 !"3 <D$3 "=, ,3!303-µ'%=,, !"3 '.="'$(0) 0+( !"#, A::18+, )23- 2+$+"#$/?#0' )"( !"#, <D$+ µ+4 -21$<'( 0+?-!"7$#!# !"#,';+$µ3*/ "3-4 0+( +23-!%+ 3$*+,=µ7,#4 0+( !-!"#µ+"(0/4 ',+!<):#!#4 µ' "# 8(+!;1:(!# "#4 23()"#"+40+( "#, -:323%#!# +,"%!"3(<=, 2$3*$+µµ1"=,.

RR77..''((44 00::''((88((11:: 23()"#"+ -2#$'!(D,, '2+**':µ+"%+4 -*'%+4, Donabedian, J(3%0#!# @:(0/4 Q3()"#"+4, 8(+-!;1:(!# 23()"#"+4

!"!#"$%&'(")* '+',)$-*,*

:/#+*?*4E -*'%+ '%,+( 7,+ 03(,=,(0) +*+?) 23- 2$72'( ,+ 2+$7-<'"+( ")!3 0+?3:(01 !"3 03(,=,(0) !C,3:3, )!3 0+(µ' "#, 2$3!/03-!+ 23()"#"+ 7"!( D!"' "+ +23"':7-!µ+"1 "#4 ,+ '%,+( "+ '2(?-µ#"1 0+( +,+*0+%+ *(+ "3-423:%"'4. E 23()"#"+, *',(01 !"#, 2+$+*=*/ +*+?D,0+( 2+$3</ -2#$'!(D,, 3$%&'"+( =4 µ(+ 8-,+µ(0/ 0+"1-!"+!# # 323%+ !-,87'"+( µ' "+ 2$3F),"+, "(4 -2#$'-!%'4, "3-4 +,?$D23-4, "(4 8(+8(0+!%'4 0+( "3 2'$(->1::3, 0+( # 323%+ +,"+230$%,'"+( / .'2'$,1 "(42$3!830%'4 "3- 2':1"# (Q+2+,(03:13-, 2007).

S!3, +;3$1 !"#, 23()"#"+ "=, -2#$'!(D, -*'%+4,3 Donabedian (1980) "#, )$(!' =4 '0'%,3 "3 '%834;$3,"%8+4, "3 323%3 +,+µ7,'"+( ,+ µ'*(!"323(/!'( "#,0+:/ -*'%+ 0+( '-'.%+ "3- +!?',/, :+µ>+,3µ7,=, -2)-9# "=, =;':'(D, 0+( "=, +2=:'(D, 23- 'µ2'$(7<'(# 8(+8(0+!%+ 2'$%?+:9#4, !' ):+ "+ '2(µ7$3-4 "#4!#µ'%+. @-!(+!"(01, µ7!+ +2) "3, 2+$+21,= 3$(!µ),

3$(3?'"'%"+( # 23()"#"+ !"(4 -2#$'!%'4 -*'%+4 µ7!++2) "$'(4 2+$+µ7"$3-4: "3 "'<,(0) µ7$34 23- 7<'( ,+01,'( µ' "(4 -2383µ74 0+( "+ µ7!+ 23- +2+("3C,"+(*(+ "#, 2+$3</ -*'%+4, "3 8(+2$3!=2(0) µ7$34 23-+;3$1 !"(4 *,D!'(4, '(8(0)"#"'4 0+( (0+,)"#"'4 "3-+,?$D2(,3- 8-,+µ(03C "3- <D$3- "#4 -*'%+4, 0+( #"$%"# 2+$1µ'"$34, 7<'( ,+ 01,'( µ' "#, .',383<'(+0/-2383µ/ 0+( "(4 !-,+;'%4 2+$3<74 2$34 "3-4 +!?'-,'%4 0+"1 "# 8(1$0'(+ "#4 ,3!#:'%+4 "3-4.

A2%!#4, 3 Maxwell (1984) 2$3!8(3$%&'( "#, 23()-"#"+ !"#, -*'%+, µ' >1!# "(4 2+$+µ7"$3-4: 2$)!>+!#– 2$3!2':+!(µ)"#"+, 8#:+8/, "# 8-,+")"#"+ "=, <$#-!"D, -2#$'!(D, -*'%+4 ,+ 7<3-, 2$)!>+!# !"# ;$3-,"%8+ -*'%+4 !"3 !=!") <$),3 0+( ")23 !Cµ;=,+ µ'"(4 +,1*0'4 "3-4, (!)"#"+, +23"':'!µ+"(0)"#"+, +23-83</ 0+( 0+"+::#:)"#"+. 5"# !-,7<'(+, 2$3!"7?#0+,+2) "3, @$*+,(!µ) @(03,3µ(0/ 5-,'$*+!%+4 0+( B,1-2"-.#4 3( 7,,3('4 "#4 ;$3,"%8+4 0+( "#4 +!;1:'(+4.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 51

Page 53: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[52] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")* '+',)$-*,*

5"+ '2)µ',+ 0';1:+(+, +,+:C'"+( # 7,,3(+ "#4 23(-)"#"+4 "=, -2#$'!(D, !"3, -*'(3,3µ(0) "3µ7+, 3( "$)-23( 0+( 3( 2$+0"(074 *(+ "# >':"%=!# "#4 23()"#"+4"#4 -*'%+4, 3 $):34 0+( # !-,'(!;3$1 "=, '$*+&3µ7-,=, !' +-"/ "# >':"%=!# 0+( "7:34, 2+$3-!(1&3,"+(2+$+8'%*µ+"+ +2) "#, ';+$µ3*/ 2$3*$+µµ1"=, >':-"%=!#4 "#4 23()"#"+4 !"3 <D$3 "#4 -*'%+4 0+( !' ,3!#-:'-"(01 (8$Cµ+"+.

= @%/A$1$+ #$/- 3@1()#,)- 3*),+-E 23()"#"+ -2#$'!(D, (service quality) '%,+( # µ3$;/0+( "3 '%834 "#4 -2#$'!%+4 23- 2$3!;7$'"+( !' 7,+,+!?',/ 0+( # +,"%:#9# 23- 7<'( 3 +!?',/4 *(’ +-"/ "#,-2#$'!%+. B-"/ µ23$'% ,+ ?'=$#?'% =4 # «*',(0/ +.(3-:)*#!# "#4 "':'()"#"+4 / "#4 +,="'$)"#"+4 µ(+4 3,")-"#"+4, 0+( )"( +-"/ # 0$%!# / +.(3:)*#!# '%,+( 2+$)-µ3(+ µ' "#, !"1!# 0+( !<'"%&'"+( µ', +::1 8', '%,+((!38C,+µ#, "#, (0+,323%#!# [H23$3Cµ'] ,+ 83Cµ' "#,23()"#"+ -2#$'!(D, )2=4 "#, :+µ>1,3-, 3( 2':1"'4+2) µ(+ !-,+::+*/» (Dedeke, 2003: 277-8) 0+( !"#,2$30'(µ7,# 2'$%2"=!# # 23()"#"+ -2#$'!(D, '%,+( +-"/23- :+µ>1,3-, 3( +!?','%4 )"+, ,3!#:'C3,"+( !' 7,+,3!303µ'%3. B-"/ # 23()"#"+ -2#$'!(D, 7<'( 8(1;3$'48(+!"1!'(4 0+( >1!# +-"D,, +,+2"C!!3,"+( "+ !<'"(01µ'?383:3*(01 '$*+:'%+. P3 !#µ+,"(0)"'$3 0+( '-$7=4<$#!(µ323(3Cµ',3 '%,+( "3 '$="#µ+"3:)*(3 SERVQUAL.@( 8(+!"1!'(4 "#4 23()"#"+4 -2#$'!(D, 23- µ'"$1'('%,+( 3( +0):3-?'4 (Parasuraman, et al., 1986 & 1988):BB..((3322((!!""%%++ ((RReelliiaabbiilliittyy)):: # 8-,+")"#"+ "3- ,3!303µ'%-3- ,+ '02:#$D!'( "(4 -23!<7!'(4 "3- 0+( ,+ 2+$7<'("#, -2#$'!%+ µ' +0$%>'(+ 0+( !3>+$)"#"+ !' ):3-4"3-4 +!?','%4. BB,,""++22))00$$((!!## ((RReessppoonnssiivveenneessss)):: # 2$3?-µ%+ "3- ,3!3-03µ'%3- 0+( "3- 2$3!=2(03C ,+ >3#?/!'( "3-4 +!?','%4!' ):+ "+ ?7µ+"+ 0+( ,+ 2+$7<'( 1µ'!+ "#, -2#$'!%+.JJ((++!!;;11::((!!## ((AAssssuurraannccee)):: # *,D!# 0+( # "'<,(0/ '.'(-8%0'-!# "3- 2$3!=2(03C 0+( 3( 8-,+")"#"74 "3- ,+µ'"+>(>1!3-, 0+( ,+ 2$3>1::3-, 'µ2(!"3!C,#, +.(3-2(!"%+ 0+( +!;1:'(+ !"3-4 +!?','%4.AA,,!!--,,++%%!!??##µµ++ ((EEmmppaatthhyy)):: # 2+$3</ "#4 -2#$'!%+4µ' ;$3,"%8+, 0+"+,)#!# 0+( '.+"3µ(0'-µ7,# 2$3!3-</ !' ):3-4 "3-4 +!?','%4.BB22""11 <<++$$++00""##$$((!!""((0011 ((TTaannggiibblleess)):: # 'µ;1,(!# "=,'*0+"+!"1!'=,, # +.(32(!"%+ 0+( # 0+:/ 0+"1!"+!#"3- '.32:(!µ3C ):=, "=, -2#$'!(D,, # 'µ;1,(!#,2+$3-!%+ 0+( 0+?+$()"#"+ "3- 2$3!=2(03C, 3( !-,-?/0'4 0+( # :'("3-$*(0)"#"+ "#4 '2(03(,=,%+4 0+( "=,-:(0D, "#4 "'<,3:3*%+4. S!3, +;3$1 !"#, 23()"#"+ -2#$'!(D, -*'%+4 (healthcareservice quality), 3 Donabedian (R(+$)23-:34, 2007:242-3) -23!"/$(.' )"( -21$<3-, "$'(4 8(+!"1!'(4 !"#,2+$3</ "#4 ;$3,"%8+4: ! P3 "'<,(0) µ7$34 (technical, science of medicine):

+,+;7$'"+( !"#, ';+$µ3*/ "#4 '2(!"/µ#4 0+( "#4"'<,3:3*%+4 *(+ "#, 0+:C"'$# 8-,+"/ +,"(µ'"D2(!#"3- 2$3>:/µ+"34 -*'%+4 "3- +!?',/.

! P3 8(+2$3!=2(0) µ7$34 (interpersonal, art ofmedicine): +,+;7$'"+( !"#, +,?$D2(,#/9-<3:3*(-0/ 8(1!"+!# "#4 +,"(µ'"D2(!#4 "3- +!?',/ +2) "3,*(+"$) 0+( "3-4 1::3-4 '2+**':µ+"%'4 -*'%+4, "#!-µ2'$(;3$1 "3-4 +27,+,"% "3- # 323%+ -2+*3$'C-'"+( +2) "#, '2+**':µ+"(0/ "3-4 #?(0/ 0+( 8'3,"3-:3*%+ "+ /?# "#4 03(,=,%+4 0+( "(4 2$3!830%'4 "=,+!?',D,.

! E .',383<'(+0/ -2383µ/ (amenities): +,+;7$'"+(!"3 <D$3, "3 2'$(>1::3, 0+( "(4 !-,?/0'4 -2) "(4323%'4 2$3!;7$3,"+( 3( ;$3,"%8'4, "#, .',383<'(-+0/ -2383µ/ 0+( "(4 +,7!'(4.

5-*0$%,3,"+4 "(4 8C3 2+$+21,= +2)9'(4 *(+ "#, 23(-)"#"+ -2#$'!(D,, "#, 2$D"# 23- '%,+( *',(0/ 0+( "#8'C"'$# 23- '.'(8(0'C'"+( !"#, 2+$3</ -*'(3,3µ(-0/4 ;$3,"%8+4, 8(+2(!"D,'"+( )"( # .',383<'(+0/ -23-83µ/ "3- Donabedian +,"(!"3(<%&'"+( µ' "+ <'($32(+-!"1 "3- Parasuraman 0+( "=, !-,+87:;=, "3-. P38(+2$3!=2(0) µ7$34 7<'( ,+ 01,'( µ' "3 ',!-,+%!?#-µ+ 0+( µ' "#, +,"+2)0$(!#, ',D "3 "'<,(0) µ7$34 µ23-$'% ,+ +,"(!"3(<(!?'% µ' "#, +.(32(!"%+ 0+( "# 8(+!;1-:(!# 23- µ'"$1'( "3 SERVQUAL.

5-µ2'$+!µ+"(01, # -9#:/4 23()"#"+4 2'$%?+:9#!"3, -*'(3,3µ(0) "3µ7+ 0+( !-*0'0$(µ7,+ !' µ(+ ,3!3-03µ'(+0/ µ3,18+ 2$72'( ,+ 8(+?7"'( "+ './4 <+$+-0"#$(!"(01 (WHO, 1993): ! T9#:) '2%2'83 '2+**':µ+"(!µ3C +2) "3 2$3!=2(-

0) – (+"$(0), ,3!#:'-"(0) 0+( 2+$+F+"$(0). ! B23"':'!µ+"(0)"#"+ !"# <$/!# "=, 8(+?'!%µ=,

2)$=, *(+ "#, 0+:C"'$# 0+( 2'$(!!)"'$3 +.()2(!"#2+$3</ ;$3,"%8+4 -*'%+4.

! H'%=!# "=, 0(,8C,=, *(+ "3-4 +!?','%4 '%"' +-"74+;3$3C, !"#, -*'(3,3µ(0/ 2'$%?+:9#, '%"' !"(4 ',83-,3!303µ'(+074 :3(µD.'(4, '%"' !"(4 <'($3-$*(074'2'µ>1!'(4.

! G0+,323%#!# "3- +!?',/ +2) "#, 2+$'<)µ',# -*'%+,;$3,"%8+ -*'%+4 0+( 2'$%?+:9#4.

! P':(0/ ?'"(0/ '2%8$+!# !"3 '2%2'83 -*'%+4 "3- +!?'-,/ µ7!+ +2) "#, ';+$µ3*/ 3:30:#$=µ7,=, 2$3-*$+µµ1"=, ;$3,"%8+4 -*'%+4, +*=*/4 0+( 2$3+*=-*/4 -*'%+4.

B(A@%/ .+/ @(+.$/.C- 7)2$,?#1- $1- @%/A$1$+-5"#, 2+$3C!+ ',)"#"+ 2+$3-!(1&3,"+( 0123(3( +2)"3-4 "$)23-4 0+( 2$+0"(074 *(+ "# >':"%=!# "#4 23(-)"#"+4 !"3, -*'(3,3µ(0) "3µ7+. @( 2+$+01"= 2$+0"(-074 7<3-, ';+$µ3!?'% !' 8(1;3$3-4 0:183-4 ")!3"#4 µ'"+23%#!#4, )!3 0+( "3- "3µ7+ "=, -2#$'!(D,0+( 2$3!+$µ)&3,"+( +,1:3*+ µ' "3 2'8%3 ';+$µ3*/4,32)"' 8', '%,+( +230:'(!"(01 '(8(01 2$3*$1µµ+"+ *(+"#, -*'%+ 0+( "3, <D$3 "=, ,3!303µ'%=,. E J(3%0#!# @:(0/4 Q3()"#"+4 (Total Quality Management- TQM) !"3<'C'( ,+ '2("C<'( !' 7,+ 3$*+,(!µ) "+ 2+$+-01"=, µ7!+ +2) "#, µ'*(!"323%#!# "#4 +.%+4 "=, 2+$'-<3µ7,=, -*'(3,3µ(0D, -2#$'!(D,, )2=4 +-"74 *%,3-,"+( +,"(:#2"74 +2) "3-4 +!?','%4, :+µ>1,3,"+4 -2)9#

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 52

Page 54: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [53]

!"!#"$%&'(")* '+',)$-*,*

0+( '2(8(D03,"+4 "#, !-µµ'"3</ "=, '$*+&3µ7,=, "3--*'(3,3µ(03C ;3$7+ (B:'.(18#4 & 5(*1:+4, 1999: 78-81):! BC.#!# "#4 (0+,323%#!#4 "3- +!?',/! 5-,'</ >':"%=!# "#4 23()"#"+4 "=, 2+$'<3µ7,=,

-2#$'!(D,! J(+!;1:(!# µ'*1:#4 +23"':'!µ+"(0)"#"+4 "3- ,3!3-

03µ'%3- !' !<7!# µ' "3 0)!"34 :'("3-$*%+4! BC.#!# "#4 (0+,)"#"+4 "3- ,3!303µ'%3- *(+ 0+(,3-

"3µ%'4 0+( '-':(.%+! 5-µ2%'!# "3- <$),3- (0+,323%#!#4 +("#µ1"=, +!?'-

,D, 0+( 2'$%?+:9#4! U':"%=!# "#4 +.(323%#!#4 0+( +23"':'!µ+"(0)"#-

"+4 "3- +,?$D2(,3- 8-,+µ(03C "3- ,3!303µ'%3-! BC.#!# "3- >+?µ3C +.(323%#!#4 ,7+4 "'<,3:3*%+4,

8#:+8/, ,73- '.32:(!µ3C 0+( :3*(!µ(03C

5"3 2:+%!(3 ';+$µ3*/4 "#4 J(3%0#!#4 @:(0/4 Q3()-"#"+4 ';+$µ)&'"+( 0+( # µ'?383:3*%+ Six Sigma, 23-!"3<'C'( !"#, 23(3"(0/ >':"%=!# "=, 3$*+,(!µD,, ")!3!"#, 2+$+*=*(0/ 8(+8(0+!%+, )!3 0+( !"#, 2+$3</-2#$'!(D,. E !-*0'0$(µ7,# µ7?3834 !"3<'C'( !"#,µ'%=!# 7=4 0+( ':+<(!"323%#!# "=, ':+""=µ+"(0D,03µµ+"(D, / 2$3F),"=, 23- 2+$1*3,"+( +2) µ(+ 2+$+-*=*(0/ 8(+8(0+!%+ 0+( # !"+"(!"(0/ "3-4 +2)0:(!# 8',.'2'$,1'( "(4 7.( "-2(074 +230:%!'(4 (Six Sigma) +2)"#, µ7!# "(µ/ ':+""=µ+"(0D, "3- 8'%*µ+"34 23- µ'"$'%-"+(. E 2+$+21,= µ7?3834 '2'0"1?#0' 0+( !"#, 2+$3-</ -2#$'!(D,, µ'"$D,"+4 2$3>:#µ+"(074 8(+8(0+!%'4!"#, 2+$3</ µ(+4 8'83µ7,#4 -2#$'!%+4 !"3, 2':1"#(Jenicke, et al., 2008). B-") !#µ+%,'( )"( # ';+$µ3*/"#4 µ23$'% ,+ '%,+( ';(0"/ 0+( +23"':'!µ+"(0/ !' 7,+-*'(3,3µ(0) %8$-µ+, 0+?D4 7<'( 2$+0"(0)"#"+ 0+( +.(3-23('% "(4 *,D!'(4 "#4 !"+"(!"(0/4 01,3,"+4 µ'"$/!'(4!"(4 2+$'<)µ','4 -2#$'!%'4, 32)"' µ23$3C, ,+ 8(+-µ3$;=?3C, +,"(0'(µ',(01 0$("/$(+ 23- ?+ 38#*3C,!"#, ';+$µ3*/ 3:30:#$=µ7,=, :C!'=, !<'"(01 µ' "#8(+<'%$(!# "#4 23()"#"+4 -2#$'!(D, !"#, -*'%+.

B2) "#, 1::# 2:'-$1, # 8(+!;1:(!# 0+( 8(+<'%$(-!# 23()"#"+4 '%,+( "3 !C,3:3 "=, 2$3*$+µµ+"(!µ7,=,0+( !-!"#µ+"(0D, ','$*'(D, 0+( 8(+8(0+!(D, *(+ ,+'.+!;+:(!?'% )"( µ(+ -*'(3,3µ(0/ -2#$'!%+ 2:#$3%!-*0'0$(µ7,'4 2$38(+*$+;74 (B:'.(18#4 & 5(*1:+4,1999: 74). @( 30"D +$<74 *(+ "# 8(+<'%$(!# 23()"#"+4!Cµ;=,+ µ' "3 J('?,/ @$*+,(!µ) P-2323%#!#4 (ISO)– 2$3!+$µ3!µ7,'4 !"#, -*'%+ – '%,+( 3( +0):3-?'4:

A!"%+!# !"3, +!?',/: 2+$3</ -*'(3,3µ(0D, -2#-$'!(D, 23- !"3<'C3-, !"#, >':"%=!# "3- '2(2783--*'%+4 0+( !"#, 3:30:#$=µ7,# 2+$3</ ;$3,"%8+4-*'%+4 0+( 2'$%?+:9#4 !"3-4 +!?','%4.EE**''!!%%++:: 'µ;1,(!# !"$+"#*(0/4 0+( 3$+µ+"(0/4 #*'-!%+4 ")!3 !"3 '2%2'83 "3- ,3!303µ'%3-, )!3 0+( "=,0:(,(0D, *(+ "#, 2+$3</ >7:"(!"=, 0+( 3:30:#$=µ7-,=, -*'(3,3µ(0D, -2#$'!(D,. 55--µµµµ''""33<<// ""33-- 22$$33!!==22((0033CC:: 'µ2:30/ 0+( ',?1$$-,-!# "3- 2$3!=2(03C ,+ !-µµ'"7<'( !"(4 2$="3>3-:%'4

23- !"3<'C3-, !"#, 2+$3</ 23(3"(0D, -2#$'!(D,. JJ((''$$**++!!((++00// 22$$33!!77****((!!##:: !-,'$*+!%+ 0+( +::#:301-:-9# µ'"+.C "=, :'("3-$*(0D, "µ#µ1"=, "3- ,3!303-µ'%3-. 55--!!""##µµ((00// 22$$33!!77****((!!##:: +,"(µ'"D2(!# "=, :'("3-$-*(D, 0+( '$*+!(+0D, +,"(0'(µ7,=, =4 -23!-!"/µ+"+23- 'µ;+,%&3-, '.1$"#!# µ'"+.C "3-4 *(+ "#, +$µ3-,(0/ :'("3-$*%+ "3- !-,3:(03C !-!"/µ+"34 23- '%,+("3 ,3!303µ'%3. 55--,,''<<//44 >>''::""%%==!!##:: +.(3:3*/!'(4 "=, 2$="3>3-:(D,23()"#"+4 *(+ ,+ -21$<'( !-,'</4 >':"%=!# 0+( 8()$-?=!# "=, :+?D, 0+( 2$3>:#µ1"=, +2) "#, ';+$µ3-*/ "=, 23(3"(0D, 2$3*$+µµ1"=,. BB2233;;11!!''((44 >>++!!((!!µµ77,,''44 !!'' 88''8833µµ77,,++:: !-!"#µ+"(0/ 0+(3$?3:3*(0/ 0+"+*$+;/ µ'"$/!'=, 0+( 8'83µ7,=,,7"!( D!"' 3( +23;1!'(4 *(+ "(4 2$="3>3-:%'4 ,+ >+!%-&3,"+( !' µ'"$/!(µ+ 0+( +.(3:3*/!(µ+ µ'*7?#. 55<<77!!''((44 ++::::##::==;;77::''((++44 µµ'' ""33--44 22$$33µµ##??''--""7744:: +,1-2"-.# !<7!'=, 0+( 8'!µD, µ' "3-4 2$3µ#?'-"74 "3-,3!303µ'%3-, 7"!( D!"' ,+ -21$<'( +µ3(>+%3 );':34+2) "#, !-,'$*+!%+ 0+( "#, +,"+::+*/ "'<,3*,=!%+40+( 2:#$3;3$(D,.

P7:34, µ(+ µ7?3834 23- <$#!(µ323('%"+( *(+ "#,+23"%µ#!# "=, 2$3*$+µµ1"=, 8(+!;1:(!#4 0+( 8(+-<'%$(!#4 23()"#"+4 '%,+( # +,1:-!# 0)!"3-4 <$#!(-µ)"#"+4 (cost utility analysis), # 323%+ <$#!(µ323(-'%"+( *(+ "#, +.(3:)*#!# ',+::+0"(0D, 8(+8(0+!(D, /+23"':'!µ1"=, =4 2$34 µ(+ µ3,+8(0/ >1!# µ7"$#-!#4 "#4 «<$#!(µ)"#"+4». E 2'$(!!)"'$3 <$#!(µ323(-#µ7,# µ3,18+ µ7"$#!#4 '%,+( "+ Q3(3"(01 Q$3!+$µ3-!µ7,+ V"# W=/4 (Quality-Adjusted Life Years – QALYs).E µ7"$#!# 8(+;3$'"(0D, µ'"+.C "3-4 2$3*$+µµ1"=,µ23$'% ,+ *%,'( µ' "#, +23"%µ#!# "3- 3$(+03C 0)!"3-4+,1 QUALY (marginal cost per QUALY) 23- '.3(03-,3µ'%"+( !' 01?' 2$)*$+µµ+ (Robinson, 1993). Eµ7"$#!# µ' "#, <$/!# "=, QUALYs 7<'( 0+"#*3$#?'%*(+ 8(+0$%!'(4 !' >1$34 "=, #:(0(=µ7,=,, *(+ µ# !C,-,3µ'4 8(+2$3!=2(074 !-*0$%!'(4, *(+ -23"%µ#!# &#"#-µ1"=, #?(0/4 0+( *(+ "#, '(!+*=*/ 2$30+"+:/9'=,!"#, 0+"+µ7"$#!# "#4 23()"#"+4 &=/4. Q+$):+ +-"1,3 Robinson (1993) -23!"#$%&'( )"( # "'<,(0/ "#4 +,1-:-!#4 0)!"3-4 <$#!(µ)"#"+4 2+$+µ7,'( # 2'$(!!)-"'$3 '2(!"#µ3,(0/ '2(:3*/ *(+ "#, 3(03,3µ(0/ +.(3-:)*#!# "=, 2$3*$+µµ1"=, -*'(3,3µ(0/4 2'$%?+:9#4,# 323%+ )µ=4 2$72'( ,+ :+µ>1,'"+( -2)9# µ' 2$3-!3</ 0+( '2(;C:+.#. X+$+0"#$(!"(0) 2+$18'(*µ+ "#4<$#!(µ323%#!#4 "#4 +,1:-!#4 0)!"3-4 <$#!(µ)"#-"+4 0+( !-*0'0$(µ7,+ "=, QUALYs 7<3-µ' !"#, L'$-µ+,%+ µ' "#, 3(03,3µ(0/ +.(3:)*#!# "=, 2$3*$+µµ1-"=, µ'"+µ)!<'-!#4 ,';$3C (Greiner, et al., 2001).

= )@,5(+#1 $?0 )(*+D%µC0?0 #$% )@,@)5% @%/A$1$+- $?0 3@1()#/'05Cµ;=,+ µ' "3 -2)8'(*µ+ "3- Donabedian (1988) #23()"#"+ !"(4 2+$'<)µ','4 -2#$'!%'4 -*'%+4, '.+$-"1"+( +2) "(4 './4 2+$+µ7"$3-4.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 53

Page 55: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[54] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")* '+',)$-*,*

PP## 8833µµ// ((ssttrruuccttuurree)),, 8#:+8/, "+ 0"%$(+, "3, '.32:(-!µ), "+ -:(01 0+( "3-4 8(+?7!(µ3-4 <$#µ+"(03C42)$3-4, "3, +$(?µ) "=, '$*+&3µ7,=, !-,3:(01 0+(+,1 0+"#*3$%+, "#, 0+"1$"(!/ "3-4. "#, 3$*+,="(0/83µ/, 23- 2'$(:+µ>1,'( "3, "$)23 8(3%0#!#4, "3,0+"+µ'$(!µ) "=, 8$+!"#$(3"/"=, 0+( "# 8(+8(0+!%+'2(:3*/4 "3- 2$3!=2(03C. PP## 88((++88((00++!!%%++ ((pprroocceessss)),, 8#:+8/, ):'4 "(4 ',7$*'('423- 01,'( 3 +!?',/4 +,+&#"D,"+4 2'$%?+:9# 0+?D40+( "3, "$)23 µ' "3, 323%3 "3- 2+$7<'"+( +-"/ # 2'$%-?+:9#, "(4 ',7$*'('4 "3- (+"$3C, 3 323%34 ?+ <$#!(-µ323(/!'( "# µ%+ / "#, 1::# 8(+*,=!"(0/ 2$3!7**(-!#, ?+ 2$3"'%,'( 0123(+ +*=*/ / ?+ 2$+*µ+"323(/!'("# <'($3-$*(0/ '27µ>+!#, "# µ7!# 8(1$0'(+ ,3!#:'%-+4 0+( µ'"'*<'($#"(0/4 ,3!#:'%+4 0+( "# <$#!(µ323%-#!# +,"(>(3"(0D, -9#:3C 0)!"3-4. PP##,, 7700>>++!!## ((oouuttccoommee)),, 8#:+8/, "+ +23"':7!µ+"+, "#µ'"+>3:/ – "$7<3-!+ / µ'::3,"(0/ – !"3 '2%2'83 -*'%-+4 0+( '-'.%+4 "3- +!?',/ 0+( "#, 3;'(:)µ',# !"#,(+"$(0/ 2+$7µ>+!# / !' 1::# 2$3#*#?'%!+ -2#$'!%+;$3,"%8+4.

R+µ>1,3,"+4 -2)9# "(4 2+$+21,= 2+$+µ7"$3-4, #'2%8$+!# "=, '$*+&3µ7,=, !"# >':"%=!# "#4 23()"#-"+4 "#4 -*'%+4 µ23$'% ,+ 0+:C2"'( 0+( "(4 "$'(4. 5-*0'-0$(µ7,+, !"# 83µ/, # 3$*1,=!# 0+( 3 0+"+µ'$(!µ)4 "3-+,?$D2(,3- 8-,+µ(03C 0+( 3( 23:("(074 23- ';+$µ)-&3,"+( +2) "# 8(3%0#!#, 2.<., '02+%8'-!# 0+( 0+"1$"(-!#, 3$*+,=!(+074 8(+8(0+!%'4, 8(+8(0+!%'4 '2(:3*/42$3!=2(03C, 0.:2., µ23$3C, ,+ 7<3-, 1µ'!# !<7!# µ'"# >':"%=!# 0+( 8(+!;1:(!# "#4 23()"#"+4. E C2+$.#2(!"323(#µ7,=, 2$3*$+µµ1"=, 0+"1$"(!#4 0+( µ'?)-8=, 8(3%0#!#4 0+( '2(:3*/4, '%,+( !-!"+"(01 !"3(<'%+"=, µ7"$=, 0+( 0$("#$%=, *(+ "#, 2(!"323%#!# 0+"1 ISO9000. S!3, +;3$1 !"# 8(+8(0+!%+, # C2+$.# "-2323(-#µ7,=, (standardized) 8(+8(0+!(D, 0+( '*<'($(8%=,23- +;3$3C, ")!3 !"#, (+"$(0/ )!3 0+( !"# ,3!#:'--"(0/ '$*+!%+, '%,+( >+!(01 !"3(<'%+ 23(3"(0/4 >':"%=-!#4 0+( µ7"$#!#4 0+( +.(3:)*#!#4 2$3*$+µµ1"=, 8(+-!;1:(!#4 0+( 8(+<'%$(!#4 23()"#"+4. @C"=4 / 1::=4,7,+ !C!"#µ+ 8(+!;1:(!#4 23()"#"+4 2$72'( ,+ 2+$'µ->+%,'( !"#, 3$*+,="(0/ 83µ/, !"(4 8(+8(0+!%'4, !"(48('$*+!%'4 0+( !"+ µ7!+. @2)"' # 2+$7µ>+!# "3- +,?$D-2(,3- 2+$1*3,"+ '%,+( 0+?3$(!"(0/, 0+?D4 3 '$*+&)-µ',34 0+:'%"+( ,+ -:323(/!'( "(4 !<'8(+!µ7,'4 8(+8(-0+!%'4, !Cµ;=,+ µ' "+ 3$(&)µ',+ 2$)"-2+ 23()"#"+4.P7:34, !<'"(01 µ' "#, 70>+!#, 3( µ'"$/!'(4 +23"':'-!µ1"=, "=, 2+$'<)µ',=, -2#$'!(D, -*'%+4 0+( '2(-2783- -*'%+4 0+( '-'.%+4 "=, 23:("D,, µ23$'% ,+ +;3-$3C, 3$*+,(!µ3C4 0+( ?'!µ3C4 23- 0+:3C,"+( ,+8(+µ3$;D!3-, 2$)"-2+ *(+ !-*0$("(074 '2(8)!'(4(benchmarking) µ' !032) "# 8(+µ)$;=!# >7:"(!"=,2$+0"(0D, (best practices), +-"3% )µ=4 23- -:323(-3C, "+ 2$3*$1µµ+"+ 0+( "(4 2$="3>3-:%'4 *(+ "# >':-"%=!# "#4 23()"#"+4 '%,+( 3( '$*+&)µ',3(. A%,+( 0+%$(+# !-µ>3:/ "3-4, )<( µ),3 *(+"% '%,+( -23<$'=µ7,3( ,+'0"':7!3-, "(4 8(+"+*74 "#4 8(3%0#!#4 "3- ,3!303µ'%-

3-, +::1 0+( *(+"% 3;'%:'( # 8(3%0#!# ,+ "3-4 'µ2:7-.'( !"(4 8(3(0#"(074 8('$*+!%'4, &#"D,"+4 "#, !-µµ'-"3</ "3-4 0+( "3 µ3%$+!µ+ "=, =;':#µ1"=, (gainsharing)+2) "#, '2%"'-.# "=, 3$*+,=!(+0D, !")<=,.

9+(+5),*µ+$+ @(?$%7%32/'0 .+/ @(+.$/.'0 */+ $1 7)2$,?#1 $1- @%/A$1$+-5' A-$=2+F0/ 7$'-,+ !<'"(01 µ' "#, -:323%#!# 2$3-*$+µµ1"=, 0+( 2$="3>3-:(D, *(+ "# >':"%=!# "#423()"#"+4 (quality improvement) !"3, "3µ7+ 0+( ;3$'%4"#4 -*'%+4, 8(+2(!"D?#0' )"( "+ 2'$(!!)"'$3 +,+;'-$)µ',+ '2("'C*µ+"+ '%<+, ,+ 01,3-, µ' (Spencer &Walshe, 2009: 24):! P3, 0+?3$(!µ) '?,(0D, !-!"#µ1"=, 2(!"323%#!#4

0+( 8(+!;1:(!#4 "#4 23()"#"+4 (+,+;7$?#0+, !' 170$1"#-µ7:# "#4 A.A.).

! P3, 0+?3$(!µ) '?,(0/4 -2#$'!%+4 / ;3$7+ *(+ "#,23()"#"+ !"3, <D$3 "#4 -*'%+4 (13 0$1"#-µ7:# "#4A.A.).

! P#, '270"+!# "#4 8-,+")"#"+4 '2(:3*/4 "3- +!?'-,3C4, "=, 8(0+(=µ1"=, 0+( "#4 +!;1:'(14 "3- (130$1"#-µ7:#).

! P# >':"%=!# "#4 0+"1$"(!#4 0+( +.(3:)*#!#4 "=,'2+**':µ+"(D, -*'%+4 (12 0$1"#-µ7:#).

5"#, 67+ W#:+,8%+, 3( +!?','%4 ?'=$3C, )"( 3( 2+$1-*3,"'4 23- 8(+µ3$;D,3-, "#, +,"%:#9/ "3-4 *(+ "#,23()"#"+ -2#$'!(D, !"#, ;$3,"%8+ -*'%+4 '%,+( # +.(3-2(!"%+, "+ +2"1 <+$+0"#$(!"(01, # 8(+!;1:(!#, "3 ',!--,+%!?#µ+, "3 ;+*#"), # 2$)!>+!# !"3 !C!"#µ+ -*'%-+4, "+ +23"':7!µ+"+ +2) "#, 2+$3</ -*'(3,3µ(0D,-2#$'!(D,, # '%!3834 !"3 0+( 7.3834 ('(!("/$(+ 0+('.("/$(+) +2) "3 ,3!#:'-"(0) %8$-µ+ 0+( # +,"+2)-0$(!# "3- -*'(3,3µ(03C 2$3!=2(03C (Clemes, et al.,2001). @( 2+$+21,= 2+$1*3,"'4 +,"(!"3(<3C, µ' +-"7423- +,+;7$3,"+( !"3 µ'?383:3*(0) '$*+:'%3 SERVQUAL0+( µ' "#, '-$'%+ +,"(µ'"D2(!/ "3-4 0+"+*$1;3,"+(+2) "3, Donabedian.

5"#, A::18+ # ';+$µ3*/ 2$3*$+µµ1"=, >':"%=-!#4 "#4 23()"#"+4 8', '%,+( '2+$0D4 +,'2"-*µ7,#,+, 0+( 7<3-, *%,'( 2$3!21?'('4 *(+ 3$*+,=µ7,# -:3-23%#!# 2$+0"(0D,, '(8(01, µ7!+ +2) "(4 +2+("/!'(4<$#µ+"38)"#!#4 23- 3$%&'( "3 A.5.Q.B. A%,+( ',8'(-0"(0) )"( µ7<$( "+ "7:# "#4 8'0+'"%+4 "3- ’90 3( +,+-;3$74 *(+ C2+$.# "7"3(=, 2$3*$+µµ1"=, !"#, -*'%+/"+, 2'$(!"+!(+074 0+( !' 2$="3>3-:(+0) '2%2'83+2) "3-4 '2+**':µ+"%'4 -*'%+4 0+( )<( +2) "(4 8(3(-0/!'(4 "=, ,3!303µ'%=, / 0',"$(01 +2) "3 +$µ)8(3-23-$*'%3 (Theodorakioglou & Tsiotras, 2000). 5-*0'-0$(µ7,+, µ7<$( 0+( "(4 +$<74 "3- 213- +(D,+, !"#,A::18+ "3 91,7% "=, ,3!303µ'%=, 8/:=,' )"( 8','%<' ?7!'( "#, 23()"#"+ !"#, 2+$3</ -*'(3,3µ(0D,-2#$'!(D, =4 8(+0$(") 0+( µ'"$/!(µ3 !")<3 / =4<=$(!"1 <$#µ+"383"3Cµ',3 !032). A2%!#4, µ),3 "316,6% "=, 8(3(0/!'=, "=, ,3!303µ'%=, ';+$µ)&'('$*+:'%+ 8(+<'%$(!#4 "#4 23()"#"+4 0+( "3 41,7% +$0'%-

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 54

Page 56: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [55]

!"!#"$%&'(")* '+',)$-*,*

"+( µ),3 !' 'µ2'($(074 2$3!'**%!'(4 0+( µ'"$/!'(4(P3C,"+4, 203: 545).

5' 'µ2'($(0/ 23!3"(0/ 7$'-,+ 23- 7*(,' !' +!?'-,'%4 8#µ)!(3- ,3!303µ'%3-, 8(+2(!"D?#0' )"( "+ &#"/-µ+"+ 23- +;3$3C, !"#, (0+,)"#"+ 0+( '2(!"#µ3!C,#"=, *(+"$D,, !"#, -*('(,/ "=, <D$=, ,3!#:'%+4 "=,+!?',D, !' !-,1$"#!# µ' "3 <$),3 ,3!#:'%+4, !"#,µ3$;/ +!;1:(!#4 0+( !"#, !-µ2'$(;3$1 "3- ,3!#-:'-"(03C 2$3!=2(03C 0+?)$(!+, "#, C2+$.# "#4 23(-)"#"+4 !"3 8#µ)!(3 ,3!303µ'%3 0+( 70+,+, ,+ ,(D?3-,(0+,323(#µ7,3( 3( +!?','%4 (Lekidou, et al., 2007).S!3, +;3$1 !"+ Pµ/µ+"+ A2'(*),"=, Q'$(!"+"(0D,(PAQ) !"+ 8#µ)!(+ ,3!303µ'%+, 8(+2(!"D?#0' )"( 3(0+?3$(!"(03% 2+$1*3,"'4 *(+ "#, 23()"#"+ "=, 2+$'-<3µ7,=, -2#$'!(D,, 7"!( D!"' ,+ +(!?1,3,"+( (0+,3-23(#µ7,3( 3( +!?','%4 +2) "#, 2+$3</ ;$3,"%8+4 -*'%-+4 '%,+( # +.(32(!"%+, 8#:+8/, # !"+?'$)"#"+ "#4;$3,"%8+4, # !-,72'(+ "#4 '0"7:'!#4 0+( # 8(1$0'(+"=, 2+$'<3µ7,=, -2#$'!(D,, # +,"+2)0$(!# 0+( #'"3(µ)"#"+ "3- 2$3!=2(03C ,+ '.-2#$'"/!3-, "3,+!?',/, # (0+,)"#"+ "3- 2$3!=2(03C, # 2$3!>+!(µ)-"#"+ !"(4 -2#$'!%'4 -*'%+4, # '-*7,'(+, 0+"+,)#!# 0+('2(03(,=,%+ "=, '2+**':µ+"(D, -*'%+4 !' !-,1$"#!#µ' "3, '2+**':µ+"(!µ) "3-, "#, +!;1:'(+ 0+( "3 2'$(->1::3, !"3, <D$3 "#4 -*'%+4 (H+::(+$3C, 0.1., 2009).

P7:34, # ';+$µ3*/ µ'?)8=, >':"%=!#4 "#4 Q$="3->1?µ(+4 Y$3,"%8+4 T*'%+4 !"#, M$/"# "+ "':'-"+%+ <$)-,(+ '%<+, ,+ 01,3-, µ' "# 8#µ(3-$*%+ 0:(,(0D, 3µ18=,8(+<'%$(!#4 "#4 23()"#"+4 +2) 5-6 *(+"$3C4 !' ):+ "+07,"$+ -*'%+4 "3- ,#!(3C 0+( "#, 0+?(7$=!# 0+$"D,-*'%+4 *(+ 6.150 +!?','%4. P3 97,6% "=, +!?',D, /"+,(0+,323(#µ7,3( +2) "#, 2$3!=2(0/ ;$3,"%8+ 23- 78'(-.+, 3( *(+"$3% *(+ "3 (+"$(0) "3-4 2$)>:#µ+, "#, (+"$(-

0/ '.7"+!/ "3-4 0+( "#, 2:#$3;)$#!# 23- '%<+, *(+ "+!-µ2"Dµ+"+ 0+( "#, +!?7,'(+. B2) "#, 1::# 2:'-$1, "+2$3>:/µ+"+ !"#, -2383µ/ 0+( "+ "'<,(01 8(+*,=!"(01µ7!+ /"+, "+ >+!(01 'µ2)8(+ *(+ "#, 2+$3</ -2#$'-!(D, -*'%+4 !' -9#:/4 23()"#"+4 (Lionis, et al., 2004).

:@,2%*%-5"#, 2+$3C!+ '$*+!%+ +,+:C?#0' # 7,,3(+ "#4 23()"#-"+4, 8%,3,"+4 7µ;+!# !"#, 23()"#"+ !"(4 2+$'<)µ','4-2#$'!%'4 0+( (8(+%"'$+ !"(4 -2#$'!%'4 -*'%+4. H7!++2) "#, +,1:-!# 8(+2(!"D?#0+, )"( "+ >+!(01 !"3(<'%+"#4 7<3-, ,+ 01,3-, µ' "3 +,?$D2(,3 8-,+µ(0), "#,3$*1,=!# 0+( "(4 8(+8(0+!%'4 0+( "+ +23"':7!µ+"+ µ'"(4 2+$'<)µ','4 -2#$'!%'4 2$34 "3-4 +!?','%4. @(µ7?383( 23- -21$<3-, *(+ "# >':"%=!# "#4 23()"#"+4'%,+( +$0'"74, 7<3-, 0+"1 >1!# *',(0/ ';+$µ3*/ !'8(1;3$'4 2'$(2"D!'(4 2+$+*=*/4 +*+?D, / 2+$3</4-2#$'!(D,, 01,3,"+4 "#, 0+"1::#:# 2$3!+$µ3*/ !"#,'2(µ7$3-4 2'$%2"=!#. B-") !#µ+%,'( )"( J(3%0#!# @:(-0/4 Q3()"#"+4 / "+ !-!"/µ+"+ 8(+!;1:(!#4 23()"#"+4+03:3-?3C, 0123(3-4 *',(01 ';+$µ)!(µ3-4 0+,),'4,3( 323%3( 2$3!+$µ)&3,"+( 0+( 7<3-, '(8(0/ ';+$µ3*/!"3, <D$3 "#4 -*'%+4 0+( !-*0'0$(µ7,+ !' 7,+ ,3!#-:'-"(0) %8$-µ+. 5"3 2:+%!(3 +-"), +,+:C?#0' 3 $):34"3- +,?$D2(,3- 2+$1*3,"+ !"# >':"%=!# "#4 23()"#-"+4 µ7!+ +2) "#, ';+$µ3*/ "3- ?'=$#"(03C -238'%*-µ+"34 "3- Donabedian 0+( 2+$3-!(1!?#0+, 2+$+8'%*-µ+"+ +2) "#, -:323%#!# 2$3*$+µµ1"=, >':"%=!#4 "#423()"#"+4 !"3 <D$3 "=, ,3!303µ'%=,, !"3 '.="'$(0)0+( !"#, A::18+, )23- 2+$+"#$/?#0' # 0+?-!"7$#!#!"#, ';+$µ3*/ "3-4 0+( # +23-!%+ 3$*+,=µ7,#4 0+(!-!"#µ+"(0/4 ',+!<):#!#4 µ' "# 8(+!;1:(!# "#4 23(-)"#"+4 0+( "#, -:323%#!# +,"%!"3(<=, 2$3*$+µµ1"=,.

ABSTRACT

RREEVVIIEEWWTTHHEE RROOLLEE OOFF HHEEAALLTTHHCCAARREE PPRROOFFEESSSSIIOONNAALLSS AANNDD TTHHEE IIMMPPRROOVVEEMMEENNTT OOFF SSEERRVVIICCEE QQUUAALLIITTYY IINN HHOOSSPPIITTAALLSSDDrr.. YYaannnniiss MMaarrkkoovviittss11,, SSooffiiaa MMoonnaassttiirriiddoouu22

[[11.. PPhhDD..,, AAssttoonn BBuussiinneessss SScchhooooll,, AAssttoonn UUnniivveerrssiittyy,, BBiirrmmiinngghhaamm,, UUKK –– NNaattiioonnaall CCeennttrree ooff PPuubblliicc AAddmmiinniissttrraattiioonn aannddLLooccaall GGoovveerrnnmmeenntt,, TThheessssaalloonniikkii,, 22.. NNuurrssee,, AAggiiooss DDiimmiittrriiooss PPuubblliicc HHoossppiittaall,, TThheessssaalloonniikkii]]

The quality in the healthcare services is important for the provision of healthcare treatment for the patients. Its maindimensions relate to human resources, organization and procedures, and the outcomes from the services offeredto patients. The methods available for the improvement of quality levels have to do with Total Quality Management,systems for quality assurance and quantitative methods relevant to quality and the relationship between cost andbenefit. The role of the human factor for the improvement of quality through Donabedian’s conceptual framework issubstantial, since it is related to all three dimensions comprising healthcare services. Finally, as far as the implementationof quality improvement programmes in hospitals, in Greece and abroad, it has been found that Greece lacks behindother developed EU and OECD countries, due to the absence of organized and systematic activity on quality assuranceand development of relative quality programmes. KKeeyywwoorrddss:: service quality, health professionals, Donabedian, Total Quality Management, quality assurance

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 55

Page 57: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[56] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")* '+',)$-*,*

6/72/%*(+8,+1. /234%56(7, /.8., !%952$7, :. 1999. ;<(13&=37 "93=$7/,-&-*--

µ3=-: :6%-)"<=37 *$% <1-*2+&3%7, >?µ-7 8’: 8%-=*(&( "<(13&%@#"93=$7-#-&-*-µ3=A#, 3µ<3%1=37, )5&3%7 *$% <1--<)%*B7. C/D,D5)1$.

2. Clemes, M.D., Ozanne, L.K., Laurensen, W.L. 2001. Patients’perceptions of service quality dimensions: An empirical examinationof health care in New Zealand. Health Marketing Quarterly 19(1),3-22.

3. Dedeke, A. 2003. Service quality: Fulfilment-oriented andinteractions-centred approach. Managing Service Quality 13(4),276-289.

4. Donabedian, A. 1980. The definition of quality and approaches toits assessment. Health Administration Press, Anne Arbor, Michigan.

5. Donabedian, A. 1988. The quality of care. How can it be assessed?JAMA 260, 1743-1748.

6. Greiner, W., Obermann, K., Graf, J.M., Schulenburg, V.D. 2001.Socio-economic evaluation of kidney transplantation in Germany.Archives of Hellenic Medicine 18(2), 147-155.

7. Jenicke, L.O., Kumar, A., Holmes, M.C. 2008. A framework forapplying six sigma improvement methodology in an academicenvironment. The TQM Journal 20(5), 453-462.

8. Lekidou, I., Trivellas, P., Ipsilandis, P. 2007. Patients’ satisfactionand quality of care: An empirical study in a Greek public hospital.MIBES Transactions on line 1(1), 46-59.

9. E%$1?<-"2-7, E.E. 2007. F195#A&( "<(13&%@# *$% &"&)(µ5)A#"93=$7: /’ >?µ-7. C*6?&3%7 G+)$, /'+#$.

10. Lionis, C., Tsikaris, M., Bardis, V., Philalithis, A. 2004. Seeking

quality improvement in primary care in Crete, Greece: The firstactions. Croatian Medical Journal 45(5), 599-603.

11. H$22%$1-., H., !$15I(7, D., J"95, !. 2009. D-%?)()$ <$1-K+7I1-#)=6$7 &)- >µ+µ$ C<3%9?#)A#. >- G+µ$ )-" /&*2(<%-. 8(1),25-40.

12. Maxwell, R.J. 1984. Quality assessment in Health. British MedicalJournal 288, 470?1473.

13. D$<$#%*-25-" G. 2007. L <-%?)()$ &)%7 ;<(13&=37 ;93=$7. C*6?-&3%7 D$<$M+&(, /'+#$.

14. Parasuraman, A., Zeithaml, V.A., Berry, L.L. 1986. SERVQUAL:A scale for measuring service quality. Working Paper, MarketingScience Institute.

15. Parasuraman, A., Zeithaml, V.A., Berry, L.L. 1988. SERVQUAL:A multiple item scale for measuring consumer perceptions ofservice quality. Journal of Retailing 64(1), 12-40.

16. Robinson, R. 1993. Economic evaluation and health care: Cost-utility analysis. British Medical Journal 307, 859-862.

17. Spencer, E., Walshe, K. 2009. National quality improvementpolicies and strategies in European healthcare systems. Qualityand Safety in Health Care 18(Suppl I), i22-i27.

18. Theodorakioglou, Y.D., Tsiotras. G.D. 2000. The need for theintroduction of quality management into Greek health care.Total Quality Management and Business Excellence 11(8), 1153-1165.

19. >-.#)$7, N. 2003. L B##-%$ )(7 <-%?)()$7 &)(# :$)1%*+ *$% )%7 "<(-13&=37 "93=$7. /1K3=$ C22(#%*+7 :$)1%*+7 20(5), 532-546.

20. WHO 1993. Continuous quality development: a proposal nationalpolicy. WHO Regional Office for Europe, Copenhagen.

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 56

Page 58: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [57]

E !-&/"#!# =4 +23"':'!µ+"(0)4 "$)234 '2(03(,=,%+4 !"#, 0+?#µ'$(,/

,3!#:'-"(0/ 2$1.#

HH++$$,,77$$++44 XX$$//!!""334411,, BB$$>>++,,%%""##44 LL''DD$$**((334422

1. 63!#:'-"/4 P.A.,MSc-Q.Y.T., Q+,'2(!"#µ(+0) 63!303µ'%3 Z%3-.2. 63!#:'-"/4 P.A., Q+,'2(!"#µ(+0) 63!303µ'%3 Z%3-.

9:;E<=>=

E '2(03(,=,%+ '%,+( µ(+ 8(+8(0+!%+ +::#:'2%8$+!#4 µ' !032) "#, +,"+::+*/ µ#,-µ1"=,, 7µ;-"# !' 01?'1,?$=23, +::1 23- 3( '2% µ7$3-4 "'<,(074 0+( 8'.()"#"74 "#4 '%,+( 8-,+") ,+ 8(8+<?3C,. @( 63!#:'-"74'%,+( +2) "# ;C!# "3- '2+**7:µ+")4 "3-4 «'2+**':µ+"%'4» "#4 '2(03(,=,%+4, +;3C # ,3!#:'-"(0/ !"#$%-&'"+( !"# 8-,+")"#"+ 23- 7<3-, +,+2"C.'( 2$30'(µ7,3- ,+ 8#µ(3-$*3C, 0+:74 8(+2$3!=2(074 !<7!'(4 µ'"3-4 +!?','%4.

RR77..''((44 MM::''((88((11:: !-&/"#!#, '2(03(,=,%+, !-µ>3-:'-"(0/, ,3!#:'-"(0/ 2$1.#, 23µ2)4, 870"#4, µ/,-µ+, +!?'-,/4.

!"!#"$%&'(")* '+',)$-*,*

:/#+*?*4E '2(03(,=,%+ '%,+( µ(+ 8(+8(0+!%+ +::#:'2%8$+-!#4 µ' !032) "#, +,"+::+*/ µ#,-µ1"=,, 7µ;-"# !'01?' 1,?$=23. (A2(03(,=,D ...1$+ -21$<=). 5"#8(+2$3!=2(0/ '2(03(¬,=,%+, +::#:'2(8$+!"(0/ !"#,3-!%+ "#4 !<7!#, 3( 1,?$=23(, 23- µ3($1&3,"+( "3-4$):3-4 "3- 23µ23C 0+( "3- 870"#, ;7$3-, +µ3(>+%+"#, '-?C,# *(+ "# 8#µ(3-$*%+ ',)4 03(,3C ,3/µ+"340+( "# 8(+µ)$;=!# ',)4 03(,3C 0D8(0+ '2(03(,=-,%+4.

P3 ;+(,)µ',3 "#4 '2(03(,=,%+4 '%,+( !C,?'"3 0+(3 "$)234 23- *%,'"+( 0+"+,3#") 0+?3$%&'( "3, "C23"=, 2+$'µ>1!'=, !"(4 +,?$D2(,'4 !<7!'(4 !' ):'4"(4 µ3$;74 (H2+0($"&/4, 2002). P$'(4 '%,+( 3( 8(+!"1-!'(4 23- 0+?3$%&3-, "#, +,?$D2(,# '2(03(,=,%+, !'!<7!# 0-$%=4 µ' "3-4 !")<3-4 +::1 0+( "3, "$)23 23-2$+*µ+"323('%"+(:! # '*=0',"$(0/! # +::30',"$(0/! # +::#:30',"$(0/.

E '*=0',"$(0/ '2(03(,=,%+ 7<'( !032) ,+ 0+:C-9'( 2$3!=2(074 +,1*0'4 "3- %8(3- "3- +")µ3-, 23-+,+:+µ>1,'( "#, 2$="3>3-:%+ ,+ '2(03(,=,/!'(. E+::30',"$(0/ '2(03(,=,%+ 7<'( !")<3 ,+ 0+:C9'( +,1-

*0'4 1::=, 2$3!D2=, 0+( )<( +-"3C 23- +,+:+µ>1-,'( "#, 2$="3>3-:%+ ,+ +,+2"C.'( µ(+ '2(03(,=,(+0/!<7!#. P7:34, # +::#:30',"$(0/ / 3µ30',"$(0/ 8(1-!"+!# "#4 '2(03(,=,%+4 '%,+( +-"/ 23- +;3$1 "#, %8(+"# !<7!# µ'"+.C "=, 2$3!D2=, 23- '2(03(,=,3C,,µ7!+ +2) "#, 323%+ (0+,323(3C,"+( µ' +µ3(>+()"#"+3( +,1*0'4 ):=, "=, !-µµ'"'<),"=,.

= :@/.%/0?0,+ #$10 .+F1µ)(/04 0%#12)3$/.4 @(GH1E 3-!(D8#4 8(1!"+!# "#4 '2(03(,=,%+4 !"3 63!303-µ'%3 )!3, +;3$1 "3 $):3 "3- ,3!#:'-"/, '%,+( +$<(-01 # +::30',"$(0/. @ ,3!#:'-"/4, 7$<'"+( !' 1µ'!#8(+2$3!=2(0/ '2(03(,=,%+ µ' "3-4 +!?','%4 "3-, µ'!032) ,+ '2(8$1!'( µ' ?'"(0) "$)23 !"# 8(+µ)$;=-!# !"1!'=,, +,"(:/9'=, 0+( !-µ2'$(;3$D,, 23- !03-2) 7<3-, "#, +,"(µ'"D2(!# "3- 2$3>:/µ+"34 -*'%+423- +,"(µ'"=2%&3-, 0+( 0+"’ '270"+!# +, +-") '%,+(';(0") "#, 2:/$# %+!# "3-4.

S!3, +;3$1 "3-4 +!?','%4, # '2(03(,=,%+ "#,323%+ 3( %8(3( 0+:3C,"+( ,+ +,+2"C.3-, µ7!+ !"3<D$3 "3- 63!303µ'%3- '%,+( # '*=0',"$(0/, +;3C!032)4 "#4 '%,+( # -(3?7"#!# !-µ2'$(;3$14 "7"3(-+4, 23- 38#*'% +$<(01 !"#, +2383</ "3- 2$3>:/µ+-

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 57

Page 59: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[58] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")* '+',)$-*,*

"34 -*'%+4 23- +,"(µ'"=2%&'(, 0+( 0+"’ '270"+!# #?'$+2'%+ "3-. Sµ=4 +-"/ # !<7!# µ'"3-!(D,'( "#,'2(03(,=,%+ µ'"+.C ,3!#:'-"/- +$$D!"3- !' µ(++::#:38(+µ3$;="(0/, '2(03(,=,(30',"$(0/ !<7!#(Mialaret, 1991), )23- ")!3 3 +!?',/4 )!3 0+( 3,3!#:'-"/4 µ7!+ +2) µ(+ 8(+:'0"(0/ !<7!# +-"30'-,"$(0/4 0+( +::30',"$(0/4 '2(03(,=,%+4 !-,+,"D-,"+( =4 2$)!=2+ !"+ 2:+%!(+ µ(+4 «!-,+,"#!(+0/4»!<7!#4. @ Carl Rogers (1952) +,+*,D$(!' "# >+?(19-<(0/ ;C!# 0+( :'("3-$*%+ "3- ;+(,3µ7,3- "#4 '2(-03(,=,%+4 µ' "(4 7,,3('4 "#4 ',!-,+%!?#!#4 0+( "#4*,#!()"#"+4, µ7!= "=, 323%=, '2("-*<1,'"+( # 3-!(+-!"(0/ !-,1,"#!# µ'"+.C 23µ23C – 870"#.

E +,1*0# *(+ 0+:/ '2(03(,=,(+0/ !<7!# '23µ7-,=4, +!?',/ 0+( ,3!#:'-"/ !"3 ,3!303µ'%3 '%,+( 2$3-;+,/4 +2) "# !"(*µ/ 23- '%,+( >+!(0) !-!"+"(0) "#40+:/4 :'("3-$*%+4 "#4 !<7!#4 µ'"+.C "3-4. (N'3;(-:%8#4, 1997), µ#, .'<,3Cµ' )"( # 0+:/ :'("3-$*%+ "#4!<7!#4 +-"/4 +23"':'% >+!(0) !-!"+"(0) "#4 8(+8(-0+!%+4 "#4 2$3+*=*/4 -*'%+4 "3- +!?',/.

@-!(+!"(01 0+:/ '2(03(,=,%+ '%,+( +-"/ 23- 8('--03:C,'( "# 8#µ(3-$*%+ !<7!'=,, 3 ,3!#:'-"/4 ',?+$-$C,'( / +23?+$$C,'(, 2$3"$72'( / +23"$72'(, 2$3-!':0C'( / +23µ+0$C,'( "3-4 +!?','%4 "3- µ' "3, "$)2323- '2(03(,=,'% µ+&% "3-4. 5-*0'0$(µ7,+, # 0+:/ '2(-03(,=,(+0/ !<7!# ,3!#:'-"/ – +!?',/ !-,"':'% !"#,+,12"-.#, "#4 +%!?#!#4 "3- +!?',/ *(+ 0+:C"'$# +,"(-µ'"D2(!# "3- 2$3>:/µ+"34 -*'%+4 23- +,"(µ'"=2%-&'( , >3#?1 !"#, 03(,=,(0/ '2+;/ 0+( !"#, +,12"-.#0+:C"'$=, 8(+2$3!=2(0D, !<7!'=, µ'"+.C "=, +!?'-,D, 0+( ,3!#:'-"D,, !-,"':'% !"#, 01:-9# "=, 9-<3-:3*(0D, +,+*0D,, +2383</4 0+( +!;1:'(+4 23- 01?'1"3µ3 0+( (8(+%"'$+ 3( +!?','%4 !' +-"/ "# ;1!# 23->$%!03,"+( <$'(1&3,"+(.

N'=$3Cµ' )"( 3 $):34 "3- ,3!#:'-"/ !-,87'"+(1µ'!+ 0+( 3-!(+!"(01 µ' "3, $):3 "3- «!-µ>3C:3-»(Maslow, 1970 & 1973, Rogers, 1969) 0+( -23!"#$%-&3-µ' "#, +,+*0+()"#"+ 2$3D?#!#4 "#4 !-µ>3-:'--"(0/4 !"3 <D$3 "3- 63!303µ'%3-, µ' "$)23 D!"' ,+8('-03:-,?'% # '.7:(.# "#4 +2:/4 !<7!#4 ,3!#:'--"/ – +!?',/ !' '-$C"'$# !-µ>3-:'-"(0/ !<7!#. (M3!µ%-83--Hardy 1993, M3!µ)23-:34 1996).

O::=!"', 3 %8(34 3 !")<34 +-"/4 "#4 2$3!21?'(-+4 !"3 63!303µ'%3 8', '%,+( 1::34 +2) "3 ,+ 8('-03-:C,'( "3, +!?',/ 2$34 µ(+ 3:)2:'-$# 0+( -*(/ +,1-2"-.#, '2("-</ +.(323%#!# "3- '+-"3C "3-, '2("-</+,"(µ'"D2(!# 2$3>:#µ1"=, 23- !-,+,"1, !"#, 2+$3C-!+ 8C!03:# ;1!# "#4 &=/4 "3-, 0+( :/9# 0+:D, +23-;1!'=,. (M+:3C$#, 1992).

Q$30'(µ7,3- )µ=4 3 ,3!#:'-"/4 ,+ '%,+( !'?7!# ,+ +,"+230$(?'% !"3, $):3 "3- =4 !-µ>3C:3-?+ 2$72'( µ'"+.C 1::=, ,+ '%,+( !' ?7!# ,+ µ23-$'% ,+ +.(323('% "+ 0+"1::#:+ <+$+0"#$(!"(01 2$3-!=2(0)"#"+4 "3- 0+( ,+ ','$*323('% '2(03-$(074*(+ "3, !032) "3- "'<,(074 '2(03(,=,%+4. N+ 2$7-2'( µ' "# !-µ2'$(;3$1 "3- ,+ 2$3!;7$'( "# 8-,+-")"#"+ >3/?'(+4 2$34 "3-4 +!?','%4 "3-, ,+ 0+:-:('$*'% 0:%µ+ 'µ2(!"3!C,#4, ',?1$$-,!#4, +2383</40+( )<( +2)$$(9#4. A%,+( 2$3;+,74 )"( # !-µ2'$(-;3$1 "3- ,3!#:'-"/ '%,+( '0'%,# 23- !#µ+"383"'%"3 '%834 "=, !<7!'=, 23- +,+2"C!!3,"+( / '%,+(8-,+"), ,+ +,+2"-<?3C, µ'"+.C ,3!#:'-"/ 0+( +!?'-,/. (M+:3C$#, 2002).

@ ,3!#:'-"/4, =4 :'("3-$*)4 !-µ>3-:'-"(0/4,<+$+0"#$%&'"+( / ?+ 72$'2' ,+ <+$+0"#$%&'"+( +2)(8(+%"'$'4 '2(03(,=,(+074 (0+,)"#"'4. S<( µ),3 ,+*,=$%&'( "+ >+!(01 <+$+0"#$(!"(01 0+( "(4 2$3[23-?7!'(4 µ(+4 +23"':'!µ+"(0/4 '2("-<#µ7,#4 !-&/-

!"#$#! %&'%&('!&' ')#"*+*!,')-./-01µ-23 )4567/3 '839-4-7µ59/:;

!<µµ-9=0329->-,?2@µ595 -8/:3/2A265

)#,)#! ,BCD,' %*("B!

!"#$%#&'&#( - )#( (**+*!"#,-(./#$+ .0!.+

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 58

Page 60: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [59]

!"!#"$%&'(")* '+',)$-*,*

"#!#4, +::1 0+( ,+ '%,+( !' ?7!# ,+ "+ <$#!(µ323(-'%. Sµ=4, +4 µ# .'<,1µ' )"( 7$'-,'4 7<3-, 0+"+8'%-.'( )"( :)*= "=, 8(+;)$=, 2$3>:#µ1"=, 23- +,"(-µ'"=2%&'( 3 ,3!#:'-"/4 23::74 ;3$74 )<( µ3,)+8-,+"'% ,+ <$#!(µ323(/!'( "'<,(074 +23"':'!µ+-"(0/4 '2(03(,=,%+4, +::1 +,+&#"1 3 %8(34 !-µ>3--:'-"(0/ 0+( 9-<3:3*(0/ -23!"/$(.# (M+:3C$#, B?+-,+!3C:+, 2002).

B, 0+:)4 ,3!#:'-"/4 '%,+( +-")4 23- 7<'( 0+:)*,=!(3:3*(0) '2%2'83 *(+ "#, '2(!"/µ# "3-, '2%!#40+:)4 ,3!#:'-"/4 '%,+( +-")4 23- <'($%&'"+( +23-"':'!µ+"(01 "(4 '2(03(,=,(+074 "'<,(074 0+( 8'.()-"#"'4. A%,+( +-")4 23- =4 23µ2)4 '027µ2'( µ' "$)-23 23- 3 870"#4 – +!?',/4 ,+ 0+"+,3'% +-"1 23-'027µ23,"+(. A%,+( +-")4 23- 7<'( "# 8-,+")"#"+ ,+8(+;3$3¬23('% "#, !-µ2'$(;3$1 "3- 2$34 );':34µ(+4 ':'C?'$#4 '2(03(,=,(+0/4/!-µ>3-:'-"(0/4!<7!#4. 5"#, 2'$%2"=!# 8', "#4 !-µ>3-:'-"(0/4 '2(-03(,=,(+0/4 !<7!#4 "3- ,3!#:'-"/ '%,+( !+;74 )"(+,+;'$)µ+!"':BB)) 5"#, +µ;%8$3µ#, -(3?'"D,"+4 8(+8$+!"(01 µ3,"7-:+ '2(03(,=,%+4 (H+0 M3-7#: 1993, M+&1&# 1995),0+( )<( "#, µ3,)8$3µ# '2(03(,=,%+, )23- 3 23µ2)4)<( µ),3, ',8(+;7$'"+( *(+ "#, 3$?/ :/9# 0+( +23-0=8(0323%#!# "3- µ#,Cµ+"34, +::1 +,+"$3;383"'%-"+( +2) "#, +,"%8$+!# "3- :/2"# 0+( # '2(03(,=,%+0+?%!"+"+( 2'$(!!)"'$3 +23"':'!µ+"(0/ (M+:3C-$#,2002)UU)) 5"#, 0-0:(0/ 0+( )<( '-?C*$+µµ# '2(03(,=,%+,)23- ',(!<C'"+( # +µ3(>+()"#"+ "#4 '2(03(,=,(+0/48(+8(0+!%+4 µ7!+ +2) "#, '2(:'0"(0/ :/9# 0+( 0+"’'270"+!# +230=8(0323%#!# "=, µ#,-µ1"=, "3-23µ23C +2) "3, +23870"# (M+:3C$#, 2002).LL)) 5"#, +::30',"$(0/ / 0+( +::#:30',"$(0/ '2(03(-,=,(+0/ 2$3!7**(!#, # 323%+ +;3$1 "#, %8(+ "# !<7-!# µ'"+.C "=, 2$3!D2=, 23- '2(03(,=,3C,, "# !-,1-,"#!#, "#, '2(03(,=,%+ 0+( )<( "#, '*=0',"$(0/'2(03(,=,%+ )23- "3 1"3µ3 '2(03(,=,'% *(+ "(4 8(074"3- µ),3, +,1*0'4 (H2+0($"&/4, 2002).JJ)) 5"#, ;-!(0/, '0 "3- !C,'**-4 0+( )<( '. +23!"1-!'=4 '2(03(,=,%+, # 323%+ 2$+*µ+"323('%"+( µ' "#;-!(0/ 2+$3-!%+ "3- 23µ23C 0+( "3- 870"#AA)) P)!3 !"#, :'0"(0/ )!3 0+( !"# µ# :'0"(0/ '2(03(-,=,%+ (Pease 1991, M3µ,#,10#4 1998, Verderber,1997). A.1::3- 8', '%,+( :%*3( '0'%,3( 23- 7<3-,0+"+:/.'( !"3 !-µ27$+!µ+ )"( "3 65% "#4 '2(03(-,=,%+4 '%,+( +23"7:'!µ+ "#4 µ# :'0"(0/4 !-µ2'$(-;3$14 0+( µ),3 "3 35% +23"7:'!µ+ "#4 :'0"(0/4(Burgoon, etal. 1989)

N'=$'%"+( +2+$+%"#"3 # '2(03(,=,%+ ,+ 2$+*µ+-"323('%"+( ':'-?7$+, ,+ -21$<'( +"µ)!;+($+ +23-83</4, ,+ -21$<3-, ',8'%.'(4 )"( 3( (87'4 "3- +!?'-,/ :+µ>1,3,"+( 2$1*µ+"( -2)9#. M1?' 1239#, !<):(3/ (87+ ,+ +,"(µ'"=2%&'"+( ?'"(01, ):+ "+ !-µµ'"7-<3,"+ µ7:# ,+ 8%,3-, 2$3!3</ !"+ 8$Dµ',+, ,+ µ#µ3,32=:'%"+( # '2(03(,=,%+ µ),3 +2) 0123(+ 1"3µ+

!"#, 3µ18+ 0+( ,+ 2$3!;7$'"+( # 8-,+")"#"+ +,"+:-:+*/4 +2)9'=, 0+( !'>+!µ3C +-"D, "=, +2)9'=,+2) ):+ "+ µ'"7<3,"+ !"#, '2(03(,=,(+0/ !<7!# 1"3-µ+ (Douglas, 2000).

A,D :3(2), # !#µ+!%+ "#4 0+:/4 '2(03(,=,(+-0/4 !<7!#4 '%,+( 2$3;+,/4, 8', '%,+( :%*'4 3( ;3$7423- 8#¬µ(3-$*3C,"+( *(+ 0123(3-4 :)*3-4 2$3>:/-µ+"+ !"#, '2(03(,=,%+, 2$3>:/µ+"+ "+ 323%+ µ23-$'% ,+ !<'"%&3,"+( µ' "3, 23µ2), "3, 870"#, "3 µ7!3-8%+-:3 '2(03(,=,%+4 / 0+( +-") +0)µ# "3 2'$('<)µ',3"3- µ#,Cµ+"34 (J#µ#"$)23-:34 & M+:3C$#, 2002).

P+ 0%,#"$+ 0+( 3( 'µ2'($%'4 "3- 23µ23C 0+( "3-870"#, "3- ,3!#:'-"/ 8#:+8/ 0+( "3- +!?',/, "+2$3!830Dµ',+, 3( 03(,=,(074 µ+4 +,"(:/9'(4, #!-,+(!?#µ+"(0/ µ+4 0+"1!"+!#, 3 0D8(0+4 23- <$#-!(µ323(3Cµ', "$32323(3C, !-,'(8#"1 / +!-,'%8#"+"#, '023µ2/ 0+( +,"%!"3(<+ "# :/9# "3- µ#,Cµ+"34.Q+$=?#"(01 '$'?%!µ+"+ !-,"':3C, !"# 8#µ(3-$*%+0+:/4 '2(03(,=,(+0/4 – 0=8(0323(#"(0/4 0+( +23-0=8(0323(#"(0/4 – !<7!#4 0+( 8(+!;+:%&3-, 0+:C-"'$'4 8(+2$3!=2(074 !<7!'(4 (J#µ#"$)23-:34 &M+:3C$#, 2002).

B0)µ#, !#µ+,"(0) $):3 !"#, 0+:/ '2(03(,=,%+0+( "(4 +23"':'!µ+"(074 8(+2$3!=2(074 !<7!'(42+%&'( "3 2D4 3( 8C3 !-,3µ(:#"74 +,"(:+µ>1,3,"+("3, '+-") "3-4. O"3µ+ µ' ?'"(0/ +-"3'(0),+ 0+( ?'"(-0) +-"3!-,+%!?#µ+, !' +,"%?'!# µ' "+ 1"3µ+ µ'<+µ#:/ +-"3'(0),+, 7<3-, "#, "1!# ,+ +2387<3,"+(0+( "3-4 1::3-4 0+( ,+ +230=8(0323(3C, "+ '2(03(-,=,(+01 µ#,Cµ+"+ µ' "3, "$)23 23- ?'=$3C, )"( ?+'2(?-µ3C!' 3 !-,3µ(:#"/4 "3-4 (Verderber, 2000.Remy, 1988) 0+?(!"D,"+4 +23"':'!µ+¬"(0)"'$# "#,'2(03(,=,%+.

I+(+.$1(/#$/.G J@%$)2)#µ+$/.4- :@/.%/0?0,+-Q)"' )µ=4 ?+ µ23$3C!+µ' ,+ <+$+0"#$%!3-µ' +23-"':'!µ+"(0/ "#, '2(03(,=,%+; N+ :7*+µ' )"+, «-:3-23(3C,"+( 3( !0323% *(+ "3-4 323%3-4 *%,'"+(», )"+,«3( 8(+2$3!=2(074 !<7!'(4 8('-03:C,3,"+( !"3,µ7*(!"3 >+?µ)», )"+, 3( !-µµ'"7<3,"'4 7<3-, 03(-,3C4 0D8(0'4, )"+, -21$<'( '2+$0/4 '2(03(,=,(+-0/ (0+,)"#"+, )"+, # '2(03(,=,(+0/ !-µ2'$(;3$1'%,+( 0+"1::#:# 0+( +23"':'!µ+"(0/ (M+:3C$#,2002). A%,+( 8' 0+"1::#:# 0+( +23"':'!µ+"(0/, )"+,'0;$1&'( "3, !-*0'0$(µ7,3 !032) 0+( "3 0%,#"$3"3- 23µ23C, )"+, '2("-*<1,'( "3-4 !")<3-4 "#4, )"+,!-µµ3$;D,'"+( µ' )!+ +,+µ7,3,"+( !"#, '2(03(-,=,(+0/ +-"/ !<7!# (Spitzberg, 1997) 0+( )"+, "':(-0D4 "3 '02'µ2)µ',3 µ/,-µ+ *%,'"+( +238'0") +2)"3, :/2"# +0$(>D4 )2=4 ?+ "3 /?':' 0+( "3 ',,3-3C!' 3 23µ2)4.

@( >+!(074 +$<74 "#4 8(+2$3!=2(0/4 '2(03(,=-,%+4, ',(!<C3,"+4 / µ#, "(4 8(+2$3!=2(074 !<7!'(4,23- 8%,3,"+( +2) "3, Verderber (2000) 8', +27<3-,23:C, !"#, ?'"(0/ "3-4 '083</ 0+( 2+$3-!%+!#, +2)"(4 >+!(074 8'.()"#"'4 "#4 !-µ>3-:'-"(0/4 !<7!#4:

TOMOS4_TEFXOS1 5/11/11 11:22 AM Page 59

Page 61: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[60] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")* '+',)$-*,*

++.. E 8(+2$3!=2(0/ '2(03(,=,%+ '%,+( 8(+8(0+!%+ 8#µ(-3-$*%+4 0+( 8(+2$+*µ1"'-!#4 !<7!'=,. P3 µ/,-µ+8', µ'"+;7$'( +2:D4 "(4 '2(?-µ#"74 -2$34 µ'"183-!#- 2:#$3;3$%'4 +::1 µ'"+;7$'( 0+( "+ !"3(<'%+ '0'%-,+ 23- 0+?3$%&3-, µ(+ !<7!#, )2=4 !"3$*/, +!;1-:'(+, +2)$$(9#, '($=,'%+, 7:'*<3, 0-$(+$<%+... >>.. E 8(+2$3!=2(0/ '2(03(,=,%+ '%,+( !0)2(µ#. «M1?'µ3$;/ 8(+2$3!=2(0/4 '2(03(,=,%+4 0+"'-?C,'"+(2$34 "#, '2%"'-.# ',)4 !")<3-, +,'.1$"#"+ +2) "3 +,+-") *%,'"+( !-,'(8#"1 / )<(» (Kellermann, 1990) **.. E 8(+2$3!=2(0/ '2(03(,=,%+ '2("-*<1,'"+( !"#$(-&)µ',# !' 8'.()"#"'4 23- 8(81!03,"+( 0+( µ+?+%,3-,"+(, 1$+ 0+( >':"(D,'"+( 2$30'(µ7,3- ,+ 0+"+!"'%2'$(!!)"'$3 +23"':'!µ+"(0/)88.. E 8(+2$3!=2(0/ '2(03(,=,%+ '%,+( 8(+$0/4. 5-,'(-8#"1 / µ# !-,'(8#"1, µ' :'0"(01 / µ# :'0"(01 µ#,C-µ+"+ 01?' 1"3µ3 '027µ2'( !-,'<D4 2$34 "3-4 1::3-4µ#,Cµ+"+, "+ 323%+ +,"%!"3(<+, !' !-,1$"#!# µ' "3',8(+;7$3, 0+( "(4 +,1*0'4 "3-4, 3( 1::3( "+ 87<3-,"+( 0+( "+ +230=8(0323(3C, / +,"%?'"+ "+ +23$$%-2"3-,.

L(+ "#, 0+:/ '2(03(,=,%+ +2+$+%"#"# 2+$3-!(1-&'"+( '0")4 "=, 1::=, (Mialaret, 1991) # <$/!# ',)4',(+%3- 0D8(0+ !-µ>):=,. S"+, "+ :'0"(01 µ#,Cµ+-"+ 8#:+8/ 8', !-µ;=,3C, / !-*0$3C3,"+( µ' "+ µ#:'0"(01 +,"%!"3(<+ 23- '027µ2'( 3 !-,3µ(:#"/4 µ+4,# '2(03(,=,%+ 2+$3-!(1&'"+( +,'(:(0$(,/4 0+( # 8(+-2$3!=2(0/ !<7!# 8(+"+$1!!'"+(. P+ ?'"(01 µ# :'0"(-01 µ#,Cµ+"+ ',(!<C3-, "#, +.(32(!"%+ 0+( "#, '(:(-0$%,'(+ "3- !-,3µ(:#"/ µ+4, 0+( ?'"(0/ '(0),+ *(+ "3!-,3µ(:#"/ µ+4 !#µ+%,'( ?'"(0/ "1!# *(+ "#, 8#µ(-3-$*%+ / "#, ',%!<-!# "#4 8(+2$3!=2(0/4 !<7!#4µ+&% "3-. P3 +µ3(>+%3 ',8(+;7$3, *(+ "#, '2(03(,=-,%+, 23µ23C 0+( 870"#, 0+( # '08/:=!# +-"3C "3-',8(+;7$3,"34 +,"%!"3(<+, +2) "3, 7,+, 2$34 "3, 1::3,8#µ(3-$*3C, "3 ?'"(0) 0:%µ+ 23- '-,3'% "#, +23"'-:'!µ+"(0/ +,"+::+*/ +2)9'=, 0+( "# 8#µ(3-$*%+ 0+(8(+"/$#!# 0+:D, 8(+2$3!=2(0D, !<7!'=, (M+:3C-$#, 2002).

@ !")<34 8', '%,+( µ3,3!/µ+,"34, '2(8(D03-µ'"#, 0+"+,)#!# 0+( "#, +2383</ +2) "3, 1::3, "3, !-,3-µ(:#"/ µ+4, 0+( +23;'C*3-µ' "3, +"7:'(="3 0+( '*=-0',"$(0) µ3,):3*3. @ 0+:)4 +0$3+"/4 >3#?1 !"#,'2(03(,=,(+0/ !<7!# 0+( 2+$1::#:+ 2$3!;7$'( "+'<7**-+ *(+ "# 8#µ(3-$*%+ 0+:/4 0+( !"',/4 8(+2$3-!=2(0/4 !<7!#4.

@ 0+:)4 !-,3µ(:#"/4 8(+µ3$;D,'( "+ µ#,Cµ+"+"3- µ' !+;/,'(+ 0+( +0$%>'(+, 8', 8(!"1&'( ,+ "+ +µ;(-!>#"/!'( 0+( ,+ "+ '2+,'.'"1!'(, !"3<'C'( !"# 8#µ(-3-$*%+ 0:%µ+"34 'µ2(!"3!C,#4, 0+"+,3D,"+4 0+( +,"(-8$D,"+4 ?'"(01 !"(4 !-,+(!?#µ+"(074 0+( :3(274'µ2'($%'4 "3- 1::3- +")µ3- (J#µ#"$)23-:34 & M+:3C-$#, 2002).

@( >+!(074 +$<74 µ(+4 +23"':'!µ+"(0/4 !-&/"#-!#4, !-,32"(01, '%,+(:

1 # +$</ "#4 23()"#"+4, !Cµ;=,+ µ' "#, 323%+ 3(2:#$3;3$%'4 23- µ'"+8%83,"+( 2$72'( ,+ '%,+(

+0$(>'%4, +:#?'%4 0+( ,+ µ#, -21$<'( !0)2(µ# "$3-2323%#!# "#4 +:/?'(+4,

2 # +$</ "#4 23!)"#"+4, !Cµ;=,+ µ' "#, 323%+ #-2'$>3:(0/ !-,"3µ%+ / # -2'$>3:(0/ ;:-+$%+,

2+$3</ 2'$(!!)"'$=, / !-,'(8#"1 :(*)"'$=, 2:#$3-;3$(D, +2) )!'4 '%,+( +,+*0+%'4 8', >3#?3C, "#,!-,'$*+"(0)"#"+, +$</ +2+$+%"#"# !"(4 0+:74 8(+2$3-!=2(074 !<7!'(4,

3 # +$</ "#4 !<'"(0)"#"+4, !-µ;=,1 µ' "#, 323%+3( 2:#$3;3$%'4 23- µ'"+8%83,"+( µ' "# !-&/"#-

!# ?+ 2$72'( ,+ !-,873,"+( µ' "3 ?7µ+. J(+032/ "#4!-&/"#!#4 +2) 7,+, +2) "3-4 !-µµ'"7<3,"'4 / +2$)-!µ',# +::+*/ ?7µ+"34 8', '-,3'% "#, 0+:/ '2(03(-,=,%+ 0+( 8(+"+$1!!'( "(4 8(+2$3!=2(074 !<7!'(4,0+( "7:34

4 # +$</ "3- "$)23-, !Cµ;=,+ µ' "#, 323%+ # !07-9# 0+( # 70;$+!# "#4 ?+ 2$72'( ,+ 2+$3-!(1-

&'"+( !+;/4 0+( 3$*+,=µ7,# +2) "3-4 !-µµ'"7<3-,"'4 !"#, !-&/"#!# (J#µ#"$)23-:34 & M+:3C$#,2002)

:@,2%*%-E '(:(0$%,'(+, 3 2$3!=2(0)4 "),34 !"+ '02'µ2)µ'-,+ µ#,Cµ+"+, # !-,3</ 0+( # ',+$µ),(!# !"+ :'0"(-01 0+( µ# :'0"(01 µ#,Cµ+"+, # 3$?/ 0+( +23"':'-!µ+"(0/ +230=8(0323%#!# "=, '02'µ2)µ',=, 0+(:+µ>+,)µ',=, µ#,-µ1"=,, # 2$3!3</ 0+( ','$*#"(-0/ +0$)+!#, # ',!-,+%!?#!# 0+( # 2+$=?#"(0/ '23(-0383µ#"(0/ 0$("(0/ !"3, !-,3µ(:#"/, # +23;-*/ "=,!-*0$3C!'=,, # 8(1?'!# *(+ +µ;%8$3µ# '2(03(,=-,%+, # 'µ2(!"3!C,#, # +;3!%=!# +::1 0+( # ':'*<)-µ',# +2301:-9# 2$3!=2(0D, !"3(<'%=, 0+( +2) "+8-3 03µµ1"(+ 23- +23"':3C, 7,+ 0:+!!(0) !</µ+'2(03(,=,%+4, '%,+( µ'$(01 +2) "+ >+!(¬01 !"3(<'%+23- ',(!<C3-, "(4 0+:74 8(+2$3!=2(074 !<7!'(4,(Nofsinger 1991, Douglas 1999, Filley 1975, Cahn1990, Prisbell & Andersen 1980, Coombs 1987,J#µ#"$)23-:34 & M+:3C$#, 2002) +23"':D,"+4 "+--")<$3,+ >+!(01 !"3(<'%+ *(+ "#, +2+$+%"#"# !-µ>3--:'-"(0/ '2(03(,=,(+0/ 8'.()"#"+ 01?' !=!"3C '2+*-*':µ+"%+-,3!#:'-"/.

E +23"':'!µ+"(0/ '2(03(,=,%+ '%,+( :3(2), "3+2+$+%"#"3 µ7!3, +::1 0+( "3 +,+*0+%3 -2)>+?$3*(+ "# 8#µ(3-$*%+ 0+:D, 8(+2$3!=2(0D, !<7!'=,.@( 0+:74 8(+2$3!=2(074 !<7!'(4 '%,+( # >1!# *(+"#, !=!"/ 0+( 3:)2:'-$# +,12"-.# -*(D, 8(+2$3-!=2(0D, !<7!'=,, 0+( '(8(0)"'$+ !"3 <D$3 "3-63!303µ'%3-, )23- "3 7,+ 03µµ1"( +2) "3 !</µ+"#4 '2(03(,=,%+4 23- +,+;'$?/0+µ' 3 +!?',/4 >$%-!0'"+( !' 8-!<'$/ ?7!# :)*= "3- 2$3>:/µ+"34 -*'%-+4 23- +,"(µ'"=2%&'(. E 0+:/ :'("3-$*%+ "3- !-*0'-0$(µ7,3- 03µµ+"(3C '%,+( 0+?3$(!"(0)4 2+$1*=, *(+"#, %+!# "3-.

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 60

Page 62: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [61]

!"!#"$%&'(")* '+',)$-*,*

6/72/%*(+8/.C- +0+8%(C-1. Cahn. D.D. (1990). Intimates in Conflict: A communication

Perspective. Hillsdale, NJ: Erbaum.2. Coombs, C.H. (1987). The structure of conflict. American Psychologist,

42, 355-363.3. Douglas, T. (1997). L C<%O=A&( &)%7 Fµ5637. G$&%*B7 /1KB7 )(7!"µµ3)-K+7 &3 Fµ5637. /'+#$: C22(#%*5 N15µµ$)$.

4. Kellermann, 0. & Reynolds, R. (1990). When ignorance is bliss:The role of motivation to reduce uncertainty in uncertain reductiontheory. Human Communication Research, 17,5-75.

5. Maslow, A. (1970). Motivation and Personality. New York: Harperand Row.

6. Nofsinger, R.E., (1991). Everyday Conversation. Newbury Park,CA: Sage.

7. Pease, A. (1991). L N2@&&$, )-# !@µ$)-7. /'+#$: C*6. P&--<)1-#.

8. Prisbell, M. & Andersen, J.F. (1980). The importance of perceivedhomophily, level of uncertainty, feeling good, safety, and self-disciosure in interpersonal relationships, Communication Quarterly.28, 22-23.

9. Remy, Y. (1988). Lesjeunes et l’ Orientation. Paris: Ed. Alternatives.10. Rogers, C.R. (1969). Freedom to Learn. Columbus : Merrill.

Spitzberg, B.H. (1997). A model of intercultural communicationcompetence, in Samovar, L.A.- Porter, R.E. Intercultural

communication: A reader. (8ed). Belmont, CA: Wadsworth.11. Verderber, R. (1998). L >BK#( )(7 C<%*-%#A#=$7. /'+#$: C*6?-

&3%7 P22(#. 12. Verderber, R. (2000). Inter-act Using interpersonal communication

skills, (8ed), Wadsworth.13. 8(µ()1?<-"2-7, C. & 0$2-.1(-/#)A#-<-.2-", F. (2003). D$%-

6$9A9%*+ Q"K-2-9=$. /<? )( R3A1=$ H5'(&(7 &)(# C*<$=63"-&( ,BA# *$% C#(2=*A#, /'+#$, 3*6. CEEL,

14. R3-I%2=6(7, S. (1997). 834%?)()37 8%6$&*$2=$7: 2. C<%*-%#A#=$./'+#$: C*6. N1(9?1(7.

15. 0$M5M(, H. (1995). /#'1@<%#37 !KB&3%7 *$% C<%*-%#A#=$. /'+#$:C*6. CEEL,.

16. 0-µ#(#5*(7, H. (1998). L 92@&&$ )-# !@µ$)-7... *$% <@7 #$ )(H323)+&3)3 0$2.)31$. /'+#$: C*6. CEEL,.

17. 0-&µ?<-"2-7, /. (1996). !.µO-"2-7 *$% 65&*$2-7. 8"- ?T3%7)-" %6=-" #-µ=&µ$)-7; C<%'3@1(&( !"µO-"23")%*+7 *$% D1-&$-#$)-2%&µ-., ). 38-39, 1996, 102-109.

18. Mialaret, G. (1991). Pedagogic Generate. Paris; P.U.F.19. H$* 0-"B(2, ,. & G%#)52, !. (1993). H-#)B2$ C<%*-%#A#=$7, (µ)I1.).

/'+#$: C*6. 0$¬&)$#%@)(7.20. H<$*%1)M+7 0. (1996). L 6"#$µ%*+ )(7 $22(23<=61$&(7 &)(# 3<%-

*-%#A#=$, /'+#$, Gutenberg.21. H<$*%1)M+7, 0. (2002). C<%*-%#A#=$ *$% /9A9+. /'+#$: C*6.

Gutenberg.

ABSTRACT

RREEVVIIEEWWTTHHEE DDIISSCCUUSSSSIIOONN AASS AANN EEFFFFEECCTTIIVVEE WWAAYY OOFF CCOOMMMMUUNNIICCAATTIIOONN IINN DDAAIILLYY NNUURRSSIINNGG PPRRAACCTTIICCEE MMaarrnneerraass CChhrriissttooss11,, AArrvvaanniittiiss GGeeoorrggiiooss22

[[11.. NNuurrssee TT..EE..,, MMSScc --PPHHDDcc,, UUnniivveerrssiittyy HHoossppiittaall ooff RRiioo,, 22.. NNuurrssee TT..EE..,, HHoossppiittaall ooff RRiioo]]

The communication is an interaction process aiming at the exchange of messages. It is innate in each person, butsome techniques and skills are teachable. The nurses are considered "professionals" in communication, sincenursing is based upon the competence to create good interpersonal relations with the patients.

WWoorrddss KKeeyyss:: discussion, communication, consultation, nursing practice, transmitter, receptor, message, patient.

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 61

Page 63: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[62] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

A-;-/ ;3$'"1 !-!"/µ+"+ -*'%+4 *(+ "#, '0"%µ#!# 0+$8(+**'(+0D, 0+( +,+2,'-!"(0D, 2$3>:#µ1"=,

XX.. MM++::3300++(($$((,,))4411,, JJ.. WW//00334422,, GG.. HH++,,""114433

1. Y-!(0)4, MsC Q:#$3;3$(0/4 T*'%+4, 2. 63!#:'-"/4 QA, MsC, PhD Q:#$3;3$(0/4 T*'%+4, 3. M+?#*#"/4 Q:#$3;3$(0/4 T*'%+4

A$*+!"/$(3 2:#$3;3$(0/4 -*'%+4 "µ/µ+"34 63!#:'-"(0/4 AMQB

9:;E<=>=

A%,+( 8('?,D4 03(,/ # 2$+0"(0/ 0+( # 2$3!21?'(+ "#4 µ'%=!#4 "3- µ7!3- <$),3- ,3!#:'%+4 !' 8'-"'$3->1?µ(3 / "$("3>1?µ(3 ,3!#:'-"(0) %8$-µ+. @( ,7'4 "'<,3:3*%'4 8%,3-, "# 8-,+")"#"+ +.()2(!"+ ,+ -21$<'(',8-,+µ=µ7,# ;$3,"%8+ 0+( '0")4 ,3!303µ'(+0D, µ3,18=,, *'*3,)4 (8(+%"'$+ !#µ+,"(0) !' µ%+ 03(,=,%+µ' 8(+$0D4 +-.+,)µ',3 2:#?-!µ) 1,= "=, 65 '"D,.P+ 7.-2,+ ;3$'"1 !-!"/µ+"+ µ23$3C, ,+ +23"':7!3-, '$*+:'%3 *(+ "#, 2$3:#2"(0/ ;$3,"%8+ ):=, "=,+,?$D2=,. E !-*0'0$(µ7,# '$*+!%+ +23"':'% µ(+ 'µ2'$(!"+"=µ7,# µ':7"#, >+!(!µ7,# !"#, +,+!0)2#!#"#4 !<'"(0/4 7,"-2#4 0+( #:'0"$3,(0/4 A::#,(0/4 0+( J('?,3C4 >(>:(3*$+;%+4. V<'( !032) "#4 ,+ 2+$3--!(1!'( "#, -21$<3-!+ 0+"1!"+!# 23- +;3$1 "+ '-;-/ ;3$'"1 !-!"/µ+"+ µ' 7µ;+!# !"#, '0"%µ#!# 0+$-8(+**'(+0D, 0+( +,+2,'-!"(0D, 2$3>:#µ1"=,.Q+$3-!(1&3,"+( ?7µ+"+ 23- !<'"%&3,"+( µ' "#, "#:'(+"$(0/, "#, "#:';$3,"%8+, "(4 "'<,3:3*%'4 2:#$3;3$(-0/4 0+( '2(03(,=,(D,. 5"# !-,'<'%+, 2'$(*$1;3,"+( 7,,3('4 !' !<7!# µ' "+ >(3:3*(01 !/µ+"+, "# :'("3-$-*%+ "=, >(3+(!?#"/$=, 23- +;3$3C, µ'"$/!'(4 &="(0D, 2+$+µ7"$=, "3- +,?$D2(,3- 3$*+,(!µ3C.

RR77..''((44 00::''((88((11:: P#:'(+"$(0/, ;3$'"1 !-!"/µ+"+, >(3+(!?#"/$+4, >(3!/µ+"+, -2#$'!%'4 -*'%+4, "#:'2(03(-,=,%'4, "#:';$3,"%8+, '-;-74 >(3(+"$(0) 7,8-µ+

!"!#"$%&'(")* '+',)$-*,*

:/#+*?*4E >':"%=!# "#4 23()"#"+4 0+( "#4 +23"':'!µ+"(0)"#-"+4 "#4 2+$+03:3C?#!#4 "#4 -*'%+4 !-,'21*'"+( "#,+,12"-.# ',+::+0"(0D, 2$3"1!'=, !"(4 2+$+83!(+074µ'?)83-4 *(+ "#, 2$):#9# "=, +!?','(D, 0+( "# !-,'-</ 2+$+03:3C?#!# "#4 -*'%+4 !"3 <D$3 "#4 M3(,)"#"+4(Q$=-"3>1?µ(+ Y$3,"%8+4 T*'%+4).Q3::3% 8(+;3$'"(03% )$3( <$#!(µ323(3C,"+( *(+ "3,2$3!8(3$(!µ) ',)4 ,73- "3µ7+, )2=4 Y3$7!(µ3( T23-:3*(!"74 (Wearable Computers), V.-2,+ A,8Cµ+"+(Smart Clothes), A-;-/ M:=!"3[;+,"3-$*(01 Q$3F-),"+ (Intelligent Textiles). E !-,7,=!# #:'0"$3,(0D,0+( 0:=!"3[;+,"3-$*(0D, 2$3F),"=, ?+ 2$3!;7$'(!#µ+,"(074 '-0+($%'4 >':"%=!#4 !"#, -*'%+ 0+( "#,+!;1:'(+ "=, +")µ=, 23- !-µµ'"7<3-, !' 2$3*$1µ-µ+"+ 0+"’ 3%03, ,3!#:'%+4 µ' "+-")<$3,# <$/!# "#4

P#:'F+"$(0/4 µ7!= 7.-2,=, ;3$'"D, !-!"#µ1"=,.5032)4 "#4 2+$3C!+4 >(>:(3*$+;(0/4 +,+!0)2#-

!#4 '%,+( # µ':7"# "=, ;3$'"D, !-!"#µ1"=, !"#, -*'%+0+( "=, "'<,3:3*(D, -23!"/$(.#4 "3-4. Q$)0'("+(,3-!(+!"(01 *(+ "# :'2"3µ'$/ 0+"+*$+;/ 0+( 2$3"'(,)-µ',# ';+$µ3*/ "3- ?'!µ3C 0+"’ 3%03, ,3!#:'%+4 µ'"+-")<$3,# <$/!# "#4 P#:'F+"$(0/4 µ7!= 7.-2,=,;3$'"D, !-!"#µ1"=, *(+ +!?','%4 µ' 0+$8(+**'(+010+( +,+2,'-!"(01 ,3!/µ+"+.

K2/.A .+/ µCF%5%-Q$+*µ+"323(/?#0' 5-!"#µ+"(0/-M$("(0/ >(>:(3*$+;(-0/ +,+!0)2#!# !' >1!'(4 8'83µ7,=, 0+( !' A::#,)-;=,# 0+( B**:);=,# #:'0"$3,(0/ 0+( 7,"-2# >(>:(3-*$+;%+ .@( :7.'(4 '-$'"#$%3- 23- <$#!(µ323(/?#0+,/"+, P#:'F+"$(0/, ;3$'"1 !-!"/µ+"+, >(3+(!?#"/$+4,

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 62

Page 64: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [63]

!"!#"$%&'(")* '+',)$-*,*

>(3!/µ+"+, -2#$'!%'4 -*'%+4, "#:'2(03(,=,%'4, "#:'-;$3,"%8+, '-;-74 >(3(+"$(0) 7,8-µ+.

J@%$)2C#µ+$+ 5/µ'$+ "3 !2%"( ?'=$'%"+( "3 2:73, 0+"1::#:3 2'$(->1::3, *(+ "3, +!?',/ 0+( "#, +,"(µ'"D2(!# "=, 2$3->:#µ1"=, "3- (0+"’ 3%03, ,3!#:'%+). L(+ "3 :)*3 +-") 3("#:'µ+"(074 "'<,3:3*%'4 >$%!03,"+( !"3 '2%0',"$3 "3-',8(+;7$3,"34 0+?D4 '%,+( 3( 0+"+::#:)"'$'4 *(+ ,++::1.3-, 8(+8(0+!%'4 0+( 8('$*+!%'4 +,"(µ'"D2(!#42$3>:#µ1"=, -*'%+4. @µ18'4 '(8(0D, µ23$3C, ,+ '2(-:#;?3C, "3- 2'$(!"+"(03C, +0)µ+ 0( +, 3( '(8(03% >$%-!03,"+( !' 8(+;3$'"(01 !#µ'%+. [Richard Wootton, 0+(:3(23%. 2006]

Q+$1 "3 -9#:) 0)!"34 "=, !<'"(0D, '2',8C!'=,,3( "#:'µ+"(074 "'<,3:3*%'4 2$3!;7$3-, "(4 0+:C"'$'48-,+"74 :C!'(4 *(+ "3, 7:'*<3 "=, 8+2+,D,.[http://mpl.med.uoa.gr/ekpaideytiko-yliko/i-y-stin-iatrik/tileiatrik.pdf]

E 7.-2,# 7,8-!# µ23$'% ,+ ',(!<C!'( +0)µ+ 2'$(!-!)"'$3 "+ '2(?-µ#"1 +23"':7!µ+"+.

9;LMEJN;JO:! OL;:BP" !K!B=QJBP" KN:EJ!E '2("-</4 <$#!(µ323%#!# ")!3 "=, ;3$'"D, !-!"#-µ1"=, )!3 0+( "3- !-,3:(03C !-!"/µ+"34 "#:';$3,"%-8+4, 2$3[23?7"'( "#, C2+$.# 0+( ';+$µ3*/ >+!(0D,2$3"C2=, (standars). B,+;'$)µ+!"' !"3, -2):3(23'.32:(!µ) µ'"+;3$14 "#4 2:#$3;3$%+4, 8#:+8/ "3-4E/T 0+( "+ 8%0"-+ µ'"183!#4 0+( :/9#4 "=, 8'83µ7,=,23- ?+ !-::7*3,"+( +2) "+ ;3$'"1 !-!"/µ+"+ 0-$()"'-$+ )µ=4 +,+;'$)µ+!"' !"3 2$3!=2(0) 23- ?+ 2$72'(,+ '%,+( '.'(8(0'-µ7,3 !"#, ';+$µ3&)µ',# "'<,3:3*%+,3C"=4 D!"' ,+ µ23$'% ,+ "+ 2+$+03:3-?'% 0+( ?+ "+-23!"#$%&'(.[ A.C.Norris 2002]

V,+ 2:1,3 :'("3-$*%+4 µ23$'% ,+ '%,+( "3 +0):3-?3:A,")4 ,3!303µ'%=, / (+"$(0D, 07,"$=, ,+ -21$<'(

µ%+ ?7!# ':7*<3- # 323%+ µ' "3, +,1:3*3 '.32:(!µ)2+$+03:3-?'% "+ '(!'$<)µ',+ 8'83µ7,+. @( <'($(!"74"=, E/T ?+ 2$72'( ,+ '%,+( *,D!"'4 "3- +,"(0'(µ7,3-, µ'+,1:3*# '02+%8'-!# 0+( '.'(8%0'-!#. @( +2+("3Cµ',3(*(+"$3% ?+ 2$72'( 0( +-"3% ,+ µ23$3C, ,+ <$#!(µ323(/-!3-, "#, '(!'$<)µ',# 2:#$3;3$%+ 0+( ,+ :1>3-, 7*0+(-$+ "#, >7:"(!"# +2);+!# *(+ "#, -*'%+ "3- +!?',3C4.

V,+ '-;-74 ;3$'") !C!"#µ+ 2$72'( ,+ '%,+( ':+-;$C 0+( 1,'"3. E 0+"+,1:=!# ',7$*'(+4 2$72'( ,+ '%,+(µ(0$/. B, +2+("'%"+( ;)$"(!#, +-"/ ?+ 2$72'( ,+ *%,'-"+( 'C03:+, *$/*3$+. P3 0)!"34 "3- ?+ 2$72'( ,+ '%,+(µ(0$) 6+ '%,+( +2:) !"# <$/!#, 0+( +!;+:74. 6+ 7<'(',!=µ+"=µ7,# (0+,)"#"+ '2'.'$*+!%+4 0+( ','$*323%-#!#4 !-,+*'$µ3C. A2(2$3!?7"=4, 2$72'( ,+ '%,+( +$0'-"1 +,?'0"(01 !' !-,?/0'4 0+"+2),#!#4.[H. Q'$8(03C-$#, 0+( :3(23% 2005], [Fabrice Axisa, 0+( :3(23% SEPTEMBER2005]

E 2$)3834 !"(4 '2(!"/µ'4 0+( "(4 "'<,3:3*%'4 2<.µ(0$3- 0+( ,+,3"'<,3:3*%'4 7<'( 8D!'( ,7'4 8-,+")"#-

"'4 !"#, 0+"+!0'-/ 0( ';+$µ3*/ >(3+(!?#"/$=, 23-'%,+( +)$+"3( 0+( 23:C +23"':'!µ+"(03%.

@( >(3+(!?#"/$'4 !-::7*3-, "+ >(3F+"$(01 8'83µ7-,+ )µ=4 +2) '0'% 0+( 27$+ # µ'"183!#, # µ3$;323%#-!# 0+( # +.(323%#!/ "3-4 +2+("'% 7,+ !C,3:3 +2) "'<,3-:3*%'4 "#:'2(03(,=,(D,. A8D 2'$(:+µ>1,3,"+( +!C$µ+"'4"'<,3:3*%'4 µ(0$/4 0+( µ'*1:#4 'µ>7:'(+4 )2=4 Bluetooth,GPRS & UMTS. [Field M.J. 1996], [http://el.wikipedia.org/wiki/Bluetooth/GSM]

:8+(µ%*C- :383'0 O%()$'0 !3#$1µG$?05/µ'$+, !"#, 2+*0)!µ(+ +*3$1 8(+"%?'"+( 7,+ 2'$(3$(-!µ7,3 2:/?34 "'<,3:3*(D, 23- +;3$3C, '-;-/ ;3$'"1>(3F+"$(01 !-!"/µ+"+. [H. Q'$8(03C$#, 0+( :3(23% 2005]

P3 Lifeshirt "#4 Bµ'$(0+,(0/4 '"+($%+4 VIVOMETRICS+23"':'% "3 2:73, +,+2"-*µ7,3 0+( 0:(,(01 830(µ+!µ7-,3 ;3$'") (+"$(0) !C!"#µ+, "3 323%3 2+$7<'( +8(1:'(-2"# 2+$+03:3C?#!# 2'$(2+"#"(0D, +!?',D,, µ7!=0+"+*$+;/4 0+( "32(0/4 +23?/0'-!#4 +,+2,'-!"(0D,0+( 0+$8(+0D, 2+$+µ7"$=,.

A%,+( "3 2$D"3 ;3$'") !C!"#µ+ µ# '2'µ>+"(0/4!-,'<3C4 2+$+03:3C?#!#4 23- µ23$'% ,+ !-::7.'(8'83µ7,+, 8#µ(3-$*D,"+4 µ(+ !-,'</ '(0),+ – 2$3;%:"#4 -*'%+4 "3- +")µ3- ',D +-") '0"':'% 0+,3,(01 "(40+?#µ'$(,74 "3- 8$+!"#$()"#"'4.[ http:// www.msobiz.com/site/SleepApnea /Vivo/]

@( <$/!"'4 ;3$3C, 7,+ ':+;$C 7,8-µ+ "3 323%3 µ23-$'% ,+ 2:-?'% 0+,3,(01 0+( !' 2:-,"/$(3. A,!=µ+"=-µ7,3( +(!?#"/$'4 !-::7*3-, !"3(<'%+ 23- +;3$3C, "#,0+$8(32,'-µ3,(0/ :'("3-$*%+ "3- 3$*+,(!µ3C. H23$'%,+ !-,8-+!"'% µ' 2$3+($'"(074 2'$(;'$'(+074 !-!0'--74 0+( ,+ 2+$+03:3-?'% :'("3-$*%'4 )2=4, #:'0"$30+$-8(3*$1;#µ+, #:'0"$3-µ-3*$1;#µ+, 2'$(38(0/ 0%,#!#238(D,, ?'$µ30$+!%+ !Dµ+"34, 03$'!µ)4 3.-*),3-+%µ+"34, 2%'!# CO2 !"3 +%µ+, +$"#$(+0/ 2%'!#, >/<+4.[http:// www. pdacortex. com/Vivo Metrics.htm]

E 0+$8(1 "3- !-!"/µ+"34 Lifeshirt '%,+( µ(+ "'<,3-:3*%+ 2+$+03:3C?#!#4 23- !"#$%&'"+( !' µ(+ '2+*=-*(0/ µ7?383 # 323%+ 3,3µ1&'"+( 2:#?-!µ3*$+;%+(plethysmografhy).

P3 -2) 2+$+03:3C?#!# 1"3µ3 µ23$'% ,+ +,+;7$'(µ1:(!"+ +2) µ),3 "3- !-µ2"Dµ+"+, 8$+!"#$()"#"'40+?D4 0+( "# ;+$µ+0'-"(0/ +*=*/ 23- :+µ>1,'( !'7,+, ;3$#") -23:3*(!"/ 2+:1µ#4 (PDA), 23- !-,87'-"+( +2'-?'%+4 µ' "3 *(:703.

P3 !C!"#µ+ µ23$'% '2%!#4 ,+ 2'$(:+µ>1,'( 7,+ #:'-0"$3,(0) #µ'$3:)*(3 "=, +!?',D, (Vivolog Digital Diary))23- µ23$3C, ,+ 0+"+*$1;3,"+( "+ 8'83µ7,+ "3- <$/!"#.

P3 Lifeshirt Sleep Diagnosis µ23$'% ,+ <$#!(µ3-23(#?'% 0+( *(+ "#, 2+$+03:3C?#!# "3- C2,3- H' "#<$/!# +-"/4 "#4 !-!0'-/4 >':"(D,'"+( # "+<C"#"+, #23()"#"+ 0+( # 3(03,3µ(0/ +2)83!# "=, µ':'"D, C2,3-,+;3C 2:73, 3( +!?','%4 µ23$3C, ,+ 2+$+03:3-?3C,"+(+2) "3 !2%"( "3-4. 5#µ+,"(0/ '%,+( # <$/!# "3- LifeshirtSleep Diagnosis !' )"( +;3$1 "#, +,%<,'-!# "#4 Obstructive

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 63

Page 65: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

[64] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")* '+',)$-*,*

Sleep Apnea (OSA). P3 Lifeshirt '%,+( 7,+ 1,'"3 7,8--µ+ "3 323%3 µ23$'% ,+ 2+$7<'( µ(+ -9#:/4 23()"#"+4!-::3*/ 8'83µ7,=, !' 1,'"3 *(+ "3, +!?',/ 2'$(>1:-:3, +,"(0+?(!"D,"+4 "#, 2(?+,), 8-!1$'!"# '.7"+!/"3- !"3 '$*+!"/$(3.[5;1:µ+! E +,+;3$1 "#4 -2'$-!C,-8'!#4 8', '%,+( 7*0-$#.], [\-<1$# X. 2005]

P3 Vivo Responder '%,+( 7,+ +0)µ# ;3$'") !C!"#-µ+ 2+$+03:3C?#!#4 23- µ23$'% !' 2$+*µ+"(0) <$),3,+ !-*0',"$D!'( !"3(<'%+ &="(0/4 !#µ+!%+4 (+,+2,'--!"(01, 0+$8(+01 0+?D4 0+( 1::3-4 ;-!(3:3*(03C4 8'%-0"'4) 2$(,, 0+"1 "# 8(1$0'(+ 0+( µ'"1 +2) 0123(+ 8$+-!"#$()"#"+. B;3$1 3µ18'4 23- '0"':3C, '2(0%,8-,'40+( 8C!03:'4 '$*+!%'4 – +23!"3:74, )2=4 2-$3!>7-!"'4 0+( 2$3!=2(0) "=, !=µ1"=, +!;+:'%+4.[http://www.vivometrics.com/]

Q'$(:+µ>1,'( 7,+ ':+;$C 0( 1,'"3 (µ1,"+ ';+2")-µ',3 !"3 ?D$+0+, 23- 2+$7<'( ;-!(3:3*(01 8'83µ7,+!' 2$+*µ+"(0) <$),3. A%,+( !<'8(+!µ7,3 D!"' ,+ +,"7-<'( +0)µ+ 0+( !"+ 2(3 0+"+23,#"(01 2'$(>1::3,"+.

P3 Y3$'") 5C!"#µ+ Wealthy '%,+( 7,+ ;3$#") !C!"#-µ+ 2+$+03:3C?#!#4 "=, &="(0D, !#µ'%=, "3- +,?$D-2(,3- 3$*+,(!µ3C '2% 24D$3- >1!'=4, µ'!032):[http://www.wealthy.gr]! P3, 7:'*<3 "#4 0+"1!"+!#4 -*'%+4 0+( "#, 7*0+($# +,%-

<,'-!# "#4 +!?7,'(+4.! P#, >3/?'(+ "=, <$#!"D, !' ;1!# +230+"1!"+!#4! P#, ',#µ7$=!# "=, <$#!"D, *(+ "#, 23$'%+ "#4 -*'%-

+4 "3-4! P#, µ'%=!# "=, 3(03,3µ(0D, 8+2+,D, "=, <$#!"D,

X$#!(µ323('% !C*<$3,+ '$*+:'%+ -9#:/4 "'<,3:3-*%+4 )2=4 7.-2,3-4 +(!?#"/$'4 -2) µ3$;/ (,D, 0+(,#µ1"=, 0+?D4 0+( 2$3#*µ7,'4 "'<,(074 '2'.'$*+!%+4!#µ1"=,.

P3 -:(0) '%,+( -23-+::'$*(0), µ23$'% ,+ 2:-?'%,'%,+( +$0'"1 ':+!"(0) D!"' +03:3-?'% "# µ3$;/ "3-!Dµ+"34, <=$%4 ,+ ',3<:'% "3 <$/!"#, ',D "+ +*D*(µ+!"3(<'%+ '%,+( ):+ ',!=µ+"=µ7,+ !"3 C;+!µ+, D!"' ,+'2("$723-, "#, 1,'!# 0+( "#, +2):-"# ':'-?'$%+ 0(,/-!'=, 0+"1 "# 8(1$0'(+ "3- ':7*<3- "=, !#µ1"=,. JC3µ#--;+,"(03% µ(0$3#:'0"$3,(03% +(!?#"/$'4 <$#!(µ3-23(3C,"+( *(+ ,+ !-::7.3-, "#, '!="'$(0/ ?'$µ30$+-!%+ 0+( ?'$µ30$+!%+ 87$µ+"34 "3- <$/!"#.[http://www.wealthy-ist.com/]

P3 Healthwear 21"#!' 21,= !"+ +23"':7!µ+"+ "#4'$'-,#"(0/4 83-:'(14 23- 7*(,' !"3 2:+%!(3 "3- Wealthy0+( +278'(.' !"#, 2$1.# "+ µ'*1:+ 3;7:# +2) "#, -:3-23%#!# ',)4 "7"3(3- '*<'($/µ+"34 !"#, 0+?#µ'$(,/2$+0"(0/.

H%+ +0)µ# ;3$'"/ !-!0'-/ '%,+( "3 Smart Shirt "#4Sensatex, 23- +$<(01 '%<' !<'8(+!"'% +2) "3 GeorgiaInstitute of Technology. A%,+( 7,+ 03,"3µ1,(03 µ2:3--&10( 23- !-::7*'( +2) )23(3, "3 ;3$1'( +$0'"1 +2) "+>+!(01 &="(01 !/µ+"+ "3- 3$*+,(!µ3C, ',D '%,+( !'?7!# ,+ +,(<,'C'( 0+( "(4 0(,/!'(4 "3-. H23$'% ,+ $+;"'%+,1:3*+ D!"' ,+ µ23$'% ,+ ;3$'?'% +2) 323(3,8/23-"'. V,+ µ=$) 23- ;3$1'( "3 smart shirt, µ23$'% ,+ 7<'(

-2) 2+$+03:3C?#!# "+ &="(01 "3- !/µ+"+ D!"' ,+ +23-;'-<?'% "3 !C,8$3µ3 "3- +(;,%8(3- >$';(03C ?+,1"3-(sudden infant death syndrome, SIDS), 23- 2+$+"#-$'%"+( 0-$%=4 0+"1 "# 8(1$0'(+ "3- C2,3-.[Park J. AndMar 2009]

L(+ ,+ 0+:-;?3C, 3( +,1*0'4 !<'"(01 µ' "# µ+0$3-2$)?'!µ#, !-,'</ 2+$+03:3C?#!# +!?',D,, 0-$%=4µ'*1:=, !' #:(0%+, +,+2"C<?#0' µ%+ 8(+0$("(0/, µ(0$/!-!0'-/ 2+$+03:3C?#!#4 !' µ3$;/ 8+<"-:(8(3C.[IkedaK., 0+( :3(23%. 1991]

@ +(!?#"/$+4 '%,+( ';38(+!µ7,34 µ' 32"3#:'0"$(-01 '.+$"/µ+"+ 23- '2("$723-, "# µ+0$32$)?'!µ# 2+$+-03:3C?#!# "#4 +$"#$(+0/4 2%'!#4 "3- +%µ+"34 0+?D40+( "3, 03$'!µ) "3- 3.-*),3- !"3 +%µ+ !-,'<D4 0+( µ'µ# '2'µ>+"(0) "$)23. B-"1 "+ !/µ+"+ +,+µ'"+8%83,"+(!' 7,+, !2("(0) -23:3*(!"/ *(+ 8(1*,=!# "#4 0+$8(+*-*'(+0/4 0+"1!"+!#4 "3- +!?',3C4. P3 8+<"-:%8( µ' "3,+(!?#"/$+ '%,+( ',"':D4 +!C$µ+"3 0+( µ' µ(0$) µ7*'-?34 D!"' 3 +!?',/4 ,+ µ23$'% ,+ "3 ;3$1'( 1,'"+ 24D$'4 "#, #µ7$+.

H%+ +,"%!"3(<# !-!0'-/ '2%!#4 +,+2"C<?#0' 0+(+2) "3-4 µ#<+,(03C4 "3- HGP.

P+ 7.-2,+ ',8Cµ+"+ 0+( *',(0)"'$+ "+ 7.-2,+ 0:=-!"3[;+,"3-$*(01 2$3F),"+ +23"':3C, ,7+ 0';1:+(+!"#, (!"3$%+ "=, 2$3F),"=,. E 2$)3834 !"#, -;+,"(0/"'<,3:3*%+, # ';+$µ3!µ7,# µ#<+,(0/ µ7!= -23:3*(-!"D, 0+( # '2(!"/µ# "=, -:(0D, 2$31*3-, µ(+ ,7+ *',(1:'("3-$*(0D, -;+!µ1"=,. E +,12"-.# 2$+*µ+"(01 8(+-8$+!"(0D, #:'0"$3,(0D, 0:=!"3[;+,"3-$*(0D, 2$3F-),"=, '%,+( "'<,(01 8-,+"/

E !-,'</4 ':1""=!# "3- µ'*7?3-4 "=, #:'0"$3,(-0D, !"3(<'%=, 7<'( 0+"+!"/!'( 8-,+"/ "# 8#µ(3-$*%+):3 0+( µ(0$)"'$=, #:'0"$3,(0D, !-!0'-D,. 5-!0'--74 3( 323%'4 '%,+( 2(3 'C03:3 ,+ µ'"+;'$?3C, / +0)µ+0+( ,+ ;3$'?3C,, )2=4 3( ';+$µ3*74 "3- wearablecomputing (;3$7!(µ# -23:3*(!"(0/ 8-,+")"#"+), 7<3-,+$<%!'( ,+ 'µ;+,%&3,"+( 0+( ,+ '.+2:D,3,"+( µ' "+<C-"+"3-4 $-?µ3C4. P3 )$+µ+ "#4 ;3$7!(µ#4 "'<,3:3*%+4'%,+( ,+ µ23$'% ,+ ':7*.'(, ,+ 2$3'(8323(/!'(, ,+ ',#-µ'$D!'(, ,+ <+:+$D!'(, / 0+( ,+ 8(+!0'81!'( +-"), 23-"# ;3$1'(. A2(2:73,, 2+$7<'"+( !"3 <$/!"# # '2(?-µ#-"/ (8(="(0)"#"+ 0+( +!;1:'(+ [Mann S., 1997]

@( ;3$7!(µ3( -23:3*(!"74 µ23$3C, ,+ ',323(#?3C,µ' "3 0+?#µ'$(,) ,"C!(µ3, µ' "# <$/!# +(!?#"/$(=,0-0:=µ1"=, ',!=µ+"=µ7,=, !' +*D*(µ+ -;+,"(01. L(+-") 0+( # 7.-2,# 7,8-!# '%,+( 0+"1 µ%+ 7,,3(+ # '.7-:(.# "3- wearable computing.

@( 2'$(!!)"'$'4 ';+$µ3*74 "=, -23:3*(!"D, 23-µ23$3C, ,+ ;3$'?3C, '%,+( !' '$'-,#"(0) '2%2'83.Q3::1 +0+8#µ+F01 (8$Cµ+"+, !-µ2'$(:+µ>+,3µ7,=,"=, MIT, Carnegie Mellon University (CMU), GeorgiaTech 0+( Tampere University of Technology, 7<3-,µ':'"/!'( ','$*1 "# ;3$7!(µ# -23:3*(!"(0/ 8-,+")-"#"+.

H(+ ';+$µ3*/ '%,+( "3 VIvago WristCare 23- '%,+(µ(+ !-!0'-/ *(+ "#, +-")µ+"# 0+"+*$+;/ "#4 '-'.%+4

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 64

Page 66: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1 [65]

!"!#"$%&'(")* '+',)$-*,*

!"#$ %&#µ'( #)' &' !*+',*&!&-./-' +%* &0" %1',&')2&/" 3!3'µ4"/" ,! 4"% +4"&-' 1'( '"'µ.5!&%* MultiLink+%* %146!* µ46-* 20 µ4&-%. 7' AMON (Advanced Care Alert Portable Telemedical

MONitor) !8"%* 4"% %+#µ% 1%-.3!*9µ% :'-4,*µ'( ,(,&2-µ%&'$ 1%-%+')';<0,0$ &0$ (9!8%$. =8"%* ,6!3*%,µ4"'9*% "% +%&%9-.:!* +%* "% %>*')'9!8 &% 5/*+. ,0µ!8% µ!&0 6-2,0 1-'09µ4"/" ?*'%*,<0&2-/". 7' SenseWear PRO armband &0$ BodyMedia, !8"%*

4"%$ 1')(-%*,<0&2-%$ 1'( 1%-%+')'(<!8 &' ,@µ% +%*!1*&-41!* &0 ,("!62 +%&%9-%:2 &/" 5/&*+@" ,0µ!8/"+%* &/" 3!3'µ4"/" &0$ :(,*+2$ 3-%,&0-*#&0&%$. A Micropaq %1# &0" WelchAllyn !8"%* 4"% 1%-.3!*9-

µ% µ*+-2$, !)%:-*.$, :'-4,*µ0$ %1# &'" %,<!"2, ,(,+!(-2$, µ! 6%-%+&0-*,&*+. :'-0&'; µ#"*&'-. 7' R TESTEvolution 3 %1# &0" Novacor %1'&!)!8 µ*% %+#µ% !:%--µ'92 1'( 38"!* &0 3("%&#&0&% ,("!6';$ %(&#µ%&0$ 1%-%-+')';<0,0$ &0$ +%-3*.$. B*% ,!*-. %1# 1%-#µ'*!$!:%-µ'94$ 46'(" +%&%,+!(%,&!8 %1# &*$ !&%*-!8!$Baxter, CardGuard +%* Reynolds Medical.C*% &0 µ4&-0,0 &/" +%-3*%+@" 1%)µ@" +%* &'( 0)!-

+&-'+%-3*'9-%:2µ%&'$, %"%1&;6<0+%" &% Textrodes,&% '1'8% !8"%* +%&%,+!(%,µ4"% %1# 8"!$ %"'>!83/&'(%&,%)*'; +%* 6-0,*µ'1'*';"&%* ,! .µ!,0 !1%:2 µ! &'34-µ% ,&' D%"!1*,&2µ*' Ghent.C*% &0 µ4&-0,0 &0$ %"%1"'2$ %"%1&;6<0+! 4"%$ %+#-

µ% %*,<0&2-%$ %1# +)/,&'E:%"&'(-9*+. ()*+.. A 5@"0Respibelt !8"%* !18,0$ +%&%,+!(%,µ4"0 %1# "2µ% %"'->!83/&'( %&,%)*'; [Axisa F., +%* )'*1'8 2005]

!"#$%&'&F* );,!*$ &/" :'-4,*µ/" %(&@" ,(,&0µ.&/" 1-41!* "%!8"%* 4&,* ,6!3*%,µ4"!$ @,&! "% !8"%* :*)*+4$ 1-'$ &'6-2,&0, +%* %-+!&. !(:(!8$ @,&! "% !"&'185'(" %" '%,<!"2$ &*$ 6-0,*µ'1'*!8 ,/,&.. =1*1-',<4&/$, &% ,(,&2-µ%&% <% 1-41!* "% !8"%* !1%-+@$ 3*%+-*&*+. 9*% "% µ0"3*%&%-.,,'(" &' ,("0<*,µ4"' &-#1' 5/2$ &'( %,<!"2+%* "% !1*&-41'(" &0" !1*+'*"/"8% µ! 4"%" !*3*+#, #1'-&! %(&2 +-8"!&%* %1%-%8&0&0.[ Wollina U+%* )'*1'8, 2003]

!"µ()*+'µ,%, F 4)!96'$ &/" 3%1%"@" µ1'-!8 "% 98"!* µ4,/ &/" &0)!-µ%&*+@" &!6"')'9*@", )%µ?."'"&%$ (1#G0 #&* #)!$ '*1)0-':'-8!$ +%* &% 3!3'µ4"% 1'( 1%-.9'"&%* 2 %>*'-1'*';"&%* 9*% &0" %"&*µ!&@1*,0 !"#$ 1!-*,&%&*+';, +%&%-9-.:'"&%* µ! 0)!+&-'"*+# &-#1'. A +%&%9-%:2 !1*&-4-1!* &0" %".)(,0 +%* %>*')#90,0 +%* +%&. ,("41!*% &0"%"&*,&'860,0 µ! 3!8+&!$ %1'&!)!,µ%&*+#&0&%$ +%* :(,*-+@" 3%1%"@".H" &4)'$ <(µ0<';µ! #&* 0 70)!I%&-*+2 !8"%* '(,*%-

,&*+. «(1'?'0<';,!$ &!6"')'98!$» +* #6* 4"%$ "4'$+).3'$ *%&-*+2$, &#&! µ1'-';µ! !;+')% "% 3!6&';µ!#&* 0 '-9."/,0 +%* 1%-'62 9*% 1%-.3!*9µ% +%&’ '8+'""',0)!8%$, <% %1'&!)4,!* %"&*+!8µ!"' 4"&'"'( %"&%9/-"*,µ'; µ!&%>; 30µ',8/" +%* *3*/&*+@" :'-4/". H1'&!)!8 '(,*%,&*+. (1'6-4/,0 &/" !1%99!)µ%-

&*@" (9!8%$ "% !8"%* ,! <4,0 "% 6-0,*µ'1'*';" &% &0)!-µ%&*+. ,(,&2µ%&% 1-'$ #:!)'$ &/" %,<!"@" +%* &/"*38/".

ABSTRACT

RREEVVIIEEWW““SSMMAARRTT WWEEAARRAABBLLEE BBIIOOMMEEDDIICCAALL SSYYSSTTEEMMSS”” FFOORR TTHHEE MMOONNIITTOORRIINNGG OOFF CCAARRDDIIOOVVAASSCCUULLAARR AANNDD RREESSPPIIRRAATTOORRYYDDIISSOORRDDEERRSSCChh.. KKaallookkaaiirriinnooss11,, DD.. ZZiikkooss22,, JJ.. MMaannttaass33

[[11.. PPhhyyssiicciisstt,, MMSScc HHeeaalltthh IInnffoorrmmaattiiccss,, 22.. NNuurrssee RRNN,, BBSScc,, MMSScc,, PPhhDD HHeeaalltthh IInnffoorrmmaattiiccss,, 33.. PPrrooffeessssoorr HHeeaalltthh IInnffoorrmmaattiiccss,,LLaabboorraattoorryy HHeeaalltthh IInnffoorrmmaattiiccss ooff NNuurrssiinngg DDeeppaarrttmmeenntt,, NNaattiioonnaall aanndd KKaappooddiissttrriiaann UUnniivveerrssiittyy ooff AAtthheennss]]

In an international level, the effort of reducing the mean time of hospitalization in secondary and tertiary health careinstitutions constitutes a common practice. Modern technologies provide the possibility of reliable and empoweredhealth care, out of hospitals. This fact becomes very important given that in contemporary societies the populationolder than 65 years old constantly increases. “Smart Wearable Biomedical Systems” could play a key-role in thepreventive health care. The present article constitutes a thorough study, based on the review of relevant printed andon-line Greek and International literature. The purpose of the study is to present current situation about “Smart WearableBiomedical Systems”, focusing on the monitoring of cardiovascular and respiratory disorders. Topics like telemedicine,telecare, informatics’ and communications’ technologies are presented as well. Additionally, concepts relatively biologicalsigns and the operation of biosensors regarding measuring vital parameters of human body are described.

KKeeyywwoorrddss:: Telemedicine, wearable systems, biosensors, life signs, health services, telecommunications, telecare,smart clothes.

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 65

Page 67: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

-./0.12*,34,!!""""##$$%%&&""''((((## ))**))""**++&&,,--..//--1. 0. 12,3*4+5,#, 1. 6*%)-7, 8.. 1-9-3%&*-$$#7 & :;$2,&<=27

[2005] «>#"2?-=,*4@ (=#$ 1,<A#», !43%(2*7 !$ 9"', BC@$- 2. D;E<,# F. (2005), “1,+7 =+ -5,*+”, >+ )@µ-, 20-08-20053. http://mpl.med.uoa.gr/ekpaideytiko-yliko/i-y-stin-iatrik/tileiatrik.pdf4. http://www.msobiz.com/site/SleepApnea/Vivo/5. http://www.pdacortex.com/VivoMetrics.htm6. http://www.vitatherapy.gr/DCA0AFF6.el.aspx7. http://www.vivometrics.com/8. http://www.wealthy.gr9. http://el.wikipedia.org/wiki/Bluetooth/GSM

GG22$$%%&&""''((((## ))**))""**++&&,,--..//--10. A.C.Norris [2002] Essentials of Telemedicine and Telecare,

WILEY11. Axisa F., Schmitt P. M., Gehin C., Delhomme G., McAdams E.,

Dittmar A., [2005], Flexible technologies and smart clothingfor Citizen Medicine, Home Healthcare, and Disease Prevention,H!!! Transactions on Information Technology in Biomedicine

12. Axisa F., Schmitt P. M., Gehin C., Delhomme G., McAdams E.,Dittmar A., [2005], Flexible technologies and smart clothingfor Citizen Medicine, Home Healthcare, and Disease Prevention,H!!! Transactions on Information Technology in Biomedicine

13. Boekhorst F., [2002], Ambient Intelligence, the Next Paradigmfor Consumer Electronics: How will it Affect Silicon, IEEE

International Solid-State Circuits Conference14. Ikeda K., Watanabe A. and Saito M. [1991], “A Vital Sign Sensor

for Elderly .People at Home”, Biotelemetry, Vol. 1115. John Mantas, Arie Hasman. [2007] 1"#,+.+,*4@ =#7 I&2/-7

J+(#"2;=*4@ 1,+(K&&*(#. H-=,*4K7 !43%(2*7 1.F. 1-(E-"/3#7 16. Mann S., [1997], Smart Clothing: The Wearable Computer

and WearCam, Personal and Ubiquitous Computing17. Fabrice Axisa, Pierre Michael Schmitt, Claudine Gehin, Georges

Delhomme, Eric McAdams, and André Dittmar [SEPTEMBER2005] Flexible Technologies and Smart Clothing for Citizen,Medicine, Home Healthcare, and Disease Prevention. IEEETRANSACTIONS ON INFORMATION TECHNOLOGY INBIOMEDICINE, VOL. 9, NO. 3

18. Field M.J. [1996] “Telemedicine: A guide to assessingtelecommunications in health care”, Washington, DC: NationalAcademy Press

19. Park J. And Martin S. [2009], “Smart Clothes”, CS147: Introductionto Human-Computer Interaction Design, Stanford University

20. Richard Wootton, John Gray, Victor Pathecon. [2006] Introductionto Telemedicine. Second edition. The Royal Society MedicinePress Ltd

21. Van Langenhove L., Hertleer C., [2004], Smart clothing: a newlife, International Journal of Clothing Science and Technology

22. Wollina U., Heide M., Müller-Litz W., Obenauf D., Ash J., [2003],Functional Textiles in Prevention of Chronic Wounds, WoundHealing and Tissue Engineering, Textiles and the Skin

[66] !""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

!"!#"$%&'(")H '*'+)$,-+H

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 66

Page 68: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1

56789:! 89; <5=! !=88>;?:9!

7' =))0"*+# D!-*'3*+# &0$ J',0)!(&*+2$ =1*,&2µ0$(=DJ=) !8"%* &' !18,0µ' 1!-*'3*+# &0$ =JKLAL JFLA-M=N7KJ =MMHOFL. =8"%* 4"% 3*!1*,&0µ'"*+# 1!-*'-3*+# µ! ,;,&0µ% +-*&@", µ! ,+'1# &0" 1-'@<0,0 &0$J',0)!(&*+2$ !1*,&2µ0$ ,&0" =)).3%.7' =))0"*+# D!-*'3*+# &0$ J',0)!(&*+2$ =1*,&2µ0$1%-46!* &0" 3("%&#&0&% 9*% &0 30µ',8!(,0 %+%30µ%I-+@" .-<-/" 1'( !+<4&'(" !-!("0&*+. ,(µ1!-.,µ%-&%, %"%,+'12,!*$ ?%,*,µ4"!$ ,&0" 4-!("%, .-<-%,(52&0,0$ +%* ,6#)*% 1'( !"3*%:4-'(" &' 3*!<"4$%"%9"/,&*+# +'*"# &/" !1%99!)µ%&*@", &/" !+1%*3!(-&*+@", &/" 3*'*+0&@" +%* &/" !-!("0&@" ,! #)'($ &'($&'µ!8$ &0$ "',0)!(&*+2$, +%* &/" !1*,&0µ@" :-'"&8-3%$ (9!8%$.

<=@59 ;>A>BC 7' =DJ= 30µ',*!;!* &% .-<-% +.&/ %1# &-!*$ +;-*!$+%&09'-8!$: - P-<-% ,;"&%>0$ - 7% .-<-% ,;"&%>0$ 1'( !8"%* ,6!&*+. ,;"&'µ% (µ49*-,&' 200 )4>!/").

- D-/&#&(1% .-<-% - !-!("0&*+4$ !-9%,8!$

• 7% 1)2-0 .-<-% 1'( %"%:4-'"&%* ,! 1-/&'9!"24-!("% µ1'-';" "% !8"%* µ46-* 5.000 )4>!*$.

• 7% 1-/&#+'))% &/" +)*"*+@" 3'+*µ@" 1-41!* "%!8"%* µ46-* 2.500 )4>!*$. F* ,(99-%:!8$ 1-41!* "%30)@,'(" &'" %-*<µ# µ0&-@'( &0$ 3'+*µ2$ (!."(1.-6!*), +%<@$ !18,0$ +%* 1#&! <% 1%-'(,*%,&';"&% ,(µ1!-.,µ%&%.

H"%,+'12,!*$ +%* ,;"&'µ!$ 1%-'(,*.,!*$ (µ46-* 2000)4>!*$)

• H"%,+'12,!*$, 1'( 1!-*)%µ?."'(": - ,(,&0µ%&*+4$ %"%,+'12,!*$, µ!&%-%".)(,0,- ?*?)*'9-%:*+4$ %"%,+'12,!*$, - 1')*&*+4$ %"%,+'12,!*$.- .))'( !83'($ (1.6 +'*"/"*+'-'*+'"'µ*+4$)

• P-<-% +-*&*+2$ ?*?)8/": J% !8"%* µ46-* 1000 )4>!*$.

69;69D;!9; =@5-5E7! ;>A>BC F* ,(99-%:!8$ 1-41!* "% (1'?.))'(" &% 6!*-#9-%:%,&' 1!-*'3*+# 0)!+&-'"*+. µ4,/ &'( 0)!+&-'"*+';

&%6(3-'µ!8'( &'( 1!-*'3*+';: [email protected]. Q)00 %))0)'9-%:8%, ,(µ1!-*)%µ?%"'µ4"0$ &0$ %"%+'8-"/,0$ &0$ %1#:%,0$ &'( (1!;<("'( ,;"&%>0$ +%* &/"%*&0µ.&/" 9*% !1%"!>4&%,0, <% 98"'"&%* µ! &' 0)!-+&-'"*+# &%6(3-'µ!8'. A (1'?')2 !"#$ .-<-'(, 1-'-E1'<4&!* #&* 3!" 46!* 30µ',*!(<!8 1-'09'(µ4"/$, #&*3!" !8"%* (1# !>4&%,0 9*% 30µ',8!(,0 %))'; +%* #&*!." 98"!* %1'3!+&# 3!" <% 30µ',*!(<!8 %))';, ,&%%99)*+. 2 ,! '1'*%321'&! .))0 9)@,,%, 6/-8$ &0 9-%-1&2 ,(9+%&.<!,0 &'( !+3#&0.

6.,F.G,'4, ,H.10I2&'&JH-6*+. #)% &% .-<-% %>*')'9';"&%* %1# &0" ,("&%+&*-+2 !1*&-'12 +%* +%&%"4µ'"&%* %". <!µ%&*+# &'µ4%,&'($ +-*&4$. H+')';</$ 98"'"&%* %1'3!+&. 9*% 30µ'-,8!(,0 µ!&. %1# µ*% 3*1)2 µ(,&*+2 %>*')#90,0 %1#&'().6*,&'" 3;' +-*&4$. F* +-*&4$ %1':%8"'"&%* !." &' .-<-' !8"%*: (%) H1'3!+&# 9*% 30µ',8!(,0 6/-8$ &-'1'1'*2,!*$. (?) H1'3!+&# 9*% 30µ',8!(,0 µ! µ*+-4$ &-'1'1'*2-,!*$.

(9) H1'3!+&# 9*% 30µ',8!(,0 +%&#1*" ,0µ%"&*+@" &-'-1'1'*2,!/".

(3) B0 %1'3!+&# 9*% 30µ',8!(,0 ,&0" 1%-';,% µ'--:2.

@>5:<59K;!9; <5= L:9>58>;?5=CC!!""**++44$$ ''33009988!!$$:: F* (1'?)0<!8,!$ !-9%,8!$ 1-41!*"% !8"%* +%&.))0)!$ 9*% 3*!<"4$ %+-'%&2-*' +%* '*,(99-%:!8$ 3!" 1-41!* "% 1!-*'-85'"&%* µ#"' ,&*$!<"*+4$ +%* 1')*&*+4$ 1-%+&*+4$ +%* &0" !96@-*% "'µ'-<!,8%. R.<! .-<-' 1-41!* "% ,("'3!;!&%* %1# !1*-,&')2 &'( ,(99-%:4%, (1#3!*9µ% &0$ '1'8%$ (1.-6!*,&0" ,!)83% &'( 1!-*'3*+'; 1'( :*)'>!"!8&%* ,&0"0)!+&-'"*+2 3*!;<(",0 &0$ =J=: www.enne.gr L&0" !1*,&')2 <% %"%:4-'"&%* &% %+#)'(<%:• S!?%8/,0 #&* 0 !-9%,8% 3!" 46!* 30µ',*!(&!8 ')#-+)0-0 2 &µ2µ% %(&2$ ,! .))' 1!-*'3*+#.

• O2)/,0 #&* &' &!)*+# +!8µ!"' &0$ !-9%,8%$ %"%9"@-,&0+! +%* !9+-8<0+! %1# #)'($ &'($ ,(99-%:!8$.

• C-%1&2 ?!?%8/,0 .3!*%$ (H-. 1-/&'+#))'( 49+-*-,0$) 3*!>%9/92$ &0$ µ!)4&0$ %1# &0" =1*&-'12 A<*-+2$ +%* O!'"&')'98%$ &'( :'-4% ,&'" '1'8' 3*!>2-6<0 0 !" )#9/ µ!)4&0.

• 7' '"'µ%&!1@"(µ', &0" &%6(3-'µ*+2 +%* &0" 0)!-+&-'"*+2 3*!;<(",0 +%<@$ +%* &' &0)4:/"' &'( ,(9-9-%:4% 1'( !8"%* (1!;<("'$ 9*% &0" %))0)'9-%:8%.H"%)(&*+4$ 1)0-':'-8!$ ,6!&*+. µ! &0 3*%3*+%,8%

! " " # $ % & '( ) * % + , % & ' - # ./+0#")1-%&2.! ( % 0 - 2 µ # .

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 67

Page 69: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

%.*")'

0)!+&-'"*+2$ (1'?')2$ &'( .-<-'( 30µ',*!;'"&%*,&0" *,&',!)83% µ%$.

5>8;CB!7 <5= L:9>58>;?5=F-9%"@,&! &' 6!*-#9-%:' ,&0" %+#)'(<0 ,!*-.: &8&-)'$ &'( .-<-'(, ,!)83% &8&)'(, !(6%-*,&8!$, 1!-8)0-G0 +%* )4>!*$ +)!*3*., +!8µ!"', ?*?)*'9-%:*+4$ %"%-:'-4$, 18"%+!$, %-*<µ'8, 1%-.-&0µ% (9-%µµ%&',!*-.:TIMES NEW ROMAN µ49!<'$ 12, 1.5 3*.,&0µ% 9-%µ-µ@"). D%-%+%)';µ! %-*<µ2,&! &*$ ,!)83!$ &'( 6!*-'-9-.:'( ,%$.

7788&&))''$$:: F &8&)'$ !"#$ .-<-'( 1-41!* "% 1!-*9-.:!* &'<4µ% &'( +%* #1'( !8"%* ,6!&*+# &'" 1)0<(,µ#, &' +)*-"*+# 1-#?)0µ% +%* &0" µ4<'3' &0$ 4-!(".$ &'(.

LL!!))8833%% &&88&&))''((:: A ,!)83% &8&)'( 1!-*)%µ?."!*:• 7' 1)2-!$ #"'µ%, &'" 1)2-0 &8&)' &'( .-<-'( (µ46-*

90 6%-%+&2-!$), &% %+%30µ%I+. +%* !1%99!)µ%&*+.1-',#"&% +%* &' *",&*&';&' 9*% +.<! ,(99-%:4%.

• 70" 3*!;<(",0 0)!+&-'"*+'; &%6(3-'µ!8'( 9*% &'"+.<! ,(99-%:4%.

• 70" 0µ!-'µ0"8% (1'?')2$ &'( .-<-'(.

==((66%%--**,,&&88!!$$:: C-.:'"&%* !(6%-*,&8!$ ,&'($ ?%,*+';$,("!*,:4-'"&!$.

DD!!--88))00GG00:: F* 1!-*)2G!*$ 1-41!* "% !8"%* µ46-* 250)4>!*$, +%* 3!" 1-41!* "% 1!-*).?'(" ?*?)*'9-%:*+4$%"%:'-4$ 2 &*$ ,("&µ2,!*$.F* 1!-*)2G!*$ &/" !-!("0&*+@" !-9%,*@" 1-41!* "%(*'<!&2,'(" &'($ %+#)'(<'($ &8&)'($, #1'( !8"%*3("%&#": (%) =*,%9/92, (?) N)*+# +%* µ4<'3'$, (9)H1'&!)4,µ%&%, (3) L(52&0,0, (!) D!-*'-*,µ'8 µ!)4-&0$ +%* (,&) L(µ1!-.,µ%&%, &% '1'8% 1-41!* "% %:'--';" &'($ ,&#6'($ +%* &*$ (1'<4,!*$ µ!)4&0$. K%*1-'&.,!*$ 9*% !:%-µ'92 &/" %1'&!)!,µ.&/" ,&0"+)*"*+2 1-.>0. F* 1!-*)2G!*$ 9*% &*$ %"%,+'12,!*$ 1-41!* "% 1%-4-6'(" µ*% 1!-8)0G0 (1# &'($ %+#)'(<'($ &8&)'($,#1'( !8"%* 3("%&#": =*,%9/92, ,+'1#$, !18 µ4-'($,&#6'*, %"%,+#10,0 ?*?)*'9-%:8%$: 1094$ 3!3'µ4-"/", µ4<'3'* %"%,+#10,0$, %1'&!)4,µ%&%, ,(µ1!--.,µ%&%. F* 1!-*)2G!*$ 9*% &% .-<-% +-*&*+2$ ?*?)8/" 1-41!*"% 1%-46'(" µ*% ,("'1&*+2 1!-8)0G0 &0$ 9-%µµ2$!1*6!*-2µ%&'$ 1'( %+')'(<!8&%* +%* ,(µ1!-%,µ.&/".

MM44>>!!**$$--++))!!**33**..:: F %-*<µ#$ %(&@" "% !8"%* µ46-* 4>*)4>!*$-+)!*3*. +%&. %):%?0&*+2 ,!*-., '* '1'8!$1-',3*'-85'(" %+-*?@$ &' <4µ% &'( .-<-'(, ,+'1#+%* µ4<'3'. T-0,*µ'1'*2,&! &'" *%&-*+# <0,%(-# &8&-)/" (MeSH®) +%* (CINAHL) #1'( !8"%* 3("%&#".

RR!!88µµ!!""'':: L&0" !*,%9/92 &'( +!*µ4"'( %1%*&!8&%* 9*%

#)% &% .-<-% "% 46'(" µ*% %"%:'-. ,! %(&# 1'( !8"%*230 9"/,&# 9*% &' <4µ% +%* &* !8"%* %(&# 1'( &' .-<-'1-',<4&!* ,&0" "',0)!(&*+2 !1*,&2µ0. H"%)#9/$ &0$+%&09'-8%$ &'( .-<-'( %+')'(<!8&%* 0 %+#)'(<0 µ'--:2:F* %"%,+'12,!*$ 1-41!* %1%-%8&0&% "% 1!-*)%µ?.-"'(" (%) =*,%9/92, (?) L+'1#, (9) N)*+# +%* µ4<'3',(3) H1'&!)4,µ%&%, (!) L(52&0,0, (,&) L(µ1!-.,µ%&%+%* "% %+')'(<';" &0" %".1&(>0 &0$ 1!-8)0G0$ %)).,! µ!9%);&!-0 4+&%,0.F* !-!("0&*+4$ !-9%,8!$ 1-41!* "% %+')'(<';" ,(9+!-+-*µ4"0 3'µ2: (%) =*,%9/92, (?) N)*+# +%* µ4<'3'$,(1-41!* %1%-%8&0&% "% %"%:4-!&%* 0 6-'"*+2 1!-8'-3'$ ,(9+4"&-/,0$ &/" 3!3'µ4"/", 0 1092 &/" 3!3'-µ4"/", &' µ49!<'$ +%* 0 µ4<'3'$ !1*)'92$ &'( 3!89-µ%&'$, )!1&'µ4-!*!$ 9*% &' 1@$ !1*)46<0+%", +-*&2-*%!1*)'92$ +%* %1'+)!*,µ';, %-*<µ'8 %(&@" 1'( !*,.-9'"&%* +%* 1'( %:2"'(" &0 µ!)4&0, &% ,6!&*+. +)*"*-+. +%* 30µ'9-%:*+. 6%-%+&0-*,&*+., 0 µ!<'3')'98%,())'92$ &/" 3!3'µ4"/", &' !-9%)!8' 9*% &0 ,())'-92 &/" 3!3'µ4"/", 0 .3!*% 6-2,0$ %(&';, 0 3*%3*+%-,8% ,&.<µ*,0$ %(&';, &' 1',',&# %"&%1#+-*,0$, &'!83'$ &0$ ,&%&*,&*+2$ %".)(,0$ 1'( 6-0,*µ'1'*2<0-+!), (9) H1'&!)4,µ%&% 1'( 1-41!* "% ,("'3!;'(" %+-*-?!8$ &*µ4$ ,&%&*,&*+2$ ,0µ%"&*+#&0&%$ (3) L(52&0,0,(!) D!-*'-*,µ'8 µ!)4&0$ +%* (,&) L(µ1!-.,µ%&%, &%'1'8% 1-41!* "% %:'-';" &'($ ,&#6'($ +%* &*$ (1'-<4,!*$ µ!)4&0$. +%* 1-'&.,!*$ 9*% !:%-µ'92 &/" %1'-&!)!,µ.&/" ,&0" +)*"*+2 1-.>0. F* !"3*%:4-'(,!$ 1!-*1&@,!*$ 3*%+-8"'"&%* ,&% &µ2-µ%&%: (%) =*,%9/92, (?) D!-*9-%:2 1!-81&/,0$, (9)L6#)*'.F* ?-%6!8!$ 30µ',*!;,!*$ 3*%+-8"'"&%* ,&% &µ2µ%&%:(%) =*,%9/92, (?) N)*+# +%* µ4<'3'$, (9) H1'&!)4,µ%-&%, (3) L(52&0,0.

DD88""%%++!!$$//%%--**<<µµ''88:: F* 18"%+!$ +%* '* %-*<µ'8 !8"%* &(1/-µ4"'* µ#"' #&%" !+:-.5'(" +.&* 1!-*,,#&!-' %1# %(&#1'( µ1'-!8 "% 98"!* %1# &*$ )4>!*$. F* 18"%+!$ 1-4-1!* "% %-*<µ0<';" µ! ,("41!*% +%* "% &'($ 3'<!8 4"%$+%&.))0)'$ &8&)'$ +%* +.<! 18"%+%$ "% 3%+&()'9-%-:!8&%* ,! >!6/-*,&2 ,!)83%.

BB''""..33!!$$ µµ44&&--00,,00$$:: B!&-2,!*$ µ2+'($, ;G'($, ?.-'($+%* #9+'( 1-41!* "% %"%:4-'"&%* ,! µ!&-*+4$ µ'".-3!$ ,;µ:/"% µ! &% 3*!<"@$ %"%9"/-*,µ4"% ,;µ?'-)%.

LL((""&&µµ22,,!!**$$:: H1':;9!&! &*$ ,("&µ2,!*$ '1'(321'&!!8"%* 3("%&#". F1'*!,321'&! ,("&µ2,!*$ 1'( '* ,(9-9-%:!8$ ,+'1!;'(" "% 6-0,*µ'1'*2,'(", 1-41!* "%+%&%9-%:';" 1)2-/$ +%* "% %+')'(<0<';" %1# 9-.µ-µ%&% !"&#$ 1%-!"<4,!/$ &0" 1-@&0 :'-. 1'( !µ:%-"85'"&%*. F* ,("&µ2,!*$ &/" &8&)/" &/" 1!-*'3*+@" 1-41!* "%

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 68

Page 70: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1

%.*")'

9-.:'"&%* ,;µ:/"% µ! &' Index Medicus, 1'( 30µ'-,*!;'"&%* +.<! 6-#"', &'" U%"'(.-*', ,! 6/-*,&# &!;-6'$ (List of Journals Indexed in Index Medicus). C*%&*$ ,("&µ2,!*$ &/" !))0"*+@" 1!-*'3*+@" (1.-6!* o,6!&*+#$ +%&.)'9'$ &'( UH7VO7=R.

LL&&%%&&**,,&&**++22:: D-41!* "% 6-0,*µ'1'*0<';" 1-#&(1'* +%*3*!<"@$ %"%9"/-*,µ4"'* µ4<'3'* 1%-'(,8%,0$ ,&%-&*,&*+'; ()*+';.

LL((99++%%&&..<<!!,,00 ==""00µµ44--//,,00$$:: F* ,(99-%:!8$ <% 1-41!*"% !1*?!?%*@,'(" #&* &2-0,%" &*$ %-64$ 3!'"&')'-98%$ 9*% &0" 4-!("%, #1/$ %(&4$ 3*%&(1@"'"&%* ,%:@$%1# &0 O*!<"2 =1*&-'12 =+3'&@" U%&-*+@" =1*,&0µ'-"*+@" D!-*'3*+@" (International Committee of MedicalJournal Editors, www. icmje.org) +%* &0 O*%+2-(>0&'( =),8"+* (World Medical Association Declarationof Helsinki, 2000). O0)%32 #1'( !8"%* %1%-%8&0&' '*,(99-%:!8$ 1-41!* "% !1*?!?%*@,'(" #&* &% %1'&!-)4,µ%&% &/" µ!)!&@" &'($ 1-'4+(G%" %1# !-!("0&*-+4$ !-9%,8!$, 1'( 0 ,(9+%&.<!,0 !"0µ4-/,0$ )2:<0-+! %1# &'($ ,(µµ!&46'"&!$ %"<-@1'($ +%* &*$ %-µ#3*!$%-64$ 0<*+2$ +%* 3!'"&')'98%$.

PP33!!**!!$$:: A .3!*% "% %"%1%-%6<!8 &' 1-'09'(µ4"/$30µ',*!(µ4"' ()*+# 1-41!* "% )0:<!8 !99-.:/$ %1#&'" +.&'6' 1"!(µ%&*+@" 3*+%*/µ.&/".

==--//&&00µµ%%&&''))##99**%%:: =-/&0µ%&')#9*% +%* 1-'9-.µµ%&%%>*')#90,0$ 1'( 6-0,*µ'1'*';"&%* ,&*$ !-!("0&*+4$µ!)4&!$ 1'( 3!" !8"%* +%<*!-/µ4"% +%* 9"/,&. 1-4-1!* "% 1!-*)0:<';" /$ 1%-.-&0µ%.

SS**??))**''99--%%::**++44$$ HH""%%::''--44$$:: Q)!$ '* 30µ',*!;,!*$ 1'(%"%:4-'"&%* ,&' +!8µ!"' 1-41!* "% 1%-'(,*%,&';",! 4"%" +%&.)'9' ?*?)*'9-%:*+@" %"%:'-@". F* %"%-:'-4$ 1-41!* "% 3'<';" µ! &' ,;,&0µ% «Harvard»Revised for 2009 version 3.0 editions of: The CoventryUniversity (CU) Harvard Reference Style Guidev3.0,Quickstart Guide v3.0,Glossary v3.0.

D%-.3!*9µ%:1. 6*- )*)"/+ µ2 K$- (;&&,-.K-: Biggs, G. (2000) Gender and Scientific

Discovery. 2nd edn. London: Routledge 2. 6*- )*)"/+ µ2 9+""-9"+57 (;&&,-.2/7: Ong, E., Chan, W. and Peters,

J. (2004) Advances in Engineering. 2nd edn. London: Routledge3. 6*- K$- 42.<"-*+ @ 3+4/µ*+ (;&424,*µK$+; (;&&,-.K- (2 K$-)*)"/+: Aggarwal, B. (2004) “Has the British Bird PopulationDeclined?” In a Guide to Contemporary Ornithology. ed by Adams,G. London: Palgrave, 66-99

4. 6*- K$- =;9'µK$+ <,C,+ (2 92,*+3*4%: Padda, J. (2003) “CreativeWriting in Coventry”. Journal of Writing Studies 3 (2) 44-59

5. 6*- µ*- *(=+(2"/3-: Centre of Academic Writing The List of ReferencesIllustrated [online] available from http://home.ched.coventry.ac.uk/caw/harvard/index.htm [Sept 2009]

6. 6*- K$- <,C,+ (2 #"24=,+$*4% 92,*+3*4%: Dhillon, B. (2004) “ShouldDoctors Wear Ties?” Medical Monthly [online] 3 (1) 55-88. availablefrom http://hospitals/infections/latest-advice [20 April 2005]

!7K;C<9D7 !7K:9B!7=." (1'?.))!&! 4"% .-<-' 1'( 46!* 230 %>*')'90<!8%1# &0" ,("&%+&*+2 !1*&-'12 &'( =DJ=, 1%-%+%)@"% ,("(1'?.))!&! 0)!+&-'"*+# µ2"(µ% 1'( 1%-46!*&*$ &(6#" 1%-%&0-2,!*$ ,%$ ,&% ,6#)*% &'( !+3#&0 +%*&/" +-*&@".

=@7>:!9:! @>5! !=88>;?:9! F* H1'3!8>!*$ &0$ 3*%+8"0,0$ &/" .-<-/" 98"'"&%*BFJF 0)!+&-'"*+..

;M+%"(, 7-8% %".&(1% <% 3'<';" 3/-!." ,&'" (1!;<("' !1*-+'*"/"8%$ &'( .-<-'(.

@M)"µ,%.G+ F.G,.Nµ,%, 7% D"!(µ%&*+. 3*+%*@µ%&% &/" 30µ',*!(<4"&/" .-<-/"%"2+'(" ,&'($ ,(99-%:!8$. 7' D!-*'3*+# 3*%&0-!8 &'3*+%8/µ% &0$ %"%1%-%9/92$ 2 &0$ %"%30µ',8!(,0$&'( .-<-'( µ! ,+'1# &0" 1-'%9/92 &0$ J',0)!(&*-+2$ =1*,&2µ0$.A =J= <% 1-'?!8 ,! #)!$ &*$ %1%-%8&0&!$ !"4-9!*!$9*% &0" !99;0,0 &0$ 1-',&%,8%$ &/" 1"!(µ%&*+@"3*+%*/µ.&/" &/" ,(99-%:4/".

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 69

Page 71: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

:(.%1µ$ O*$'.µPM (0&*131*.NM

!Q'%,'& %&J :C:A =J= ,(,&2<0+! 3*% &'( J#µ'( 3252/2004 (1# &0" µ'--:2 J'µ*+'; D-',@1'( O0µ',8'( O*+%8'( +%* )!*&'(--9!8 /$ !18,0µ'$ !1%99!)µ%&*+#$ ,;))'9'$ &/" J',0-)!(&@". A !99-%:2 ,! %(&2" #)/" &/" J',0)!(&@", !8"%*(1'6-!/&*+2, #1/$ ,(µ?%8"!* ,! +.<! %"&8,&'*6' !1*-µ!)0&2-*' .))/" !1%99!)µ%&*@" 1'( )!*&'(-9!8 /$ -(<-µ*,&*+#$ :'-4%$ +%* !18,0µ'$ ,;µ?'()'$ &0$ D')*&!8-%$ (D%"!))2"*'$ U%&-*+#$ L;))'9'$, O*+09'-*+#$ L;))'9'$H<0"@", 7!6"*+# =1*µ!)0&2-*' =)).3'$, +.&.)).

D"*.I%)*1. 'G1(14 %&J :C:C*% "% 98"'(" +%&%"'0&'8 '* )#9'* 1'( 1-41!* #)'* '*"',0)!(&4$ "% !8"%* !99!9-%µµ4"'*, 1%-%<4&'(µ! &'($?%,*+#&!-'($ ,&#6'($ 1'( 1!-*9-.:!* ' J#µ'$ 3252/2004+%* 1'( +%)!8&%* "% !1*&!)4,!* 0 =.J.=:

• &0" 1-'%9/92 +%* %".1&(>0 &0$ J',0)!(&*+2$ /$%"!>.-&0&0$ +%* %(&#"'µ0$ !1*,&2µ0$ +%* &46"0$

• &0" 4-!("%, %".)(,0 +%* µ!)4&0 &/" "',0)!(&*+@"<!µ.&/" +%* &0 ,;"&%>0 +%* (1'?')2 !1*,&0µ'"*+.&!+µ0-*/µ4"/" µ!)!&@" 9*% &% 3*.:'-% "',0)!(&*+.1-'?)2µ%&% &0$ 6@-%$

• &0 3*%&;1/,0 !*,092,!/" 9*% "',0)!(&*+. <4µ%&%• &0 3*%-+2 !+1%83!(,0, µ!&!+1%83!(,0 +%* !1*µ#--:/,0 &/" J',0)!(&@" +%* &0" ()'1'80,0 +%* %>*'-1'80,0 !+1%*3!(&*+@" 1-'9-%µµ.&/"

• &0 ,(µµ!&'62 ,&0" ()'1'80,0 1-'9-%µµ.&/" 1'( !1*-6'-09';"&%* %1# &0" =(-/1%I+2 W"/,0 2 .))'($ 3*!-<"!8$ '-9%"*,µ';$

• &0" 4+3',0 1*,&'1'*0&*+@", %1%-%8&0&/" 9*% &0" .3!*%.,+0,0$ !1%994)µ%&'$ &/" J',0)!(&@"

• &'" 1!-*'-*,µ# &0$ %"&*1'80,0$ &'( "',0)!(&*+';!1%994)µ%&'$

• &0" %>*')#90,0 &0$ 1%-!6#µ!"0$ "',0)!(&*+2$ :-'-"&83%$

• &0" !+1-',@10,0 &0$ 6@-%$ ,! 3*!<"!8$ '-9%"*,µ';$&'( "',0)!(&*+'; +).3'(

• &0" 4+3',0 1!-*'3*+';, !"0µ!-/&*+'; 3!)&8'(, ,(9-9-%µµ.&/" +%* :())%38/" 9*% &0" !"0µ4-/,0 &/"µ!)@" &0$ %)). +%* &'( +'*"/"*+'; ,("#)'(

• &0 µ!)4&0 (9!*'"'µ*+@" <!µ.&/" +%* &0" '-9."/,0!1*,&0µ'"*+@" ,("!3-8/" %(&#"'µ% 2 ,! ,("!-9%,8%µ! .))'($ :'-!8$

• &0 30µ*'(-98% !1*&-'12$ 3!'"&')'98%$ +%* 0<*+2$ &'(!1%994)µ%&'$ &'( "',0)!(&2

• &'" +%<'-*,µ# +%* +',&')#90,0 &/" "',0)!(&*+@"1-.>!/" +%*

• &0" 1-',&%,8% +%* 1-'%9/92 &0$ (9!8%$ &'( =))0"*-+'; M%';.

KR0& %&J :C:B4)0 &0$ =.J.= !8"%* (1'6-!/&*+@$ #)'* '* "',0)!(&4$1'( !8"%* %1#:'*&'*: %) 7µ0µ.&/" J',0)!(&*+@" A.E.I.,?) J',0)!(&*+@" 7µ0µ.&/" T.E.I., 9) D-@0" H"@&!-/"L6')@" H3!):@" J','+#µ/", =1*,+!1&-*@" H3!):@"J','+#µ/", %-µ'3*#&0&%$ N1'(-9!8'( N9!8%$, D-#"'*-%$ +%* R'*"/"*+@" H,:%)8,!/", 3) D-@0" J',0)!(&*-+@" L6')@" RH7==, !) J',0)!(&*+@" L6')@" 2 7µ0µ.-&/" &0$ %))'3%12$, &/" '1'8/" &% 3*1)@µ%&% 46'("%"%9"/-*,&!8 /$ *,#&*µ% µ! &% 1&(68% &/" "',0)!(&*+@",6')@" &0$ 0µ!3%12$ %1# &*$ %-µ#3*!$ (10-!,8!$ +%*,&) L&-%&*/&*+@" H"/&.&/" J',0)!(&*+@" L6')@".

6.+*S*P'& %&J :C:A =J= 3*%-<-@"!&%* ,! R!"&-*+2 O*'8+0,0, 1'( !3-!;-!* ,&0" H<2"% +%* ,! !1&. D!-*:!-!*%+. 7µ2µ%&%, 1'()!*&'(-9';" ,! +.<! N9!*'"'µ*+2 D!-*:4-!*% &0$ 6@-%$.

D)M%*.G$ 6.14G&'&A R!"&-*+2 O*'8+0,0 %1'&!)!8&%* %1# 15µ!)4$ O.L +%*46!* 43-% &0" H<2"%. A 3*!;<(",0 &/" 9-%:!8/" !8"%*:M!/:#-'$ S%,*)8,,0$ L':8%$ 47, 7.R. 10676, &0). 2103648044, 048 +%* fax. 210 3617859 +%* 210 3648049. A*,&',!)83% &0$ =.J.= !8"%* www.enne.gr +%* &' e-mail:[email protected].

@)*.3)*).,G+ <µ$µ,%,7% !1&. D!-*:!-!*%+. 7µ2µ%&% (D.7) &0$ =.J.=, %+'-)'(<';" &'" %-*<µ# &/" N9!*'"'µ*+@" D!-*:!-!*@"(N.D.=) +%* !8"%* &% %+#)'(<%:1. 1' D.7. H&&*+2$: M!/:#-'$ S%,*)8,,0$ L':8%$ 47,7.R. 10676, &0). 210 3648044, 048 +%* fax. 210 3617859+%* 210 3648049

2. 2' D.7. D!*-%*@$ +%* H*9%8'(: M!/:#-'$ S%,*)8,-,0$ L':8%$ 47, 7.R. 10676, &0). 210 3648044, 048+%* fax. 210 3617859 +%* 210 3648049

3. 3' D.7. B%+!3'"8%$: B%?8)0 11, X!,,%)'"8+0, 7.R.54630, &0). 2310522822 +%* fax. 2310522219

4. 4' D.7. B%+!3'"8%$ +%* X-.+0$: B%?8)0 11, X!,,%-)'"8+0, 7.R. 54630, &0). 2310522229 +%* fax. 2310522219

5. 5F D.7. X!,,%)8%$ +%* L&!-!.$ =)).3%$: J%(%-8"'(2, M.-*,%, 7.R. 41223, &0). 2410284866 +%* fax. 2410284871

6. 6' D.7. D!)'1'""2,'(, U'"8/" "2,/", A1!8-'( +%*

! " " # $ % & '( ) * % + , % & ' - # ./+0#")1-%&2.! ( % 0 - 2 µ # .

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 70

Page 72: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!"µ#$ 4 - !%&'#$ 1

%.*")'

O(&*+2$ =)).3%$: N1.&0$ 1 +%* J.=.F D.&-%$ – H<2-"%$, D.&-%, 7.R. 26441, &0) +%* fax. 2610 423830

7. 7' D.7. R-2&0$: B!"!).'( D%-)%µ. 116, A-.+)!*',7.R. 73105, &0). 2810310366, 2810311684 +%* fax.2810310014

:22*,3$ G,. '"MF*1µ$ %PM µ)0NMR.<! J',0)!(&2$ (1'6-!';&%* "% (1'?.))!* %8&0,0 !99-%-:2$ ,&' '*+!8' D!-*:!-!*%+# 7µ2µ%. A %8&0,0 ,("'3!;-!&%* (1'6-!/&*+. %1# !1*+(-/µ4"% %"&89-%:% 1&(68'(+%* %,&("'µ*+2$ &%(&#&0&%$, 3(' 496-/µ!$ :/&'9-%:8!$,&' %1'3!*+&*+# &0$ &-%1!5*+2$ +%&.<!,0$ &/" 65 e, %1)#:/&'%"&89-%:' &0$ .3!*%$ .,+0,0$ !1%994)µ%&'$ +%*1-'%*-!&*+. %1# &'($ &8&)'($ 1'( &(6#" +%&46!* &' (1'-G2:*' µ4)'$ (µ!&%1&(6*%+'8 &8&)'*, 1*,&'1'*0&*+. 9"@-,0$ >4"0$ 9)@,,%$, +'*"/"*+4$ 3-%,&0-*#&0&!$ +.&.)).R.<! J',0)!(&2$ (1'6-!';&%* "% %"%"!@"!* &0" !99-%-:2 &'( !&0,8/$, %(&'1-',@1/$ 2 &%6(3-'µ*+@$ (#6* µ!fax) µ46-* &' &4)'$ Y!?-'(%-8'(, (1'?.))'"&%$ ,6!&*+232)/,0 ,&' D!-*:!-!*%+# 7µ2µ% #1'( %"2+!*. A 32)/-,0 (1'?.))!&%* &%(&#6-'"% µ! &0" +%&%?')2 &0$ !&2,*%$,("3-'µ2$, 1'( 46!* '-*,&!8 3*% &'( J#µ'( 3252/2004,&' 1',# &/" ,%-."&% 14"&! (45) !(-@. L! +.<! J',0-)!(&2 1'( !99-.:!&%* 2 %"%"!@"!* &0" !99-%:2 &'( ,&0"=J= 6'-09!8&%* O!)&8' 7%(&#&0&%$ J',0)!(&2.

TF)., +'G&'&J )(,22R0µ,%1JC*% &0" 4+3',0 %1# &*$ +%&. &#1'($ J'µ%-68!$ &0$ .3!*-%$ .,+0,0$ &'( "',0)!(&*+'; !1%994)µ%&'$, '* "',0-)!(&4$ ':!8)'(" "% ,(µ1!-*).?'(", µ!&%>; &/" 3*+%*'-)'90&*+@", +%* ?!?%8/,0 !99-%:2$ ,&' '*+!8' D!-*:!-!*%+#7µ2µ% &0$ =.J.=. B! &0" 1%-%)%?2 &0$ .3!*%$ .,+0,0$!1%994)µ%&'$, (1'6-!';"&%* "% +%&%<4,'(" .µ!,% %"&8-9-%:' %(&2$, ,&' D!-*:!-!*%+# 7µ2µ% #1'( %"2+'(".S.,!* &'( J#µ'( 3252/2004, #1'*'$ %,+!8 &0 "',0)!(&*-+2 6/-8$ "% 46!* .3!*% .,+0,0$ !1%994)µ%&'$ 3*@+!&%*1'*"*+. ,;µ:/"% µ! &' .-<-' 458 &'( D'*"*+'; R@3*+%. R%&%99!)8% 9*% 1%-."'µ0 .,+0,0 &'( "',0)!(&*+';!1%994)µ%&'$ µ1'-!8 "% +."!* '1'*',321'&! *3*@&0$,&% D!-*:!-!*%+. L(µ?';)*% 2 ,&' O.L. &0$ =.J.=., &''1'8' ,&0 ,("46!*% (1'6-!';&%* "% 9"/,&'1'*2,!* &'9!9'"#$ ,&*$ %-µ#3*!$ 3*+%,&*+4$ %-64$.L&*$ 1!-*1&@,!*$ 1'( !1*?.))!&%* 1!*<%-6*+2 1'*"21-',/-*"2$ 2 '-*,&*+2$ 3*%9-%:2$ %1# &0" =.J.=., %"%-,&4))!&%* %(&'38+%*% 0 .3!*% .,+0,0$ !1%994)µ%&'$.

U*2,M, F.14G&'&JA =.J.= 3*'*+!8&%* %1# &0" L("4)!(,0 &/" H"&*1-',@-1/" +%* &' O*'*+0&*+# L(µ?';)*'. 7% D!-*:!-!*%+. 7µ2-µ%&% 3*'*+';"&%* %1# &0" C!"*+2 L("4)!(,0 +%* &' D!-*-:!-!*%+# L(µ?';)*'.

6.)SM$J )G(*1'N(&'& %&J :.C.:A =.J.= !8"%* µ4)'$ &0$ =(-/1%I+2$ Fµ',1'"38%$ J'µ*-+@" D-',@1/" O0µ',8'( O*+%8'( J',0)!(&@" (F.E.P.I),+%&46'"&%$ µ*% %1# &*$ !1&. <4,!*$ &'( O*'*+0&*+'; &0$

L(µ?'()8'(. L&0" !" )#9/ =(-/1%I+2 Fµ',1'"38% ,(µ-µ!&46'(" %+#µ% 0 H99)8%, 0 U&%)8%, 0 U,1%"8%, 0 U-)%"-38%, 0 D')/"8%, 0 R-'%&8%, 0 V'(µ%"8%, 0 D'-&'9%)8%+%* (1# 4"&%>0 !8"%* 0 C%))8%, 0 R;1-'$ +%* &' S4)9*'.C*% 1!-*,,#&!-!$ 1)0-':'-8!$, ,("3!<!8&! µ! &0" *,&'-,!)83% www.fepi.org.

;M+F).H& G,. S&%)4, %PM ,.*)%NM 1*2+MPM F.14G&'&J7' O*'*+0&*+# L(µ?';)*' &0$ =.J.=, !+)49!&%* %1# &0"L("4)!(,0 &/" H"&*1-',@1/". F* H"&*1-#,/1'* !+)49'-"&%* 6/-*,&. 9*% +.<! D!-*:!-!*%+# 7µ2µ% %1# &% µ4)0&0$ C!"*+2$ L("4)!(,0$ &'( 7µ2µ%&'$. 7% D!-*:!-!*%+.L(µ?';)*% !+)49'"&%* 'µ'8/$ %1# &% µ4)0 &0$ C!"*+2$L("4)!(,0$ &'( D!-*:!-!*%+'; 7µ2µ%&'$. F* !+)'94$3*!>.9'"&%* +.<! &-8% (3) 6-#"*%, !"@ ,(µµ!&46'(" ,’%(-&4$ #,'* J',0)!(&4$ !8"%* '*+'"'µ*+@$ &%+&'1'*0µ4"'*.

@).S,*O.GIJ R0)2O1JF 1!*<%-6*+#$ 4)!96'$ &/" µ!)@" &0$ =.J.= %,+!8&%*,! 1-@&' ?%<µ# %1# &% D!-*:!-!*%+. L(µ?';)*%, 1'()!*&'(-9';" +%* /$ D!*<%-6*+. L(µ?';)*%. F 3!(&!-'?.<µ*'$ 1!*<%-6*+#$ 4)!96'$, +%<@$ +%* '1!*<%-6*+#$ 4)!96'$ &/" µ!)@" &'( O*'*+0&*+'; L(µ-?'()8'( +%* &/" D!-*:!-!*%+@" L(µ?'()8/" %,+!8&%*%1# &' H"@&%&' D!*<%-6*+# L(µ?';)*', ,&' '1'8' 1-'-!3-!;!* =:4&0$ &/" D')*&*+@" O*+%,&0-8/".

:(.'%&µ1M.GI @)*.1F.GIA W"/,0 J',0)!(&@" =)).3'$ 30µ*';-90,! &' 2008 &'«=))0"*+# D!-*'3*+# &0$ J',0)!(&*+2$ =1*,&2µ0$» 1'(%1'&!)!8 +%* &' !18,0µ' 1!-*'3*+# &0$. =8"%* 4"% 1!-*'-3*+# 1')(3*.,&%&' µ! +-*&*+2 !1*&-'12 1'( ,&'6!;!* ,&0"1-'@<0,0 &0$ J',0)!(&*+2$ =1*,&2µ0$ ,&0" =)).3%.7' «=))0"*+# D!-*'3*+# &0$ J',0)!(&*+2$ =1*,&2µ0$»%1'&!)!8 4"% %>*#1*,&', ,;96-'"', &-*µ0"*%8' !1*,&0-µ'"*+# 1!-*'3*+# 1'( !+383!&%* ,&0" =))0"*+2 +%* &0"H99)*+2 9)@,,% +%* !8"%* 3*%<4,*µ' ,! 0)!+&-'"*+2 +%*4"&(10 µ'-:2 µ! ,(µ?')*+2 %µ'*?2 ,! #)'($ &'($ !"3*%-:!-#µ!"'($ !-!("0&4$, 1%"!1*,&0µ*%+';$ 3%,+.)'($,:'*&0&4$, ,! #)0 &0 "',0)!(&*+2 +'*"#&0&% 9!"*+#&!-%%)). +%* ,&% %"@&%&% !+1%*3!(&*+. *3-;µ%&% (H7=U +%*H=U) &0$ 0µ!3%12$ +%* &0$ %))'3%12$. D%-.))0)% 1%-46!* &0 3("%&#&0&% ,! "4'($ !1*,&2µ'-"!$ "% 46'(" !;+')0 1-#,?%,0 ,&0 9"@,0 +%* ,&0" 1-#-'3' &0$ "',0)!(&*+2$ !"@ %1'&!)!8 &' !1*,&0µ'"*+# ?2µ%9*% &'($ "',0)!(&4$ 1'( %1%,6')';"&%* ,&0" !+1%83!(-,0 +%* ,&0" +)*"*+2 "',0)!(&*+2 "% 30µ',*!;,'(" &' 4-9'&'($ +%* "% 3!6<';" !1'*+'3'µ0&*+4$ +-*&*+4$. L&' 1!-*'-3*+# 30µ',*!;'"&%* !-!("0&*+4$ µ!)4&!$, %"%,+'12,!*$,1-/&#&(1!$ 1-%9µ%&!8!$ +%* ?*?)*'+-*&*+4$. F* !-9%-,8!$ 1'( 30µ',*!;'"&%*, µ'-*'3'&';"&%* µ! &-#1' <!,µ*-+. 1-'?)!1#µ!"' +%* !1*+(-/µ4"' %1# &0" !))0"*+2"'µ'<!,8% +%* ,;µ:/"% 1."&% µ! &0 3*!<"2 1-%+&*+2.

:M&µ)*P%.GI ()*.1F.GIA W"/,0 J',0)!(&@" =)).3'$ 30µ*';-90,! &' 2008

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 71

Page 73: Ελληνικό περιοδικό της Νοσηλευτικής Επιστήjournal-ene.gr/wp-content/uploads/2011/05/TOMOS4_TEFXOS1.pdf1, Ι Α Ν Ο Υ Α Ρ Ι Ο Σ-Φ Ε Β

!""#$%&' ()*%+,%&' -#. /+0#")1-%&2. !3%0-2µ#.

%.*")'

&' µ0"*%8' !"0µ!-/&*+# 1!-*'3*+# «F V(<µ#$ &0$ N9!8-%$», µ! ,+'1# &0" %".3!*>0 &'( "',0)!(&2 /$ !"*%8%$G(6',/µ%&*+2$, +%* !1%99!)µ%&*+2$ '"&#&0&%$, µ!!"3*%:4-'"&% 1'( +*"';"&%* 14-% %1# &% &!&-*µµ4"%,%9+%)*.5'"&%$ #)% &% !181!3% &0$ 1');1)!(-0$ +'*-"/"*+2$ &'( (1#,&%,0$.F W))0"%$ "',0)!(&2$, !+&#$ %1# &0" %".9+0 9*% &0"!18)(,0 1-/&%-6*+@" 50&0µ.&/" 1'( &'" %1%,6')';"/$ !1%99!)µ%&8%, 46!* %".9+0 "% !+:-%,&!8, "% !1*+'*-"/"2,!*, "% 3*%,+!3.,!* +%* "% 1-'?.))!* 1');1)!(--% &'" +'*"/"*+# &'( 1-''-*,µ#.W&,*, «F V(<µ#$ &0$ N9!8%$», ,+'1!;!* "% !"@,!* &0:/"2 #)/" &/" "',0)!(&@" &0$ 6@-%$ +%* "% %1'&!)4-,!* 4"% .µ!,' +%* 49+(-' +%".)* !1*+'*"/"8%$, 38"'-"&%$ ?2µ% ,! #)!$ %"!>%*-4&/$ &0$ :/"4$ &0$ !1%9-9!)µ%&*+2$ –+%* #6* µ#"'- +'*"#&0&%$.

K)001M%.G14 !%IO1.A W"/,0 J',0)!(&@" =)).3%$, µ! &0 ,("!-9%,8% #)/"&/" µ!)@" &0$, ,&'6!;!* "% ()'1'*2,!* +%* "% ')'+)0--@,!* +.1'*% ,0µ%"&*+. 4-9% 1'( %1'&!)';" 1.9*% %*&2-µ%&% &0$ "',0)!(&*+2$ +'*"#&0&%$, '-*,µ4"% %1# &%'1'8% 230 .-6*,%" "% !+1'"';"&%*: • R%<'-*,µ#$ +%* +',&')#90,0 &/" "',0)!(&*+@" 1-.->!/"

• O0µ*'(-98% %"'*6&2$ 9-%µµ2$ !1*+'*"/"8%$ µ! ,+'-1# &0" +%&%9-%:2 +%* !18)(,0 &/" 1-'?)0µ.&/" &/""',0)!(&@"

• ="8,6(,0 &/" 3*!<"@" ,64,!/" &/" !))2"/" "',0-)!(&@" µ! '-9%"*,µ';$, fora +%* *",&*&';&% &'( !>/-&!-*+';

• O0µ*'(-98% 0)!+&-'"*+2$ G0:*%+2$ ?*?)*'<2+0$ 06-2,0 &0$ '1'8%$ <% !8"%* 3/-!." 9*% &% µ4)0 &0$=J= +%* 1-',?.,*µ0 %1# #)0 &0" !1*+-.&!*%

• D-',:'-. !*3*+@" !+1%*3!(&*+@" +%* µ!&!+1%*3!(-&*+@" 1-'9-%µµ.&/"

• O*'-9."/,0 !1*,&0µ'"*+@" ,("!3-8/" +%* 0µ!-83/"µ! µ'-*'3#&0,0 &/" ,("43-/" "'µ*+. *,6;'(,% +%*+%&'6(-/µ4"0

• O0µ*'(-98% =*3*+@" =1*&-'1@" W-9'(, #1/$ =+1%8-3!(,0$, 7!+µ0-8/,0$, O*!<"@" L64,!/" +%* ="0µ4--/,0$

• F-9."/,0 3*+&;'( !µ1!*-'9"/µ#"/" 9*% "',0)!(&*-+. <4µ%&% +%* 1%-'62 "'µ'&!6"*+@" ,(µ?'()@"

• F-9."/,0 +%* )!*&'(-98% 1-'9-%µµ.&/" !>!*38+!(-,0$

• D*,&'1'80,0 J',0)!(&*+@" =*3*+'&2&/" +%* J',0-)!(&*+2$ !1.-+!*%$

:(.G1.MPM4,F* "',0)!(&4$ µ1'-';" "% %1!(<;"'"&%* ,&% &0)4:/-"%: 210 3648044, 3648048 (08:00- 15:00), ,&% fax:2103648049, 3617859 +%* ,&' e- mail: [email protected]

• 9*% !1%99!)µ%&*+. <4µ%&%• 9*% <4µ%&% !+1%83!(,0$• 9*% "'µ*+. <4µ%&%• 9*% &0" !99-%:2 &'($ 2 &0" %"%"4/,0 %(&2$• 9*% 9!"*+2 !"0µ4-/,0 (,("43-*%, 3-.,!*$, !+30)@-,!*$ +)1)

• 9*% &*$ 1-'+0-;>!*$ µ4,/ HL=D• 9*% <4,!*$ !-9%,8%$ ,&'" !(-;&!-' &'µ4% &0$ (9!8%$

TOMOS4_TEFXOS1 5/11/11 11:23 AM Page 72